{
  "graph": {
    "directed": false,
    "type": "BEL-V1.0",
    "label": "Mapk-2.0-Hs",
    "metadata": {
      "description": "The Mapk network depicts the causal mechanisms that regulate different families of MAPK signaling (p38, JNK, ERK, MAP2K) in the context of cell proliferation.",
      "species_common_name": "Human",
      "version": "2.0",
      "boundary_conditions": "The human model sets represent early COPD (GOLD stage I and II) processes. If supporting literature from early COPD studies were not available, stage-independent COPD studies were used. If COPD studies were not found, we expanded our inclusion criteria to studies from healthy context and incorporated mechanisms active in processes implicated in COPD into the disease models. Literature describing processes active in acute exacerbation in COPD patients was excluded from supporting edges of the network models. We prioritized data collected from studies of lung and COPD-relevant cell types, but excluded literature related to asthma or bronchitis. Human-specific connections were preferred, but rat and mouse were also included where human data was not available."
    },
    "nodes": [
      {
        "id": "p(HGNC:EGFR)",
        "label": "p(HGNC:EGFR)",
        "metadata": {
          "coordinate": [
            0.9468506100912388,
            0.6290481670228506
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c340526fe"
        }
      },
      {
        "id": "a(SCHEM:U0126)",
        "label": "a(SCHEM:U0126)",
        "metadata": {
          "coordinate": [
            0.4923051555457843,
            0.4487643158529234
          ],
          "bel_function_type": "abundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c340526ff"
        }
      },
      {
        "id": "p(HGNC:HRAS,sub(G,12,V))",
        "label": "p(HGNC:HRAS,sub(G,12,V))",
        "metadata": {
          "coordinate": [
            0.3032318346707706,
            0.6498712258205929
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052700"
        }
      },
      {
        "id": "kin(p(SFAM:\"MAPK p38 Family\"))",
        "label": "kin(p(SFAM:\"MAPK p38 Family\"))",
        "metadata": {
          "coordinate": [
            0.34335495218203804,
            0.8164556962025317
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052701"
        }
      },
      {
        "id": "bp(GOBP:\"lung development\")",
        "label": "bp(GOBP:\"lung development\")",
        "metadata": {
          "coordinate": [
            0.7050126415301747,
            0.9545454545454545
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052702"
        }
      },
      {
        "id": "path(SDIS:\"cell senescence\")",
        "label": "path(SDIS:\"cell senescence\")",
        "metadata": {
          "coordinate": [
            0.22353523139496537,
            0.8022083401830237
          ],
          "bel_function_type": "pathology",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052703"
        }
      },
      {
        "id": "p(HGNC:RAF1,pmod(P,S,259))",
        "label": "p(HGNC:RAF1,pmod(P,S,259))",
        "metadata": {
          "coordinate": [
            0.14493789161261952,
            0.6750780864704915
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052704"
        }
      },
      {
        "id": "kin(p(EGID:51776))",
        "label": "kin(p(EGID:51776))",
        "metadata": {
          "coordinate": [
            0.6764317907002309,
            0.34793687325332895
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052705"
        }
      },
      {
        "id": "p(SFAM:\"MAPK JNK Family\")",
        "label": "p(SFAM:\"MAPK JNK Family\")",
        "metadata": {
          "coordinate": [
            0.9078267560734308,
            0.293687325332895
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052706"
        }
      },
      {
        "id": "gtp(p(SFAM:\"RAS Family\"))",
        "label": "gtp(p(SFAM:\"RAS Family\"))",
        "metadata": {
          "coordinate": [
            0.2691546663735297,
            0.33971724478053594
          ],
          "bel_function_type": "gtpBoundActivity",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052707"
        }
      },
      {
        "id": "p(SFAM:\"MAPK Erk1/2 Family\",pmod(P))",
        "label": "p(SFAM:\"MAPK Erk1/2 Family\",pmod(P))",
        "metadata": {
          "coordinate": [
            0.6626909970319885,
            0.2279302975505507
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052708"
        }
      },
      {
        "id": "p(SFAM:\"MEK1/2 Family\")",
        "label": "p(SFAM:\"MEK1/2 Family\")",
        "metadata": {
          "coordinate": [
            0.4010662855886556,
            0.4043783220998411
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052709"
        }
      },
      {
        "id": "p(HGNC:RASSF1)",
        "label": "p(HGNC:RASSF1)",
        "metadata": {
          "coordinate": [
            0.8611080576014071,
            0.4093100991835169
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c3405270a"
        }
      },
      {
        "id": "bp(GOBP:\"G1/S transition of mitotic cell cycle\")",
        "label": "bp(GOBP:\"G1/S transition of mitotic cell cycle\")",
        "metadata": {
          "coordinate": [
            0.5043970539738375,
            0.045454545454545456
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c3405270b"
        }
      },
      {
        "id": "p(HGNC:JUN,pmod(P))",
        "label": "p(HGNC:JUN,pmod(P))",
        "metadata": {
          "coordinate": [
            0.7929537210069253,
            0.49534221053208394
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c3405270c"
        }
      },
      {
        "id": "p(SFAM:\"MAPK p38 Family\")",
        "label": "p(SFAM:\"MAPK p38 Family\")",
        "metadata": {
          "coordinate": [
            0.4428382983401121,
            0.8022083401830237
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c3405270d"
        }
      },
      {
        "id": "p(HGNC:RAF1)",
        "label": "p(HGNC:RAF1)",
        "metadata": {
          "coordinate": [
            0.08282950423216444,
            0.5912378760480026
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c3405270e"
        }
      },
      {
        "id": "bp(GOBP:\"cell proliferation\")",
        "label": "bp(GOBP:\"cell proliferation\")",
        "metadata": {
          "coordinate": [
            0.6654391557656371,
            0.5758945695654556
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c3405270f"
        }
      },
      {
        "id": "kin(p(SFAM:\"MAPK JNK Family\"))",
        "label": "kin(p(SFAM:\"MAPK JNK Family\"))",
        "metadata": {
          "coordinate": [
            0.8127404638891942,
            0.2602608362102033
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052710"
        }
      },
      {
        "id": "p(HGNC:RAF1,pmod(P,S,43))",
        "label": "p(HGNC:RAF1,pmod(P,S,43))",
        "metadata": {
          "coordinate": [
            0.045454545454545456,
            0.5052057646994356
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052711"
        }
      },
      {
        "id": "gtp(p(HGNC:HRAS))",
        "label": "gtp(p(HGNC:HRAS))",
        "metadata": {
          "coordinate": [
            0.2911399362427174,
            0.5090415913200723
          ],
          "bel_function_type": "gtpBoundActivity",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052712"
        }
      },
      {
        "id": "kin(p(SFAM:\"RAF Family\"))",
        "label": "kin(p(SFAM:\"RAF Family\"))",
        "metadata": {
          "coordinate": [
            0.2323293393426404,
            0.23231409940270698
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052713"
        }
      },
      {
        "id": "p(HGNC:NF1)",
        "label": "p(HGNC:NF1)",
        "metadata": {
          "coordinate": [
            0.3219193140595801,
            0.16381719546276508
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052714"
        }
      },
      {
        "id": "p(HGNC:HRAS)",
        "label": "p(HGNC:HRAS)",
        "metadata": {
          "coordinate": [
            0.38952401890733207,
            0.5742506438708971
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052715"
        }
      },
      {
        "id": "p(SFAM:\"MAPK JNK Family\",pmod(P))",
        "label": "p(SFAM:\"MAPK JNK Family\",pmod(P))",
        "metadata": {
          "coordinate": [
            0.7896559305265471,
            0.3512247246424462
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052716"
        }
      },
      {
        "id": "p(SFAM:\"MAPK Erk1/2 Family\")",
        "label": "p(SFAM:\"MAPK Erk1/2 Family\")",
        "metadata": {
          "coordinate": [
            0.6615917335385292,
            0.12326702833031945
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052717"
        }
      },
      {
        "id": "p(SFAM:\"MAPK p38 Family\",pmod(P,T,180))",
        "label": "p(SFAM:\"MAPK p38 Family\",pmod(P,T,180))",
        "metadata": {
          "coordinate": [
            0.4126085522699791,
            0.906871609403255
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052718"
        }
      },
      {
        "id": "kin(p(SFAM:\"MEK1/2 Family\"))",
        "label": "kin(p(SFAM:\"MEK1/2 Family\"))",
        "metadata": {
          "coordinate": [
            0.4444871935803012,
            0.29313935010137543
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052719"
        }
      },
      {
        "id": "p(SFAM:\"RAF Family\")",
        "label": "p(SFAM:\"RAF Family\")",
        "metadata": {
          "coordinate": [
            0.1224029899967022,
            0.2728642665351526
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c3405271a"
        }
      },
      {
        "id": "p(SFAM:\"MAPK p38 Family\",pmod(P,Y,182))",
        "label": "p(SFAM:\"MAPK p38 Family\",pmod(P,Y,182))",
        "metadata": {
          "coordinate": [
            0.4329449268989777,
            0.705216724204066
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c3405271b"
        }
      },
      {
        "id": "p(HGNC:CCND1)",
        "label": "p(HGNC:CCND1)",
        "metadata": {
          "coordinate": [
            0.9545454545454545,
            0.4679434489561072
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c3405271c"
        }
      },
      {
        "id": "kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
        "label": "kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
        "metadata": {
          "coordinate": [
            0.5615587556337254,
            0.18957203134418324
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c3405271d"
        }
      },
      {
        "id": "p(SFAM:\"RAS Family\")",
        "label": "p(SFAM:\"RAS Family\")",
        "metadata": {
          "coordinate": [
            0.34720237440914586,
            0.2684804646829963
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c3405271e"
        }
      },
      {
        "id": "p(HGNC:RAF1,pmod(P,S,338))",
        "label": "p(HGNC:RAF1,pmod(P,S,338))",
        "metadata": {
          "coordinate": [
            0.140540837638782,
            0.46081977094635324
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c3405271f"
        }
      },
      {
        "id": "p(HGNC:JUN)",
        "label": "p(HGNC:JUN)",
        "metadata": {
          "coordinate": [
            0.7929537210069253,
            0.5928818017425612
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052720"
        }
      },
      {
        "id": "kin(p(HGNC:RAF1))",
        "label": "kin(p(HGNC:RAF1))",
        "metadata": {
          "coordinate": [
            0.1718698472023744,
            0.5583593621568305
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052721"
        }
      },
      {
        "id": "p(EGID:51776)",
        "label": "p(EGID:51776)",
        "metadata": {
          "coordinate": [
            0.6220182477739914,
            0.4526001424735602
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052722"
        }
      },
      {
        "id": "tscript(p(SFAM:\"CEBP Family\"))",
        "label": "tscript(p(SFAM:\"CEBP Family\"))",
        "metadata": {
          "coordinate": [
            0.6132241398263164,
            0.7194640802235739
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052723"
        }
      },
      {
        "id": "kin(p(HGNC:EGFR))",
        "label": "kin(p(HGNC:EGFR))",
        "metadata": {
          "coordinate": [
            0.8797955369902165,
            0.7200120554550934
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052724"
        }
      },
      {
        "id": "bp(GOBP:\"cell differentiation\")",
        "label": "bp(GOBP:\"cell differentiation\")",
        "metadata": {
          "coordinate": [
            0.8583598988677585,
            0.8728971450490438
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052725"
        }
      },
      {
        "id": "p(HGNC:MAPK14)",
        "label": "p(HGNC:MAPK14)",
        "metadata": {
          "coordinate": [
            0.6593932065516104,
            0.8372787550002739
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052726"
        }
      },
      {
        "id": "kin(p(HGNC:MAPK14))",
        "label": "kin(p(HGNC:MAPK14))",
        "metadata": {
          "coordinate": [
            0.7429372320545234,
            0.7682338758288125
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052727"
        }
      },
      {
        "id": "a(SCHEM:PD0325901)",
        "label": "a(SCHEM:PD0325901)",
        "metadata": {
          "coordinate": [
            0.5384742222710783,
            0.33971724478053594
          ],
          "bel_function_type": "abundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052728"
        }
      },
      {
        "id": "p(SFAM:\"CEBP Family\")",
        "label": "p(SFAM:\"CEBP Family\")",
        "metadata": {
          "coordinate": [
            0.5516653841925909,
            0.815907720971012
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3518d3fbfd4c34052729"
        }
      },
      {
        "id": "p(HGNC:EGR1)",
        "label": "p(HGNC:EGR1)",
        "metadata": {
          "coordinate": [
            0.903823432933457,
            0.620242080940046
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "edwardsanders",
          "nodeId": "52cbf05ebf21ca0644010b2d"
        }
      },
      {
        "id": "r(HGNC:GGPS1)",
        "label": "r(HGNC:GGPS1)",
        "metadata": {
          "coordinate": [
            0.952104053437758,
            0.525049710425106
          ],
          "bel_function_type": "rnaAbundance",
          "createdBy": "edwardsanders",
          "nodeId": "52cbf05ebf21ca0644010b2f"
        }
      },
      {
        "id": "p(HGNC:GGPS1)",
        "label": "p(HGNC:GGPS1)",
        "metadata": {
          "coordinate": [
            0.101863762411225,
            0.18433986007438
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "edwardsanders",
          "nodeId": "52cbf83bbf21ca064401f292"
        }
      },
      {
        "id": "a(SCHEM:\"Smoke, cigarette\")",
        "label": "a(SCHEM:\"Smoke, cigarette\")",
        "metadata": {
          "coordinate": [
            0.444996427951845,
            0.682444081959521
          ],
          "bel_function_type": "abundance",
          "createdBy": "shaman.qn",
          "nodeId": "552c197689e36208d47855c8"
        }
      }
    ],
    "edges": [
      {
        "source": "p(SFAM:\"MEK1/2 Family\")",
        "relation": "actsIn",
        "target": "kin(p(SFAM:\"MEK1/2 Family\"))",
        "directed": false,
        "label": "p(SFAM:\"MEK1/2 Family\") actsIn kin(p(SFAM:\"MEK1/2 Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526fb",
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"MEK1/2 Family\") actsIn kin(p(SFAM:\"MEK1/2 Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070522"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:HRAS,sub(G,12,V))",
        "relation": "increases",
        "target": "path(SDIS:\"cell senescence\")",
        "directed": false,
        "label": "p(HGNC:HRAS,sub(G,12,V)) increases path(SDIS:\"cell senescence\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526d1",
          "evidences": [
            {
              "bel_statement": "p(HGNC:HRAS,sub(G,12,V)) increases path(SDIS:\"cell senescence\")",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070553"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:MAPK14))",
        "relation": "increases",
        "target": "bp(GOBP:\"lung development\")",
        "directed": false,
        "label": "kin(p(HGNC:MAPK14)) increases bp(GOBP:\"lung development\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526de",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:MAPK14)) increases bp(GOBP:\"lung development\")",
              "summary_text": "We found that p38alpha positively regulates factors such as CCAAT/enhancer-binding protein that are required for lung cell differentiation.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Genet 2007 Jun 39(6) 750-8",
                "id": "17468755"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070598"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"MAPK JNK Family\",pmod(P))",
        "relation": "directlyIncreases",
        "target": "kin(p(SFAM:\"MAPK JNK Family\"))",
        "directed": false,
        "label": "p(SFAM:\"MAPK JNK Family\",pmod(P)) directlyIncreases kin(p(SFAM:\"MAPK JNK Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526f1",
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\",pmod(P)) directlyIncreases kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "These data indicate that in BMMC, Lyn contributes to SCF-induced phosphorylation of Kit, as well as phosphorylation of Jnks and Stat3.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2005 Jan 17(1) 103-9",
                "id": "15451030"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705e8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(EGID:51776))",
        "relation": "decreases",
        "target": "bp(GOBP:\"cell proliferation\")",
        "directed": false,
        "label": "kin(p(EGID:51776)) decreases bp(GOBP:\"cell proliferation\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526f6",
          "evidences": [
            {
              "bel_statement": "kin(p(EGID:51776)) decreases bp(GOBP:\"cell proliferation\")",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RASSF1)",
        "relation": "decreases",
        "target": "p(SFAM:\"MAPK JNK Family\",pmod(P))",
        "directed": false,
        "label": "p(HGNC:RASSF1) decreases p(SFAM:\"MAPK JNK Family\",pmod(P))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526cb",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RASSF1) decreases p(SFAM:\"MAPK JNK Family\",pmod(P))",
              "summary_text": "The exogenous expression of RASSF1A suppressed JNK phosphorylation, and cells stably transfected with RASSF1A showed reduced JNK and c-Jun phosphorylation and Cyclin D1 down-regulation. An in vitro kinase assay showed that the exogenous expression of RASSF1A inhibited JNK activity and that JNK activity suppression due to ectopically expressed RASSF1A was revived by RASSF1A siRNA treatment.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 May 1 65(9) 3682-90",
                "id": "15867363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407062d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:JUN)",
        "relation": " hasModification",
        "target": "p(HGNC:JUN,pmod(P))",
        "directed": false,
        "label": "p(HGNC:JUN)  hasModification p(HGNC:JUN,pmod(P))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526cc",
          "evidences": [

          ]
        }
      },
      {
        "source": "kin(p(SFAM:\"RAF Family\"))",
        "relation": "increases",
        "target": "kin(p(SFAM:\"MEK1/2 Family\"))",
        "directed": false,
        "label": "kin(p(SFAM:\"RAF Family\")) increases kin(p(SFAM:\"MEK1/2 Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526fc",
          "evidences": [
            {
              "bel_statement": "kin(p(SFAM:\"RAF Family\")) increases kin(p(SFAM:\"MEK1/2 Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"MAPK Erk1/2 Family\")",
        "relation": "actsIn",
        "target": "kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
        "directed": false,
        "label": "p(SFAM:\"MAPK Erk1/2 Family\") actsIn kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526d6",
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"MAPK Erk1/2 Family\") actsIn kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"MAPK Erk1/2 Family\")",
        "relation": " hasModification",
        "target": "p(SFAM:\"MAPK Erk1/2 Family\",pmod(P))",
        "directed": false,
        "label": "p(SFAM:\"MAPK Erk1/2 Family\")  hasModification p(SFAM:\"MAPK Erk1/2 Family\",pmod(P))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526ef",
          "evidences": [

          ]
        }
      },
      {
        "source": "kin(p(EGID:51776))",
        "relation": "increases",
        "target": "p(SFAM:\"MAPK JNK Family\",pmod(P))",
        "directed": false,
        "label": "kin(p(EGID:51776)) increases p(SFAM:\"MAPK JNK Family\",pmod(P))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526f7",
          "evidences": [
            {
              "bel_statement": "kin(p(EGID:51776)) increases p(SFAM:\"MAPK JNK Family\",pmod(P))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707b4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "gtp(p(HGNC:HRAS))",
        "relation": " isA",
        "target": "gtp(p(SFAM:\"RAS Family\"))",
        "directed": false,
        "label": "gtp(p(HGNC:HRAS))  isA gtp(p(SFAM:\"RAS Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526e4",
          "evidences": [

          ]
        }
      },
      {
        "source": "p(SFAM:\"MAPK p38 Family\")",
        "relation": " hasModification",
        "target": "p(SFAM:\"MAPK p38 Family\",pmod(P,T,180))",
        "directed": false,
        "label": "p(SFAM:\"MAPK p38 Family\")  hasModification p(SFAM:\"MAPK p38 Family\",pmod(P,T,180))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526ea",
          "evidences": [

          ]
        }
      },
      {
        "source": "p(HGNC:RAF1)",
        "relation": " hasModification",
        "target": "p(HGNC:RAF1,pmod(P,S,338))",
        "directed": false,
        "label": "p(HGNC:RAF1)  hasModification p(HGNC:RAF1,pmod(P,S,338))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526d7",
          "evidences": [

          ]
        }
      },
      {
        "source": "p(HGNC:RAF1)",
        "relation": " hasModification",
        "target": "p(HGNC:RAF1,pmod(P,S,259))",
        "directed": false,
        "label": "p(HGNC:RAF1)  hasModification p(HGNC:RAF1,pmod(P,S,259))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526ec",
          "evidences": [

          ]
        }
      },
      {
        "source": "p(HGNC:RAF1,pmod(P,S,259))",
        "relation": "directlyDecreases",
        "target": "kin(p(HGNC:RAF1))",
        "directed": false,
        "label": "p(HGNC:RAF1,pmod(P,S,259)) directlyDecreases kin(p(HGNC:RAF1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526ed",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RAF1,pmod(P,S,259)) directlyDecreases kin(p(HGNC:RAF1))",
              "summary_text": "Phosphorylation. Raf is principally activated by phosphorylation of specific amino acid residues as shown for each isoform in Figure 4. From an evolutionary standpoint, the Raf activation sites are highly conserved from yeast to humans. Several amino acids in Raf, particularly serine (S) 259 and S621, which bind 14-3-3 and maintain C-Raf in a closed auto-inhibited conformation, are phosphorylated in the basal state.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Oncol 2005 Sep 20 23(27) 6771-90",
                "id": "16170185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070907"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1,pmod(P,S,259)) directlyDecreases kin(p(HGNC:RAF1))",
              "summary_text": "the phosphorylation of Raf-1 on Ser-259 induced by paclitaxel he region surrounding Ser-259 in Raf-1 conforms to a consensus sequence for phosphorylation by Akt",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 6 277(36) 33490-500",
                "id": "12087097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708b8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1,pmod(P,S,259)) directlyDecreases kin(p(HGNC:RAF1))",
              "summary_text": "The cyclic AMP (cAMP)-dependent protein kinase (PKA) can inhibit Raf-1 by direct phosphorylation.  We have mapped all cAMP-induced phosphorylation sites in Raf-1, showing that serines 43, 259, and 621 are phosphorylated by PKA in vitro and induced by cAMP in vivo. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 May 22(10) 3237-46",
                "id": "11971957"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070865"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1,pmod(P,S,259)) directlyDecreases kin(p(HGNC:RAF1))",
              "summary_text": "This zinc-induced protein kinase A activation inhibited Raf-1 activity by phosphorylation at serine 259, preventing activation of Raf-1 by phosphorylation of serine 338. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2007 Sep 15 179(6) 4180-6",
                "id": "17785857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407084e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1,pmod(P,S,259)) directlyDecreases kin(p(HGNC:RAF1))",
              "summary_text": "Raf itself is negatively regulated by phosphorylation at Ser259 through Akt, an important effector of phosphoinositide 3-kinase (PI3K) signaling (30, 44).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2009 Mar 1 69(5) 1748-57",
                "id": "19223555"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070713"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1,pmod(P,S,259)) directlyDecreases kin(p(HGNC:RAF1))",
              "summary_text": "This inhibitory phosphorylation on Raf reduces the activity of MAPK pathway (Zimmermann and Moelling, 1999).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Sep 18 27(41) 5527-41",
                "id": "18794886"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070615"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RAF1)",
        "relation": " hasModification",
        "target": "p(HGNC:RAF1,pmod(P,S,43))",
        "directed": false,
        "label": "p(HGNC:RAF1)  hasModification p(HGNC:RAF1,pmod(P,S,43))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526da",
          "evidences": [

          ]
        }
      },
      {
        "source": "p(SFAM:\"MAPK p38 Family\",pmod(P,Y,182))",
        "relation": "directlyIncreases",
        "target": "kin(p(SFAM:\"MAPK p38 Family\"))",
        "directed": false,
        "label": "p(SFAM:\"MAPK p38 Family\",pmod(P,Y,182)) directlyIncreases kin(p(SFAM:\"MAPK p38 Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526db",
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\",pmod(P,Y,182)) directlyIncreases kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In pilot experiments we found that both TGF1-induced Smad3 and p38 MAPK phosphorylation was still detectable after 18 h and correlated with the increased levels of3 and5 integrins (supplemental Fig. 4S and Fig. 1C).....Smad3 phosphorylation was determined using rabbit mAb against phospho-Src (Tyr-416)...p38MAPKphosphorylation was determined using mousemAb against human phosphorylated p38MAPK(Thr180/Tyr182)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 May 9 283(19) 12898-908",
                "id": "18353785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407093d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(EGID:51776))",
        "relation": "increases",
        "target": "p(SFAM:\"MAPK Erk1/2 Family\",pmod(P))",
        "directed": false,
        "label": "kin(p(EGID:51776)) increases p(SFAM:\"MAPK Erk1/2 Family\",pmod(P))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526f5",
          "evidences": [
            {
              "bel_statement": "kin(p(EGID:51776)) increases p(SFAM:\"MAPK Erk1/2 Family\",pmod(P))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709b8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:PD0325901)",
        "relation": "directlyDecreases",
        "target": "kin(p(SFAM:\"MEK1/2 Family\"))",
        "directed": false,
        "label": "a(SCHEM:PD0325901) directlyDecreases kin(p(SFAM:\"MEK1/2 Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526ee",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:PD0325901) directlyDecreases kin(p(SFAM:\"MEK1/2 Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709fc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(SFAM:\"MEK1/2 Family\"))",
        "relation": "directlyIncreases",
        "target": "kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
        "directed": false,
        "label": "kin(p(SFAM:\"MEK1/2 Family\")) directlyIncreases kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526fa",
          "evidences": [
            {
              "bel_statement": "kin(p(SFAM:\"MEK1/2 Family\")) directlyIncreases kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a0f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
        "relation": "increases",
        "target": "bp(GOBP:\"G1/S transition of mitotic cell cycle\")",
        "directed": false,
        "label": "kin(p(SFAM:\"MAPK Erk1/2 Family\")) increases bp(GOBP:\"G1/S transition of mitotic cell cycle\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526f3",
          "evidences": [
            {
              "bel_statement": "kin(p(SFAM:\"MAPK Erk1/2 Family\")) increases bp(GOBP:\"G1/S transition of mitotic cell cycle\")",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a15"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(EGID:51776))",
        "relation": "increases",
        "target": "kin(p(SFAM:\"MAPK JNK Family\"))",
        "directed": false,
        "label": "kin(p(EGID:51776)) increases kin(p(SFAM:\"MAPK JNK Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526f4",
          "evidences": [
            {
              "bel_statement": "kin(p(EGID:51776)) increases kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a28"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"MAPK JNK Family\")",
        "relation": " hasModification",
        "target": "p(SFAM:\"MAPK JNK Family\",pmod(P))",
        "directed": false,
        "label": "p(SFAM:\"MAPK JNK Family\")  hasModification p(SFAM:\"MAPK JNK Family\",pmod(P))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526f2",
          "evidences": [

          ]
        }
      },
      {
        "source": "kin(p(HGNC:MAPK14))",
        "relation": "decreases",
        "target": "kin(p(HGNC:EGFR))",
        "directed": false,
        "label": "kin(p(HGNC:MAPK14)) decreases kin(p(HGNC:EGFR))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526e1",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:MAPK14)) decreases kin(p(HGNC:EGFR))",
              "summary_text": "In addition, p38alpha controls self-renewal of the lung stem and progenitor cell population by inhibiting proliferation-inducing signals, most notably epidermal growth factor receptor",
              "citation": {
                "type": "PubMed",
                "name": "Nat Genet 2007 Jun 39(6) 750-8",
                "id": "17468755"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070aab"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:MAPK14))",
        "relation": "increases",
        "target": "tscript(p(SFAM:\"CEBP Family\"))",
        "directed": false,
        "label": "kin(p(HGNC:MAPK14)) increases tscript(p(SFAM:\"CEBP Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526df",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:MAPK14)) increases tscript(p(SFAM:\"CEBP Family\"))",
              "summary_text": "We found that p38alpha positively regulates factors such as CCAAT/enhancer-binding protein that are required for lung cell differentiation.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Genet 2007 Jun 39(6) 750-8",
                "id": "17468755"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b08"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "gtp(p(HGNC:HRAS))",
        "relation": "increases",
        "target": "kin(p(HGNC:RAF1))",
        "directed": false,
        "label": "gtp(p(HGNC:HRAS)) increases kin(p(HGNC:RAF1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526d4",
          "evidences": [
            {
              "bel_statement": "gtp(p(HGNC:HRAS)) increases kin(p(HGNC:RAF1))",
              "summary_text": "Activated Ras has the ability to interact with the serine/threonine kinase Raf-1, leading to its activation. The targets for Raf- 1 kinase activity are the dual-specificity kinases Mek1 and Mek2 [63], which are activated by phosphorylation. The serine/threonine kinases Erk1 and Erk2 are activated through phosphorylation by Mek1/2 [64]. Activated Erks dimerize and are translocated to the nucleus [65], where transcription factors are phosphorylated whereby their activities are regulated, influencing gene transcription",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2004 Oct 61(19-20) 2535-48",
                "id": "15526160"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070594"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "gtp(p(HGNC:HRAS)) increases kin(p(HGNC:RAF1))",
              "summary_text": "IGF1 binding activates the IGF1 receptor (IGFR), a receptor tyrosine kinase. The IGFR subsequently recruits the insulin receptor substrate (IRS1), which results in the activation of two signaling pathways: the RasRaf MEK ERK pathway  and the PI3K Akt pathway",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2003 Aug 9(8) 344-50",
                "id": "12928036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b58"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "gtp(p(HGNC:HRAS)) increases kin(p(HGNC:RAF1))",
              "summary_text": "HER2/Neu overexpression stimulates the ability of p300 to acetylate ER81, likely by inducing phosphorylation of p300 through the Ras--Raf--mitogen-activated protein kinase pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Sep 23(17) 6243-54",
                "id": "12917345"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ab8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "gtp(p(HGNC:HRAS)) increases kin(p(HGNC:RAF1))",
              "summary_text": "In this paper, we present a comprehensive pathway map of EGFR signaling and other related pathways. The map reveals that the overall architecture of the pathway is a bow-tie (or hourglass) structure with several feedback loops.  See figure 2: The bow-tie architecture of the EGFR signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Syst Biol 2005 1 2005.0010",
                "id": "16729045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ab5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "gtp(p(HGNC:HRAS)) increases kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 12 278(37) 35609-19",
                "id": "12832399"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070853"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "gtp(p(HGNC:HRAS)) increases kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Jun 1 60(11) 3031-8",
                "id": "10850453"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070748"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "gtp(p(HGNC:HRAS)) increases kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1994 Apr 29 269(17) 12741-8",
                "id": "8175686"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070659"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "gtp(p(HGNC:HRAS)) increases kin(p(HGNC:RAF1))",
              "summary_text": "14-3-3 beta isoform has been shown to bind to the product of the protooncogene cRaf-1 and to facilitate its activation by Ras.",
              "citation": {
                "type": "PubMed",
                "name": "DNA Cell Biol 1999 Aug 18(8) 653-61",
                "id": "10463061"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407063b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "gtp(p(HGNC:HRAS)) increases kin(p(HGNC:RAF1))",
              "summary_text": "Kit and other RTKs will activate the MAP kinase signaling pathway and has been reported both to increase the transcriptional activity of Mitf as well as down-regulate Mitf protein levels.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Jul 15 14(14) 1712-28",
                "id": "10898786"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407058e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:HRAS)",
        "relation": " hasVariant",
        "target": "p(HGNC:HRAS,sub(G,12,V))",
        "directed": false,
        "label": "p(HGNC:HRAS)  hasVariant p(HGNC:HRAS,sub(G,12,V))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526d2",
          "evidences": [

          ]
        }
      },
      {
        "source": "p(SFAM:\"MAPK Erk1/2 Family\",pmod(P))",
        "relation": "increases",
        "target": "kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
        "directed": false,
        "label": "p(SFAM:\"MAPK Erk1/2 Family\",pmod(P)) increases kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526f0",
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"MAPK Erk1/2 Family\",pmod(P)) increases kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b93"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "gtp(p(SFAM:\"RAS Family\"))",
        "relation": "directlyIncreases",
        "target": "kin(p(SFAM:\"RAF Family\"))",
        "directed": false,
        "label": "gtp(p(SFAM:\"RAS Family\")) directlyIncreases kin(p(SFAM:\"RAF Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526e3",
          "evidences": [
            {
              "bel_statement": "gtp(p(SFAM:\"RAS Family\")) directlyIncreases kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Figure 1 | The ErbB signalling network.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2001 Feb 2(2) 127-37",
                "id": "11252954"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070be4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "gtp(p(SFAM:\"RAS Family\")) directlyIncreases kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Fig.1",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Nov 26 306(5701) 1506-7",
                "id": "15567848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b38"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "gtp(p(SFAM:\"RAS Family\")) directlyIncreases kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Moreover, Erbin inhibits the Erk activation by active Ras, while it fails to do so in the presence of active Raf-1. Erbin associates with active Ras, but not inactive Ras nor Raf. Consistently, Erbin interferes with the interaction between Ras and Raf both in vivo and in vitro. Erbin associates with active Ras, but not inactive Ras nor Raf.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 10 278(2) 1108-14",
                "id": "12379659"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407079b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "gtp(p(SFAM:\"RAS Family\")) directlyIncreases kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Because Raf binds tightly to the GTP-bound form of Ras but not to the GDP-bound form, such differential affinity can be used to determine the GTP-bound status of Ras. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 5 274(45) 31981-6",
                "id": "10542228"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407068e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RAF1,pmod(P,S,43))",
        "relation": "directlyDecreases",
        "target": "kin(p(HGNC:RAF1))",
        "directed": false,
        "label": "p(HGNC:RAF1,pmod(P,S,43)) directlyDecreases kin(p(HGNC:RAF1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526d9",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RAF1,pmod(P,S,43)) directlyDecreases kin(p(HGNC:RAF1))",
              "summary_text": "The cyclic AMP (cAMP)-dependent protein kinase (PKA) can inhibit Raf-1 by direct phosphorylation.  We have mapped all cAMP-induced phosphorylation sites in Raf-1, showing that serines 43, 259, and 621 are phosphorylated by PKA in vitro and induced by cAMP in vivo. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 May 22(10) 3237-46",
                "id": "11971957"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c18"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RAF1,pmod(P,S,338))",
        "relation": "directlyIncreases",
        "target": "kin(p(HGNC:RAF1))",
        "directed": false,
        "label": "p(HGNC:RAF1,pmod(P,S,338)) directlyIncreases kin(p(HGNC:RAF1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526d8",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RAF1,pmod(P,S,338)) directlyIncreases kin(p(HGNC:RAF1))",
              "summary_text": "bFGF activated Raf-1 via p21-activated protein kinase-1 (PAK-1) phosphorylation of serines 338 and 339, resulting in Raf-1 mitochondrial translocation and endothelial cell protection from the intrinsic pathway of apoptosis, independent of the mitogen-activated protein kinase kinase-1 (MEK1)",
              "citation": {
                "type": "PubMed",
                "name": "Science 2003 Jul 4 301(5629) 94-6",
                "id": "12843393"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070808"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1,pmod(P,S,338)) directlyIncreases kin(p(HGNC:RAF1))",
              "summary_text": "Pak3 phosphorylates Raf-1 on serine 338 in vitro and in vivo. The p21-activated protein kinases are regulated by the Rho-family GTPases Rac and Cdc42.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1998 Nov 12 396(6707) 180-3",
                "id": "9823899"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c24"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1,pmod(P,S,338)) directlyIncreases kin(p(HGNC:RAF1))",
              "summary_text": "This zinc-induced protein kinase A activation inhibited Raf-1 activity by phosphorylation at serine 259, preventing activation of Raf-1 by phosphorylation of serine 338. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2007 Sep 15 179(6) 4180-6",
                "id": "17785857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b8c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1,pmod(P,S,338)) directlyIncreases kin(p(HGNC:RAF1))",
              "summary_text": "The recent suggestion that Pak3 could stimulate Raf-1 activity by directly phosphorylating S338 through a Ras/phosphatidylinositol 3-kinase (Pl3-K)/-Cdc42-dependent pathway has attracted much attention. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Apr 21(7) 2423-34",
                "id": "11259591"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070aa4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1,pmod(P,S,338)) directlyIncreases kin(p(HGNC:RAF1))",
              "summary_text": "PKA also decreased Raf-1 serine 338 phosphorylation of Raf-1, previously shown to be required for Raf-1 activation. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 May 22(10) 3237-46",
                "id": "11971957"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708fd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1,pmod(P,S,338)) directlyIncreases kin(p(HGNC:RAF1))",
              "summary_text": "Maximal binding of the Raf kinase domain to MEK1 and its kinase activity are achieved upon phosphorylation of the region (338)SSYY(341)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 22 277(47) 44996-5003",
                "id": "12244094"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706bb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:U0126)",
        "relation": "directlyDecreases",
        "target": "kin(p(SFAM:\"MEK1/2 Family\"))",
        "directed": false,
        "label": "a(SCHEM:U0126) directlyDecreases kin(p(SFAM:\"MEK1/2 Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526e7",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:U0126) directlyDecreases kin(p(SFAM:\"MEK1/2 Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c4e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:HRAS,sub(G,12,V))",
        "relation": "directlyIncreases",
        "target": "gtp(p(HGNC:HRAS))",
        "directed": false,
        "label": "p(HGNC:HRAS,sub(G,12,V)) directlyIncreases gtp(p(HGNC:HRAS))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526d3",
          "evidences": [
            {
              "bel_statement": "p(HGNC:HRAS,sub(G,12,V)) directlyIncreases gtp(p(HGNC:HRAS))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Biosensors &amp; bioelectronics 2004 Oct 15;20(3):448-53",
                "id": "15494224"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070caa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS,sub(G,12,V)) directlyIncreases gtp(p(HGNC:HRAS))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Cancer research 2001 Sep 1;61(17):6340-4",
                "id": "11522622"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bbe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS,sub(G,12,V)) directlyIncreases gtp(p(HGNC:HRAS))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1993 Apr 1 53(7) 1625-9",
                "id": "8453633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070af5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS,sub(G,12,V)) directlyIncreases gtp(p(HGNC:HRAS))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1990 Jul 5(7) 1037-43",
                "id": "2197591"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407078b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS,sub(G,12,V)) directlyIncreases gtp(p(HGNC:HRAS))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2002 Jun 27 417(6892) 949-54",
                "id": "12068308"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407066c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(EGID:51776))",
        "relation": "increases",
        "target": "kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
        "directed": false,
        "label": "kin(p(EGID:51776)) increases kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526f8",
          "evidences": [
            {
              "bel_statement": "kin(p(EGID:51776)) increases kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cf5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"MAPK p38 Family\")",
        "relation": " hasModification",
        "target": "p(SFAM:\"MAPK p38 Family\",pmod(P,Y,182))",
        "directed": false,
        "label": "p(SFAM:\"MAPK p38 Family\")  hasModification p(SFAM:\"MAPK p38 Family\",pmod(P,Y,182))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526dc",
          "evidences": [

          ]
        }
      },
      {
        "source": "kin(p(HGNC:MAPK14))",
        "relation": "increases",
        "target": "bp(GOBP:\"cell differentiation\")",
        "directed": false,
        "label": "kin(p(HGNC:MAPK14)) increases bp(GOBP:\"cell differentiation\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526e0",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:MAPK14)) increases bp(GOBP:\"cell differentiation\")",
              "summary_text": "We found that p38alpha positively regulates factors such as CCAAT/enhancer-binding protein that are required for lung cell differentiation.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Genet 2007 Jun 39(6) 750-8",
                "id": "17468755"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d1c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"RAF Family\")",
        "relation": "actsIn",
        "target": "kin(p(SFAM:\"RAF Family\"))",
        "directed": false,
        "label": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526fd",
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "To elucidate the role of MAPKs in keratinocyte differentiation, activation of ERK, JNK, and p38 in response to stimulation with extracellular calcium was analyzed. We provide evidence that calcium-induced differentiation of keratinocytes is associated with rapid and transient activation of the Raf/MEK/ERK pathway. Stimulation of keratinocytes with extracellular calcium resulted in activation of Raf isozymes and their downstream effector ERK within 10-15 min, but did not increase JNK or p38 activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Dec 29 275(52) 41011-7",
                "id": "11018025"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070938"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Ariadne: Thus, the major components of the AP-1 in MEK-DD-transformed CEFs were shown to be Fra-2 and c-Jun, and Fra-2 was highly phosphorylated, as reported in CEFs transformed by v- src , Ha- ras , and activated raf (17 , 22) . [Regulation] Here, we report that the transcriptional activity of Fra-2/c-Jun heterodimer was greatly enhanced by cotransfecting a constitutively active mutant of MEK1 gene (MEK-DD) into F9 cells, indicating that Fra-2 was converted into an active transactivator after phosphorylation by MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1999 May 10(5) 333-42",
                "id": "10359014"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070622"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "three members of the Raf family of protein-serine/threonine kinases have been identified (Raf-1, A-Raf, and B-Raf), whose activation is linked to receptor protein-tyrosine kinases by Ras (24).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Aug 19(8) 5308-15",
                "id": "10409722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070583"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Because Raf binds tightly to the GTP-bound form of Ras but not to the GDP-bound form, such differential affinity can be used to determine the GTP-bound status of Ras. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 5 274(45) 31981-6",
                "id": "10542228"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d2b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "hKSR-2 selectively inhibited the Cot-mediated activation of MEK by  60%. In contrast, hKSR-2 up-regulated the Rafmediated MEK activation by up to 70%.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 21 278(47) 47089-97",
                "id": "12975377"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bf3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "inhibition of LPAAT-beta inhibits signaling in both the Ras/Raf/Erk and PI3K/Akt pathway",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2003 Oct 2(10) 1067-78",
                "id": "14578472"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ba2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Rap-1 antagonizes Ras in T cells42 but activates the Raf-ERK cascade, as does Ras, in PC12 cells43 and contributes to the integrin-mediated adhesion of T lymphocytes and embryonic fibroblasts.44,45",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2002 Nov 1 91(9) 769-75",
                "id": "12411390"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b82"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Figure 1 | The ErbB signalling network.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2001 Feb 2(2) 127-37",
                "id": "11252954"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b80"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Oncogenic Ras decreases Rac activity through sustained Raf/MAP kinase signaling, which causes transcriptional downregulation of Tiam1, an activator of Rac in epithelial cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2000 May 15 149(4) 775-82",
                "id": "10811819"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a4a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "STAT3 inhibited myogenic differentiation induced by low serum or MyoD as efficiently as the Ras/mitogen-activated protein kinase cascade",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2003 Dec 24(12) 659-66",
                "id": "14644140"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709b0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "The RasRafMek pathway is involved in signaling downstream from EGFR and in other pathways leading to the growth of cancer cells and tumor progression (Fig. 2).",
              "citation": {
                "type": "PubMed",
                "name": "N Engl J Med 2008 Sep 25 359(13) 1367-80",
                "id": "18815398"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070923"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Moreover, Erbin inhibits the Erk activation by active Ras, while it fails to do so in the presence of active Raf-1. Erbin associates with active Ras, but not inactive Ras nor Raf. Consistently, Erbin interferes with the interaction between Ras and Raf both in vivo and in vitro. Erbin associates with active Ras, but not inactive Ras nor Raf.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 10 278(2) 1108-14",
                "id": "12379659"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708fb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "from full text - Figure 1 ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Jul 35(1) 3-9",
                "id": "16484682"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070817"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "we found that PGE2 stimulated the activation of Ras and ERK, but not Akt, and reduced matrix deprivation-induced apoptosis, in untransformed epithelial cells",
              "citation": {
                "type": "PubMed",
                "name": "Mol Carcinog 2007 Dec 46(12) 958-70",
                "id": "17477350"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707db"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Ras R115777 (tipifarnib) Phase III treatment (194-197) SCH 66336 (lonafarnib; Sarasar) Phase I treatment (194,195,198) BMS-214662 Phase I treatment (194,195,198) L-744,832 Preclinical development (199-202) L-778,123 Phase I treatment (203,204) XR-3054 Preclinical development (205) Raf Bay 43-9006 Phase II treatment (206,207) ISIS 5132 Phase II treatment (208-211)",
              "citation": {
                "type": "PubMed",
                "name": "J Mammary Gland Biol Neoplasia 2003 Jan 8(1) 45-73",
                "id": "14587863"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "The abundance of cyclin D1 is induced by a variety of oncogenic and growth factor signaling pathways, including activating mutations of Ras, Src, Rac, and erbB2 (HER-2/neu)",
              "citation": {
                "type": "PubMed",
                "name": "Curr Cancer Drug Targets 2004 Aug 4(5) 403-24",
                "id": "15320717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "he independent signaling competence of Tnfr1 and Tnfr2 was further confirmed in the studies of various kinases of the Erk/Mapk signal transduction cascade; Erk1, Erk2, Raf-1, Raf-B, Mek-1, Mekk, and p90rsk all were found to be activated independently by Tnfr1 as well as Tnfr2. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Nov 8 271(45) 28097-104",
                "id": "8910423"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070647"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Growth factor and other survival signals are transduced through receptor tyrosine kinases via adaptor proteins (such as GRB2 and the guanine-nucleotide exchange factor SOS) and activate Ras and its downstream targets, Raf and MEK1/2, which results in the activation of ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2008 Sep 118(9) 3003-6",
                "id": "18725993"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705fa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "whereas p27kip-1 and other inhibitors of cyclin-dependent kinases (cdk) are negatively regulated.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Oncol 2005 Sep 20 23(27) 6771-90",
                "id": "16170185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Fig.1",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Nov 26 306(5701) 1506-7",
                "id": "15567848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705c7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Finally, disruption of microtubule polymerization by 2-methoxyoestradiol (2ME2) has also been shown to result in decreased HIF-1a levels and decreased VEGF mRNA expression in cultured cells88.In vivo, 2ME2 decreases tumour-xenograft growth and vascularization.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2003 Oct 3(10) 721-32",
                "id": "13130303"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070545"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAF Family\") actsIn kin(p(SFAM:\"RAF Family\"))",
              "summary_text": "Figure 1. Pathways to MUC5AC expression in COPD",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82",
                "id": "17615396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070515"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"CEBP Family\")",
        "relation": "actsIn",
        "target": "tscript(p(SFAM:\"CEBP Family\"))",
        "directed": false,
        "label": "p(SFAM:\"CEBP Family\") actsIn tscript(p(SFAM:\"CEBP Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526ce",
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"CEBP Family\") actsIn tscript(p(SFAM:\"CEBP Family\"))",
              "summary_text": "Endothelin-1 is not only a powerful vasoconstrictor but also a potent mitogen for vascular smooth muscle cells (SMC), acting through both the endothelin-A and endothelin-B receptor (ET(B)-R). Although vascular SMC are known to express the ET(B)-R, its transcriptional regulation has not been studied thus far. Here we demonstrate that the potent inhibitor of nuclear factor kappaB activation, pyrrolidine dithiocarbamate (PDTC; 30-100 microM), induces de novo ET(B)-R expression in rat aortic and mesenteric cultured SMC. Electrophoretic mobility shift analyses revealed that besides inhibition of nuclear factor kappaB, PDTC enhances activator protein-1 (AP-1), CCAAT/enhancer-binding protein (C/EBP), and GATA-2 activity in these cells. Preincubation of PDTC-stimulated cells with appropriate decoy oligodeoxynucleotides confirmed the involvement of these three transcription factors, namely that of AP-1, in ET(B)-R expression. The stimulatory effect of PDTC on ET(B)-R expression was also confirmed functionally by monitoring an enhanced ET-1-induced apoptosis in PDTC-treated cells that was sensitive to the ET(B)-R antagonist, BQ788. Taken together, these findings demonstrate that C/EBP, GATA-2, and in particular AP-1 can control ET(B)-R expression in vascular SMC. They further support the notion that ET(B)-R expression in these cells may play an important role in cardiovascular complications, such as restenosis following angioplasty that in the early phase is characterized by prominent SMC apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2000 Dec 58(6) 1333-40",
                "id": "11093771"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c38"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"CEBP Family\") actsIn tscript(p(SFAM:\"CEBP Family\"))",
              "summary_text": "The potential role of AP-1 and C/EBP in deformation-induced ET(B)-R expression was verified both by using decoy oligodeoxynucleotides mimicking the DNA-binding sites of these transcription factors and a nuclear run-on-based assay employing specific antibodies directed against AP-1 and C/EBP.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Oct 5 276(40) 36999-7003",
                "id": "11457849"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070af4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"CEBP Family\") actsIn tscript(p(SFAM:\"CEBP Family\"))",
              "summary_text": "The mC/EBP HO-1 promoter activity in the presence of Elk-1 alone or Elk-1 + PGN was significantly decreased compared with the wild-type HO-1 promoter (Fig. 7A). These data suggest that the C/EBP binding site is important for activation of the HO-1 promoter by Elk-1 and PGN and support the hypothesis that Elk-1 may activate the HO-1 promoter through the C/EBP binding site.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2010 Jun 298(6) L870-9",
                "id": "20348279"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c67"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"CEBP Family\") actsIn tscript(p(SFAM:\"CEBP Family\"))",
              "summary_text": "The CBP protein (cAMP response element binding protein (CREB) binding protein) is a co-activator for several transcription factors with a wide range of important biological functions, such as sterol regulatory element binding proteins (SREBPs), CCAAT/enhancer-binding proteins (C/EBPs), nuclear receptors (including peroxisome proliferator-activated receptors, PPARs), and signal transducers and activators of transcription (STATs).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Genet 2002 Feb 30(2) 221-6",
                "id": "11818964"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070745"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"CEBP Family\") actsIn tscript(p(SFAM:\"CEBP Family\"))",
              "summary_text": "We found that p38alpha positively regulates factors such as CCAAT/enhancer-binding protein that are required for lung cell differentiation.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Genet 2007 Jun 39(6) 750-8",
                "id": "17468755"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d35"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"CEBP Family\") actsIn tscript(p(SFAM:\"CEBP Family\"))",
              "summary_text": "C/EBP proteins bound to the P3(I) site are participants in the induction of PEPCK gene expression by thyroid hormone and cAMP.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 2 277(31) 27606-12",
                "id": "11997389"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cbd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"CEBP Family\") actsIn tscript(p(SFAM:\"CEBP Family\"))",
              "summary_text": "# Ariadne: We show that p53 wild type and  tumor-derived p53 mutations repress C/EBP-mediated transactivation of the  albumin promoter. [Expression]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 5 274(45) 32137-44",
                "id": "10542249"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bed"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"CEBP Family\") actsIn tscript(p(SFAM:\"CEBP Family\"))",
              "summary_text": "ST3 gene promoter that is accessible to nuclear factors such as C/EBP and retinoic acid receptors",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jul 12 277(28) 25527-36",
                "id": "12006591"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070999"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"CEBP Family\") actsIn tscript(p(SFAM:\"CEBP Family\"))",
              "summary_text": "he CS-dependent induction of ho-1 may be achieved potentially, at least in part, via activation of transcription factors binding to AP-1 and C/EBP recognition elements, which are both integral parts of the murine ho-1 promoter",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2002 May 23(5) 741-8",
                "id": "12016146"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407090d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"CEBP Family\") actsIn tscript(p(SFAM:\"CEBP Family\"))",
              "summary_text": "Mutational analysis revealed that the activator protein 1 and CCAAT/enhancer binding protein (C/EBP) sites on the FGF-BP gene promoter were required for the EGF effect, whereas deletion of the C/EBP site resulted in a significant increase in promoter basal activity indicating a basal repressive control mechanism.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Apr 1 63(7) 1696-705",
                "id": "12670924"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708fa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"CEBP Family\") actsIn tscript(p(SFAM:\"CEBP Family\"))",
              "summary_text": "Both putative promoter sequences were TATA-less, CAAT-less, contained highly GC-rich sites, and had multiple putative regulatory cis-elements (e.g., AP1, AP2, C/EBP, SP1, NF1, and GATA). The activities of the putative promoters were confirmed",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2002 Mar 19 1574(2) 187-92",
                "id": "11955628"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"CEBP Family\") actsIn tscript(p(SFAM:\"CEBP Family\"))",
              "summary_text": "C/EBP family members significantly activate the CD14 promoter.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Aug 13 274(33) 23242-8",
                "id": "10438498"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407072d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"MAPK JNK Family\")",
        "relation": "actsIn",
        "target": "kin(p(SFAM:\"MAPK JNK Family\"))",
        "directed": false,
        "label": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526e6",
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "However, translation inhibitors, such as anisomycin, cycloheximide, emetine, harringtonine, and puromycin, unlike several transcription inhibitors, significantly sensitized PC3-neomycin (PC3-neo) cells to TRAIL-induced apoptosis.Translation inhibitors led to activation of c-Jun N-terminal kinase (JNK), which plays a role in this sensitization process because inhibition of JNK activation resulted in protection against TRAIL plus translation inhibitor-induced apoptosis.  % These effects were inhibited in PC3 cells engineered to express bcl2 (PC3-bcl2)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jun 6 278(23) 20593-602",
                "id": "12663665"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070da0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Treatment of cells with the JNK specific inhibitors, SP600125 (3-30 uM) or a JNK inhibitory peptide (JNKI1) (3-30 uM), resulted in significant attenuation of thrombin-induced ICAM-1 protein expression in a concentration-dependent manner (67  3% and 72  7% inhibition at 30 ?M, respectively; Fig. 2A)...Similarly, thrombin-induced ICAM-1 promoter activity was also inhibited by SP600125 or by JNKI1, while PD98059 and SB203580 had only slight inhibitory effect (Fig. 2B).",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2005 Nov 1 68(2) 289-98",
                "id": "15979056"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d79"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Moreover, uPAR is known to take part in the release of both inflammatory cytokines TNF-a, IL-1b, and IL-6 and chemokines IL-8 and monocyte chemoattractant protein (MCP)-1 from human blood mononuclear cells through p38, c-Jun N-terminal kinases (JNKs), and NF-kB activation (Khan et al. 2006; Del Rosso et al. 2008).",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2009 Apr 50 Suppl S189-94",
                "id": "19064999"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d6d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "peripheral blood mononuclear cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Ras-driven epidermal neoplasias generated on the surface of immunodeficient SCID mice were treated topically with DMSO vehicle or SP600125 daily for 5 weeks. DMSO and untreated control tissues displayed typical findings of neoplasia, including invasion and disruption of the BMZ, as visualized by type VII collagen staining (Fig. 2A). In contrast, tissues treated with SP600125 lacked invasive neoplasia and retained sharp delineation of the BMZ, with a human-specific desmoglein-3 antibody confirming the human origin of these tissues (Fig. 2A).....SP600125 (30), which has been shown to inhibit JNK function",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2007 Apr 15 67(8) 3827-34",
                "id": "17440097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d6a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Akt-dependent phosphorylation of Bad on Ser112 and Ser136 allows it to associate with 14-3-3 proteins and thereby suppresses its pro-apoptotic activity. Apoptotic kinases including JNK directly activate the cell death machinery by phosphorylating Bad at Serine 128 (Donovan et al., 2002Go). The phosphorylation of Bad at this residue disrupts the interaction of Bad with 14-3-3 proteins, thus allowing Bad to induce apoptosis (Konishi et al., 2002Go).",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2003 Dec 10 23(36) 11373-81",
                "id": "14673001"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d55"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "The recent observation that diesel exhaust, a known source of particles and other agents that induce oxidative stress, activates redox-sensitive transcription factors and kinases in human airways (31) [From primary paper: DE induced a significant increase in the nuclear translocation of NF-{kappa}B (P = 0.02), AP-1 (P = 0.02), phosphorylated JNK (P = 0.04), and phosphorylated p38 (P = 0.01), as well as an increase in total (cytoplasmic + nuclear) immunostaining of phosphorylated p38 (P = 0.03). ]",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Jun 34(6) 666-9",
                "id": "16484683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d39"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Alveolar type II cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "JNK activity after FOXO3a activation was evaluated using an in vitro kinase assay. Strong activation of JNK was detected after 24 hours of TM-FOXO3a gene transduction compared with the control, which was near completely reversed by Ad-DN-FOXO3a (Figure 3A). Figure 3. FOXO3a activates JNK, turning TNF receptor pathway toward apoptosis. A, Immunoprecipitation/Kinase assay for JNK activity. c-jun N-terminal phosphorylation activities determined by in vitro kinase assay. ",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2008 Jan 28(1) 112-20",
                "id": "18032780"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ce1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Alternatively, Kit signaling may also activate JNK kinase, a MAP kinase activated in response to stress [35]. NF1, a GTPase activating protein, is considered to be involved in modulating Ras activation through Kit signaling [36]. NF1 deficiency that occurs in cases of neurofibromatosis may induce an increase in MAP kinase activity. Pathways with JAK/STAT or with Src family members may be involved in Kit signaling [33] (fig. 1). Some studies showed the association of JAK2 with Kit and also its activation by Kit signaling [37]. Other reports also indicated the increased activity of Lyn, a Src family member, by Kit signaling [38].",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2004 Dec 61(23) 2924-31",
                "id": "15583854"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ca0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Northern analysis of the apoptosis-associated genes Gadd34 and Gadd45 verified their higher expression in JNK2AS-treated cells (Fig. 4C)Citation , and the mRNA levels of Gadd153, another gene whose expression is often up-regulated by conditions that induce Gadd34 and Gadd45, were also elevated. The induction of the Gadd genes suggested that JNK2AS-treated cells were under stress and prompted us to examine the expression of two other stress-regulated genes: (a) Grp78, a molecular chaperone involved in protein folding; and (b) the cyclin-dependent kinase inhibitor p21Cip1/Waf1, which we had found previously to be up-regulated in other JNK2AS-treated cells (17 , 18) . Both genes were markedly up-regulated in JNK2AS-treated cells (Fig. 4C)Citation , suggesting that depletion of JNK2 in PC3 cells facilitates the induction of several independent stress-signaling pathways. Activation of the JNK pathway is important for the phosphorylation and activation of protein components of AP-1 transcription factor complexes (1, 2, 3, 4 , 5, 6, 7 , 28) , suggesting that genes regulated by AP-1-dependent transcription could be negatively affected by JNKAS treatment. Indeed, we detected reduced expression of several AP-1-regulated genes, including lamin A-C (29) , and integrin b-4 (Ref. 30 ; Fig. 4DCitation ). Among other genes whose lower expression after JNK2AS treatment was verified by Northern blotting were HMG-I(Y), a protein highly expressed in prostate cancer (31) and recently identified as a myc-regulated oncogene (32) , Lsm5 (33) , transcobalamin, and DSS1 (Ref. 34 ; Fig. 4Citation D, and data not shown). Importantly, although most JNK2AS-altered genes appeared to be specific for treatment with this oligonucleotide, some gene expression changes were also seen in the JNK1AS- and JNKScr-treated groups, indicating that a more global response to the uptake of oligonucleotides (Fig. 4E)Citation was elicited. Within this group were two IFN-inducible genes, ISGF-3 and ISG15, suggesting that application of phosphorothioate oligonucleotides could induce IFN-dependent responses.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Jun 1 62(11) 3257-63",
                "id": "12036942"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c9b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "In other models of oxidant stress, the activation of ASK1 has been shown to exert its pro-apoptotic effects by activating the JNK pathway. To determine whether ASK1 was required for PM2.5-induced JNK activation, we measured the phosphorylation of c-Jun by lysates of PM- or PBS-treated wild type and ASK1-/- MEFs using a commercially available JNK kinase assay. Activation of JNK was observed in wild type but not ASK1-/- MEFs 4 h after exposure to PM2.5  (Fig. 6E).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jan 23 284(4) 2176-86",
                "id": "19033436"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c29"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "IL-1 beta-induced phosphorylation of c-Jun N-terminal kinase was inhibited by BMP-7. [cJun Nterminal kinase1->cJun Nterminal kinase1{P@?}] [cJun Nterminal kinase2->cJun Nterminal kinase2{P@?}] [cJun Nterminal kinase3->cJun Nterminal kinase3{P@?}] ilbcp1=IL1B^[cJun Nterminal kinase1->cJun Nterminal kinase1{P@?}] IL1B^[cJun Nterminal kinase1->cJun Nterminal kinase1{P@?}]; occursInTissue; mesangial cell ilbcp2=IL1B^[cJun Nterminal kinase2->cJun Nterminal kinase2{P@?}] IL1B^[cJun Nterminal kinase2->cJun Nterminal kinase2{P@?}]; occursInTissue; mesangial cell ilbcp3=IL1B^[cJun Nterminal kinase3->cJun Nterminal kinase3{P@?}] IL1B^[cJun Nterminal kinase3->cJun Nterminal kinase3{P@?}]; occursInTissue; mesangial cell BMP7-|ilbcp1; occursInTissue; mesangial cell BMP7-|ilbcp2; occursInTissue; mesangial cell BMP7-|ilbcp3; occursInTissue; mesangial cell",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2003 Mar 1 170(5) 2557-63",
                "id": "12594282"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bf7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Proper H(2)O to mucin ratio of airway mucus is important for mucociliary clearance. Recent studies suggest that decreased aquaporin 5 (AQP5) is correlated with increased staining of MUC5AC in submucosal glands of COPD patients. Lipopolysaccharide (LPS) is one of the major insults in airway mucin secretion in COPD. In this study, changes in both AQP5 and MUC5AC expression levels in SPC-A1, a human airway submucosal gland cell line, were quantified after exposure of the cells to LPS. AQP5 transcription and protein expression were decreased while MUC5AC expression was increased by LPS exposure in SPC-A1 cells. Further studies revealed that AQP5 expression was down-regulated via the p38/JNK signaling pathway, while MUC5AC was up-regulated through the EGFR-p38/JNK pathway. Therefore, p38 and JNK may become promising targets to preserve AQP5 expression and prevent MUC5AC over-expression to restore proper H(2)O to mucin ratio of the airway mucus, which may be beneficial to the clinical management of COPD patients.",
              "citation": {
                "type": "PubMed",
                "name": "Respir Physiol Neurobiol 2010 May 31 171(3) 212-7",
                "id": "20362698"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b6a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Chronic Obstructive Pulmonary Disease",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Subsequently, they reported that synthesis of the predominant airway mucin MUC5AC was transcriptionally upregulated by cigarette smoke and was mediated by an AP-1?containing response element binding JunD and Fra-1 (8). These events required activation of the ERK and JNK pathways with EGFR activation critical to ERK but not JNK activation, which was Src dependent. Studies using scavengers of ROS showed that EGFR and JNK cascades were independently initiated pathways by ROS in cigarette smoke.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Jun 34(6) 666-9",
                "id": "16484683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b3d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "As shown in Figs. 3A-C, TNF-alpha induced transient phosphorylation of ERK1/2, JNK, and p38 in HUVECs, with the maximal response being seen within 15 min, followed by a decline to the basal level within 60 min. In addition, pretreatment for 1 h with the indicated concentrations of PD98059 (an ERK1/2 inhibitor), SP600125 (a JNK inhibitor), or SB203580 (a p38 inhibitor) inhibited the TNF-alpha-induced VCAM-1 expression seen at 6 h of TNF-alpha treatment (Figs. 3D-F).",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2011 Oct 1 51(7) 1337-46",
                "id": "21767632"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b36"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "In order to investigate the role of IRAK-4 kinase function in vivo, we generated \\\"knock-in\\\" mice where the wild-type IRAK-4 gene is replaced with a mutant gene encoding kinase-deficient IRAK-4 protein (IRAK-4 KD). IRAK-4 kinase is rendered inactive by mutating the conserved lysine residues in the ATP pocket essential for coordinating ATP. Analyses of embryonic fibroblasts and macrophages obtained from IRAK-4 KD mice demonstrated lack of cellular responsiveness to stimulation with IL-1beta or Toll-like receptor 4 (TLR4) and TLR7 agonists. IRAK-4 KD cells were severely impaired in NF-kappaB, JNK, and p38 activation in response to IL-1beta or TLR7 ligand.",
              "citation": {
                "type": "PubMed",
                "name": "Ernst Schering Found Symp Proc 2007 (3) 63-82",
                "id": "18510099"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ab2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We demonstrated here that long-term tamoxifen treatment causes G2/M cell cycle arrest through c-jun N-terminal kinase (JNK) activation, which is dependent on phosphorylation of Fas-associated death domain-containing protein (FADD) at 194 serine in an oestrogen (ER) receptor-positive breast cancer cell line, MCF-7. We conclude that JNK-mediated phosphorylation of FADD plays an important role in the negative regulation of cell growth and metastasis, independent of the ER status of a breast cancer, so that JNK/FADD signals might be promising targets for cancer therapy.",
              "citation": {
                "type": "PubMed",
                "name": "Br J Cancer 2006 Feb 27 94(4) 532-9",
                "id": "16450001"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a71"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "The exogenous expression of RASSF1A suppressed JNK phosphorylation, and cells stably transfected with RASSF1A showed reduced JNK and c-Jun phosphorylation and Cyclin D1 down-regulation. An in vitro kinase assay showed that the exogenous expression of RASSF1A inhibited JNK activity and that JNK activity suppression due to ectopically expressed RASSF1A was revived by RASSF1A siRNA treatment.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 May 1 65(9) 3682-90",
                "id": "15867363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a5d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "TGFbeta induces JNK-dependent actin stress fiber formation, matrix contraction, and expression of profibrotic genes in fak+/+, but not fak-/-, fibroblasts. Overexpression of MEKK1, a kinase acting upstream of JNK, rescues TGFbeta responsiveness of JNK-dependent transcripts and actin stress fiber formation in FAK-deficient fibroblasts. Thus we propose a FAK-MEKK1-JNK pathway in the transmission of TGFbeta signals leading to the control of alpha-SMA cytoskeleton reorganization, matrix contraction, and profibrotic gene expression and hence to the physiological and pathological effects of TGFbeta on connective tissue remodeling by fibroblasts",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2007 Jun 18(6) 2169-78",
                "id": "17409352"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a53"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "The pro-inflammatory cytokine, interleukin (IL)-1beta, induced a >100-fold increase in MMP-12 gene expression and a >10-fold enhancement in MMP-12 activity of primary airway smooth muscle cell cultures. Selective inhibitors of extracellular signal-regulated kinase, c-Jun N-terminal kinase and phosphatidylinositol 3-kinase reduced the activity of IL-1beta on MMP-12, indicating a role for these kinases in IL-1beta-induced induction and release of MMP-12.",
              "citation": {
                "type": "PubMed",
                "name": "Respir Res 2005 6 148",
                "id": "16359550"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070975"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "In contrast to ERK, the activities of p38 and SAPK/JNK are very low in insulin- or EGF-stimulated fibroblasts and, therefore, insufficient to phosphorylate ATF2 Thr71 and/or Thr69 efficiently by themselves (Figures 1D and 4A). However, these low levels of active p38 are essential and appear to be sufficient to phosphorylate Thr69 when ATF2 Thr71 is already mono-phosphorylated by ERK (see the model in Figure 7).",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Jul 15 21(14) 3782-93",
                "id": "12110590"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070903"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "TGF-beta led to activation of Smad2/3, p38, p42/44, and c-Jun NH2-terminal kinase (JNK) pathways, assessed by phosphorylation, immunofluorescence, and reporter gene analysis. TGF-beta-dependent growth inhibition was specifically attenuated by pharmacological blockade of the TGF-beta type I receptor (TbetaRI) kinase or p38 mitogen-activated protein kinase pathways, whereas blockade of p42/44 or JNK kinases did not influence the effect of TGF-beta. TbetaRI kinase inhibition blocked all downstream pathways including Smad and p38 phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Exp Ther 2005 Dec 315(3) 1005-12",
                "id": "16120811"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070879"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Bone marrow stromal cells upregulated interleukin-8 mRNA in T-cell acute lymphoblastic leukemia cells through the activity of CXCR4, the CXCL12 receptor, as assessed by the use of neutralizing antibodies. Exogenous CXCL12 induced a significant increase in the production of IL-8 mRNA and protein in all T-cell acute lymphoblastic leukemia cases. We showed that CXCL12 activates the nuclear factor-kappaB and JNK/AP-1 pathways, and that these events are required for increased expression of interleukin-8.",
              "citation": {
                "type": "PubMed",
                "name": "Haematologica 2008 Apr 93(4) 524-32",
                "id": "18322253"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407085d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Fibroblast growth factor (Yoshida et al., 1997), insulin-like growth factor-1 (Rhoads et al., 1997), epidermal growth factor (Heinrich and Kraiem, 1997), endothelin-1 (Salamonsen et al., 1997), oncostatin M (Isozaki et al., 1997), nerve growth factor (Courtney et al., 1997), tumor necrosis factor alpha (Yoshida et al., 1997), and interleukin-1alpha  and beta  (Lu et al., 1997) activate Jun kinase and increase c-jun gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2002 Jun 61(6) 1476-88",
                "id": "12021409"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070837"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "minimally modified LDL (mmLDL) mainly activated components involved in stress response and apoptotic cell death including p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase/stress-activated protein kinase (JNK) as well as neutral and acid sphingomyelinase",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2004 Oct 14 1690(2) 150-8",
                "id": "15469904"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Abdominal aortic aneurysm (AAA) is a common disease among elderly people that, when surgical treatment is inapplicable, results in progressive expansion and rupture of the aorta with high mortality. Although nonsurgical treatment for AAA is much awaited, few options are available because its molecular pathogenesis remains elusive. Here, we identify JNK as a proximal signaling molecule in the pathogenesis of AAA. Human AAA tissue showed a high level of phosphorylated JNK. We show that JNK programs a gene expression pattern in different cell types that cooperatively enhances the degradation of the extracellular matrix while suppressing biosynthetic enzymes of the extracellular matrix. Selective inhibition of JNK in vivo not only prevented the development of AAA but also caused regression of established AAA in two mouse models. Thus, JNK promotes abnormal extracellular matrix metabolism in the tissue of AAA and may represent a therapeutic target.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2005 Dec 11(12) 1330-8",
                "id": "16311603"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070785"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Hyperoxia was associated with a significant increase in pJNKs and pERKs in WT mice as seen by Western blot. NOX1, but not NOX2, deficiency decreased ERK and JNK phosphorylation without modification of JNK and ERK protein levels (Figures 7A?7F).NOX1, but not NOX2, deficiency decreased ERK and JNK phosphorylation without modification of JNK and ERK protein levels (Figures 7A?7F). pERK staining was associated with type II pneumocytes and endothelial cell markers during hyperoxia (Figure 8A), whereas pJNK staining was detected mainly in endothelial cells (Figure 8B). ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Crit Care Med 2009 Nov 15 180(10) 972-81",
                "id": "19661248"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407072a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Phosphorylation of c-jun at serines 63 and 73 has also been reported to be involved in mammalian stress responses (45,46). As shown in Figure 9D , c-jun protein levels remained fairly constant after treatment of HME87 cells with BPDE, but highly increased phosphorylation of both Ser63 and Ser73 of c-jun was detected beginning 30 min after BPDE treatment. Phosphorylation at these residues remained higher than control levels for at least 10 h. Phosphorylation of these residues is known to be controlled by the stress activated protein kinases (SAPK), in particular by the jun N-terminal kinase (JNK)",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2003 Feb 24(2) 225-34",
                "id": "12584171"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070724"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "All five cell lines did not express FADD by immunoblot analysis and were completely resistant to Fas-induced death. Complementation of the FADD mutant cell lines with wild-type FADD restored Fas-mediated apoptosis. Fas activation of caspase-2, caspase-3, caspase-7, and caspase-8 and the proteolytic cleavage of substrates such as BID, protein kinase Cdelta, and poly(ADP-ribose) polymerase were completely defective in the FADD mutant cell lines. In addition, Fas activation of the stress kinases p38 and c-Jun NH2 kinase and the generation of ceramide in response to Fas ligation were blocked in the FADD mutant cell lines",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1999 Dec 10(12) 797-804",
                "id": "10616904"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706fa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "In order to investigate the role of IRAK-4 kinase function in vivo, we generated \\\"knock-in\\\" mice where the wild-type IRAK-4 gene is replaced with a mutant gene encoding kinase-deficient IRAK-4 protein (IRAK-4 KD). IRAK-4 kinase is rendered inactive by mutating the conserved lysine residues in the ATP pocket essential for coordinating ATP. Analyses of embryonic fibroblasts and macrophages obtained from IRAK-4 KD mice demonstrated lack of cellular responsiveness to stimulation with IL-1beta or Toll-like receptor 4 (TLR4) and TLR7 agonists. IRAK-4 KD cells were severely impaired in NF-kappaB, JNK, and p38 activation in response to IL-1beta or TLR7 ligand.",
              "citation": {
                "type": "PubMed",
                "name": "Ernst Schering Found Symp Proc 2007 (3) 63-82",
                "id": "18510099"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706c1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "A study similar to the one conducted by Liu et al. was done in human HBE1  cells to address the role of MAPK signaling pathway activation in the induction of GCL in response to HNE [49]  D.A. Dickinson, K.E. Iles, N. Watanbe, T. Iwamoto, H. Zhang, D.M. Krzywanski and H.J. Forman, 4-hydroxynonenal induces glutamate cysteine ligase through JNK in HBE1 cells, Free Radic. Biol. Med. 33  (2002), pp. 974987. Article  |  PDF (439 K)  | View Record in Scopus | Cited By in Scopus (64)[49]. Both direct and indirect measures of JNK pathway involvement were assayed. The phosphorylation of both JNK and c-Jun was significantly increased following treatment with HNE",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2005 Mar 1 38(5) 547-56",
                "id": "15683710"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070672"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "By blocking TRAF6 activity using retroviral expression of a dominant-negative TRAF6 in endothelial cells, we show that TRAF6 is absolutely required for the LPS-initiated angiogenic response in vitro and in vivo. Inhibition of either c-Jun N-terminal kinase (JNK) activity or nuclear factor kappaB (NF-kappaB) activity, downstream of TRAF6, is sufficient to inhibit LPS-induced endothelial sprouting",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2003 Sep 1 102(5) 1740-2",
                "id": "12714497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407065c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We show that Crry increases early TCR-dependent activation signals, including p56lck-, zeta-associated protein-70 (ZAP-70), Vav-1, Akt, and extracellular signal-regulated kinase (ERK) phosphorylation but also costimulation-dependent mitogen-activated protein kinases (MAPK), such as the stress-activated c-Jun N-terminal kinase (JNK). It is intriguing that Crry costimulus enhanced p38 MAPK activation in T helper cell type 1 (Th1) but not in Th2 cells. ",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2005 Dec 78(6) 1386-96",
                "id": "16301324"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705c5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Recombinant TTP was phosphorylated by three members of the mitogen-activated protein (MAP) kinase family, p42, p38, and JNK, with half-maximal phosphorylation occurring at approximately 0.5, 0.25, and 0.25 microM protein, respectively....we expressed human and mouse TTP as glutathione S-transferase and maltose-binding protein (MBP) fusion proteins in Escherichia coli, and purified them by affinity resins and Mono Q chromatography. ",
              "citation": {
                "type": "PubMed",
                "name": "Arch Biochem Biophys 2003 Apr 1 412(1) 106-20",
                "id": "12646273"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705b3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "The principal substrate for JNK phosphorylation is the AP-1 subunit c-Jun. Phosphorylation by JNK increases the ability of c-Jun to activate AP-1-dependent transcription. To determine whether the sustained JNK activation that occurred in response to TNF and NF-kappaB inhibition resulted in increased c-Jun activation, AP-1-dependent transcriptional activity was measured in untreated and TNF treated cells. RALA hepatocytes were transiently transfected with the AP-1-driven firefly luciferase reporter construct Coll73-Luc, and the constitutively expressing Renilla luciferase reporter pRL-TK for normalization. No significant increase in AP-1 transcriptional activity occurred in Ad5LacZ-infected cells at 4 hours after TNF treatment (Fig. 1B). AP-1 transcriptional activity in Ad5IkappaB-infected cells was increased slightly in untreated cells and almost 3-fold in cells treated with TNF (Fig. 1B). JNK overactivation resulting from NF-kappaB inactivation therefore led to increased AP-1-dependent transcription.",
              "citation": {
                "type": "PubMed",
                "name": "Hepatology 2002 Apr 35(4) 772-8",
                "id": "11915022"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407053d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Thus, stimuli that activate these kinases, including exposure to pro-inflammatory cytokines, UV irradiation, DNA damage or change in ROS, are among the classic inducers of ATF2 transcriptional activity (van Dam et al., 1995).ATF2 mediates both transcription and DNA damage control, through its phosphorylation by JNK/p38 or ATM/ATR respectively. ",
              "citation": {
                "type": "PubMed",
                "name": "Pigment Cell Res 2007 Dec 20(6) 498-506",
                "id": "17935492"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a82"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Inhibitors of PI3K and JNK pathways, but not p38 MAPK and ERK1/2 pathways, suppressed HO-1 induction by LPS in macrophages (Fig. 7C). The most dramatic effect occurred with PI3K inhibition, which dramatically reduced the overall expression of Ets-2. Inhibitors of p38 MAPK and Erk1/2, even given in doses 5-fold higher than those shown in Fig. 7C, did not markedly reduce HO-1 protein levels (data not shown). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Feb 11 280(6) 4578-84",
                "id": "15590657"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707b5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "The mRNA and protein levels of VEGF in CRH-treated HaCaT cells were significantly attenuated. However, this downregulation was abrogated by pretreatment with antalarmin, SB203580 and SP600125; pretreatment with PD98059 did not attenuate the effects of CRH on the expression of VEGF. In addition, CRH treatment induced rapid phosphorylation of p38 MAPK and JNK1/2, and antalarmin, SB203580 and SP600125 inhibited CRH-induced phosphorylation of p38 MAPK and JNK1/2. ",
              "citation": {
                "type": "PubMed",
                "name": "Regul Pept 2010 Feb 25 160(1-3) 115-20",
                "id": "19852986"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407052d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We show that initially exposure of fibroblasts to Cr (III) induced membrane-dependent signaling including activation of Rac1 GTPase, Src and apoptosis signal-regulating kinase 1 (ASK-1) kinases leading to increased activities of p38 and particularly Jun N-terminal kinase (JNK) and subsequent activation of caspase-3. ",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Lett 2009 Aug 10 188(3) 236-42",
                "id": "19406221"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d81"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Binding to DOK4 and DOK5 is implicated in ERK stimulation, whereas binding to DOK1 is involved in recruiting the NCK adaptor leading to c-Jun N-terminal kinase (JNK) stimulation [10, 40] (fig. 3). Enigma is endowed with LIM and PDZ domains and is involved in shuttling rearranged RET/PTC oncoproteins to the membrane (see below).",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2004 Dec 61(23) 2954-64",
                "id": "15583857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d54"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We demonstrate that JNK can act to suppress TNF-stimulated apoptosis. However, we find that JNK can also potentiate TNF-stimulated necrosis by increasing the production of reactive oxygen species (ROS).",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2004 Dec 1 18(23) 2905-15",
                "id": "15545623"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d2d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "The phosphorylation of MAPKs including ERK1/2, p38, and JNK was measured by immunoblot analysis using specific Abs. LPS-induced phosphorylation of ERK1/2, p38, and JNK was inhibited by EGCG (Fig. 4A?C). However, in 67LR-ablated cells, the inhibitory effect of EGCG on LPSinduced upregulation of phosphorylation was attenuated (Fig. 4A?C).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Jul 1 185(1) 33-45",
                "id": "20511545"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d1f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "leukemia",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "The alkylating agent methylmethanesulfonate (MMS) activates the c-jun N-terminal kinase (JNK)/stress-activated protein kinase (SAPK) and the p38 mitogen-activated protein kinase (p38MAPK) pathways via different mechanisms of action.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Carcinog 2001 Jun 31(2) 63-7",
                "id": "11429782"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ca3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Pretreatment of THP-1 cells with pharmacological inhibitors of PI3K (LY294002), MAPK (PD98059), p38 MAPK (SB203580), and JNK (SP600125) inhibited ET-1-mediated MIP-1b mRNA expression by 89 6 5%, 104 6 7%, 102 6 8%, and 118 6 1%, respectively, when compared with that of untreated cells (Fig.1B).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Oct 15",
                "id": "20952681"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c22"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Control experiments demonstrated that MKK3(Ala) also inhibited JNK activation, but it did not inhibit ERK activation (data not shown)....The constitutive activation of MKK3 caused by the replacement of Ser-189 and Thr-193 with Glu suggests that the replacement of these residues with Ala [producing MKK3(Ala)] would yield an inactive MKK3 protein kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Mar 16(3) 1247-55",
                "id": "8622669"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c0d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Indoxyl sulfate treatment enhanced the activation of JNK, p38 MAPK, and NF-kB in TNF-alpha-activated HUVEC. Inhibitors of JNK and NF-kB attenuated indoxyl sulfate-induced E-selectin expression in HUVEC and subsequent THP-1 adhesion. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 Dec 10 285(50) 38869-75",
                "id": "20937831"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bf9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Consequently, we have used the recently described specific JNK inhibitor SP600125 and RNA interference to inhibit endogenous JNK activity in the prostate carcinoma cell line DU 145. We demonstrated that endogenous JNK activity increased the expression of a kinase, HIPK3, that has previously been implicated in multidrug resistance in a number of tumors.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 23 279(17) 17090-100",
                "id": "14766760"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bc9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We demonstrate that induction of IL-23 p19 gene expression by LPS depends on the TLR4 and MyD88 pathways. All three MAPK pathways (ERK, JNK, and p38) that are activated by lipopolysaccharide (LPS) stimulation were shown to exert a positive effect on p19 expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Sep 4 284(36) 24006-16",
                "id": "19592489"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b04"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "A549 and HEK293 epithelial cells were transiently transfected with SP-C(Deltaexon4) or SP-C(L188Q) mutants. Expression of either mutant promoted upregulation of multiple UPR genes including HERPUD1 and GRP78. Commensurate with induction of ER stress, increases in IL-8 secretion occurred accompanied by activation of c-Jun N-terminal kinase (JNK) / AP-1 signaling",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2010 May 12",
                "id": "20463293"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b02"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "The JNK inhibitor SP600125 abolished the ANP-induced expression of MKP-1 protein and mRNA (Figure 6A and 6B), suggesting an involvement of JNK in MKP-1 upregulation by ANP.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2005 Jan 7 96(1) 43-53",
                "id": "15569826"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "In the case of TNF-alpha-treated cells, activation of ERK1/2 was transient, with a maximum at 10-20 min and decreasing to the baseline at 30 min, whereas strong activation of p38 kinase was sustained up to 60 min. Activation of JNK was transient, with maximum levels detected at 10 min. ",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2001 Jan 15(1) 230-242",
                "id": "11149911"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070980"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Inhibition of AR by sorbinil or tolrestat prevented TNF-alpha-induced increase in Bax and Bak and the downregulation of Bcl-2. Inhibition of AR abrogated AP-1 DNA binding activity and prevented the activation of caspase-3, JNK, and p38 MAPK in cells stimulated by TNF-alpha. Exposure to TNF-alpha also induced apoptotic cell death, which was attenuated by AR inhibition or antisense ablation",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2004 Jul 16 570(1-3) 189-94",
                "id": "15251463"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070949"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We show that Gab1 associates with the EGFR in vivo and in vitro via pTyr sites 1068 and 1086 in the carboxy-terminal tail of the receptor and that overexpression of Gab1 potentiates EGF-induced activation of the mitogen-activated protein kinase and Jun kinase signaling pathways A mutant of Gab1 unable to bind the p85 subunit of PI-3 kinase is defective in potentiating EGFR signaling, confirming a role for PI-3 kinase as a downstream effector of Gab1",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Feb 20(4) 1448-59",
                "id": "10648629"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070941"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Furthermore, p38(MAPK), ERK1/2, JNK, and Smad1 were phosphorylated by BMP4. Using specific MAPK inhibitors, a dominant negative Smad1 construct, and Smad1 siRNA, we found that the antiproliferative and prodifferentiation effects of BMP4 were Smad1 dependent with JNK also contributing to differentiation.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2005 Feb 288(2) L370-8",
                "id": "15516492"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "TAK1-deficient keratinocytes cannot activate NF-kappaB or JNK upon TNF treatment. These results suggest that TNF induces TAK1-deficient keratinocyte death because of the lack of NF-kappaB (and possibly JNK)-mediated cell survival signaling. {Tak1 Official Gene Symbol: MAP3K7} ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Jul 14 281(28) 19610-7",
                "id": "16675448"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708d2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "In T cells CD137-induced signals lead to the recruitment of TRAF family members and activation of several kinases, including ASK-1, MKK, MAPK3/ MAPK4, p38, and JNK/SAPK  CD137 = TNFRSF9 ASK1 = MAP3K5",
              "citation": {
                "type": "PubMed",
                "name": "Immunol Res 2004 29(1-3) 197-208",
                "id": "15181282"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070806"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "RANKL has been demonstrated to activate JNK, which phosphorylates the AP-1 components to potentiate its transcriptional activity, through RANK in osteoclastic cells (6, 13, 24, 25), whereas p38 MAPK-mediated signals have been shown to regulate osteoclast differentiation (26).",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2003 Apr 21 197(8) 1029-35",
                "id": "12707301"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070805"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Bone and Bones"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We identified Thr450 of Akt as a residue that is phosphorylated by JNKs, and the phosphorylation status of Thr450 regulates reactivation of Akt after hypoxia, apparently by priming Akt for subsequent phosphorylation by 3-phosphoinositide-dependent protein kinase. ",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2006 Jan 6 98(1) 111-8",
                "id": "16306447"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707f8"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Induction of gene 33 requires the stress-activated protein kinases (SAPKs)/c-Jun NH(2)-terminal kinases. This expression pattern suggests that gene 33 is a potential marker for diabetic nephropathy and other pathologic responses to persistent sublethal stress.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jun 9 275(23) 17838-47",
                "id": "10749885"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707f1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "When HEMEC were exposed to acidic pH for various time periods, there was a rapid and significant activation of JNK which was seen as early as 1 min. Activation of p44/42 MAPK was first detected at 15 min and maximized by 30 min, while activation of p38 MAPK was delayed, appearing at 60 min (Fig. 3A).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2006 Nov 291(5) C931-45",
                "id": "16790501"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707c5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Cyclic stretch significantly increased GADD153 protein and mRNA expression after 18 h of stretch. Addition of c-jun N-terminal kinase (JNK) inhibitor SP600125, JNK siRNA, tumour necrosis factor-alpha (TNF-alpha) and TNF-alpha receptor antibody 30 min before stretch inhibited the induction of GADD153 protein",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2008 Feb 1 77(3) 551-9",
                "id": "18006442"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070786"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "ANG II-mediated MAPK activation is followed by an increase in c-fos  (activated by ERK) and c-jun (activated by JNK) gene expression, as well as increased AP-1 activity. AP-1 is a transcription factor complex (formed from dimerization of c-Jun and c-Fos) and ultimately influences cell differentiation, migration, and adhesion by binding to gene promoter sequences (191). ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2007 Jan 292(1) C82-97",
                "id": "16870827"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705f6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We report here that the predominant airway mucin (MUC5AC) undergoes transcriptional up-regulation in response to tobacco smoke; this is mediated by an AP-1-containing response element, which binds JunD and Fra-2.These transcription factors require phosphorylation by upstream kinases JNK and ERK, respectively. Whereas ERK activation results from the upstream activation of EGFR, JNK activation is chiefly EGFR-independent.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Sep 10 279(37) 39085-93",
                "id": "15262961"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705f1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "However, the activities of c-Jun N-terminal kinases (JNKs) were markedly decreased in Rac2(-/-) mast cells. Our results suggest that cytokine-stimulated activation of MMCP-7 gene transcription is selectively regulated by a Rac2-dependent JNK signaling pathway",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Nov 22(21) 7645-57",
                "id": "12370311"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070586"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Mice that develop lung cancer from activation of a latent K-ras oncogene had high intratumoral JNK activity and low RARalpha levels and were resistant to treatment with an RAR ligand.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Feb 25(3) 1054-69",
                "id": "15657432"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070578"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Fas ligation activated apoptosis signal-regulating kinase 1 (ASK1) and c-Jun N-terminal kinase (JNK; also known as stress-activated protein kinase (SAPK)) in Gln-deprived cells but not in normal cells, suggesting that Gln might be involved in the activity control of ASK1 and JNK/SAPK",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 23 276(8) 6030-6",
                "id": "11096076"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407055a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Thrombin induced increases in JNK phosphorylation and kinase activity",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2009 Jun 15 182(12) 7916-27",
                "id": "19494316"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d9a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Here, we show that engagement of CD81 on human B cells by a combination of HCV-E2 and an anti-CD81 mAb triggers the JNK pathway and leads to the preferential proliferation of the na??ve (CD27-) B cell subset. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Dec 20 102(51) 18544-9",
                "id": "16339892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d8f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Phosphorylated ERK1/2, JNK, p38 and ERK5 were significantly increased by exposure to TS, indicating the activation of these MAPK pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2005 Dec 26(12) 2187-95",
                "id": "16051644"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d89"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "UV irradiation strongly induced JNK phosphorylation at two sites, Thr-183 and Tyr-185, whose phosphorylation correlates with and is required for JNK activation (Fig. 6A).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1998 Apr 18(4) 1946-55",
                "id": "9528766"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d72"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "These results implicate galectin-8 as a modulator of cellular growth through up-regulation of p21. This process involves activation of JNK, which enhances the synthesis of p21, combined with the activation of PKB, which inhibits p21 degradation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 May 13 280(19) 19105-14",
                "id": "15753078"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d6c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We have now shown that SGK1 inhibits the activation of SEK1 and thereby negatively regulates the JNK signaling pathway. SGK1 was found to physically associate with SEK1 in intact cells.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2007 Jul 11 26(13) 3075-85",
                "id": "17568772"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d60"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Thrombin induced a transient phosphorylation of SAPK/JNK and p38 MAP kinase. Maximal activation of SAPK/JNK was observed after 10 min and declined to basal level within 30 min. p38 MAP kinase phosphorylation started at 5 min, maximized at 15 min, and declined after 15 min (Fig. 6B).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2010 Apr 298(4) C952-60",
                "id": "20032511"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d50"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "TNF facilitates cell death via the activation of downstream molecules including Jun N-terminal kinase (JNK) or ROS [9, 30].",
              "citation": {
                "type": "PubMed",
                "name": "Apoptosis 2011 Feb 16(2) 114-26",
                "id": "20963496"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d49"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "mong the MAPKs, it was interesting that whereas TNF-induced c-Jun N-terminal kinase (JNK) activation was abolished, activation of p44/p42 MAPK and p38 MAPK was potentiated in PKR-deleted cells.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2007 Feb 22 26(8) 1201-12",
                "id": "16924232"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d45"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "In two independent experiments, Crkl Y207F activated JNK more efficiently than wild-type Crkl (Fig. 8, top), consistent with the hypothesis that mutation of Y207 activates Crkl function.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1998 Sep 18(9) 5082-90",
                "id": "9710592"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d32"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "TAK1-induced iNOS-Luc activity was substantially inhibited by pharmacological inhibitors of the known downstream kinases, p38 MAPK and JNK (SB203580 and SP620125), and was almost completely blocked by co-expression of a phosphorylation mutant of IkappaB. TAK1/TAB1 also induced the production of NO and the expression of iNOS in microglial cells in a p38 MAPK-, JNK- and NFkappaB-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2003 Oct 87(1) 238-47",
                "id": "12969270"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d27"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "glial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We found that CCR7 induced a Gi-dependent activation of MAPK members ERK1/2, JNK, and p38, with ERK1/2 and p38 controlling JNK. MAPK members regulated chemotaxis, but not the migratory speed, of DCs.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Apr 1 174(7) 4070-80",
                "id": "15778365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d26"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We have recently shown that LPS-stimulated neutrophils express monocyte chemoattractant protein 1 (MCP-1), an AP-1-dependent gene, suggesting that LPS activates the c-Jun N-terminal kinase (JNK) pathway in neutrophils.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Mar 19 279(12) 10883-91",
                "id": "14699155"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d24"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "When two additional subjects were studied using a one-legged exercise protocol, JNK activity increased only in the exercising leg, indicating that exercise-induced JNK signaling represents an intrinsic response of the contracting muscle, rather than a systemic response to exercise.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1998 Oct 9 251(1) 106-10",
                "id": "9790915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d20"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "From Cell Signaling Technologies Pathway Maps for p38 and JNK signaling.",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2001 Apr 81(2) 807-69",
                "id": "11274345"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d13"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "The results herein showed that FC loading of macrophages leads to an apoptotic response that is partially dependent on initiation by activation of IRE1alpha. Taken together, these results showed that the IRE1-apoptosis-signaling kinase 1-c-Jun NH2-terminal kinase cascade pathway was required in this process.",
              "citation": {
                "type": "PubMed",
                "name": "Acta Biochim Biophys Sin (Shanghai) 2008 Mar 40(3) 226-34",
                "id": "18330477"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d0e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Similar to H(2)O(2), inhibition of PP1 induces phosphorylation of Sp1 and activation of JNK in HAE cells.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2006 Nov 291(5) L983-92",
                "id": "16815888"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d0a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "while Ser246 is phosphorylated by the c-Jun N-terminal kinase.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Jun 5 273(23) 14315-21",
                "id": "9603939"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d09"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Exposure of rats to the smoke from 5 to 15 cigarettes produced a marked increase in phosphorylation of p38, JNK and ERK2 (maximal inductions of ~2.4-fold, ~2.5-fold and ~1.6-fold, respectively).",
              "citation": {
                "type": "PubMed",
                "name": "Chem Biol Interact 2005 Jun 30 155(1-2) 31-42",
                "id": "15970277"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cf8"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "JNK was also activated by ERK2 expression in the absence of VEGF",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Oct 9 273(41) 26722-8",
                "id": "9756915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cf2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Inhibition of AR also attenuated the increase in p38 mitogen-activated protein kinase and c-Jun N-terminal kinase phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2003 Feb 17(2) 315-7",
                "id": "12490536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cf1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Cigarette smoke increased CD95L expression in bronchioles of male Wistar rats, in association with phosphorylation of c-Jun NH2-terminal kinase (JNK) (355).",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82",
                "id": "17615396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ce9"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "The high-fat diet increased phosphorylation of IRS-1 (Ser307; Fig. 6A), the membrane-to-cytosolic ratio of PKCtheta (Fig. 6B), and the phosphorylation of JNK (Thr183/Tyr185) {modeled as activity-SE}. However, these effects were ameliorated by CPT1 overexpression (Fig. 6A?C). ",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2009 Mar 58(3) 550-8",
                "id": "19073774"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cd7"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Treatment with LPS resulted in significant increases in ERK, JNK, and p38 phosphorylation compared with control, and these events were not inhibited by cotreatment with lutein (Fig. 4D).",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2008 Sep 15 45(6) 885-96",
                "id": "18620044"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cd4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "leukemia",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "c-Jun NH(2)-terminal kinase tended to induce the phosphorylation of Smad2/3L in human colorectal adenoma-carcinoma sequence (phosphorylation increases formation of SMAD234 complex)",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Jan 1 65(1) 157-65",
                "id": "15665291"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cbc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "The cytoplasmic tail of the endothelin B receptor was found to be required for activation of all three mitogen-activated protein kinases and stimulation of intracellular calcium levels.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Dec 6 271(49) 31572-9",
                "id": "8940174"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cb4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Ligand binding to vascular endothelial cell growth factor (VEGF) receptors activates the mitogen-activated protein kinases extracellular signal-regulated kinase (ERK) and c-Jun N-terminal protein kinase (JNK).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Oct 9 273(41) 26722-8",
                "id": "9756915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cb1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "CXCL13 treatment significantly increased (3.5-fold) phospho-c-Jun levels in these cells and a c-Jun-NH(2)-kinase inhibitor abolished CXCL13-stimulated RANKL expression. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2009 Aug 7(8) 1399-407",
                "id": "19671684"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070caf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Squamous Cell",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "As ETS activates transcription factors like NF-kB and AP-1, we also assayed the JNK upon exposure to ETS. ETS activated JNK almost in all the regions of the brain that were exposed to ETS as compared to control (Fig. 4A).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2006 May 28 71(11) 1602-9",
                "id": "16569398"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cac"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "striatum"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "These ROS provoke prolonged JNK activation, which contributes to TNFinduced necrotic cell death (61).",
              "citation": {
                "type": "PubMed",
                "name": "Sci Signal 2010 3(115) re4",
                "id": "20354226"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ca8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Use of the JNK inhibitor SP600125 or expression of dominant-negative JNK-activator SAPK kinase (SEK1) prevented the induction of ATF2-Thr69+71, but not ATF2-Thr71 phosphorylation by insulin.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2006 Aug 20(8) 1786-95",
                "id": "16601071"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ca7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We show in this study that exposure of mice to aerosolized LPS increased PAI-1 expression in the lung and alveolar compartment, which was decreased by pretreatment with the JNK inhibitor SP600125. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Sep 15 175(6) 4049-59",
                "id": "16148154"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c86"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Histamine induced a time-dependent, H1 receptor-mediated activation of p38 MAP kinase (p38), p44/42 MAP kinase (ERK), and c-jun terminal NH2 kinase (JNK).",
              "citation": {
                "type": "PubMed",
                "name": "Circulation 2005 Jul 19 112(3) 341-9",
                "id": "16009787"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c6f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Gene 33 inhibits EGFR autophosphorylation and specifically blunts epidermal growth factor (EGF)-induced activation and/or phosphorylation of Ras, ERK, JNK, Akt/PKB, and retinoblastoma protein.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 28 280(4) 2924-33",
                "id": "15556944"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c6c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Jab1 activates c-Jun amino-terminal kinase (JNK) activity and enhances endogenous phospho-c-Jun levels, and MIF inhibits these effects. MIF also antagonizes Jab1-dependent cell-cycle regulation by increasing p27Kip1 expression through stabilization of p27Kip1 protein",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2000 Nov 9 408(6809) 211-6",
                "id": "11089976"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c6a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Mechanistically, Cbl-b selectively down-modulates CD40-induced activation of NF-kB and JNK.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2007 Oct 1 179(7) 4473-9",
                "id": "17878343"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c68"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "H2O2 treatment led to increases in c-fos and c-jun mRNA levels, Jun nuclear kinase activity, and AP-1 DNA binding. AP-1 transcriptional activity measured with an AP-1-driven luciferase reporter gene was also increased. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol 1997 Oct 273(4 Pt 1) G795-803",
                "id": "9357820"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c63"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "M3/6 is the first phosphatase of this family to display highly specific inactivation of JNK/SAPK and p38 MAP kinases.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Nov 1 271(44) 27205-8",
                "id": "8910287"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c5f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Consequently, p38, JNK and Nuclear factor-kappaB (NF-kappaB) activation induced by IL-33 was completely inhibited in TRAF6-deficient MEFs.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2008 Sep 20(9) 1679-86",
                "id": "18603409"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c5a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "As shown in Fig. 5, OX40 activating antibody synergistically enhanced IL- 17A production in the cells stimulated by OVA over time. Inhibition of various signaling pathways (PI3K, JNK, NF-kB, and MEK) significantly mitigated IL-17A expression (Fig. 5). ",
              "citation": {
                "type": "PubMed",
                "name": "Cytokine 2010 Jun 50(3) 253-9",
                "id": "20400327"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c58"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "CD4+ T-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Investigation into the downstream targets and mechanisms involved in ALK7-induced apoptosis revealed that the TGF-beta signaling intermediates, Smad2 and -3, were activated, as well as the MAPKs JNK and p38. In addition, caspase-3 and -9 were also activated, and cytochrome c release from the mitochondria was observed",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 2 279(27) 28458-65",
                "id": "15107418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c4f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Overexpression of wild-type Crkl activates the stress-activated protein kinase/ JNK pathway (40).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1998 Sep 18(9) 5082-90",
                "id": "9710592"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c4c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 1 278(31) 28694-702",
                "id": "12756254"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c3f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "In contrast, adults had increased p-JNK, whereas neonates did not (Figure 4). ",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2004 Sep 114(5) 669-78",
                "id": "15343385"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c33"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Stably expressing MKK7siRNA effectively blocked the expression of endogenous MKK7 and TNFa-induced JNK activation (Figure 2D)",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2003 Oct 3 115(1) 61-70",
                "id": "14532003"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c2a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "As expected, JNK activator treatment obviously decreased the transcriptional activity of TR3 in a time-dependent manner (Fig. 5B).",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2007 Jan 148(1) 34-44",
                "id": "17023523"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c17"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "In this report, we demonstrate that IRAK-4 is recruited to the IL-1R complex upon IL-1 stimulation and is required for the recruitment of IRAK-1 and its subsequent activation/degradation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Sep 24 279(39) 40653-8",
                "id": "15292196"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c04"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "c-Fos and c-Jun, the major downstream components of MAPKs, were up-regulated by ERK and JNK, respectively",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Sci 2010 Feb 18",
                "id": "20331627"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c02"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Elafin prevented lipopolysaccharide-induced phosphorylation of AP-1, c-Jun, and JNK but had no effect on phosphorylation of p38. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Nov 17 281(46) 34730-5",
                "id": "16980310"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bf8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "In C3H/HeOuJ mice treated with ETX, activation of p38 MAP kinase was also evident in macrophages and endothelial cells, and JNK kinase in macrophages. In contrast, reduced protein kinase B (AKT) was noted in macrophages.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Mol Pathol 2007 Dec 83(3) 311-26",
                "id": "17996232"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bea"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "proliferate in response to TGF-beta1 indirectly by the release of FGF-2, which induces phosphorylation of p38 MAPK and JNK.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Dec 30 280(52) 43000-9",
                "id": "16246848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070be9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Cerebral ischemia up-regulates the sphingomyelin-ceramide pathway, which involves calcium-independent JNK and PP2A activation in hippocampal glia",
              "citation": {
                "type": "PubMed",
                "name": "Brain Inj 2009 Dec 23(13-14) 1073-80",
                "id": "19891536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070be8"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "glial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Immunostaining for TJ demonstrated that pretreatment with SP-600125 significantly diminished ZO-1 and OCLN expression at cell-cell contact sites (Fig. 6C), suggesting that EGFR-mediated TJ formation is dependent on JNK activation.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2011 Jan 300(1) L56-63",
                "id": "21036915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070be7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "CS-induced IL-8 synthesis was found to be mediated through c-Jun N-terminal kinases (JNKs), which correlated with the increased amounts of active phospho-c-Jun associated with the AP-1 binding site in the promoter region of IL-8.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Lung Res 2009 Aug 35(6) 439-85",
                "id": "19842832"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070be6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Since Txnip is involved in ceramide-induced ASK1 activation, the regulation of ASK1 on ceramide-activated p38 MAPK and JNK was subsequently determined. In ASK1 siRNA-transfected EGFP+ Jurkat T cells, ceramide-induced phosphorylation of p38 MAPK and JNK was inhibited (Figures 6B,S4E,F).",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2008 Apr 15 111(8) 4365-74",
                "id": "18270325"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070be2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "FIGURE 6. Activated Rac induces phosphorylation of JNK1.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 Feb 12 285(7) 4511-9",
                "id": "20018857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bd3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Additionally, JNK inhibitor nearly completely blocked tumor necrosis factor-alpha (TNF-alpha)-induced RANTES production in GF.",
              "citation": {
                "type": "PubMed",
                "name": "Cytokine 2003 Jun 7 22(5) 107-15",
                "id": "12842758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bcd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Thrombin-stimulated activation of JNK gradually increased to a peak at 1 h and then dropped slightly to a plateau. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Aug 20 279(34) 36142-7",
                "id": "15201277"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bbc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We find that although pretreatment of BMMs with IL-4 does not alter M-CSF signaling, it reversibly blocks RANKL-dependent activation of the NF-kappa B, JNK, p38, and ERK signals.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Feb 22 277(8) 6622-30",
                "id": "11719504"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bb2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "the IL-16-mediated activation of SAPKs and p38 MAPK in macrophages alone induces no detectable apoptotic cell death.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1998 Jun 15 160(12) 5874-9",
                "id": "9637499"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070baa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "It is known that LPS stimulation leads to increased activation of three subgroups of MAPKs, i.e., ERK, JNK, and p38, in murine macrophages and human monocytes (38, 39).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Aug 1 169(3) 1401-9",
                "id": "12133965"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ba4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "As shown in Figure 5A, Tsc2-/- cells have significantly higher JNK activity when compared to cells expressing TSC2. treatment with either rapamycin or PBA in Tsc2-/- cells resulted in reduction of JNK activity, indicating its link to increased ER stress.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2008 Mar 14 29(5) 541-51",
                "id": "18342602"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ba1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We found that the catalytic activity of MKP-2 was enhanced dramatically by ERK and JNK but was affected only minimally by p38. By contrast, p38 and ERK bound MKP-2 with comparably strong affinities, whereas JNK and MKP-2 interacted very weakly",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 3 276(31) 29440-9",
                "id": "11387337"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b9f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Activation of c-Jun N-terminal kinase (JNK) by TNF-? was also diminished by depletion of SphK1 (Fig. 1a) or its inhibition (Supplementary Fig. 3b). Likewise, SK1-I reduced activation of p38 (Supplementary Fig. 3a).",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2010 Jun 24 465(7301) 1084-8",
                "id": "20577214"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b9b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Although the phosphorylation of ERK remained at the same level in wild-type and Mekk1?KD/?KD mice, the phosphorylation of JNK was depended on MEKK1 and was reduced almost to basal levels in the wounds of the Mekk1?KD/?KD mice (Figure 3B).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2006 Aug 17(8) 3446-55",
                "id": "16760432"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b98"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Following the expression of ASK1, activated forms of JNK and p38 were observed in apoptotic cells detected by the TUNEL method",
              "citation": {
                "type": "PubMed",
                "name": "J Neuropathol Exp Neurol 1999 May 58(5) 442-50",
                "id": "10331432"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b97"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "SAPKs/JNKs were also rapidly activated",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1998 Jun 1 332 ( Pt 2) 459-65",
                "id": "9601075"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b95"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": " Human ASM cells exposed to the primary proasthmatic T helper type 2 (Th2) cytokine, IL-13, exhibited upregulated expression of 11beta-HSD1, an effect that was attributed to activation of the transcription factor, AP-1, coupled to MAPK signaling via the ERK1/2 and JNK pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2009 May 296(5) L790-803",
                "id": "19251840"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b90"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We have previously shown that LZK activates the c-Jun-NH2 terminal kinase (JNK) pathway, but not the extracellular signal-related kinase (ERK) pathway, by acting as a mitogen-activated protein kinase kinase kinase (MAPKKK) [Ikeda, A., Hasegawa, K., Masaki, M., Moriguchi, T., Nishida, E., Kozutsumi, Y., Oka, S., and Kawasaki, T. (2001) J. Biochem.130, 773-781]. ",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2003 Jan 270(1) 76-83",
                "id": "12492477"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b89"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Serines 63 and 73, the sites of c-Jun phosphorylation by JNK, are essential for v-src-induced, pgs2 promoter-mediated luciferase expression",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Nov 17 270(46) 27622-8",
                "id": "7499226"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b6e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Thus, we conclude that RELT does not rely on the canonical TRAF pathways for its function, but instead uses a kinase, SPAK, to mediate p38 and JNK activation  RELT = TNFRSF19L SPAK = STK39",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 Apr 28 343(1) 125-34",
                "id": "16530727"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b61"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "# Ariadne: Moreover, c-Jun N-terminal kinase,  activated by inflammatory cytokines and cellular stress, has been reported to  be inhibited by IGF-I . [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Dec 8 275(49) 38620-5",
                "id": "10973957"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b55"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We report here that VHR, a Vaccinia virus VH1-related dual-specific protein phosphatase that inactivates the mitogen-activated kinases Erk2 and Jnk, is phosphorylated at Y138 by ZAP-70.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Immunol 2003 Jan 4(1) 44-8",
                "id": "12447358"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b51"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "In the present study, we show that Fas receptor ligation or cellular treatment with synthetic C6-ceramide results in activation or phosphorylation, respectively, of the small G-protein Rac1, Jun N-terminal kinase (JNK)/p38 kinases (p38-K), and the transcription factor GADD153",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Aug 29 272(35) 22173-81",
                "id": "9268362"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b50"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Sorbitol resulted in activation of the extracellular signal-regulated kinase (ERK), p54 c-Jun N-terminal kinase (JNK), and protein kinase B",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 3 278(40) 38484-94",
                "id": "12881532"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b4c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "When analyzing the role of these pathways on neutrophil functions, we observed that up-regulation of CD11b triggered by bacterial DNA was decreased by pharmacological inhibitors of the p38 MAPK, ERK1/2, and JNK, whereas stimulation of IL-8 release was dependent on p38, ERK1/2, and NF-kappaB.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2006 Sep 15 177(6) 4037-46",
                "id": "16951367"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b42"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "The present study indicated that TGF-beta-responsive ERK1/2 and JNK cascades negatively regulate Smad3-induced transcriptional activity as well as ALP activity and mineralization in osteoblasts",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 27 277(39) 36024-31",
                "id": "12130649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b41"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Cisplatin-induced DNA damage rapidly leads to specific activation of the Jun kinase pathway leading to increased phosphorylation of c-Jun and ATF2-DNA complexes at hundreds of sites within 3 hours. ",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2005 Nov 1058 162-85",
                "id": "16394135"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b33"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We report that, in human endothelial cells, HDLs prevent the oxLDL-induced activation of the ER stress sensors IRE1alpha, eIF2alpha and ATF6 and subsequent activation of the proapoptotic mediators JNK and CHOP.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Death Differ 2011 May 18(5) 817-28",
                "id": "21113143"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b30"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We found that the overexpression of FADD sensitizes etoposide-induced apoptosis through a rapid activation of c-Jun NH(2)-terminal kinase (JNK) and, subsequently, of caspase 3.",
              "citation": {
                "type": "PubMed",
                "name": "Jpn J Cancer Res 2002 Oct 93(10) 1164-74",
                "id": "12417047"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b20"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Map3k2 also synergized with anti-CD3 antibody to activate JNK in T cells, and stimulation of T cells led to induction of Map3k2 tyrosine phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 4 276(18) 14784-90",
                "id": "11278622"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b1f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "IL-2/IL-18 strongly prevented the TGF-beta-induced NKG2D down-regulation in NK cells via the JNK pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Immunol 2006 Jul 242(1) 39-45",
                "id": "17070508"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b1d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "natural killer cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "This caspase activation and apoptotic changes occur through JNK",
              "citation": {
                "type": "PubMed",
                "name": "Genes Cells 2001 Jun 6(6) 519-30",
                "id": "11442632"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b13"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Activation of c-Jun N-terminal kinase (JNK) by TNF-? was also diminished by depletion of SphK1 (Fig. 1a) or its inhibition (Supplementary Fig. 3b). Likewise, SK1-I reduced activation of p38 (Supplementary Fig. 3a).",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2010 Jun 24 465(7301) 1084-8",
                "id": "20577214"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b00"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Whereas ILPIP moderately activates JNK family members when expressed alone, it strongly enhances XIAP-mediated activation of JNK1, JNK2, and JNK3",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 23 277(34) 30454-62",
                "id": "12048196"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070afe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "In contrast to the modest increase in pJNK that was observed, there was a dramatic increase in the phosphorylation of c-Jun (Fig. 5).",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2005 Aug 1 39(3) 355-64",
                "id": "15993334"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070afc"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "These results suggest that inhibin/activin beta(A) gene activation is achieved by the JNK and p38 kinase activation through the calmodulin pathway in mast cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2003 Jun 15(6) 605-13",
                "id": "12681448"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070af8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "The levels of phosphorylated JNK and p38 MAPK were increased following mechanical ventilation (20 ml/ kg, 4 hours), as determined by Western immunoblot analyses of corresponding phospho- and dephospho- forms (Figure 4A and B).",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2008 3(2) e1601",
                "id": "18270588"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070aef"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Treatment with TNF induced increased JUN N-terminal kinase activity within 5 min of stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "Immunity 1998 Aug 9(2) 267-76",
                "id": "9729047"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070add"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "JNK phosphorylates human GR at Ser226",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2002 Oct 16(10) 2382-92",
                "id": "12351702"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ad2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Inhibition of RACK1 expression by siRNA attenuates JNK activation, sensitizes melanoma cells to UV-induced apoptosis, and reduces their tumorigenicity in nude mice",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2005 Aug 5 19(3) 309-20",
                "id": "16061178"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070acf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Signaling through TNFR1 can also lead to the formation of reactive oxygen species, sustained c-Jun N-terminal kinase (JNK) activation and apoptotic cell death via a caspase-independent mechanism . ",
              "citation": {
                "type": "PubMed",
                "name": "Pediatr Rheumatol Online J 2009 7 21",
                "id": "20028520"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ac9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "merbarone caused activation of c-Jun NH2-terminal kinase/stress-activated protein kinase, c-jun gene induction, activation of caspase-3/CPP32-like protease",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 1999 Mar 55(3) 548-56",
                "id": "10051540"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070aaf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": " FIG. 5.   Defective activation of SAPK in U-937 and HeLa cells expressing the kinase-inactive Lyn(K-R) mutant in response to DNA damage. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Aug 20(15) 5370-80",
                "id": "10891478"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070aac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "In this paper, we present a comprehensive pathway map of EGFR signaling and other related pathways. The map reveals that the overall architecture of the pathway is a bow-tie (or hourglass) structure with several feedback loops.  See figure 2: The bow-tie architecture of the EGFR signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Syst Biol 2005 1 2005.0010",
                "id": "16729045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070aa3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Here we have identified human Rev7 (hRev7)/MAD2B/MAD2L2 as an interaction partner for Elk-1 and demonstrate that hRev7 acts to promote Elk-1 phosphorylation by the c-Jun N-terminal protein kinase (JNK) MAP kinases.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 Apr 27(8) 2861-9",
                "id": "17296730"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070aa0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We have identified a novel signaling protein, termed Daxx, that binds specifically to the Fas death domain. Overexpression of Daxx enhances Fas-mediated apoptosis and activates the Jun N-terminal kinase (JNK) pathway",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1997 Jun 27 89(7) 1067-76",
                "id": "9215629"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a9d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Kinases that were inhibited by low levels of GSTp expression included JNK, MKK3, p38, and MKK7.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Aug 1 60(15) 4053-7",
                "id": "10945608"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a9a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "JunB binds directly to the P1 site and synergizes with c-Maf to activate an IL-4 luciferase reporter gene. JunB-control of IL-4 expression is mediated by the phosphorylation of JunB at Thr102 and -104 by JNK MAP kinase",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 Jan 15 18(2) 420-32",
                "id": "9889198"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a8d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "The 3 members of the JNK group of serine/threonine kinases, JNK-1, -2, and -3, JNK has recently emerged as a central metabolic regulator, playing an important role in the development of insulin resistance in obesity In response to stimuli such as ER stress, cytokines, and fatty acids, JNK is activated, whereupon it associates with and phosphorylates IRS-1 on Ser307, impairing insulin action",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2005 May 115(5) 1111-9",
                "id": "15864338"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a87"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Oct 19 19(44) 5063-72",
                "id": "11042694"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a79"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "As anticipated, TNF-a strongly stimulated the phosphorylation of JNK1/2 (Fig. 5A). However, pretreatment of cells with the JNK inhibitor SP600125 suppressed TNF-a-stimulated JNK1/2 activation (Fig. 5B, compare lane 4 and lane 1).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2006 Nov 15 177(10) 7193-202",
                "id": "17082637"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a78"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Here we show that c-Jun N-terminal kinases JNK1, JNK2 and JNK3 phosphorylate tau at many serine/threonine-prolines",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2004 Jul 90(2) 352-8",
                "id": "15228592"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a5b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "phosphorylation of JNK was induced 2 fold in normal cells but not in Perk-/- MEF cells (Figure 4).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2006 Jan 1 393(Pt 1) 201-9",
                "id": "16124869"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a48"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "(3) capsaicin induces apoptosis by stabilization of p53 through JNK activation.",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2007 Apr 1773(4) 565-76",
                "id": "17292493"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a38"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Transforming growth factor beta-activated kinase 1 (TAK1) functions downstream of inflammatory cytokines to activate c-Jun N-terminal kinase (JNK) as well as NF-kappaB in several cell types.{Tak1 Official Gene Symbol: MAP3K7}",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Jul 14 281(28) 19610-7",
                "id": "16675448"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a2e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "The following studies indicated that LZK serves as a MAPKKK in the JNK/SAPK pathway in cells, and a scaffold protein, JIP-1, enhances LZK-induced JNK/SAPK pathway activation via physical association.",
              "citation": {
                "type": "PubMed",
                "name": "J Biochem Mol Biol Biophys 2002 Apr 6(2) 113-7",
                "id": "12186766"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a2d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Thrombin induced increases in JNK phosphorylation and kinase activity",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2009 Jun 15 182(12) 7916-27",
                "id": "19494316"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a29"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "rapamycin efficiently and rapidly induced JNK phosphorylation with a very similar kinetic (Fig. 7B).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Nov 3 281(44) 33045-52",
                "id": "16914544"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a26"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "IL-33 rapidly activated ERK1/2, JNK, p38, and NF-kB signaling cascades, as evidenced by phosphorylation of MAP kinases and phosphorylation and degradation of the NF-kB inhibitor IkB-a.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2009 Feb 12 113(7) 1526-34",
                "id": "18955562"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a1b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "basophil",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "LPS stimulation was shown to activate the JNK signaling pathway in addition to NF-kB via the TLR4 signaling pathway. Similar to NF-kB activation, the Kdo2-Lipid A-induced phosphorylation of JNK was completely blocked in ATF3-/- MEF cells, whereas these pathways were potently activated in ATF3+/+ MEF cells at 30 min (Fig. 1B). ",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2010 5(12) e14181",
                "id": "21152039"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a13"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "GSTP1-1 interacts with c-Jun NH(2)-terminal kinase (JNK) and suppresses its activity",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Sep 21 25(42) 5787-800",
                "id": "16636664"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a10"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "t-RA inhibited JNK activation by serum in a pattern that correlated with JNK phosphorylation (Fig. 1A).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Mar 19(3) 1973-80",
                "id": "10022884"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a0c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "In addition to inducing G protein- and non-G protein-related signaling pathways, ANG II, via AT(1) receptors, carries out its functions via MAP kinases (ERK 1/2, JNK, p38MAPK), receptor tyrosine kinases [PDGF, EGFR, insulin receptor], and nonreceptor tyrosine kinases [Src, JAK/STAT, focal adhesion kinase (FAK)].",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2007 Jan 292(1) C82-97",
                "id": "16870827"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a09"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Stable over-expression of Smad7 in K562 cells (K562/7) prevented activation of Smad2/3 and MAPK (ERK1/2, p38 and JNK1/2) proteins by activin-A/TGF-beta1 and subsequent induction of erythroid differentiation.",
              "citation": {
                "type": "PubMed",
                "name": "Platelets 2007 Dec 18(8) 566-78",
                "id": "18041647"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a02"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Stem Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "HSV-1 infection of HCECs resulted in a two-phase activation of nuclear factor-kappaB (NF-kappaB), JNK and p38, with the first peak at 1-4 hr and a second peak at 8 hr. HSV-1 infection resulted in I?B-? phosphorylation and degradation in a time-dependent manner in both HUCL cells and primary HCECs.",
              "citation": {
                "type": "PubMed",
                "name": "Immunology 2006 Feb 117(2) 167-76",
                "id": "16423052"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Overexpressed TRAF2 or TRAF6 activate JNK, p38, or IKK in the absence of extracellular stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 May 15 13(10) 1297-308",
                "id": "10346818"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709ef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "N-CoR-HDAC3 complex inhibits JNK activation through the associated GPS2 subunit",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2002 Mar 9(3) 611-23",
                "id": "11931768"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "c-Jun N-terminal kinase (JNK), which phosphorylates and inactivates GR",
              "citation": {
                "type": "PubMed",
                "name": "Drug Metab Rev 2003 Nov 35(4) 255-68",
                "id": "14705859"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "When WT endothelial cells were incubated with S100b, an approximately 4.5-fold increase in phospho-JNK MAP kinase was observed versus baseline (P < 0.0001; Figure ?Figure4F).4F).",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2008 Jan 118(1) 183-94",
                "id": "18079965"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709cc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Beta-arrestin2 acts as a scaffold to enhance signaling to JNK3 stimulated by overexpression of the MAP3 kinase ASK1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jul 27 276(30) 27770-7",
                "id": "11356842"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709bc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Dishevelled-dependent WNT/PCP signals are transduced to the RHOA signaling cascade through Formin homology proteins DAAM1 and DAAM2, and to the JNK signaling cascade through MAPKKKs and MAPKK4/7",
              "citation": {
                "type": "PubMed",
                "name": "Oncol Rep 2005 Dec 14(6) 1583-8",
                "id": "16273260"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709ae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "The ATF2 transcription factor is phosphorylated by the stress-activated mitogen-activated protein kinases (MAPKs) JNK and p38. We show that this phosphorylation is essential for ATF2 function in vivo, since a mouse carrying mutations in the critical phosphorylation sites has a strong phenotype identical to that seen upon deletion of the DNA-binding domain",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2007 Aug 15 21(16) 2069-82",
                "id": "17699753"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709aa"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "positive regulatory events, such as activation of Syk, Btk, JNK, p38, Akt, and NF-kappaB, are substantially reduced in hck(-/-) mast cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2007 May 18",
                "id": "17513616"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709a5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Histamine (10(-4) M) also led to an approximately 4.5-fold increase in Jun NH(2)-terminal kinase activity in a PKC-, PKA-, and MAP kinase-independent but rapamycin-sensitive manner",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2000 Jun 278(6) C1246-55",
                "id": "10837353"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407099b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "after 15 minutes of 50 ug/ml IgE treatment, macrophages from WT mice, but not those from Fcer1a -/- mice, showed increased phosphorylation of ERK1/2 and JNK",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2011 Sep 121(9) 3564-77",
                "id": "21821913"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407098e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "The pro-survival effects detected in serum starved GD25beta1A cells were due to direct, PI3K-mediated stimulation of PKB/Akt activity by beta1-integrins and induced p130Cas and paxillin phosphorylation. Phosphorylated p130Cas and paxillin subsequently prevented activation of cell death-regulating JNK.",
              "citation": {
                "type": "PubMed",
                "name": "Radiother Oncol 2005 Aug 76(2) 129-34",
                "id": "16024122"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407097f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "IL-18-enhanced TSP-1 expression was blocked by SP600125, a c-Jun N-terminal kinase (JNK) specific inhibitor",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 Jun 16 344(4) 1284-9",
                "id": "16650813"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407097a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Interestingly, although the ERK1/2, p38 and JNK MAPKs were still induced in the Mekk3 knockdown cells, their levels were consistently lower than those in the control cells with similar kinetics at early time-points",
              "citation": {
                "type": "PubMed",
                "name": "Immunology 2007 Feb 120(2) 242-50",
                "id": "17116170"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070969"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Insulin stimulation of JNK activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 31 278(5) 2896-902",
                "id": "12417588"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070968"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We also show that overexpression of BCMA in 293 cells activates NF-kappa B, Elk-1, the c-Jun N-terminal kinase, and the p38 mitogen-activated protein kinase.  ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2000 Aug 1 165(3) 1322-30",
                "id": "10903733"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070964"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Induction of STAT3 Tyr705 and Ser727 phosphorylations by Galpha(s)QL was suppressed by inhibition of protein kinase A, Janus kinase 2/3, Rac1, c-Jun N-terminal kinase (JNK), or phosphatidylinositol 3-kinase, and a similar profile was observed in response to beta2-adrenergic receptor stimulation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Nov 24 281(47) 35812-25",
                "id": "17008315"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070963"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We found that KGF induced rapid activation of Akt, p70 S6K, JNK, and extracellular signal-regulated (ERK) ",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2005 Dec 46(12) 2624-35",
                "id": "16162944"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407095c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Mice with haploinsufficiency of the Grb2 gene (Grb2(+/-) mice) appear normal at birth but have defective T cell signaling. In response to pressure overload, cardiac p38 MAPK and JNK activation was inhibited and cardiac hypertrophy and fibrosis was blocked in Grb2(+/-) mice.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2003 Mar 111(6) 833-41",
                "id": "12639989"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070958"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Additionally, transient activation of JNK can also  mediate survival signaling via JunD, which collaborates with NF-kappaB to  increase the expression of the survival gene cIAP-2 ( 13 ).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 7 278(45) 44091-6",
                "id": "12939259"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070955"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Recent studies have revealed that oxidative stress can activate c-Jun N-terminal kinase (JNK), and the oxidative stress-JNK pathway is an important apoptotic pathway of cells exposed to various stresses.",
              "citation": {
                "type": "PubMed",
                "name": "Nephron 2002 May 91(1) 142-7",
                "id": "12021531"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070946"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "kidney epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "12351702;9199329",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070939"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": " inhibition of JNK activation with SP600125 decreased pulmonary neutrophil recruitment after exposure to aerosolized LPS ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Sep 15 175(6) 4049-59",
                "id": "16148154"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070936"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Correspondingly, TACI activation in a B cell line results in nuclear factor kappaB and c-Jun NH(2)-terminal kinase activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2000 Jul 3 192(1) 137-43",
                "id": "10880535"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407091d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We found that MAP kinases JNK1 and JNK2 were specifically phosphorylated in macrophages exposed to oxLDL. Using cells isolated from SRA, TLR2, or CD36 null mice, and phospholipid ligands specific for either SRA or CD36, we showed that JNK activation was mediated by CD36.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Metab 2006 Sep 4(3) 211-21",
                "id": "16950138"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070908"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "As shown in Fig. 3D, the JNK phosphorylation enhanced by JSAP1 was suppressed by the Src inhibitor and a dominant negative form of p130Cas (?SD). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Nov 11 280(45) 37772-81",
                "id": "16141199"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070905"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "expression of dominant interfering mutants of p130Cas or Crk specifically inhibited JNK but not ERK activation by Pyk2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 May 21 274(21) 14893-901",
                "id": "10329689"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Stimulation of TLRs leads to activation of NF-?B, MAPKs, JuN N-terminal kinases (JNKs), p38 and ERKs, and interferon regulatory factor (IRF3, IRF5 and IRF7) signalling pathways5.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2009 Jan 9(1) 57-63",
                "id": "19052556"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708d3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Results showed a time-dependent response of increased Txnip expression and p38 MAPK and JNK phosphorylation by ceramide in both Jurkat T cells (Figure 6A) and 10I cells (Figure S4A). ",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2008 Apr 15 111(8) 4365-74",
                "id": "18270325"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708d1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Katz et al. (2000) presented evidence that overexpression of mammalian tensin activates both the JNK (601158) and p38 MAPK (600289) pathways. Tensin-mediated JNK activation was independent of the activities of Rac (602048) and Cdc42 (116952), but did depend on Sek (601335).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Jan 22 99(2) 733-8",
                "id": "11792844"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708cd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "It is known that LPS stimulation leads to increased activation of three subgroups of MAPKs, i.e., ERK, JNK, and p38, in murine macrophages and human monocytes (38, 39).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Aug 1 169(3) 1401-9",
                "id": "12133965"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708cb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "In embryonic fibroblasts (EFs) derived from TRAF6 knockout mice, IL-17 failed to activate the IkappaB kinases (IKKs) and JNK. Consequently, IL-17-induced IL-6 and intercellular adhesion molecule 1 expression in the TRAF6-deficient cells was abolished.",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2000 Apr 3 191(7) 1233-40",
                "id": "10748240"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708c3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "the transcriptional activity of the AP1 subunit c-Jun is enhanced through phosphorylation on Ser63/73 by members of the JNK subfamily in response to inflammatory cytokines",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Med 2003 Mar 81(3) 168-74",
                "id": "12682725"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "DNA damage and pro-inflammatory cytokines can induce activation of ATF2 transcriptional activity by JNK .",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2011 6(8) e23802",
                "id": "21901137"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708bc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We generated Card9(-/-) mice and found that CARD9-deficient macrophages had defects in activation of the kinases p38 and Jnk but not of transcription factor NF-kappaB after bacterial and viral infection. ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Immunol 2007 Feb 8(2) 198-205",
                "id": "17187069"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708b5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "FHC is induced downstream of NF-kappaB and is required to prevent sustained JNK activation and, thereby, apoptosis triggered by TNFalpha. FHC-mediated inhibition of JNK signaling depends on suppressing ROS accumulation and is achieved through iron sequestration.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2004 Nov 12 119(4) 529-42",
                "id": "15537542"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "mong the MAPKs, it was interesting that whereas TNF-induced c-Jun N-terminal kinase (JNK) activation was abolished, activation of p44/p42 MAPK and p38 MAPK was potentiated in PKR-deleted cells.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2007 Feb 22 26(8) 1201-12",
                "id": "16924232"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708aa"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "JNK1 associates with p53 in vivo, with or without activation, confirming that JNK1 is indeed a p53 kinase. Interestingly, activated JNK2 and JNK3 also phosphorylate serine 34 of mouse p53. Furthermore, JNK2 and JNK3 also associate with p53 in vivo, indicating that not only JNK1, but also JNK2 and JNK3 are p53 N-terminal serine 34 kinases",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1997 Nov 6 15(19) 2277-87",
                "id": "9393873"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708a9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "loss of MKK7 expression resulted in impaired JNK activation in MEFs at the basal level and after stimulation with tumour necrosis factor alpha (TNF-alpha) or UV irradiation (Fig. 2a).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2004 Mar 6(3) 215-26",
                "id": "15039780"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708a4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "JNK, which phosphorylates ATF2 in Thr-69 and Thr-71,",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jun 25 279(26) 27458-65",
                "id": "15105425"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407089e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "activation of AKT2 inhibits UV- and TNF alpha-induced c-Jun N-terminal kinase and p38 activities that have been shown to be required for stress- and TNF alpha-induced programmed cell death",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 16 277(33) 29973-82",
                "id": "12048203"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407089c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Fetal hematopoietic cells and embryonic fibroblasts deficient in p38alpha showed increased proliferation resulting from sustained activation of the c-Jun N-terminal kinase (JNK)-c-Jun pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Genet 2007 Jun 39(6) 741-9",
                "id": "17468757"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070891"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "hematopoietic",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Addition of LPC (30 ug/mL, 12 hours) to WT-EC induced the expression of TNFalpha mRNA and protein in a ROS- and JNK-dependent manner (Figure 4A)",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2011 May 31(5) 1084-92",
                "id": "21372295"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407088f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "As shown in Fig. 1A, the phosphorylation of p38 and ERK was decreased in Traf2-/- cells, indicating that TRAF2 also functions in the TNF-induced activation of p38 and ERK. Consistent with a previous study (Yeh et al., 1997), JNK activation by TNF in Traf2-/- cells was also decreased.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO Rep 2003 Jun 4(6) 623-7",
                "id": "12776182"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407088a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Large VT ventilation of JNK knockout mice and pharmacologic JNK inhibition with SP600125 attenuated neutrophil sequestration and blocked MIP-2 messenger RNA expression and MIP-2 production.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Crit Care Med 2004 Feb 15 169(4) 518-24",
                "id": "14644930"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070888"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We further demonstrate that JNK1, activated by its upstream kinase MKK7, negatively regulated the tyrosine phosphorylation and DNA binding and transcriptional activities of Stat3 stimulated by EGF.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Oct 22 274(43) 31055-61",
                "id": "10521505"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070887"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We show that H(2)O(2) increases acetylcholinesterase (AChE) expression via transcriptional activation through c-Jun N-terminal kinase (JNK)",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2008 Apr 4",
                "id": "18385943"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070882"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "MLK2 is an upstream activator of JNKs and activation of MLK2-mediated signaling cascades play roles in neurodegenerative and apoptotic mechanisms in the central nervous system.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Endocrinol 2003 Dec 31 213(1) 71-8",
                "id": "15062575"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070872"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Overexpression of either wild-type (WT)-FAK or WT-JIP3 enhanced phosphorylation and kinase activation of JNK and reduced the inhibitory effect of cyclic MS. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2009 Sep 297(3) L520-9",
                "id": "19574423"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070870"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Furthermore, GA treatment induces MAPKs activation (SAPK/JNK and p38) and Hsp70 expression in ROS dependent manner, suggesting that GA turns on the signaling pathway by generation of ROS through Rac1.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biochem 2004 Apr 259(1-2) 23-33",
                "id": "15124904"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070849"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Rapid activation of mitogen-activated protein kinases (Erk1/2, p38, and JNK MAPK) were observed in CSE-treated NL cells.  ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Am Thorac Soc 2006 Aug 3(6) 466",
                "id": "16921106"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070844"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We found JNK to be downstream of RhoB activation and that suppression of RhoB activity, either by reducing RhoB protein levels directly or reducing the amount of stimulating GEFs, Ect2 and Net1, was sufficient to inhibit JNK phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2011 6(2) e17108",
                "id": "21373644"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070841"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Importantly, we found that c-Jun NH(2)-terminal kinase (JNK) was activated in HCC cell lines overexpressing Pak1",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2007 Apr 15 67(8) 3601-8",
                "id": "17440071"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070834"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Although TRAF2 is known to be required for TNF-induced JNK and NF-kappaB activation",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Aug 23(16) 5849-56",
                "id": "12897154"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070832"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Figure 3.  T1/ST2 activates AP-1 via c-Jun N-terminal kinase",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 20 277(51) 49205-11",
                "id": "12368275"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407081e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "DHC induced rapid and high-sustained c-Jun NH(2)-terminal kinase (JNK)/extracellular signal-regulated kinase (ERK) activation",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Exp Ther 2009 Apr 329(1) 112-22",
                "id": "19139269"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": ". NESK belongs to the germinal center kinase (GCK) family and selectively activates the c-Jun N-terminal kinase (JNK) pathway when overexpressed in cultured cells",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2005 Nov 17(11) 1439-48",
                "id": "15913957"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707ea"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "2 hours after the LPS stimulation, the phosphorylation levels of ERK1/2, p38 MAPK and JNK all increased.  ",
              "citation": {
                "type": "PubMed",
                "name": "Chin Med J (Engl) 2007 Jun 20 120(12) 1075-81",
                "id": "17637225"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "As ETS activates transcription factors like NF-kB and AP-1, we also assayed the JNK upon exposure to ETS. ETS activated JNK almost in all the regions of the brain that were exposed to ETS as compared to control (Fig. 4A).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2006 May 28 71(11) 1602-9",
                "id": "16569398"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707e2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Overexpression of full-length JSAP1 in COS-7 cells led to a considerable enhancement of JNK3 activation, and modest enhancement of JNK1 and JNK2 activation, by the MEKK1-SEK1 pathway",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Nov 19(11) 7539-48",
                "id": "10523642"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707d8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Fetal hematopoietic cells and embryonic fibroblasts deficient in p38alpha showed increased proliferation resulting from sustained activation of the c-Jun N-terminal kinase (JNK)-c-Jun pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Genet 2007 Jun 39(6) 741-9",
                "id": "17468757"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707d1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "inhibition of Rac1, PI3-kinase, or JNK blocked the fibroblast migration significantly",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2010 5(8) e12228",
                "id": "20808927"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707cf"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "a dimeric Smac/DIABLO molecule is required for binding to BIR2, but not to BIR3, which indicates significant differences in the affinity or mechanism by which Smac/DIABLO binds to these domains Figure 5: Association of IAPs with signalling complexes.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2002 Jun 3(6) 401-10",
                "id": "12042762"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707cd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": " We confirmed this hypothesis by showing that p53-dependent signaling through c-jun N-terminal kinase (JNK) led to increased cJun-Ser63 phosphorylation and that inhibition of JNK-mediated cJun activation using p53- or JNK-specific inhibitors significantly reduced IL gene expression and subsequent production of IL8.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2010 Jun 31(6) 1149-57",
                "id": "20382639"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "In contrast, targeted deletion of Jnk3 not only reduces the stress-induced JNK activity",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Dec 9 100(25) 15184-9",
                "id": "14657393"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707b0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "t seems that at least two different pathways, JNK pathway and Rho-associated kinase pathway, are involved in the CCR7-mediated migration of mature DCs. Thus, we demonstrate herein a novel role of JNK for regulating chemokine-induced DC migration.",
              "citation": {
                "type": "PubMed",
                "name": "Int Immunol 2005 Sep 17(9) 1201-12",
                "id": "16027136"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707ad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "IgE triggers the activation of three members of the mitogen-activated protein (MAP) kinase family, c-Jun amino-terminal kinase (JNK), p38 MAP kinase (p38), and extracellular signal-regulated kinases. SCF similarly activates all three MAP kinases.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Feb 15 162(4) 2087-94",
                "id": "9973482"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707a9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "(Fig. 1) The PCP pathway activates Dvl, small G proteins (Rho or Rac), and Rho kinase or JNK, resulting in regulation of the cytoskeleton, cell migration, and cell polarity.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Mol Med 2006 Feb 28 38(1) 1-10",
                "id": "16520547"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070797"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "In addition, TNF-a activates the JNK pathway, mediating an increased serine phosphorylation of IRS-1 and reducing insulin- stimulated tyrosine phosphorylation of IRS-1",
              "citation": {
                "type": "PubMed",
                "name": "Prostaglandins Leukot Essent Fatty Acids 2005 Jul 73(1) 65-75",
                "id": "15936183"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070794"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "These results indicate that JNK is the primary kinase to phosphorylate Bim, but its requirement can be overturned by increasing the level of stress.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2006 Feb 20 580(5) 1320-6",
                "id": "16458303"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070792"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Treatment with roflumilast significantly suppressed LPS-induced activation of JNK and p38 MAP kinase concentration dependently (Fig. 6)",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Exp Ther 2005 Dec 315(3) 1188-95",
                "id": "16126838"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070784"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We have found that JNK catalyzes the phosphorylation of the BH3-only protein BAD at the distinct site of serine 128 in vitro. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 25 277(43) 40944-9",
                "id": "12189144"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070783"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "The similarities between Bmf and Bim include the presence of a conserved phosphorylation site (Bmf Ser74 and Bim Thr112) that is a substrate for the c-Jun NH2-terminal kinase (JNK) (15). Data from biochemical studies indicate that the JNK-mediated phosphorylation of Bmf and Bim may increase apoptotic activity (15).  ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2010 Jan 30(1) 98-105",
                "id": "19841067"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070774"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Here, we have shown that MKK7, but not SEK1/ MKK4, is activated by Fas as an activator for JNK/ SAPK and that MKK6 is a major activator for p38 in Fas signaling",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 1997 Nov 17 139(4) 1005-15",
                "id": "9362518"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070772"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "exercise leads to the activation of at least three MAPK signalling pathways, i.e. ERK1/2, p38 MAPK and JNK, in skeletal muscle (Zierath, 2002).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Nutr Soc 2004 May 63(2) 227-32",
                "id": "15294035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070771"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "These data indicate that in BMMC, Lyn contributes to SCF-induced phosphorylation of Kit, as well as phosphorylation of Jnks and Stat3.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2005 Jan 17(1) 103-9",
                "id": "15451030"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407076b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We found that 20% CSE caused significant increases in the phosphorylation of all three MAPK members (ERK1/2, p38, and JNK) within from 10 min to 1hr of exposure (Fig. 2).",
              "citation": {
                "type": "PubMed",
                "name": "J Toxicol Sci 2010 35(1) 33-9",
                "id": "20118622"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070769"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "In HUVECs under low shear stress, siRNA knockdown and SP600125 inhibition of JNK attenuated nuclear factor (NF)-kB activity and VCAM-1 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Med 17(9-10) 990-9",
                "id": "21629969"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070758"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "SUMO-1 modification inhibited HIPK2-induced JNK activation and p53-independent antiproliferative function",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Aug 12 280(32) 29224-32",
                "id": "15958389"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407074f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "IL-22 induces the activation of the ERK, JNK, and p38 MAPK pathways that are not activated by IL-10 ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 13 277(37) 33676-82",
                "id": "12087100"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407074b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatoblastoma cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "found that Chat-H forms a complex with Pyk2H and enhances its tyrosine 402 phosphorylation, an up-regulator of the JNK pathway",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 21 278(8) 6012-7",
                "id": "12486027"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070749"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "in Chat-overexpressed cells, the activity of c-Jun N-terminal kinase was up-regulated",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Mar 3 275(9) 6404-10",
                "id": "10692442"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070728"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "ROS activated autophagy via the c-Jun NH(2)-terminal kinase (JNK).",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2011 Oct 1 51(7) 1365-75",
                "id": "21763418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070727"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Eighty-one percent of SCCs examined exhibited either strong or moderately strong induction of phosphorylated JNK (pJNK) over normal tissues (Fig. 1A).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2007 Apr 15 67(8) 3827-34",
                "id": "17440097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407071f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Squamous Cell",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Interestingly, highly activated JNK was detected in IPF- and BLM-instilled lung tissue samples, which was dramatically suppressed by ad-cav-1 infection.",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2006 Dec 25 203(13) 2895-906",
                "id": "17178917"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407071c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "he platelet-derived growth factor controls c-myc expression through a JNK- and AP-1-dependent signaling pathway",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 12 278(50) 50024-30",
                "id": "14523011"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407070f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Here, we reveal that LZK forms dimers/oligomers through its dual leucine zipper-like motif, and that this is necessary for activation of the JNK/SAPK pathway. ",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2001 Jan 19 488(3) 190-5",
                "id": "11163770"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070709"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "c-Jun N-terminal kinase (JNK) is a serine threonine protein kinase that phosphorylates c-Jun (1, 2), a component of the transcription factor activator protein-1 (AP-1; refs. 3 and 4).",
              "citation": {
                "type": "PubMed",
                "name": "Cell Death Differ 2011 Jan 18(1) 26-37",
                "id": "20539307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706e9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Cyclosporin A inhibited Fc epsilon RI-mediated JNK and p38 activation, but did not affect the activation of these kinases when stimulated through the SCFR.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Feb 15 162(4) 2087-94",
                "id": "9973482"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706e4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "FGF-1-induced OPN expression was blocked by inhibitors of JNK or MEK1/2 but not of PI3K, p70S6K, or p38MAPK",
              "citation": {
                "type": "PubMed",
                "name": "J Appl Physiol 2004 Oct 97(4) 1550-8; discussion 1549",
                "id": "15121739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706c7"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "the transcriptional activity of the ATF-2 transcription factor, as a direct p38 and JNK target in syndecan-4-null and wild type cells. In the absence of syndecan-4, both ATF-2 phosphorylation and transcriptional activity were significantly more elevated compared with wild type cells, and both activities were decreased either by the re-expression of syndecan-4 or by the expression of RacN17.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 5 279(45) 47172-6",
                "id": "15371457"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706bc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We found that the overexpression of FADD sensitizes etoposide-induced apoptosis through a rapid activation of c-Jun NH(2)-terminal kinase (JNK) and, subsequently, of caspase 3.",
              "citation": {
                "type": "PubMed",
                "name": "Jpn J Cancer Res 2002 Oct 93(10) 1164-74",
                "id": "12417047"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706b2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "This report documents the fact that inhibition of arachidonate 5-lipoxygenase induces rapid activation of c-Jun N-terminal kinase (JNK) in human prostate cancer cells which is prevented by the 5-lipoxygenase metabolite, 5(S)-HETE",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2003 Jul 25 307(2) 342-9",
                "id": "12859962"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706aa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": " In addition, inhibition of JNK and p38 suppressed TGFbeta induction of TGFbeta3 transactivation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Oct 6 281(40) 29479-90",
                "id": "16891311"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407069e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "In addition, in vivo matrigel plug assay further showed that SP600125 inhibited VEGFA-induced angiogenesis. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Biochem Biophys 2012 May 17",
                "id": "22592917"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070698"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Significantly, the JNK activation induced by anti-CD3 and anti-CD28 antibodies, but not by 12-O-tetradecanoylphorbol-13-acetate and Ca(2+) ionophore A23187, was inhibited by dominant negative Map3k2 mutant",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 4 276(18) 14784-90",
                "id": "11278622"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070694"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Interestingly, Wnt5a and Ror2 activate the non-canonical Wnt pathway, as assessed by activation of JNK in cultured cells a",
              "citation": {
                "type": "PubMed",
                "name": "Genes Cells 2003 Jul 8(7) 645-54",
                "id": "12839624"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070693"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "expression of activated mNET1 also activates the SAPK/JNK pathway",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1998 Jul 15 17(14) 4075-85",
                "id": "9670022"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070687"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "c-Jun NH(2)-terminal kinase tended to induce the phosphorylation of Smad2/3L in human colorectal adenoma-carcinoma sequence (phosphorylation increases formation of SMAD234 complex)",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Jan 1 65(1) 157-65",
                "id": "15665291"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070682"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "paraquat activates the IRE1/ASK1/JNK cascade associated with apoptosis in SY5Y cells",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Lett 2009 Dec 15 191(2-3) 203-10",
                "id": "19735704"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407067e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "neuroblastoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Consistent with this finding, we found that the JNK pathway was activated when acLDL was applied to HEK 293-SR-A cells (Fig. 7B). Moreover, when these cells were treated with a JNK inhibitor (SP600125), the uptake of DiI-acLDL was reduced dose-dependently (by 20.059.8%, Fig. 7A).",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 2009 Nov 47(5) 646-55",
                "id": "19699207"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070670"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Mitogen-activated protein kinase upstream kinase/dual leucine zipper-bearing kinase/leucine-zipper protein kinase (MUK/DLK/ZPK) is a MAPKKK class protein kinase that induces JNK/SAPK activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jul 14 275(28) 21247-54",
                "id": "10801814"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070667"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "The bFGF-mediated surface cadherin downregulation was significantly reversed only when the HUVECs were treated with JNK inhibitor (SP600125), but not ERK (PD98059) or p38 inhibitor (SB203580).",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2008 Feb 1 314(3) 421-9",
                "id": "18164704"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070655"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We also show that, in response to DNA damage, activation of the c-Jun N-terminal kinase (Jnk) induces phosphorylation of 14-3-3 proteins and their release from c-Abl. Together with these results, expression of an unphosphorylated 14-3-3 mutant attenuates DNA-damage-induced nuclear import of c-Abl and apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2005 Mar 7(3) 278-85",
                "id": "15696159"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070653"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Traf2- and Nck-interacting kinase (TNIK) mediates the transactivation of Wnt target genes and promotes the activity of c-Jun N-terminus kinase (JNK)2 when overexpressed",
              "citation": {
                "type": "PubMed",
                "name": "Hum Cell 2011 Sep 24(3) 121-6",
                "id": "21710359"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070651"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "colorectal adenoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "paclitaxel greatly increased c-Jun N-terminal protein kinase (JNK) activity whereas showing a small enhancing effect on extracellular-regulated kinases (ERK) activity.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Lett 2003 Apr 10 193(1) 57-64",
                "id": "12691824"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407064d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "As shown in Fig. 4A, IL-33 induced transient increases in the levels of phospho-IkBalpha (IKK-2 substrate) and phospho-c-JUN (JNK substrate) with peak times at 5 and 30 min, respectively.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2010 Sep 10 316(15) 2527-37",
                "id": "20406635"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070646"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "GRX is a negative regulator of ASK1 and dissociation of GRX from ASK1 activates ASK1-SEK1-JNK1 signaling leading to cytotoxicity during glucose deprivation. These results support the hypothesis that the GRX-ASK1 interaction is redox sensitive and regulated in a glutathione-dependent fashion by H(2)O(2).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 29 277(48) 46566-75",
                "id": "12244106"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407063d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Frabin is an actin filament-binding protein which shows GDP/GTP exchange activity specific for Cdc42 small G protein and induces filopodium-like microspike formation and c-Jun N-terminal kinase (JNK) activation presumably through the activation of Cdc42",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Jun 22 19(27) 3050-8",
                "id": "10871857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070636"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "JNK inhibitor downregulated TF expression in thrombin/paclitaxel-stimulated HAECs",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2010 Jan 1 391(1) 716-21",
                "id": "19944065"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070634"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "cyclosporin A blocks angiotensin II-induced mitogen-activated protein kinase activation in cultured primary cardiomyocytes and in the heart of hypertensive mice.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Dec 29 275(52) 40867-73",
                "id": "11016940"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407062b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "These results demonstrate that activin B promotes epithelial wound closure in vivo through the RhoA-Rock-JNK-cJun signaling pathway",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2011 6(9) e25143",
                "id": "21949871"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070625"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Unexpectedly, in tumors induced by the K12D oncogene, the K-Ras mutant protein does not interact with Raf-1 nor activates the Erk canonical pathway. Instead, it transduces signals through the PI3K/Akt, JNK, p38 and FAK pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2006 Nov 27(11) 2190-200",
                "id": "16679305"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070624"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "GLK specifically activated the JNK, but not the p42/44(MAPK)/extracellular signal-regulated kinase or p38 kinase signaling pathways",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1997 Sep 2 94(18) 9687-92",
                "id": "9275185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070619"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Signal transduction pathway inhibitors (SB203580, curcumin, and PD98059) implicated p38 and JNK",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2005 Mar 19(3) 443-5",
                "id": "15640282"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070618"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We also showed that 7-Kchol activated the IRE-1/Jun-NH(2)-terminal kinase (JNK)/AP-1 signaling pathway to promote Nox-4 expression. Silencing of IRE-1 and JNK inhibition downregulated Nox-4 expression and subsequently prevented the UPR-dependent cell death induced by 7-Kchol. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Dec 24(24) 10703-17",
                "id": "15572675"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070616"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "activation of Jnk was inhibited by dominant-negative Ras and Rac1 and by the phosphoinositide 3-kinase inhibitor",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 May 1 16(9) 2365-75",
                "id": "9171350"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070613"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Inhibitors of ERK (U0126, PD98059, and ERK1/2 antisense phosphorothioate oligonucleotide), JNK (SB203580, SP600125, and curcumin), and p38 (SB203580 and SB202190) pathways down-regulated the TNF-stimulated expression of MMP-13.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2003 Aug 1 288(1) 208-17",
                "id": "12878172"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070604"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "chondrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "sLRP1, which was purified from human plasma, and full-length LRP1, purified from mouse liver, activated cell signaling when added to cultures of RAW 264.7 cells and BMMs. Robust activation of p38 MAPK and JNK was observed. The IKK-NF-??B pathway was transiently activated.",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2010 Oct 88(4) 769-78",
                "id": "20610799"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705fc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Pretreating the confluent EC monolayer with a blockingtype anti-avb3 mAb blocked shear stress activation of ERK, c-Jun N-terminal kinase (JNK), and the IkB complex.19,24",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2002 Nov 1 91(9) 769-75",
                "id": "12411390"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705f4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Stimuli such as ultraviolet irradiation and chemical reagents that damage genomic DNA induce the activation of the SAPK/JNK signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Jul 26 25(14) 3286-97",
                "id": "16810318"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705df"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "MKK7, a c-Jun N-terminal kinase (JNK) activator",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 28 277(26) 23919-26",
                "id": "11959862"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705dc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "DN mutants of Rac1 (DN-Rac1) and MEK kinase (DN-MEKK1) also abolished it",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Sep 1 275(35) 26856-63",
                "id": "10856308"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705cf"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "The small GTP-binding protein Rac is a downstream effector of the oncogene product p21-ras. Rac is involved in actin polymerization, Jun kinase activation, and intracellular superoxide anion production, through distinct pathways in tumor cells.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Sep 27 20(43) 6263-8",
                "id": "11593437"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705c9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "IL-18 induced CXCL16 expression via a MyD88 --> IRAK1-IRAK4-TRAF6 (tumor necrosis factor receptor-associated factor 6) --> c-Src--> PI3K --> Akt --> JNK --> AP-1 pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 May 11",
                "id": "15890643"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705c3"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "The neurotrophin receptor p75 can induce apoptosis both in vitro and in vivo p75 activates Rac GTPase, which in turn activates c-jun N-terminal kinase (JNK), including an injury-specific JNK3, in an NGF-dependent manner",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2002 Jan 1 22(1) 156-66",
                "id": "11756498"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705b5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Expression of activated ALK7 in PC12 cells resulted in activation of Smad2 and Smad3, but not Smad1, as well as the mitogen-activated protein kinases extracellular signal-regulated kinase and c-Jun N-terminal kinase",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 16 276(7) 5140-6",
                "id": "11084022"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705a1"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "senescence-like growth arrest was accompanied by impaired activation of mitogen-activated protein kinase (MAPK) pathways, namely, extracellular-regulated protein kinase, c-jun N-terminal kinase and p38 MAPK, in response to epidermal growth factor (EGF) and insulin-like growth factor-I (IGF-I)",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Jan 12 25(2) 176-85",
                "id": "16170353"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070599"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Thus, both p38 and SAPK/Jun N-terminal kinase mitogen-activated protein kinases (MAPKs) are activated on stimulation of these cells with either T- or M-tropic gp120, as well as with SDF-1alpha or MIP-1beta.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2001 Aug 1 98(3) 541-7",
                "id": "11468147"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070585"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "JNK is activated by TNF-alpha in cardiomyocytes",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2002 Nov 16(13) 1732-7",
                "id": "12409315"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070584"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Activation of IKK and JNK requires the N-terminal RING and Zn-finger motifs of TRAF2 [15] and [22] .",
              "citation": {
                "type": "PubMed",
                "name": "Trends Cell Biol 2001 Sep 11(9) 372-7",
                "id": "11514191"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407057e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Malfolded proteins in the endoplasmic reticulum (ER) induce cellular stress and activate c-Jun amino-terminal kinases (JNKs or SAPKs).",
              "citation": {
                "type": "PubMed",
                "name": "Science 2000 Jan 28 287(5453) 664-6",
                "id": "10650002"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070574"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "We showed that the fast-releasing NO donor DPTA-NO significantly enhanced the phosphorylation levels of the MAP kinases JNK and p38, which increased to a peak within 3 h (about six- and ninefold, respectively), but did not affect the high basal level of ERK1/2 kinase phosphorylation in U937 cells (Figs. 6A, B, and D)",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2010 Jan 15 48(2) 298-305",
                "id": "19892011"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070570"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "TNF can also activate JNK (Kyriakis et al. 1994; Sluss et al. 1994) by a TRAF2-dependent mechanism (Yeh et al. 1997).",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2004 Dec 1 18(23) 2905-15",
                "id": "15545623"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070567"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "These data demonstrate that BimL is phosphorylated in vivo on Thr-56 and that JNK also phosphorylates BimL on at least one serine residue (Ser-44 and/or Ser-58)...JNK Phosphorylation of Bim on Thr-56 Increases Apoptotic Activity. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Mar 4 100(5) 2432-7",
                "id": "12591950"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407054f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "retroviral-mediated RNA interference knockdown of MKK7, the upstream activator of JNK, also prevented s.c. tumor growth of A431, SCC25, and primary keratinocytes transformed by Ras and IkBa (Fig. 2B-D).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2007 Apr 15 67(8) 3827-34",
                "id": "17440097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407052c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "TNFR-associated factor 2 recruitment, which in turn recruits and activates apoptosis signal-regulating kinase-1, leading to downstream activation of c-Jun N-terminal/stress-activated protein kinases (JNK/SAPK)",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Sep 15 163(6) 2990-8",
                "id": "10477561"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070528"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Transforming growth factor-beta-activated kinase 1 (TAK1) is a member of the MAPK kinase kinase (MAPKKK) family and can activate JNK and p38.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Sep 29 281(39) 28802-10",
                "id": "16893890"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070525"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Ectopic expression of a dominant-negative SEK1 mutant or chemical JNK inhibition reduced Abeta-induced JNK activation and p66Shc phosphorylation (Ser36), suggesting that JNK phosphorylates p66Shc. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2005 Apr 25 169(2) 331-9",
                "id": "15837797"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070521"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "PKCalpha, betaI, and betaII were all involved in activation of JNK, Map3k2, and ERK5",
              "citation": {
                "type": "PubMed",
                "name": "Cell Immunol 2005 Nov 238(1) 10-8",
                "id": "16430878"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407051b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Interestingly, Wnt5a and Ror2 activate the non-canonical Wnt pathway, as assessed by activation of JNK in cultured cells a",
              "citation": {
                "type": "PubMed",
                "name": "Genes Cells 2003 Jul 8(7) 645-54",
                "id": "12839624"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070519"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK JNK Family\") actsIn kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "Treatment of BEAS-2B cells with TFF2 resulted in the phosphorylation of the MAPK ERK1/2 and the JNK (Fig. 4).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 24 277(21) 18440-6",
                "id": "11884401"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407050e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:HRAS)",
        "relation": "actsIn",
        "target": "gtp(p(HGNC:HRAS))",
        "directed": false,
        "label": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526d5",
          "evidences": [
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "This result indicates that activation of MEK1, which is located downstream of the pathway, is able to cancel the induction of CNTF expression by Gap1 m .Human: The protein encoded by this gene is member of the GAP1 family of GTPase-activating proteins. The gene product stimulates the GTPase activity of normal RAS p21 but not its oncogenic counterpart. Acting as a suppressor of RAS function, the protein enhances the weak intrinsic GTPase activity of RAS proteins resulting in the inactive GDP-bound form of RAS, thereby allowing control of cellular proliferation and differentiation. This particular family member has a perinuclear localization and is an inositol 1,3,4,5-tetrakisphosphate-binding protein; a compound suggested to function as a second messenger. Rat: activates Ras GTPase [RGD]",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2001 Apr 77(2) 700-3",
                "id": "11299332"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d7c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Schwann cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "However, expression of mGFP-H-RasG12V resulted in a substantial increase both in the extent of mRFP-Gal-1 clustering (Figure 1A), and in the total amount of mRFP-Gal-1 recruited to the plasma membrane. To validate this interpretation plasma membrane sheets from cells co-expressing mGFP-H-RasG12V and mRFP-Gal-1 were co-labeled with different sized gold particles. The bivariate K-function analysis of the resulting 2nm / 6nm point 7 pattern shows that H-RasG12V and Gal-1 co-localize in nanoscale clusters on the inner leaflet of the plasma membrane.These results formally demonstrate that Gal-1 is a component of GTP-H-Ras signaling nanoclusters.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2008 Jan 30",
                "id": "18234837"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d30"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "The zinc finger transcription factor GLI1, which mediates Sonic hedgehog signaling during development, is expressed in several human cancers, including basal cell carcinoma, medulloblastoma, and sarcomas. We identified 147 genes whose levels of expression were significantly altered in RNA obtained from cells demonstrating a transformed phenotype with stable GLI1 expression or stable Ha-ras expression. Comparison of expression profiles from GLI1- and Ha-ras-expressing cells established a set of genes unique to GLI1-induced cell transformation. Thirty genes were altered by stable GLI1 expression, and 124 genes were changed by stable Ha-ras expression. Seven genes had altered expression levels in both GLI1- and Ha-ras-expressing cells. Genes whose expression was altered by GLI1 included cell cycle genes, cell adhesion genes, signal transduction genes, and genes regulating apoptosis. GLI1 consensus DNA-binding sequences were identified in the 5' regions of cyclin D2, IGFBP-6, osteopontin, and plakoglobin, suggesting that these genes represent immediate downstream targets. Gel shift analysis confirmed the ability of the GLI1 protein to bind these sequences. Up-regulation of cyclin D2 and down-regulation of plakoglobin were demonstrated in GLI1-amplified compared with non-amplified human rhabdomyosarcoma cells. Many of the GLI1 targets with known function identified in this study increase cell proliferation, indicating that GLI1-induced cell transformation occurs through multiple downstream pathways.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Feb 15 277(7) 5548-55",
                "id": "11719506"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Therefore, the apoptotic effects of cytotoxic chemotherapy on proliferating vascular endothelium could contribute to the anti-tumor efficacy of chemotherapy in vivo. While it is relatively simple, however, to study chemotherapy-induced apoptosis of endothelial cells or tumor cells separately in vitro, it is not trivial to analyze apoptosis in these two populations when they are crowded together in a tumor. Browder et al. approached this problem by carrying out animal experiments in which the apoptotic effect of cytotoxic chemotherapy on endothelial cells in a tumor bed was dissociated from the apoptotic effect of cytotoxic chemotherapy on tumor cells supported by these endothelial cells [35]. Browder et al. hypothesized, that the tradition of administering chemotherapy at maximum tolerated dose (MTD), required a treatment-free interval to allow recovery of the bone marrow and gastrointestinal tract. During the treatment-free interval, microvascular endothelial cells in the tumor bed could resume their proliferation and support tumor regrowth. When tumor-bearing mice were treated with cyclophosphamide at a conventional maximum tolerated dose followed by a 21-day interval to rescue bone marrow, ('conventional schedule'), tumors recurred after each cycle. All animals eventually died of large tumors which had a diminished response to cyclophosphamide after each cycle, i.e. the tumors developed acquired drug resistance. In contrast, if cyclophosphamide was administered more frequently and at lower doses ('antiangiogenic schedule'), without a prolonged treatment-free interval, all tumors regressed and all animals survived without bone marrow suppression or other toxicity. Then the tumors were made drug-resistant to cyclophosphamide. On the 'conventional schedule', animals died even more rapidly with large tumors as drug resistant tumor cells continued to proliferate unaffected by cyclophosphamide. However, the 'antiangiogenic schedule' significantly inhibited tumor growth, but there was still very slow tumor growth. It was not possible to raise the low dose of cyclophosphamide to a level sufficient to induce apoptosis of the remaining endothelial cells in the tumor bed, without provoking bone marrow suppression. Therefore, a low dose of a pure angiogenesis inhibitor, TNP-470 was added. This inhibitor by itself could not slow this tumor by more than 65%. However, when combined with cyclophosphamide on the antiangiogenic schedule, there was complete tumor regression and long-term survival in all but one animal. Immunohistochemical analysis (Fig. 3) revealed extensive endothelial apoptosis that preceded tumor cell apoptosis by 4-5 days, despite the fact that the tumor cells were resistant to cyclophosphamide and not directly affected by TNP-470. This experiment reveals an endothelial-dependence of cytotoxic chemotherapy that is concealed before tumor cells have acquired drug resistance. Klement et al. obtained similar results by administering continuous low dose vinblastine to tumor-bearing mice in combination with a VEGF receptor antibody [36]. Furthermore, these results might also help to explain why some patients who receive long-term maintenance or even palliative chemotherapy have stable disease beyond the time that the tumor would have been expected to develop drug resistance. Patients with slow-growing cancers who are on 'antiangiogenic scheduling' of chemotherapy involving continuous infusion 5-fluorouracil [37-39], weekly paclitaxel [40,41], or daily oral etoposide [42-44], have shown an improved outcome--despite the fact that in some of these patients the tumors had already become drug resistant to conventional chemotherapy. Antiangiogenic chemotherapy has also been called 'metronomic' therapy [45], but the two terms do not have precisely the same meaning. 'Antiangiogenic chemotherapy' signifies that the target of the chemotherapy is microvascular endothelium in the tumor b...",
              "citation": {
                "type": "PubMed",
                "name": "Semin Cancer Biol 2003 Apr 13(2) 159-67",
                "id": "12654259"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Oncogene-induced senescence is a cellular response that may be crucial for protection against cancer development1, 2, but its investigation has so far been restricted to cultured cells that have been manipulated to overexpress an oncogene. Here we analyse tumours initiated by an endogenous oncogene, ras, and show that senescent cells exist in premalignant tumours but not in malignant ones. Senescence is therefore a defining feature of premalignant tumours that could prove valuable in the diagnosis and prognosis of cancer.  We used a mouse model for cancer initiation in humans: the animals have a conditional oncogenic K-rasV12 allele that is activated only by the enzyme Cre recombinase3, causing them to develop multiple lung adenomas (premalignant tumours) and a few lung adenocarcinomas (malignant tumours). Senescence markers previously identified in cultured cells were used to detect oncogene-induced senescence in lung sections from control mice (expressing Cre) and from K-rasV12-expressing mice (expressing Cre and activated K-rasV12). We analysed p16INK4a, an effector of in vitro oncogene-induced senescence1, and de novo markers that we identified by using DNA microarray analysis of in vitro oncogene-induced senescence (see supplementary information). These de novo markers are p15INK4b (also known as CDKN2B), Dec1 (BHLHB2) and DcR2 (TNFRSF10D). In addition, we looked for two features evident in cultured senescent cells, namely the expression of senescence-associated beta-galactosidase4 and the presence of senescence-associated heterochromatin foci5.  Staining with antibodies against p16INK4a, p15INK4b, Dec1 and DcR2 revealed abundant positive cells in adenomas, whereas adenocarcinomas were essentially negative (Fig. 1a).",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2005 Aug 4 436(7051) 642",
                "id": "16079833"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c7b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "adenoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "However, p70S6K inhibition by rapamycin did not preclude the transactivation of the UCP-1-CAT construct induced by IGF-I but partly inhibited IGF-I induced UCP-1 mRNA expression (Valverde et al. 1997a). In addition, RAS proteins seem to be involved in insulin/IGF-I-induced UCP-1 expression. In fact, transient transfection of primary brown adipocytes with a dominant-negative form of p21ras completely abolished insulin-induced UCP-1-CAT transactivation (Lorenzo et al. 1996).",
              "citation": {
                "type": "PubMed",
                "name": "Mini Rev Med Chem 2005 Mar 5(3) 269-78",
                "id": "15777261"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c3a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "J. Adaptors Adaptors are molecules that are devoid of intrinsic catalytic activity; after binding to the PDGF receptors through their SH2 domains, they connect the receptor with downstream effector molecules. The regulatory subunits of PI 3-kinase and Grb2, which form complexes with the catalytic subunit of PI 3-kinase and Sos, respectively, are examples of adaptor molecules that have been discussed already. Other adaptor molecules that bind to PDGF receptors are Shc, Grb7, Nck, and Crk.  After binding of Shc to the PDGF receptors, it becomes phosphorylated on Tyr-317, which can be recognized by Grb2/Sos and thus contributes to Ras activation (398), as well as on Tyr-239 and Tyr-240, which initiates another signaling pathway leading to induction of c-myc (148).",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 1999 Oct 79(4) 1283-316",
                "id": "10508235"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c08"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "The RET gene encodes a transmembrane tyrosine kinase (TK) receptor whose expression and function is normally restricted to a subset of cells derived from the neural crest. In thyroid follicular cells, RET activation occurs through chromosomal recombination resulting in illegitimate expression of a fusion protein consisting of the intracellular TK domain of RET coupled to the N-terminal fragment of a heterologous gene. The promoter region of the partner gene drives constitutive expression of the chimeric gene.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2005 Apr 115(4) 1068-81",
                "id": "15761501"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c00"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "thyroid"
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Thus, one function of Rho A may be to regulate cytoskeletal organization and integrin clustering rather than integrin affinity.92 Expression of activated R-Ras increases integrin-mediated adhesion in some cells,93 but its presence in platelets has not been demonstrated. Thrombin stimulation of platelets causes GTP loading of H-Ras in a PKC-dependent manner",
              "citation": {
                "type": "PubMed",
                "name": "Blood 1998 Apr 15 91(8) 2645-57",
                "id": "9531572"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b7a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "To confirm that binding of Sin1 to H-Ras is also specific for the activated form,GSTSin1 beadswere incubated with lysates of HEK293 cells expressing either wild-type GFPH-Ras or constitutively activated GFPH-RasG12V. The beads were analysed by immunoblot using anti-GFP, which showed that GSTSin1 bound to GFPH-RasG12V (Fig. 3E, GFPH-RasG12V) but not GFPH-Ras (Fig. 3A, GFPH-Ras). These data indicate that Sin1 binds preferentially to the activated (GTP-bound) form of H- and K-Ras.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2007 Jun 19(6) 1279-89",
                "id": "17303383"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b2c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "We found that oncogenic Ras upregulates PML expression, and overexpression of PML induces senescence in a p53-dependent manner. p53 is acetylated at lysine 382 upon Ras expression, an event that is essential for its biological function. Ras induces re-localization of p53 and the CBP acetyltransferase within the PML nuclear bodies and induces the formation of a trimeric p53-PML-CBP complex. Lastly, Ras-induced p53 acetylation, p53-CBP complex stabilization and senescence are lost in PML-/- fibroblasts. ",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2000 Jul 13 406(6792) 207-10",
                "id": "10910364"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b01"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "To test whether eNOS promoted tumour growth through nitrosylation of Ras in pancreatic cancer cells, we determined which Ras family members were inactivated by eNOS shRNA in CFPac-1 and MIAPaCa-2 cells. Not surprisingly, GTP-bound KRas was unchanged on knockdown of eNOS (Fig. 4c and Supplementary Fig. 9), as KRas is mutated to remain active in these two cell lines19,20. Consistent with this, oncogenic KRas harbouring the C118S mutation remained tumorigenic (Supplementary Fig. 10), pointing towards wild-type Ras proteins as the target of eNOS signalling. Indeed, GTP-bound endogenous wild-type HRas and NRas were reduced upon shRNA knockdown of eNOS.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2008 Apr 3 452(7187) 646-9",
                "id": "18344980"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a3b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Activation of RET, either by ligand or through specific mutations, results in phosphorylation of multiple tyrosine residues that, in turn, interact with specific adaptor molecules to trigger downstream signaling. Four of the tyrosines phosphorylated on RET activation, tyrosines 905, 1015, 1062, and 1096, have been well characterized, and are known to interact with a number of adaptor molecules to stimulate signaling through phosphatidylinositol kinase (PI3K)/AKT, PLC-gamma, RAS/extracellular signal-regulated kinase (ERK), p38MAPK, JNK and ERK5.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Jul 1 64(13) 4453-63",
                "id": "15231654"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "These results imply that FRS2 and Shp2 are in a BDNF signaling pathway. Shp2 is required for complete MAPK activation by BDNF, as expression of a dominant negative Shp2 in cells attenuates BDNF-induced activation of MAPK. Moreover, expression of a dominant negative Shp2 attenuates Ras activation showing that the protein tyrosine phosphatase is required for complete activation of MAPKs by BDNF. In conclusion, Shp2 regulates BDNF signaling through the MAPK pathway by regulating either Ras directly or alternatively, by signaling components upstream of Ras.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2006 May 97(3) 834-45",
                "id": "16573649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407099a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "INTRODUCTION The ras family of oncogenes and encoded proteins has been evaluated as a putative target for anticancer therapeutic development. These efforts have resulted in new insights into Rasmediated cell signaling as it relates to human cancer. Ras plays a central role in an intricate array of signal transduction pathways, characterized by cross talk, feedback loops, and multicomponent signaling complexes.1-3 One strategy to overcome the challenges inherent in developing therapeutics against signaling elements situated in redundant pathways is to target elements downstream of convergence points of critical signaling modules. This reasoning has led, in part, to interest in Raf kinase, which is one of several downstream effectors of Ras, as a target for therapeutic development against cancer. The Raf serine/threonine kinases are the principal effectors of Ras in the mitogenactivated protein kinase (MAPK) pathway (Fig 1). Raf activation occurs immediately downstream of membrane and cytoplasmic receptors that relay mitogenic signals.4 Although principally activated by Ras,",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Oncol 2005 Sep 20 23(27) 6771-90",
                "id": "16170185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407088d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "However, it is p27 that seems to be the primary target of SKP2, given that Skp2 ko mice show a marked accumulation of p27 (REF. 24), and that prominent cellular phenotypes apparent in Skp2 00 mice (see Supplementary information S1 (table)) including nuclear enlargement, polyploidy and an increased number of centrosomes that are probably caused by overreplication of chromosomes and centrosomes disappear in Skp2 ko p27 ko double mutant mice. The oncogenic potential of SKP2 has also been shown in transgenic mouse models 35,36. Furthermore, Ras signalling induces SKP2 expression through the binding of GA-binding protein, an Ets-family transcription factor, to the SKP2 promoter37. Such evidence supports the notion that SKP2 is a growth promoter and an oncoprotein.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2006 May 6(5) 369-81",
                "id": "16633365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070859"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Oncogenic Ras induces the transcription activity of NF-kappaB that confers cell survival. Oncogenic Ras also down-modulates the expression of Par-4, a transcriptional repressor protein, that is essential but not sufficient on its own to induce apoptosis. Here we show that reintroduction of Par-4 by transient transfection leads to apoptosis in cells expressing oncogenic Ras but not in those that lack oncogenic Ras expression. Par-4 abrogates oncogenic Ras-inducible NF-kappaB transcription activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Oct 15 274(42) 29976-83",
                "id": "10514481"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407074d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "our data suggests that in N/N1003A cells, calcimycin treatment leads to RAS activation mainly through RAS-GRF2. Calcimycin not only induces translocation of the RAS-GRF2 from cytosol to plasma membrane but also causes the direct binding of RAS-GRF2 to RAS (Figure 6). Moreover, AB-crystallin that substantially blocks calcimycin-induced activation of RAS also suppresses the translocation of RAS-GRF2. Thus, through activation of the calcium-triggered RAS-GRF2, calcium can indirectly activated RAS in rabbit lens epithelial cells.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2005 Sep 16(9) 4437-53",
                "id": "16000378"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706d3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "The ERF protein is also hyperphosphorylated in cells transformed by the activated Ha-ras and v-src genes and the transcription repressor activity of ERF is decreased after co-transfection with activated Ha-ras or the kinase domain of the c-Raf-1 gene, indicating that ERF activity is probably regulated by the ras/MAPK pathway.......These data suggest that the repression ability of ERF may be regulated, at least partially, by phosphorylation of Thr526 (Substitution of Thr526 for glutamic acid also decreases the repression ability of ERF).",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1995 Oct 2 14(19) 4781-93",
                "id": "7588608"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706b4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "GST-DIP1/2 fusion protein containing the minimal Ras GAP domain (23), and either this fusion protein or GST protein was incubated with human recombinant [gamma -32P]GTP-bound Ha-Ras protein. The increasing amounts of GST-DIP1/2 (ranging from 0.2 to 1 g) stimulated Ras GTPase activity in a dose-dependent manner ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Apr 12 277(15) 12622-31",
                "id": "11812785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070686"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "From text: To determine whether the MLC-2v-ras construct would be capable of directing the expression of a functional, constitutively active Ras protein, co-transfections were performed in cultured ventricular muscle cells with an ANF luciferase reporter gene which is up-regulated by the parental Ha-ras vector, as it is by other defined hypertrophic stimuli. The studies employing the MLC-ras construct induced a 4.2  0.6-fold (mean  S.E.) increase in luciferase activity compared to the vector alone,",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Sep 29 270(39) 23173-8",
                "id": "7559464"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407059d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Despite remarkable progress in dissecting the signaling pathways that are crucial for the metabolic effects of insulin, the molecular basis for the specificity of its cellular actions is not fully understood. One clue might lie in the spatial and temporal aspects of signaling. Recent evidence suggests that signaling molecules and pathways are localized to discrete compartments in cells by specific protein interactions. Also, the rapid termination of tyrosine or lipid phosphorylation by phosphatases or serine kinases might tightly control the strength of a signaling pathway, thus determining its effect on growth, differentiation and metabolism. Insulin is the most potent anabolic hormone known, promoting the synthesis and storage of carbohydrates, lipids and proteins and inhibiting their degradation and release back into the circulation. Decreased secretion of insulin, coupled with resistance to its actions, results in type 2 diabetes, a devastating disease that is reaching epidemic proportions [1]. Even in the absence of diabetes, insulin resistance is often associated with central obesity, hypertension, polycystic ovarian syndrome, dyslipidemia and atherosclerosis. At the cellular level, insulin action is characterized by diverse effects, including changes in vesicle trafficking, stimulation of protein kinases and phosphatases, promotion of cellular growth and differentiation and activation or repression of transcription. This complexity suggests that insulin action must involve multiple signaling pathways that diverge at or near the activation of its tyrosine kinase receptor. In fact, it is likely that even individual effects of the hormone require multiple signaling inputs. Evidence is emerging that the coordination of these pathways might be governed by their intracellular compartmentalization or duration of action. Here, we consider how temporal and spatial aspects of signal transduction play a crucial role in determining the specificity of insulin action, focusing on signal initiation from the receptor that is spatially segregated into discrete domains of the plasma membrane, as well as the mechanisms that determine the duration of individual signaling pathways. Together, these factors help to differentiate insulin from other hormones that share some of the same overall signaling properties. Divergent signaling pathways are initiated by insulin receptor substrates. The insulin receptor is a tyrosine kinase that catalyzes the phosphorylation of several intracellular substrates, including the insulin receptor substrate (IRS) proteins [2], GAB-1 [3], Shc [4], APS [5], p60DOK [6], SIRPS [7] and c-Cbl [8] (Fig. 1). Each of these substrates recruits a distinct subset of signaling proteins containing Src homology 2 (SH2) domains, which interact specifically with sequences surrounding the phosphotyrosine residue. Moreover, each of these substrates can be confined to distinct locations in the cell by specific sequences that direct interactions with other proteins or lipids. Most attention in the field of insulin receptor substrates has focused on the IRS family of proteins. Mice lacking the IRS-1 protein are insulin resistant but do not develop overt diabetes [9,10]. By contrast, animals lacking IRS-2 exhibit both impaired glucose tolerance and diabetes [11], which appears to result from a defect in insulin secretion as well as insulin resistance, presumably owing to decreased b-cell proliferation in the pancreas in the face of increased demand for insulin. Despite the similarity in structure and function, the apparent differences in phenotype between IRS1 and IRS2 knockout mice underscore a specific signaling specificity that probably results from their tissue distribution, subcellular location, activation&ndash;inactivation kinetics and combinatorial interactions with downstream effectors [12]. The tyrosine phosphorylation of IRS family members generates docking sites for sev...",
              "citation": {
                "type": "PubMed",
                "name": "Trends Cell Biol 2002 Feb 12(2) 65-71",
                "id": "11849969"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070540"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Whether this model represents an accelerated version of normal cancer progression, or simply a bypass of the premalignant stages, is still unclear. Human tumours that bypass premalignant stages have not been described. The importance of the angiogenic switch was also recently demonstrated by Weinberg and colleagues55. They showed that expression of the SV40 early region, TERT and activated RAS were sufficient to transform primary epithelial cells in vitro. However, the ability to grow in vivo depended on the level of HRAS expression - cells that expressed low levels of RAS were dormant and non-angiogenic, whereas cells that expressed high levels of RAS developed into full-blown tumours.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2003 Jun 3(6) 401-10",
                "id": "12778130"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070533"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "DOC-2/DAB2 and DIP1/2 complex represent a negative feedback machinery for several exogenous stimuli-elicited signal cascade. PKC can phosphorylate the N-terminal domain of DOC-2/DAB2 (serine 24) that recruits DIP1/2 to inactivate Ras protein. On the other hand, shortly after the treatment of peptide growth factors, the C terminus of DOC-2/DAB2 (proline-rich domain) competes with SOS for Grb 2 binding, which leads to the inactivation of the MAP pathway. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 5 274(45) 31981-6",
                "id": "10542228"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c45"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "The levels of cyclin D1 were elevated in tumors resulting from high levels of ornithine decarboxylase activity and the expression of v-Ha-ras. There appeared to be a cooperative effect of ornithine decarboxylase and v-Ha-ras in causing the accumulation of G1-related cyclin D1. Histone or Rb-associated kinase activities of cyclin complexes was elevated.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1999 Nov 10(11) 739-48",
                "id": "10593650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070aba"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "# Ariadne: First, we showed that the expression of transgelin is  abolished at the level of transcription by oncogenic Ras in NIH 3T3 mouse  fibroblasts, RIE-1 rat intestinal epithelial cells, and HT1080 human  fibrosarcoma cells. [Expression] # Ariadne: We further  characterized transgelin as a gene whose expression was abolished by Ras. [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 22 277(12) 9790-9",
                "id": "11773051"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d29"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "cells were first subjected to retroviral-mediated gene transfer with a dominant-negative mutant of Ras (N17Ras). This resulted in a marked inhibition of PDGF-induced FAK tyrosine phosphorylation together with the expected reduction of PDGF-induced extracellular signal-regulated kinase activity (ERK).",
              "citation": {
                "type": "PubMed",
                "name": "Hepatology 2000 Jan 31(1) 131-40",
                "id": "10613738"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708e9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hepatic stellate cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "However, unlike Raf-1, the phosphorylation of B-Raf at Ser(445) was constitutive and was only moderately increased by expression of constitutively active H-Ras or constitutively active PAK1. These data demonstrate that B-Raf activity is autoregulated, that constitutive phosphorylation of Ser(445) primes B-Raf for activation, and that a key feature of phosphorylation within the activation loop or of oncogenic mutations within this region is to block autoinhibition.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 22 280(16) 16244-53",
                "id": "15710605"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708b4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Here, we examined whether NO could activate NF-kappaB in cells harboring a mutant, inactive p21(35) . As seen in Fig. 4, upper panel, wild type parental cells responded to sodium nitroprusside by translocating NF-kappaB to the nucleus. In contrast, the p21-defective cells did not respond to sodium nitroprusside. Thus, p21 is necessary for NO-induced cellular activation signals. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Mar 31 270(13) 7017-20",
                "id": "7706235"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407080f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Using a mutant ErbB4 receptor, which lacks kinase activity, we demonstrated that the Ras-mediated ErbB4 phosphorylation depends on the kinase activity of the receptor and facilitates ligand-independent neurite outgrowth in PC12-ErbB4 cells. These experiments demonstrate a novel mechanism controlling ErbB receptor activation. Ras induces ErbB4 receptor phosphorylation in a non-autocrine manner and this activation depends on multiple Ras effector pathways and on ErbB4 kinase activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2006 Aug 15 98(6) 1482-94",
                "id": "16518842"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707ef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Previous studies have shown that a constitutively active isoform of Ras is able to produce superoxide radical (O2(-))....ESR spin trapping measurements showed that Ras(+) cells generated more hydroxyl radical ((.)OH), O2(-) radical, and Cr(V) than Ras(-) cells following Cr(VI) stimulation. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biochem 2004 Jan 255(1-2) 119-27",
                "id": "14971653"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Prostatic Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Overexpression of RREB-1 protein in TT cells confers the ability to mediate increased transactivation of the CT gene promoter-reporter construct during Ras- or Raf-induced differentiation. These data suggest that RREB-1 may play a role in Ras and Raf signal transduction in medullary thyroid cancer and other cells.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Oct 16(10) 5335-45",
                "id": "8816445"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "3) H(2)O(2) rapidly activated Ras (peak at 2-5 min), which preceded p90RSK activation (peak at 20 min).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jan 21 275(3) 1739-48",
                "id": "10636870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070da2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In addition, the Y716(P) peptide significantly decreased the amount of GTP bound to Ras [Ras activation] in response to PDGF",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1994 Oct 14(10) 6715-26",
                "id": "7935391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d91"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Aug 22(15) 5281-95",
                "id": "12101225"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d8e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1994 Apr 29 269(17) 12741-8",
                "id": "8175686"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d6f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "We show that RanBPM can induce GTP-Ras association and Erk phosphorylation and elevate serum response element-luciferase (SRE-LUC) expression, indicating that RanBPM can activate the Ras-Erk-SRE pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 27 277(39) 36216-22",
                "id": "12147692"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d65"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Transformation by human K-Ras or H-Ras (S12 and V12 point mutations, respectively) results in a 10-fold increase in ST6Gal I mRNA, but no alteration in the expression of related sialyltransferases.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2004 Sep 271(18) 3623-34",
                "id": "15355339"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d61"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "e show here that oncogenic forms of Ha-Ras activate NF-kappaB, not through induced nuclear translocation, but rather through the activation of the transcriptional function of the NF-kappaB RelA/p65 subunit. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Sep 26 272(39) 24113-6",
                "id": "9305854"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d58"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Sep 29 270(39) 23007-12",
                "id": "7559439"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d57"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Supplementary Figure 3 Cluster of upregulated genes that correlate with INK4A locus [inactivation].",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Jun 1 65(11) 4530-43",
                "id": "15930270"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d53"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Ras induces the sequential activation of PI3 kinase, Rho, and ROCK, leading to activation of Myc through phosphorylation; phosphorylation of Myc via this mechanism enables it to repress Tsp-1 expression",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2003 Mar 3(3) 219-31",
                "id": "12676581"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d47"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Feb 17 19(7) 961-4",
                "id": "10702805"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d25"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2002 Jun 27 417(6892) 949-54",
                "id": "12068308"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d23"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "The activation of Ras by the guanine nucleotide-exchange factor Son of sevenless (Sos) constitutes the rate-limiting step in the transduction process that links receptor tyrosine kinases to Ras-triggered intracellular signalling pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2007 Jun 9(6) 706-12",
                "id": "17486115"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d21"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "overexpression of v-Ha-ras in HaCaT cells resulted in a three to five-fold decrease in the steady-state mRNA level of EF-1 delta.",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Res 18(1A) 385-92",
                "id": "9568107"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d12"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Both G-CSF and GM-CSF caused activation of p21 ras in neutrophils",
              "citation": {
                "type": "PubMed",
                "name": "Leuk Res 2005 Jan 29(1) 73-8",
                "id": "15541478"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d0f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Figure 1 | The ErbB signalling network.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2001 Feb 2(2) 127-37",
                "id": "11252954"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d0c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "activated Ha-Ras expression inhibits both the binding of cyclin E to Fbw7 and cyclin E ubiquitination",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Jul 5 102(27) 9649-54",
                "id": "15980150"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cfb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In the case of the Ras proteins, carboxyl methylation is important for targeting of the proteins to the plasma membrane.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2004 Feb 113(4) 539-50",
                "id": "14966563"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cf9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "phosphorylated IRS1 also stimulates the Ras-Raf-MEK-ERK pathway, a MAPK pathway",
              "citation": {
                "type": "PubMed",
                "name": "Sci STKE 2004 Aug 3 2004(244) re11",
                "id": "15292521"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cf6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Following platelet-derived growth factor treatment, this receptor induces persistent activation of ectopically expressed PLC epsilon through activation of Ras and Rap1.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Nov 21 21(53) 8105-13",
                "id": "12444546"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cf4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Table 2. Alteration of Gene Expression Specially Associated with H-ras Status in Skin Tumorigenesis #[JL] constituitively active HRAS",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2005 Oct 3(10) 563-74",
                "id": "16254190"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cef"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "GnT-V  transcription was stimulated by several oncogenes including src , her -2/ neu ,  H- ras , and v- sis (9 , 10 , 11) , and this overexpression was regulated  through the ras-raf-ets pathways.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jan 12 276(2) 1555-63",
                "id": "11029459"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Phosphorylated Shc binds to Grb2 which forms a complex with Sos guanine nucleotide exchange factor for p21ras.",
              "citation": {
                "type": "PubMed",
                "name": "Endocr J 2000 Aug 47(4) 373-81",
                "id": "11075717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ceb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "TNF- induced binding of Ras to beads conjugated to the Ras binding domain (RBD) of Raf, indicative of Ras activation (Figure 2A).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2003 Jun 28(6) 762-9",
                "id": "12600818"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cdc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Further, the expression of the catalytically inactive mutants of Ha-Ras, RhoA, c-Raf, and Erk2 or addition of the Mek1-specific inhibitor PD 098059 abrogated the stimulation of the urokinase promoter by HGF/SF.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jun 4 274(23) 16377-86",
                "id": "10347197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cdb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Both ras- and trk-transformed cell lines were less sensitive to cisplatin (CDDP) and doxorubicin (DXR) than the wild type. ",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 1993 May 28 54(3) 450-5",
                "id": "8509220"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cd8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In addition, pleiotrophin activates both the Ras-MAPK and the PI3K-Akt signaling axes ( 18 ), and both pathways are implicated in glial tumorigenesis",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Apr 19 277(16) 14153-8",
                "id": "11809760"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ccb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "p38, but not ERK or JNK, was found in a complex with Gadd45 proteins. The region of interaction was mapped to amino acids 71 to 96, and the central portion (amino acids 71 to 124) of Gadd45a was required for p38 MAPK activation in the presence of H-ras.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Jun 23(11) 3859-71",
                "id": "12748288"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cc0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Inhibitors of both Ha-Ras and mitogen-activated protein kinase kinase completely abolished the mob-5 expression in ras transformed cells, with concomitant loss of the transformation phenotype.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Aug 11 275(32) 24436-43",
                "id": "10825166"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c83"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "intestinal epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "H1299 cells transfected with FLAG-Epac2 showed predominantly cytosolic staining (Fig. 4B). However, upon coexpression with GFP-H-RasLeu-61 (Fig. 4, C and D), the GEF was predominantly redistributed to the plasmamembrane (Fig. 4D)where it colocalized with Ras (Fig. 4C). Similar findings were subsequently observed upon co-expression of Epac2 with activated K- and N-Ras (Fig. 5) but not M-RasLeu-71 (Fig. 4F).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Feb 3 281(5) 2506-14",
                "id": "16316996"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c82"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "from full text: H-Ras and K-Ras isoforms are activated in response to ethanol in a TNF-dependent mechanism,",
              "citation": {
                "type": "PubMed",
                "name": "Hepatology 2004 Mar 39(3) 721-31",
                "id": "14999690"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c7d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "heparin inhibits phosphorylation of EGFR on the Src-dependent site Tyr(845), but not the autophosphorylation of Tyr(1173), and decreases Ras activation and Erk phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2007 Apr 211(1) 205-12",
                "id": "17226785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c78"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Inducible Ha-Ras(V12) increases the production of PGI(2) through the coordinate up-regulation of cPLA(2), COX-2, and prostacyclin synthase (PGIS).",
              "citation": {
                "type": "PubMed",
                "name": "Gastroenterology 2004 Nov 127(5) 1391-400",
                "id": "15521009"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c76"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In in vitro cell culture study, 5-day continuous suppression of H-ras expression by antisense H-ras oligodeoxynucleotide resulted in significant inhibition of the proliferation of LCI-D20 cells (t = 31.529, P < 0.01). ",
              "citation": {
                "type": "PubMed",
                "name": "Hepatogastroenterology 47(32) 365-70",
                "id": "10791191"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c6e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "We then examined the levels of DNMT1 and methylated DNA-binding protein 2 (MBD2) expressions in these cells to determine whether this reduction in uPA expression is associated with changes in the DNA methylation machinery.  Our results showed that ectopic expression of RAS induced DNMT1 expression and activity and inhibited MBD2 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2005 Mar 26(3) 557-64",
                "id": "15618232"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c53"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Expression of CD151 specifically attenuated adhesion-dependent activation of Ras. Furthermore, activation of PKB/c-Akt and ERK1/2, downstream targets in the Ras signaling pathway, was also diminished in cells expressing CD151. In contrast, adhesion-dependent activation of FAK and c-Src were not affected by CD151.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 18 278(29) 26323-6",
                "id": "12782641"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c52"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2000 Jul 17 192(2) 171-82",
                "id": "10899904"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c51"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 1997 Jan 138(1) 114-20",
                "id": "8977393"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c2f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "We found that TPO stimulation or Ha-Ras  G12V expression led to up-regulation of cyclin D1, cyclin D2, and cyclin D3  expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Feb 25 275(8) 5553-9",
                "id": "10681535"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c16"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "By  contrast, H-ras G12V augmented CD14 and CD33 expression and reduced GPA  expression in K562/ras/PU.1.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2000 Oct 1 96(7) 2440-50",
                "id": "11001896"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bfd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 25 278(17) 14753-61",
                "id": "12584202"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bfb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Overexpression of active Ras or Raf represses PEPCK gene transcription (28)",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes. 2001 May;50(5):937-46",
                "id": "11334436"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bf2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "the results suggest that the loss of NM23 expression that is commonly observed during tumor progression could lead to increased potency of oncogenic Ras proteins.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Jul 15 63(14) 4089-94",
                "id": "12874011"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bdb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Here we demonstrate that Tiam1, a Rac-specific GEF, preferentially associates with activated GTP-bound Ras through a Ras-binding domain. Furthermore, activated Ras and Tiam1 cooperate to cause synergistic formation of Rac-GTP in a PI(3)K-independent manner. Thus, Tiam1 can function as an effector that directly mediates Ras activation of Rac.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2002 Aug 4(8) 621-5",
                "id": "12134164"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bc4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Oct 4 20(45) 6531-7",
                "id": "11641777"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bc3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Phosphorylation of Shc produces its binding to the adaptor protein Grb2, causing activation of the protooncogene ras, which is also upstream of the MAP kinase pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2001 Feb 23 104(4) 517-29",
                "id": "11239409"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Additionally, KLF6 inhibits cellular transformation induced by several oncogenes (c-sis/PDGF-B, v-src, H-Ras, and EGFR) that are components of signaling cascades implicated in GBM.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Jun 24 23(29) 5077-83",
                "id": "15064720"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b7c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Studies on mice lacking these exchange factors revealed that both p140 Ras-GRF1 and p130 Ras-GRF2 couple NMDA glutamate receptors (NMDARs) to the activation of the Ras/Erk signaling cascade...",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2004 Apr 7 23(7) 1567-75",
                "id": "15029245"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b75"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In this study, we found that H-Ras interacted with ASK1 to cause the inhibition of both ASK1 activity and ASK1-induced apoptosis in vivo",
              "citation": {
                "type": "PubMed",
                "name": "Cell Res 2004 Apr 14(2) 148-54",
                "id": "15115616"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b67"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Table 2 Summary of genes regulated by H-Ras V12, RhoA QL, Rac1 QL and Cdc42 QL [activated forms]",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 May 1 22(17) 2689-97",
                "id": "12730683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b4a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Experiments with a C-terminal-truncated Ras or a farnesyltransferase inhibitor demonstrate that the CAAX motif of Ras is essential for apoptotic signaling and Bcl-2 association.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 21 278(8) 5775-85",
                "id": "12477721"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b37"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "V12S35 transformed NIH-3T3 cells showed enhanced Erk1/2 activity which led to increase in tumorigenicity and metastasis.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1998 Jul 21 95(15) 8773-8",
                "id": "9671754"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b15"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "A mutant form of p21(ras), in which Cys118 was changed to a serine residue and termed p21(ras)C118S, was not S-nitrosylated. NO-related species stimulated guanine nucleotide exchange on wild-type p21(ras), resulting in an active form, but not on p21(ras)C118S. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Feb 14 272(7) 4323-6",
                "id": "9020151"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070af6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Lysates of 293T cells transfected with either H-RasG12V alone, or with RASSF1A, were subjected to immune complex kinase assays with the immobilized c-Jun bead as a JNK substrate. HRasG12V expression enhanced c-Jun phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "Int J Oncol 2006 Dec 29(6) 1541-7",
                "id": "17088994"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070af2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Upon stimulation with epidermal growth factor, similar translocation of ectopically expressed PLCepsilon is observed, which is inhibited by coexpression of dominant negative Ha Ras.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jan 26 276(4) 2752-7",
                "id": "11022048"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ae3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "IGF1 binding activates the IGF1 receptor (IGFR), a receptor tyrosine kinase. The IGFR subsequently recruits the insulin receptor substrate (IRS1), which results in the activation of two signaling pathways: the RasRaf MEK ERK pathway  and the PI3K Akt pathway",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2003 Aug 9(8) 344-50",
                "id": "12928036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ada"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Stably transfected C2C12-RasV12 myoblasts actively proliferated as indicated by the sustained expression of proliferating cell nuclear antigen and retinoblastoma at the hyperphosphorylated state and failed to express differentiation markers. ",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2008 Feb 149(2) 793-801",
                "id": "17962350"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ad3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Accordingly, acute expression of H-Ras(V12) or of a constitutively active MEK1 also blocked TSH-induced expression of Tg and NIS.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Jul 10 22(28) 4406-12",
                "id": "12853977"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070acc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "expression of H-ras.V12 caused a 2- to 3-fold elevation in the level of RalA-GTP",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2004 Sep 15 104(6) 1679-87",
                "id": "15166036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ab4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "HER2/Neu overexpression stimulates the ability of p300 to acetylate ER81, likely by inducing phosphorylation of p300 through the Ras--Raf--mitogen-activated protein kinase pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Sep 23(17) 6243-54",
                "id": "12917345"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a93"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "An antagonistic effect of EP3 against EP4 through the modulation of cyclic AMP level is required for PGE2-mediated activation of Ras signal pathway in A549 cells.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2002 May 8 518(1-3) 154-8",
                "id": "11997037"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a8c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Germline expression of the endogenous H-RasG12V oncogene, even in homozygosis, resulted in hyperplasia of the mammary gland.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2008 Jun 118(6) 2169-79",
                "id": "18483625"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a8a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Oncogenic transformation of ovarian epithelial cells with H-Ras(V12) or expression of Bcr-Abl in hematopoietic cells causes elevated ROS generation and renders the malignant cells highly sensitive to PEITC",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2006 Sep 10(3) 241-52",
                "id": "16959615"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a65"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In this report, we show that growth factor-induced transcriptional activation of Egr-1 gene is downregulated by chronic expression of oncogenic H-Ras in NIH3T3 fibroblasts",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Mar 8 25(5) 1093-103",
                "id": "16456537"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Thus, while p120 and NF1 (neurofibromatosis-related protein 1) are clearly Ras-specific and do not enhance the catalytic activity of Rap, RASA1 (p120-RASGAP)",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Soc Trans 2006 Nov 34(Pt 5) 846-50",
                "id": "17052212"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709df"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Assays for GTP loading and H-Ras interactions with the Ras-binding domain on Raf-1 demonstrated a decrease in H-Ras activity in the presence of NO*. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2006 Jul 15 397(2) 329-36",
                "id": "16569214"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709d3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Dec 15 61(24) 8909-16",
                "id": "11751416"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709c0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "KLF5 in mediating cellular transformation caused by oncogenic H-Ras.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2005 Aug 29 579(21) 4757-62",
                "id": "16102754"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709a3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Induction of H-Ras(G12V) down-regulates caveolin-1 protein  expression and caveolin-1 promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 5 274(45) 32333-41",
                "id": "10542274"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070998"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "We report here that oncogenic Ras (H-Ras) downregulates Fas expression and renders cells of fibroblastic and epitheloid origin resistant to Fas ligand-induced apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 Apr 1 18(7) 1824-31",
                "id": "10202146"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070985"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "The mutant and, to a lesser extent, the normal ras gene caused reduction of the AFP mRNA but not the albumin mRNA level in transfected HuH-7 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1990 Apr 10(4) 1461-9",
                "id": "1690841"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407097b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Grb2 constitutively associates with Sos, the guanine nucleotide exchange factor for plasma membrane-bound Ras (36). Docking of Grb2 to IRS proteins recruits Sos to Ras, resulting in activation of its GTPase Following insulin stimulation, Grb2 binds to both IRS proteins and to Shc, and it is not clear which pathway is more important for its activity (37, 38)",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 1999 Apr 103(7) 931-43",
                "id": "10194465"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070971"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Molecular cloning and biological activity of a novel Ha-Ras suppressor gene",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 5 274(45) 32192-7",
                "id": "10542256"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407096f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "When c-H-ras expression was induced with heavy metal ions there was a marked reduction in the expression of two glycosylphosphatidylinositol (GPI) anchored proteins, TAP/Ly-6A.2 and Thy-1, on the plasma membrane of the transformed cells.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1991 Aug 6(8) 1445-51",
                "id": "1679532"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070953"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Ariadne: In this study, we show that H-Ras, N-Ras, K-Ras, EGFR and ErbB2 but not v-Src suppress RhoB promoter transcriptional activity in NIH3T3 cells and human cancer cell lines derived from lung (A-549), pancreatic (Panc-1) and cervical (C33A) tumors. [Expression]",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Feb 5 23(5) 1136-45",
                "id": "14647415"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070945"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Site-directed mutagenesis replaced each of the serine residues within this region with alanine and demonstrated that serine 916 is a major site of in vivo phosphorylation of Ras-GRF1 in both COS-7 cells and NIH-3T3 fibroblasts.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Dec 24 274(52) 37379-84",
                "id": "10601308"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070943"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Of potential functional relevance, the expression of Par-4 allows TNFalpha to induce apoptosis in NIH-3T3 cells. In addition, the down-regulation of Par-4 levels by oncogenic Ras sensitizes cells to TNFalpha-induced NF-kappaB activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jul 9 274(28) 19606-12",
                "id": "10391896"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407092b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Collectively these results indicate that H-Ras up- regulates the glut1 promoter, at least in part, by increasing HIF-1alpha  protein levels leading to transactivation of promoter through the HIF-1 binding  site.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem. 2001 Mar 23;276(12):9519-25",
                "id": "11120745"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070929"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": " The agent that we have employed is R115777, which is an orally bioavailable imidazole analog that blocks prenylation of Ha-ras, but not Ki-ras and N-ras (6).",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2006 Jul 27(7) 1420-31",
                "id": "16403772"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070925"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Jun 1 60(11) 3031-8",
                "id": "10850453"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407091f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "We found that oncogenic Ras (61L), but not a dominant negative allele (17N), induced strong rpS6 phosphorylation at Ser235/236 (Fig. 2B). This stimulation was strongly inhibited by U0126 (Fig. 2C), indicating that ERK signaling is required for rpS6 phosphorylation under mTOR-independent conditions.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 May 11 282(19) 14056-64",
                "id": "17360704"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070913"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "#WB-F344 rat liver epithelial (WB)# H-Ras induced the invasive and migrative phenotypes of WB cells with a selective up-regulation of matrix metalloproteinase (MMP)-9, but not MMP-2. Cyclooxygenase (COX)-2 and the subsequent production of prostaglandin E2 (PGE2) were also induced by H-Ras. ",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2006 Oct 15 119(8) 1767-75",
                "id": "16721810"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708de"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "However, overexpression of v-Ha-ras in HaCaT cells resulted in a three to five-fold decrease in the steady-state mRNA level of EF-1 delta.",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Res 18(1A) 385-92",
                "id": "9568107"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708d4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Indirect confocal immunofluorescence of transfected PC12 cells using antibody 2152 demonstrated reactivity only under conditions in which Ras-GRF1 was phosphorylated at Ser(916/898).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 11 278(15) 13278-85",
                "id": "12538592"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708d0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1990 Jul 5(7) 1037-43",
                "id": "2197591"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708cf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Here we report that in fibroblasts, activated H-Ras and Raf-1 oncogenes decrease biosynthesis, association with beta1 integrins, and surface expression of tTG because of down-regulation of tTG mRNA.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 12 278(37) 35609-19",
                "id": "12832399"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708c7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "hDAB2IP (human DAB2 (also known as DOC-2) interactive protein) is a novel GTPase-activating protein for modulating the Ras-mediated signal pathway",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 31 278(5) 3121-30",
                "id": "12446720"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708ba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Caco-2 cells were transfected with homer-6 a control vector(Caco-2-H), Ha-ras gene (Caco-2-T) and Py-MT gene (Caco-2-MT\\\") to constitutively activate c-SRC, observed that the level of the PKC-alpha transcript was 4-fold higher in Caco-2-T and Caco-2-MT cells than in Caco-2-H cells. And also Caco-2-T and Caco-2-MT cells exhibited a 3-fold increase in the level of immunoreactive PKC-alpha and tended to display a higher  PKC specific activity than the cytosolic fractions.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1993 Jun 15 53(12) 2762-70",
                "id": "8504416"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070896"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Cancer research 2001 Sep 1;61(17):6340-4",
                "id": "11522622"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070857"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "B , activated H-Ras also represses the SRG3 promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 21 279(21) 21903-15",
                "id": "15016814"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070850"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Recently, we and others identified phospholipase C (PLC) epsilon as an effector of Ras.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Dec 15 64(24) 8808-10",
                "id": "15604236"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070835"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Down-regulation of RI alpha subunit of cAMP-dependent protein kinase induces growth inhibition of human mammary epithelial cells transformed by c-Ha-ras Our results suggest that cAKI may act as a mediator of ras and erbB-2 oncogene action in human breast cells and that interference with cAKI action provides a potential tool for inhibiting the growth-promoting effects of these oncogenes.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 1993 Feb 1 53(3) 438-43",
                "id": "8094073"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407082f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1993 Apr 1 53(7) 1625-9",
                "id": "8453633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407082e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Expression of dominant active Ras or dominant active MEKK1 alone can also stimulate NF-kappaB activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 2 276(5) 3650-9",
                "id": "11062239"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070826"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Activated Src and p21ras were able to induce CD69 expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Apr 28 270(17) 9833-9",
                "id": "7730364"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070818"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "We compared human fibroblasts malignantly transformed by overexpression of H-Ras(V12) oncogene to their nontransformed parental cells and found that the malignant cells express a high level of Spry2. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Jan 25 283(4) 2002-9",
                "id": "18048363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707eb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In vitro studies have delineated two primary intracellular pathways that appear to mediate the effects of IGF-I in skeletal muscle: the Ras-ERK pathway and the phosphoinositide-3 kinase pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Appl Physiol 2004 Jan 96(1) 203-10",
                "id": "12959952"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707e7"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Kit and other RTKs will activate the MAP kinase signaling pathway and has been reported both to increase the transcriptional activity of Mitf as well as down-regulate Mitf protein levels.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Jul 15 14(14) 1712-28",
                "id": "10898786"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707de"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Although inhibitors of PKC had no effect on this suppression, MAPK inhibitors completely prevented the TPA effect. RasGRP1 activates the MAPK pathway through activation of the small G protein H-Ras. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2007 Dec 11 104(50) 20120-5",
                "id": "18077438"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707c8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "kidney epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Different signalling molecules such as the ?-subunit of G-proteins, Ha-Ras, Src-kinases, eNOS, EGF receptors and some protein kinase-C isoenzymes bind directly to the scaffolding domain of caveolins. This binding results in the inactivation of these molecules (Casey, 1994, Feron et al., 1998 and Li et al., 1996);",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Endocrinol 2005 Dec 21 245(1-2) 128-37",
                "id": "16368181"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Oncogenic ras induces upregulation of the transcriptional repressor SLUG",
              "citation": {
                "type": "PubMed",
                "name": "Surgery 2005 Aug 138(2) 306-12",
                "id": "16153441"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707af"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "intestinal epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Shc phosphorylation and Ras activity were inhibited by expression of PTEN",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 1998 Nov 30 143(5) 1375-83",
                "id": "9832564"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070799"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Although there are now four known adenosine receptors, and the nomenclature has been changed and refined, the early classification scheme still mirrors the generally accepted profile of adenosine receptor G protein coupling (Table 1)",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2003 Sep 15(9) 813-27",
                "id": "12834807"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070791"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "The oncoprotein p21ras further activates transcription of the cyclin D1 gene, through sites within the promoter that bind the transcriptional regulators Ets or CREB.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1999 Apr 1 398(6726) 422-6",
                "id": "10201372"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070766"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Ras inhibits ME promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jun 18 274(25) 17997-8004",
                "id": "10364249"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407075c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In addition, we found that Rheb inhibits the association of B-Raf with H-Ras.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Sep 1 281(35) 25447-56",
                "id": "16803888"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070750"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In this study, we show that JunD, a member of the AP-1 family of transcription factors, reduces tumor angiogenesis by limiting Ras-mediated production of ROS.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2004 Sep 17 118(6) 781-94",
                "id": "15369676"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407074e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Stable transfection of activated Ha-ras into a number of murine cells correlated with a down-regulation of the expression of the NF1 genes NF1/CTF and NF1/X.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1994 Mar 11 269(10) 7371-8",
                "id": "8125955"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070747"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "dominant negative S17N Rap2B (n = 36; p < 0.002). In addition, expression of this Rap2B mutant suppressed activation of H-Ras induced by the beta2-AR (Fig. 6D).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 5 279(45) 46497-508",
                "id": "15319437"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070733"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In previous studies we have shown that oncogenic Ras inhibits the expression of Fas (CD95) and renders Ras-transformed cells resistant to Fas-induced death",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Jan 15 62(2) 450-8",
                "id": "11809695"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070731"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Our results show that invasive cell lines which overexpress the c-Ha-ras gene also have increased epidermal EGF-R expression.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1991 Aug 15 51(16) 4486-91",
                "id": "1868471"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070714"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "These results were consistently found when using K-rasV12 mice carrying Cre transgenic alleles that were expressed either inducibly by tamoxifen (Cre-ER) or constitutively (CMV-Cre)3; 5-10 mice were analysed for each marker. The results have also been confirmed by immunoblotting and by quantitative real-time polymerase chain reaction with reverse transcription (see supplementary information; these analyses also included p19ARF, an effector of senescence-associated -galactosidase6). ",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2005 Aug 4 436(7051) 642",
                "id": "16079833"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070711"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "ras Oncogene triggers up-regulation of cIAP2 and XIAP in intestinal epithelial cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Nov 11 280(45) 37383-92",
                "id": "16115895"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070702"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "intestinal epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "EGF induced Ha-Ras activation in the PANC-1 cells but neurotensin could not increase Ha-Ras activation in these cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 May 15 63(10) 2379-87",
                "id": "12750255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070700"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In this report we have demonstrated that MEKK1 is also a potential Ras effector and selectively binds to Ras in a GTP-stimulated manner. This finding supports at a biochemical level the observation that MEKK1 is activated in a Ras-dependent manner in response to growth factors in PC12 pheochromocytoma cells (16)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 May 19 270(20) 11757-60",
                "id": "7744823"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Co-transfection with a Ha-Ras expression vector stimulated galectin-3 promoter activity approximately 10-fold",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2003 Jun 17 1641(1) 13-23",
                "id": "12788225"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706f5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Many angiogenic growth factors, including bFGF and VEGF, stimulate endothelial cell invasion (51) through transmembrane protein kinase receptor dimerization and phosphorylation (11, 53), leading to the activation of phospholipase Cg (PLCg) and Ras, both of which ultimately result in activation of cPLA2",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2004 Mar 18(3) 568-70",
                "id": "14715700"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "The adapter protein Grb2 can directly associate with phosphorylated Y703 and Y936 in c-Kit",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2004 Oct 61(19-20) 2535-48",
                "id": "15526160"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "insulin stimulates the mitogen-activated protein (MAP) kinase extracellular signalregulated kinase (ERK) (Fig. 2). This pathway involves the tyrosine phosphorylation of IRS proteins and/or Shc, which in turn interact with the adapter protein Grb2, recruiting the Son-of-sevenless (SOS) exchange protein to the plasma membrane for activation of Ras.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2001 Dec 13 414(6865) 799-806",
                "id": "11742412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "in NIH 3T3 cells transient expression of constitutively activated forms of the small GTP-binding proteins Ras or Rac1 leads to a significant increase in intracellular ROS",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1996 Sep 1 318 ( Pt 2) 379-82",
                "id": "8809022"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706e3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Biosensors &amp; bioelectronics 2004 Oct 15;20(3):448-53",
                "id": "15494224"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In previous studies we found that the GTPase p21 Harvey-Ras (Ha-Ras) stimulates the production of reactive oxygen species and induces apoptosis by oxidative stress",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Neurosci 2007 Dec 26(11) 3261-6",
                "id": "18005061"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070691"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "GEF activity of Ras-GRF1 toward Ha-Ras, as defined by in vitro GDP binding and release assays, was augmented after tyrosine phosphorylation by ACK1.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Sep 22 275(38) 29788-93",
                "id": "10882715"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407068c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "These data suggest that H-ras participates in pathways that regulate cyclin B1 expression and therefore controls the G2/M checkpoint in a p53-independent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 2002 Oct 31 508(1-2) 49-58",
                "id": "12379461"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070683"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "While T29 cells, stably transfected with SV40 T/t antigens and hTERT, are fully immortalized, only the addition of oncogenic RAS leads to the malignant transformation of T29H cells as demonstrated by the capability of anchorage-independent growth and tumor formation in nude mice.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Sep 8 24(40) 6174-84",
                "id": "15940260"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407067f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "MPD is known to furnish prenyl groups required for prenylation, protein modification that is essential for the activity of many proteins including p21(Ras) (Ras).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2003 Mar 21 302(4) 735-42",
                "id": "12646231"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070675"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Jan 15 60(2) 400-8",
                "id": "10667594"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407066a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "activated V12-H-Ras can induce the p21 promoter through the same region of the p21 promoter by a p53-independent mechanism in NIH3T3 cells E2F1 is required for induction of the p21 promoter by activated Ras",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Feb 17 19(7) 961-4",
                "id": "10702805"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070665"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Activation of NF-kappaB by osteopontin depended on the small GTP-binding protein Ras and the tyrosine kinase Src,",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 1998 May 18 141(4) 1083-93",
                "id": "9585425"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070657"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "On the other hand, prostate cancer cells LNCaP or normal prostatic epithelial cells that were resistant to apoptosis by Par-4 did not show Fas or FasL trafficking. Par-4 is down-regulated by oncogenic-Ras, -Raf, or -Src.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Oct 1 61(19) 7255-63",
                "id": "11585763"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070640"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Recently, Crk has also been shown to bind to IRS-1 in an insulin-dependent manner (44). Crk uses its SH3 domains to bind to the guanine nucleotide exchange factors Sos and C3G, the latter of which activates the c-Jun kinase, leading to induction of transformation",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 1999 Apr 103(7) 931-43",
                "id": "10194465"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070627"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Fig.1",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Nov 26 306(5701) 1506-7",
                "id": "15567848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070617"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "However, H-Ras-inducible cells transfected with the nonphosphorylatable mutant FAK Y861F showed decreased migration/invasion, focus forming activity and anchorage-independent growth, compared with either wild-type or kinase-defective FAK.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 9 279(28) 29060-5",
                "id": "15123632"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407060d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "14-3-3 beta isoform has been shown to bind to the product of the protooncogene cRaf-1 and to facilitate its activation by Ras.",
              "citation": {
                "type": "PubMed",
                "name": "DNA Cell Biol 1999 Aug 18(8) 653-61",
                "id": "10463061"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070606"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Nov 18 18(48) 6635-40",
                "id": "10597268"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Infecting HUVECs with a dominant negative H-Ras mutant (Ras(S17N)) interferes bFGF-mediated cadherin downregulation, and the result suggests that bFGF attenuates surface cadherin expression on HUVECs via FGFR1 and intracellular Ras-JNK signaling.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2008 Feb 1 314(3) 421-9",
                "id": "18164704"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Additionally, KLF6 inhibits cellular transformation induced by several oncogenes (c-sis/PDGF-B, v-src, H-Ras, and EGFR) that are components of signaling cascades implicated in GBM.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Jun 24 23(29) 5077-83",
                "id": "15064720"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Oncogenic Ras as well as serum growth factors that activate endogenous Ras can induce mob-1 expression",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1994 Dec 20 91(26) 12515-9",
                "id": "7809069"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705e5"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "We have found that v-H-ras can induce the expression of CD5 on two CD5+ pre-B-cell lines established from murine bone marrow.",
              "citation": {
                "type": "PubMed",
                "name": "Immunology 1997 Jan 90(1) 30-7",
                "id": "9038709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Cyclooxygenase (COX)-2 and the subsequent production of prostaglandin E2 (PGE2) were also induced by H-Ras",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2006 Oct 15 119(8) 1767-75",
                "id": "16721810"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705db"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "However, sustained Ha-ras oncogene expression attenuates glucocorticoid-triggered induction of the alpha B crystallin gene completely.",
              "citation": {
                "type": "PubMed",
                "name": "Verh Dtsch Ges Pathol 1994 78 34-5",
                "id": "7534008"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Grx2 significantly activated the Ras/phosphoinositide 3-kinase/Akt/NF-kappaB cascade in parallel to the Jun N-terminal kinase (JNK)/AP1 cascade.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 15 276(24) 21618-26",
                "id": "11290748"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705cb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "It has long been known that excessive mitotic activity due to H-Ras can block keratinocyte differentiation and cause skin cancer.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2008 Sep 9 14(3) 212-25",
                "id": "18772111"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "The Ras-GRF1 exchange factor, which is regulated by increases in intracellular calcium and the release of G beta gamma subunits from heterotrimeric G proteins, plays a critical role in the activation of neuronal Ras.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 11 278(15) 13278-85",
                "id": "12538592"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705b8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In this paper, we present a comprehensive pathway map of EGFR signaling and other related pathways. The map reveals that the overall architecture of the pathway is a bow-tie (or hourglass) structure with several feedback loops.  See figure 2: The bow-tie architecture of the EGFR signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Syst Biol 2005 1 2005.0010",
                "id": "16729045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705ad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "We show that PREL1 directly binds to Ena/VASP proteins and co-localizes with them at lamellipodia tips and at focal adhesions in response to Ras activation. Moreover, PREL1 directly binds to activated Ras in a phosphoinositide-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2005 Jan 17 579(2) 455-63",
                "id": "15642358"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1994 Feb 1 91(3) 873-7",
                "id": "7508123"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070592"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Phorbol ester-dependent activation of peroxiredoxin I gene expression via a protein kinase C, Ras, p38 mitogen-activated protein kinase signaling pathway. The data indicate that a protein kinase C, Ras, MEKK1, p38 MAPK signaling pathway plays a major role for the transcriptional up-regulation of Prx I gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 14 278(46) 45419-34",
                "id": "12960165"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407056b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "IRK1 in HEK 293 cells leads to the appearance of a potassium current with strong inward rectifying properties, coexpression of the constitutively active form of Ras (Ras-L61) results in a significant reduction of the mean current density",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Apr 5 277(14) 12158-63",
                "id": "11809752"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070555"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 12 278(37) 35609-19",
                "id": "12832399"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407054e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "phosphorylation of RhoE correlates with its activity in inducing stress fibre disruption and inhibiting Ras-induced transformation.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2005 Mar 23 24(6) 1170-80",
                "id": "15775972"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070543"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "In situ end-labeling detection showed that apoptotic cell death was significantly increased in cells with 5-day treatment of antisense H-ras oligodeoxynucleotide (34.0 +/- 4.5%) in comparing with cells without treatment (2.5 +/- 1.2%, t = 13.434, P < 0.01) or treated with non-specific antisense oligodeoxynucleotide (4.8 +/- 1.4%, t = 12.453, P < 0.01) at the corresponding time. ",
              "citation": {
                "type": "PubMed",
                "name": "Hepatogastroenterology 47(32) 365-70",
                "id": "10791191"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407053f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "We report that in the CML cell line K562 Ras induces p21Cip1 expression through the Raf-MEK-ERK pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 14 280(2) 1112-22",
                "id": "15528212"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070514"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:HRAS) actsIn gtp(p(HGNC:HRAS))",
              "summary_text": "75-Ras-GRF1 expression occurred with a concomitant increase in activated Ras (GTP bound), and the activation of Ras was significantly inhibited by antisense Ras-GRF1 oligomers.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Apr 25(8) 3324-37",
                "id": "15798216"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070508"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"RAS Family\")",
        "relation": "actsIn",
        "target": "gtp(p(SFAM:\"RAS Family\"))",
        "directed": false,
        "label": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526e5",
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "from full text - Box 2 | Bcl2 and the Rb/Arf/p53 network Inactivation of the retinoblastoma (Rb) pathway  for example, by loss of cell-cycle inhibitor Ink4a, which can prevent cyclin-DCdk4 from phosphorylating Rb  unleashes the transcription factor E2f1,which increases expression of Arf, a protein that is encoded by the same locus as Ink4a (REF. 136).Arf,which is also a transcriptional target of Myc, sequesters Mdm2, a negative regulator of p53. Raised p53 levels can either impose growth arrest, typically by inducing the Waf1 cell-cycle inhibitor, or promote apoptosis through targets such as Bax, Puma and Noxa. The apoptotic targets seem to also require the p53 relative p63 or p73 (REF. 152). Circles/ovals denote oncogene products; rectangles denote known or likely tumour suppressors. For more detail, see REFS 46,136.ATM, ataxia telengiectasia mutated; Chk2, checkpoint 2; NF-?B, nuclear factor-?B.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Sep 2(9) 647-56",
                "id": "12209154"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070dab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "NF-IL6, a member of the basic leucine zipper (bZIP) family transcription factors, is involved in expression of inducible genes involved in immune and inflammatory responses. We observed that coexpression of oncogenic p21ras stimulated the transactivating activity of NF-IL6 and induced phosphorylation of Thr-235 located just N-terminal to the DNA binding domain of NF-IL6. Recently, mitogen-activated protein (MAP) kinases have been shown to be implicated in the cellular response to activated ras. Purified MAP kinases specifically phosphorylated Thr-235 of NF-IL6 in vitro. Mutation of Thr-235 abolished the ras-dependent activation of NF-IL6. From these results, we conclude that NF-IL6 is regulated through phosphorylation by MAP kinases in response to activated ras.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1993 Mar 15 90(6) 2207-11",
                "id": "8384717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d3b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "A role for PLD in cell proliferation is indicated from reports showing that PLD activity is elevated in response to platelet-derived growth factor (PDGF; 6), fibroblast growth factor (7, 8), epidermal growth factor (EGF; 9), insulin (10), insulin-like growth factor 1 (11), growth hormone (12), and sphingosine 1-phosphate (13). PLD activity is also elevated in cells transformed by a variety of transforming oncogenes including v-Src (14), v-Ras (15, 16), v-Fps (17), and v-Raf (18).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2003 Sep 1(11) 789-800",
                "id": "14517341"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d33"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Two classes of differentiation factors, the neurotrophins and fibroblast growth factors, induce rapid tyrosine phosphorylation of SNT1(FRS2alpha), which in turn enables SNT1 to recruit Shp2 tyrosine phosphatase and Grb2 adaptor protein in complex with the Ras GDP/GTP exchange factor Sos. Mutagenesis of SNT1(IRS)CX identified three classes of effector motifs within SNT critical for both sustained ERK activation and neuronal differentiation: 1) four phosphotyrosine motifs that mediate recruitment of Grb2, 2) two phosphotyrosine motifs that mediate recruitment of Shp2, and 3) a C-terminal motif that functions by helping to recruit Sos.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 20 276(16) 13049-56",
                "id": "11278583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cde"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "However, it is p27 that seems to be the primary target of SKP2, given that Skp2 ko mice show a marked accumulation of p27 (REF. 24), and that prominent cellular phenotypes apparent in Skp2 00 mice (see Supplementary information S1 (table)) including nuclear enlargement, polyploidy and an increased number of centrosomes that are probably caused by overreplication of chromosomes and centrosomes disappear in Skp2 ko p27 ko double mutant mice. The oncogenic potential of SKP2 has also been shown in transgenic mouse models 35,36. Furthermore, Ras signalling induces SKP2 expression through the binding of GA-binding protein, an Ets-family transcription factor, to the SKP2 promoter37. Such evidence supports the notion that SKP2 is a growth promoter and an oncoprotein.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2006 May 6(5) 369-81",
                "id": "16633365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cbf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The human interstitial collagenase (MMP-1) promoter has been also shown to be a Ras-responsive promoter by virtue of the presence of ETS and AP-1 cis-elements, which act synergistically to activate Ras-dependent transcription of the gene (15, 16). Similarly to what was observed previously with the synthetic ORE reporter, ESE-3 was able to repress the -1200 to +63 collagenase promoter response to Ras (Fig. 6B). In both cases, expression of ETS-2 resulted in enhanced expression of the reporter in these cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 8 276(23) 20397-406",
                "id": "11259407"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c5c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Mitogen-activated protein (MAP) kinases comprise a family of ubiquitous proline-directed, protein-serine/threonine kinases, which participate in signal transduction pathways that control intracellular events including acute responses to hormones and major developmental changes in organisms. MAP kinases lie in protein kinase cascades. This review discusses the regulation and functions of mammalian MAP kinases. Nonenzymatic mechanisms that impact MAP kinase functions and findings from gene disruption studies are highlighted. Particular emphasis is on ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "Endocr Rev 2001 Apr 22(2) 153-83",
                "id": "11294822"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ba6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Also, antioxidants decrease the mRNA abundance of MSR-1 by suppressing NF-kB and decreasing MSR-1 mRNA stability rather than through direct effects on transcription [102]. A summary of redox effects on various transcription factors as well as on some elements of signal transduction pathways is presented in Table 1. Although Table 1 presents an overview of the effects as well as the differences that may occur between different cell models, a comprehensive presentation of all redox effects on these factors and their interactions is far beyond the scope of the present discussion. For more detailed discussions of some of the effects listed in Table 1, the reader is referred to several excellent reviews [14-17,93,103-105]. Also, we have primarily focused on oxygen-centered species rather than on reactive nitrogen species; for a review of nitrogen intermediates in signal transduction, the reader is referred to the article by Lander [90]. SIGNAL TRANSDUCTION PATHWAYS Although many pathways are known to be redoxsensitive, none have been more thoroughly examined than the MAP kinase and NF-kB signal transduction pathways. Many of the redox effects on cells are mediated either directly or indirectly through these pathways, which contain multiple steps sensitive to ROS. Because of the large number of studies of oxidants on the various components of the MAP kinase and NF-kB signal transduction pathways, we provide a brief overview of both these pathways. MAP kinases Extracellular signaling molecules such as growth factors and cytokines induce changes in cell behavior via complex mechanisms that involve transmission of the signal from the plasma membrane to the nucleus, where gene expression is altered [303,304]. The first step of a signaling cascade usually involves the activation of receptors that either have protein kinase activity or activate protein kinases in the cytoplasm. The signal is eventually transmitted to the nucleus, where it activates the transcription factors that regulate gene expression. One of the most studied families of signal transduction pathways is the (MAP) kinase family (Fig. 1). Four MAP kinase subfamilies have been identified to date: (i) ERK [305- 309], (ii) JNK/SAP kinase [310-314], (iii) p38 kinases, [315-318], and (iv) big MAP kinase (BMK/ERK5) [319, 320]. All these pathways contain redox-sensitive sites (Table 1). In the ERK and JNK pathways, a guanine nucleotide exchange factor such as the mammalian homologue of Sos [321] activates Ras by conversion of Ras-GDP to Ras-GTP [322-324]. Sos must usually complex with other proteins to perform this function. It contains SH2 domains, which are a conserved sequence of 100 amino acids that bind to tyrosine phosphorylated motifs in other proteins [17]. In the cytoplasm, Sos is constitutively bound to another SH2 domain-containing protein, Grb-2 [325-327]. Activation of growth factor receptors results in tyrosine autophosphorylation and recruitment of SH2 domain-containing affectors, including Grb-2 [325,328-330]. The result is plasma membrane targeting of Sos [331], where it is tyrosinephosphorylated [332] (Fig. 1). The phosphorylated Grb-2/Sos complex binds to an adapter protein, the SH-containing (SHC) protein [330, 333-336], and the multiprotein complex activates Ras-GDP by converting it to its GTP-bound form [337]. Interestingly, treatment of cells with oxidants such as H2O2 stimulates formation of the SHC-Grb2-Sos complex [99].",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b54"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We found that activation of the Met receptor for hepatocyte growth factor results in the tyrosine phosphorylation of beta4, which is instrumental for integrin-mediated recruitment of the tyrosine phosphatase Shp2. Shp2 binding to beta4 enhances the activation of Src, which, in turn, phosphorylates the multiadaptor Gab1 predominantly on consensus sites for Grb2 association, leading to privileged stimulation of the Ras-extracellular signal-regulated kinase (ERK) cascade.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2006 Dec 18 175(6) 993-1003",
                "id": "17158954"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b45"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Figure 5. This is a figure in the review representing the cross talk between FGFR3 and IL6 signaling in multiple myeloma cell line KH11; the legend is as follows: Fig. 5. Enhanced proliferation of myeloma cells by interleu- kin- 6 cooperatingwith FGFR3-mediated signals. IL- 6 and FGF induce the distinct intracellular signaling pathways in myeloma cells carryingt(4 ;14)(p16. 3 ;q32) that ectopically express FGFR3. FGF and IL- 6 activate ERK1/ 2, PI- 3 kinase and STAT3, respectively. The serine phosphorylation of STAT3 via the FGF- induced ERK1/ 2 activation contributes to the full activation of STAT3, leadingto the expression of c-myc and bcl- 2 genes and cell proliferation 91 .FRS:FGF receptor substrate.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Exp Hematop 2006 Nov 46(2) 55-66",
                "id": "17142955"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070af1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Extensive data indicate that oncoproteins, such as oncogenic H-Ras, initiate signal transduction cascades that ultimately lead to the activation of specific transcription factors. We and others have previously demonstrated that Ras activates the inherent transcriptional activation function of the transcription factor nuclear factor kappaB (NF-kappaB). Supportive of the importance of NF-kappaB in transformation, Ras-induced cellular transformation can be suppressed by expression of IkappaBalpha, an inhibitor of NF-kappaB, or by dominant-negative forms of the upstream activator IkappaB kinase (IKK). However, conclusive evidence for a requirement for NF-kappaB subunits in oncogenic transformation has not been reported. Furthermore, there is little understanding of the gene targets controlled by NF-kappaB that might support oncogenic conversion. The data presented here demonstrate that, although both p65 and c-Rel enhance the frequency of Ras-induced cellular transformation, these NF-kappaB subunits are not essential for Ras to transform spontaneously immortalized murine fibroblasts. Microarray analysis identified a set of genes induced by Ras that is dependent on NF-kappaB for their expression and that likely play contributory roles in promoting Ras-induced oncogenic transformation.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Oct 15 64(20) 7248-55",
                "id": "15492243"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070aec"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We chose to analyze pancreatic cancer cells since this tumor type displays the highest frequency of somatic mutations of RAS genes of all human malignancies (5, 22). Hs766T cells express activated KRAS and display elevated levels of pERK1/2 and pAKT (Fig. 4C). Treatment of Hs766T cells with the PI3'-kinase inhibitor LY294002 led to a selective decrease in pAKT with little or no effect on pERK1/2. By contrast, treatment of the cells with the MEK inhibitor U0126 or CI-1040 led to a selective decrease in pERK1/2 with little or no effect on pAKT. Strikingly, both the PI3'-kinase and the MEK inhibitors led to accumulation of p27Kip1 expression. These data are consistent with the observation that both MEK and PI3'-kinase inhibitors elicited a G0/G1 cell cycle arrest in Hs766T cells (data not shown). Further consistent with these observations, treatment of a panel of pancreatic cancer cells (eight cell lines) (57) with a MEK inhibitor (U0126 or CI-1040) led to a consistent G0/G1 cell cycle arrest accompanied by induced expression of p27Kip1 in all eight cell lines tested (S. Gysin and M. McMahon, sub- mitted for publication). For the most part, treatment of cells with MEK inhibitors led to a cytostatic rather than a cytotoxic effect, although cell death was often observed after prolonged treatment (+6 days). Treatment of pancreatic cancer cells with LY294002 led in some cases to a cytostatic effect and in others to a more rapid cytotoxic effect. Consistent with the observations in Fig. 4C, inhibition of PI3'-kinase by LY294002 led to elevated p27Kip1 expression in five of eight pancreas cancer cell lines tested. These data are fully consistent with the hypothesis that the RAS-activated RAF-MEK-ERK and PI3'-kinase- PDK-AKT pathways play a role in the regulation of p27Kip1 expression in bona fide human cancer cell lines.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Dec 24(24) 10868-81",
                "id": "15572689"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070aa5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Another major signaling pathway is the Ras/MAP kinase cascade [33] (fig. 1). The activated Kit recruits SH-2-containing proteins such as Grb2, Shc and SHP2. Grb2 may bind Kit either directly or indirectly through interaction with Shc or SHP2. Since Grb2 is constitutively associated with Sos, a guanine nucleotide exchange factor, the recruitment of Grb2 to the activated Kit resultes in the colocalization of Sos and Ras and the subsequent activation of Ras. This promotes the interaction of Ras with Raf serinethreonine kinase and then the activation of MEK (a MAP kinase kinase). MEK phosphorylates ERK (a MAP kinase), and ERK phosphorylates a number of substrates, including pp90rsk [33]. Imatinib mesylate also inhibits the phosphorylation of ERK [34]. This process is considered to be due to blocking of the Kit signaling by this drug. Thus, both major signaling pathways of Kit, the PI3K/Akt system and the Ras/MAP kinase cascade, are inhibited by imatinib mesylate.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2004 Dec 61(23) 2924-31",
                "id": "15583854"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a4b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Although the growth-inhibitory effect of TGF-B is believed to be mediated by the Smad dependent TGF-B signaling pathway, there have been reports of TGF-B mediated inhibition of proliferation in Smad4 null cells.22 Proposed alternative mechanisms for resistance to TGF-B include decreased expression of TBRI,34 TBRII,35 or TBRIII36 on the cell surface; increased expression of the inhibitory Smad, Smad7; repression of TGF-B signaling by a variety of oncoproteins including p53,38 Myc,39 E1A,40 Ras,41 Ski/ SnoN,42,43 and Evi-1 44; reduced expression or inactivation of tumor suppressors that directly regulate the TGF-B signaling pathway including Menin,45 Disabled-2 ,46 and RUNX3; and activation of other signaling pathways includings protein kinase C (PKC). TGF-B is able to increase the production of mitogenic growth factors, including platelet-derived growth factor,51 fibroblast growth factor,52 TGF-B,53 and connective tissue growth factor,54 and to increase expression of the platelet derived growth factor receptor,55 and the epithelial growth factor receptor.56 In addition, TGF-B can activate Smad independent pathways, including the Ras/Raf/MAPK pathway,20-22,57,58 which often mediates the proliferative signal of growth factors. Indeed, it is in conjunction with oncogenic forms of Ras (Ha-Ras or Ki-Ras), that TGF-B drives Smad-independent proliferation of human colon and prostate cancer cells.3,49",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Oncol 2005 Mar 20 23(9) 2078-93",
                "id": "15774796"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a35"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "A specific subset of integrins (including {alpha}1{beta}1, {alpha}5{beta}1, and {alpha}v{beta}3) can induce or enhance cell proliferation through interaction of the integrin  {alpha}-subunit cytoplasmic domain with caveolin-1, a membrane protein that plays a role in organizing membrane microdomains. In this pathway, caveolin-1 recruits the src family kinases, yes or fyn, which recruit the adaptor protein shc that in turn leads to recruitment and activation of the well-characterized Ras pathway (122).",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2003 Jul 83(3) 673-86",
                "id": "12843406"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709fa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The life history of cancer cells encompasses a series of genetic missteps in which normal cells are progressively transformed into tumor cells that invade surrounding tissues and become malignant. Most prominent among the regulators disrupted in cancer cells are two tumor suppressors, the retinoblastoma protein (RB) and the p53 transcription factor. Here, we discuss interconnecting signaling pathways controlled by RB and p53, attempting to explain their potentially universal involvement in the etiology of cancer. Pinpointing the various ways by which the functions of RB and p53 are subverted in individual tumors should provide a rational basis for developing more refined tumor-specific therapies.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2002 Aug 2(2) 103-12",
                "id": "12204530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Immortalized rat colon epithelial cell lines expressed only ACBP and SCP-2 at levels of 0.75 +/- 0.13 and 0.42 +/- 0.02 ng/microgram protein. Ras and src transformation increased colon cell density and differentially altered ACBP and SCP-2 expression without affecting I-FABP or L-FABP levels. ACBP levels were 1.8-fold and 1.5-fold increased in ras- and src-transformed cells, respectively. In contrast, SCP-2 expression was significantly decreased 55 and 67% in ras- and src-transformed cells, respectively.",
              "citation": {
                "type": "PubMed",
                "name": "Lipids 1997 Jun 32(6) 577-85",
                "id": "9208385"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070862"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "By combining pharmacological and genetic approaches, we show here that the Ras/ERK pathway and phosphatidylinositol 3-kinase (PI3K) are both required for cortical neuron migration. By dissecting the downstream signals necessary for this event, we found that Rac1/p38 and Akt are required, whereas the c-Jun N-terminal kinase (JNK) and mTOR/p70(s6k) pathways are dispensable.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Feb 24 281(8) 4771-8",
                "id": "16361255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070858"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "mice lacking a functional gene for IL-5 or IL-5 receptor alpha chain (IL-5Ralpha) display a number of developmental and functional impairments in B cells and eosinophils. IL-5 receptor (IL-5R) comprises alpha and betac chains. IL-5 specifically binds to IL-5Ralpha and induces the recruitment of betac to IL-5R. Although precise mechanisms on cell-lineage-specific IL-5Ralpha expression remain elusive, several transcription factors including Sp1, E12/E47, Oct-2, and c/EBPbeta have been shown to regulate its expression in B cells and eosinophils. JAK2 and JAK1 tyrosine kinase are constitutively associated with IL-5Ralpha and betac, respectively, and are activated by IL-5 stimulation. IL-5 activates at least three different signaling pathways including JAK2/STAT5 pathway, Btk pathway, and Ras/ERK pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Adv Immunol 2009 101 191-236",
                "id": "19231596"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707d5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The human AF-6, a scaffold protein between cell membrane-associated proteins and the actin cytoskeleton, plays an important role in special cell-cell junctions and signal transduction. It can be phosphorylated by the protein kinase Bcr, which allows efficient binding of the C terminus of Bcr to the PDZ domain of AF-6 and consequently enhances the binding affinity of AF-6 to Ras. Formation of the AF-6, Bcr, and Ras ternary complex results in down-regulation of the Ras-mediated signal transduction pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Protein Sci 2007 Jun 16(6) 1053-62",
                "id": "17473018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707c9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Tyrosine phosphorylation led to the association of BCR with the RAS guanine nucleotide exchange complex GRB2-SOS in vivo via the GRB2 SH2 domain, linking BCR to RAS signaling (Maru, Y., Peters, K. L., Afar, D. E. H., Shibuya, M., Witte, O. N., and Smithgall, T. E. (1995) Mol. Cell. Biol. 15, 835-842). In the present study, we demonstrate that BCR Tyr-246 and at least one of the closely spaced tyrosine residues, Tyr-279, Tyr-283, and Tyr-289 (3Y cluster), are phosphorylated by FES both in vitro and in 32Pi-labeled cells. Mutagenesis of BCR Tyr-177 to Phe completely abolished FES-induced BCR binding to the GRB2 SH2 domain, identifying Tyr-177 as an additional phosphorylation site for FES.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Dec 20 271(51) 32930-6",
                "id": "8955135"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407070d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Oncogenic Ras induces the transcription activity of NF-kappaB that confers cell survival. Oncogenic Ras also down-modulates the expression of Par-4, a transcriptional repressor protein, that is essential but not sufficient on its own to induce apoptosis. Here we show that reintroduction of Par-4 by transient transfection leads to apoptosis in cells expressing oncogenic Ras but not in those that lack oncogenic Ras expression. Par-4 abrogates oncogenic Ras-inducible NF-kappaB transcription activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Oct 15 274(42) 29976-83",
                "id": "10514481"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705da"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "After activating Ras using EGF, the GTP-bound form of Ras was precipitated with GST-RBD (GST-Raf containing Ras binding domain). Precipitated Ras was detected using the HA-antibody. As shown in Fig. 5D, in the presence of EGF, the amount of GTP-bound Ras increased over that of the control. Levels of the GTP-bound Ras significantly decreased in cells expressing DIP1/2; however, DIP1/2m failed to stimulate Ras GTPase in cells treated with EGF.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Apr 12 277(15) 12622-31",
                "id": "11812785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705b6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The treatment of rat lung epithelial cells with nicotine for various periods differentially mobilizes multiple intracellular pathways [64]. Protein kinase C and PI3-OH-kinase are transiently activated after the treatment. Also, Ras and its downstream effector ERK1/2 are activated after long-term exposure to nicotine. The activation of Ras by nicotine treatment is responsible for the subsequent perturbation of the methotrexate (MTX)-mediated G1 cell cycle restriction, as well as an increase in production of reactive oxygen species [64].",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 659(3) 221-31",
                "id": "18495523"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705a3"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "These results link signaling pathways previously shown to be associated with cell proliferation (18) and cytoskeletal organization (29, 30) to growth factor gene activation and identify a cis element in FGF1 promoter 1D that can be defined as an SRE. This SRE is comprised of Ets and CArG sites. These sites are targets of regulation by divergent signaling pathways; Ets site target of Ras, Rac1, and Cdc42 regulation; and the CArG site target of de novo protein synthesis-independent cascade.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Sep 29 275(39) 30432-8",
                "id": "10849427"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070565"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Raf may also be activated by Ras-independent elements and, in turn, propagates signals through diverse effectors that mediate proliferation, angiogenesis, metastases, and survival.5 Raf may be activated by signaling upstream or constitutively. Constitutive activation of Raf and Ras are indistinguishable in their potential to induce malignant transformation.6-8 Activating raf mutations have been identified in melanoma, thyroid, colon, and other cancers (Table 1).9-43 Furthermore, the disappointing clinical results of farnesyltransferase (FTase) inhibitors (FTIs) that were developed based on a flawed premise that they would effectively target malignancies with a high incidence of Ras mutation has led to scrutiny of signaling elements downstream of Ras, such as Raf, as therapeutic targets.44 This review highlights relevant information about the biology of Raf and novel strategies directed at exploiting this knowledge to more effectively treat malignant diseases. SIGNALING THROUGH THE MAPK PATHWAY The molecular mechanisms and signaling pathways that regulate cell proliferation and survival are receiving considerable attention as potential targets for anticancer strategies. 45,46 Recently, there has been a notable increase in efforts directed at targeting the MAPK pathway, which integrates a wide array of proliferative signals initiated by receptor tyrosine kinases (RTKs) and G protein- coupled receptors.47,48 The network of signals emanating from the MAPK pathway are transmitted by proteins that serve as chemical switches, cycling between phosphorylated (activated) and dephosphorylated (inactivated) states.49 These on and off switches are regulated by kinases and phosphatases, respectively. Activated signaling elements, in turn, phosphorylate amino acid residues on downstream signaling proteins in a cascade-like and expansive manner.50 Not only does the centrality of the MAPK pathway render its components important targets for therapeutic development, but many genes that encode for its critical signaling elements undergo mutations, constitutively activating downstream signaling elements and conferring the potential for transformation and autonomous growth.50-52 In addition to efforts directed at Ras, therapeutic strategies directed at the MAPK pathway are targeting the cascade of downstream effector proteins including Raf, MAPK kinase (MAPKK; also called MEK or extracellular signal-regulated kinase [ERK] kinase), and ERK. The Raf/MEK/ERK module (Fig 1) of the MAPK pathway, which is immediately downstream of Ras, may be less redundant and innately resistant to therapeutic manipulations compared with Ras (as discussed in the next section). The Unfilled Promise of Targeting Ras The Raf/MEK/ERK module of the MAPK pathway has been the focus of considerable attention because therapeutic efforts directed at Ras, which is situated at the apex of the MAPK pathway, have been disappointing.44 Ras belongs to a superfamily of guanine nucleotide triphosphatases (GTPases) that transmit proliferative and survival signals to the MAPK, phosphatidylinositol 3-kinase (PI3K), and other pathways (Figs 1 and 2). Three ras proto-oncogenes encode four 21-kd proteins, called p21ras or Ras (H-Ras, N-Ras, K-Ras4A, and K-Ras4B, resulting from two alternatively spliced K-Ras gene products), that are localized to the inner surface of the cell membrane.44 Of the three ras genes, K-ras mutations are most commonly found in solid malignancies, whereas N-ras mutations are encountered less often, and H-ras mutations are rarely encountered.53,54 Ras isoforms impart distinct biologic effects as a result of the potential of these proteins to differentially activitate critical effectors.55 After synthesis as inactive cytosolic propeptides, Ras undergoes a series of post-translational modifications at its carboxyl terminus that increase its hydrophobicity.56,57 These modifications render Ras functional and capable of lo...",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Oncol 2005 Sep 20 23(27) 6771-90",
                "id": "16170185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407055b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Figure 8. Model for the role of HBP1/p16INK4A  in Ras-induced premature senescence. The results of this article are summarized in this schematic diagram. Activated Ras in primary cells initiates a premature senescence program that is orchestrated by MEK/MKK3/6-p38 MAPK/HBP1/p16INK4A pathway activation. Our study data indicate that p16INK4A is a novel target of the transcription factor HBP1. HBP1 is involved in Ras-induced premature senescence by mediating p16INK4A expression. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2010 Sep 9 29(36) 5083-94",
                "id": "20581871"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d9f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "GRB7 also maps to 17q12 and has been shown to be overexpressed in some TGCTs [21,22]. GRB7 is an adapter molecule that can bind directly to KIT and ERBB2 through its SH2 domain [23] and is also proposed to bind directly to RAS through its RAS association domain. In this way, GRB7 may have an important role in the regulation of the downstream signaling of these kinases. Furthermore, GRB7 is also known to play a role in cell migration",
              "citation": {
                "type": "PubMed",
                "name": "Neoplasia 2005 Dec 7(12) 1047-52",
                "id": "16354586"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a7f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "FAK also combines with, and may activate, phosphoinositide 3-OH kinase (PI 3-kinase), either directly or through the Src kinase (13). Finally, there is evidence that Src phosphorylates FAK at Tyr925, creating a binding site for the complex of the adapter Grb2 and Ras guanosine 5'-triphosphate exchange factor mSOS (10). These interactions link FAK to signaling pathways that modify the cytoskeleton and activate mitogen-activated protein kinase (MAPK) cascades (Fig. 3A).",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Aug 13 285(5430) 1028-32",
                "id": "10446041"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709d2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "It is also found that overexpression of the GLRX1 gene leads to deglutathionylation of Ras protein, thus inhibiting its activation [291].",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry (Mosc) 2008 Dec 73(13) 1493-510",
                "id": "19216714"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cba"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Full text: SHB binds the activated FGFR-1 at tyrosine 766, which causes SRC-dependent tyrosine phosphorylation of SHB. SHB also associates constitutively to SHP-2, and upon FGF-2 stimulation, SHB/SHP-2 bridging promotes FRS-2 phosphorylation and activation. Thus, SHB is required for an adequate activation of the RAS/ERK pathway and endothelial cell cell mitogenesis [13].",
              "citation": {
                "type": "PubMed",
                "name": "Curr Mol Med 2003 Jun 3(4) 313-24",
                "id": "12776987"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c41"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Inhibition of Ras has been reported to prevent intimal formation after vascular injury, suggesting a critical role of Ras activation inVSMC proliferation [82].",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 2004 Feb 36(2) 175-83",
                "id": "14871544"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bf6"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The activation and targeting of both RhoA and Ras to the ER further confirmed the action of Nox4 on the ER, as these GTPases function upstream and downstream of Nox4, respectively.Thus, RhoA, Nox4, and Ras appear to signal on the ER surface to mediate the Tat-dependent ER stress response.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2010 Jul 30(14) 3553-68",
                "id": "20457808"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a62"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Knockout mouse studies have established that the transformation-selective death program triggered by farnesyltransferase inhibitor (FTI) requires a gain-of-function in the stress-regulated small GTPase RhoB. In support of the concept of RhoB as a negative regulator of Ras signaling pathways, the most strongly downregulated gene scored was farnesyl pyrophosphate synthetase, the enzyme that produces the substrate used by FT to farnesylate Ras proteins.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Biol Ther 2(3) 273-80",
                "id": "12878865"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a50"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We tested the hypothesis that up-regulation of DNA methyltransferase 1 (DNMT1) will lead to methylation and silencing of uPA and inhibition of the invasiveness of metastatic breast cancer cells. Since RAS was previously shown to up-regulate DNA methylation, we examined the effects of ectopic expression of constitutively active RAS on methylation and expression of uPA.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2005 Mar 26(3) 557-64",
                "id": "15618232"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a18"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "This stimulation matched or exceeded phospholipase activation promoted by co-expression of PLC-epsilon with the known regulators Ras, Galpha12/13, or Gbeta1gamma2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 17 278(42) 41253-8",
                "id": "12900402"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407080b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The ectodomain of SHPS-1 has now been shown to be shed from cells in a reaction likely mediated by a metalloproteinase. This process was promoted by activation of protein kinase C or of Ras, and the released ectodomain exhibited minimal CD47-binding activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 2 279(27) 27878-87",
                "id": "15123722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407080a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Transcriptional up-regulation of uridine phosphorylase is shown to be mediated in a DNA binding-dependent manner, and reporter gene assays demonstrated that EWS/FLI1 and RAS mediate activation through a single activator protein 1/ETS site located in the uridine phosphorylase promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Jul 15 63(14) 4268-74",
                "id": "12874036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070804"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We analyzed jacalin-induced intracellular signaling events in CD4(+) T cells and have shown that cell activation resulted in tyrosine phosphorylation of intracellular substrates p56(lck), p59(fyn), ZAP-70, p95 (vav), phospholipase C-gamma1, and ras activation, as assessed by conversion of ras guanosine 5'-diphosphate to ras guanosine 5'-triphosphate. ",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2003 May 73(5) 682-8",
                "id": "12714584"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Gel electrophoretic analysis demonstrated that 1,10-phenanthroline almost totally abolished the labeling of methylated proteins in kidney intracellular membranes. Immunoblotting analysis showed that one of the two major peaks of (3)H-methylated proteins in intracellular membranes comigrated with the small G proteins Ras, Cdc42, RhoA, and Rab1.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1999 Aug 11 261(3) 790-7",
                "id": "10441503"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070649"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "By directly targeting ezrin expression, miR-204 functions as a new miRNA regulator of Ras activation, and its downregulation represents a novel mechanism for aberrant Ras activation in cancer development.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Transl Res 2011 Feb 3(2) 209-18",
                "id": "21416062"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of gastrointestinal tract",
                "cell": "",
                "tissue": "gastric epithelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Here, we demonstrate an activation of the small G-proteins Rac 1 and Rac 2 after Fas receptor triggering. Expression of a transdominant inhibitory Ras mutant (N17Ras) prevents Rac 1 and Rac 2 stimulation, suggesting a signaling cascade from the Fas receptor via Ras to Rac 1 and Rac 2. Genetic and pharmacological inhibition of Ras or Rac 1 and Rac 2 stimulation blocks Fas-induced apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Oct 18 271(42) 26389-94",
                "id": "8824295"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407059e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "In addition, DN Ras, DN focal adhesion kinase (FAK), but not Stat3beta, restored intercellular adhesion, which indicates that Ras and FAK may be downstream effectors of Src-mediated homotypic adhesion.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 May 1 62(9) 2669-74",
                "id": "11980666"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070589"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Moreover, Erbin inhibits the Erk activation by active Ras, while it fails to do so in the presence of active Raf-1. Erbin associates with active Ras, but not inactive Ras nor Raf. Consistently, Erbin interferes with the interaction between Ras and Raf both in vivo and in vitro. Erbin associates with active Ras, but not inactive Ras nor Raf.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 10 278(2) 1108-14",
                "id": "12379659"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070520"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Mutation of tyrosine 766 to phenylalanine prevented PLC-gamma activation and resulted in a reduced phosphorylation of FRS2 and reduced activation of the Ras/MEK/MAPK pathway relative to the wild-type chimeric receptor.  -- ([bcd]  looked at full text and they bloted with anti-phosphotyrosine)",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2002 Aug 13(8) 2881-93",
                "id": "12181353"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070507"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Figure 1. Pathways to MUC5AC expression in COPD",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82",
                "id": "17615396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d7b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "From CST pathway map for GPCR Signaling to ERK. ",
              "citation": {
                "type": "PubMed",
                "name": "Trends Endocrinol Metab 2006 Sep 17(7) 276-83",
                "id": "16890451"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d77"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Lysophosphatidic acid (LPA) is the prototypic G-protein-coupled receptor agonist that activates the Ras-mitogen-activated protein (MAP) kinase cascade",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1999 Apr 1 339 ( Pt 1) 11-4",
                "id": "10085221"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d4a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "three members of the Raf family of protein-serine/threonine kinases have been identified (Raf-1, A-Raf, and B-Raf), whose activation is linked to receptor protein-tyrosine kinases by Ras (24).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Aug 19(8) 5308-15",
                "id": "10409722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d40"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Ras is required to recruit Raf-1 to the plasma membrane, which is where S338 phosphorylation occurs. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Apr 21(7) 2423-34",
                "id": "11259591"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d3f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "RTK signaling potentiates GLI activity through PI3K-AKT-mediated GSK3 inactivation or RAS-STIL1-mediated SUFU inactivation, while GPCR signaling to Gs represses GLI activity through adenylate cyclase-mediated PKA activation",
              "citation": {
                "type": "PubMed",
                "name": "Curr Mol Med 2009 Sep 9(7) 873-86",
                "id": "19860666"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d00"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Active Ras was reduced in Sirtinol-treated senescent cells",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Jan 12 25(2) 176-85",
                "id": "16170353"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cfc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Although ligation of both receptors induces Ras and Raf-1 activation,",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Feb 15 162(4) 2087-94",
                "id": "9973482"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cf7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Shc and FRS2 mediates recruitment of Grb2-SOS complexes leading to Ras/ERK stimulation, and of Grb2-GAB1/2 complexes leading to stimulation of the phosphatidylinositol-3-kinase (PI3K)/AKT pathway. ShcC and IRS are required to trigger PI3K/AKT activation.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2004 Dec 61(23) 2954-64",
                "id": "15583857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ce5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Growth factor and other survival signals are transduced through receptor tyrosine kinases via adaptor proteins (such as GRB2 and the guanine-nucleotide exchange factor SOS) and activate Ras and its downstream targets, Raf and MEK1/2, which results in the activation of ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2008 Sep 118(9) 3003-6",
                "id": "18725993"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ce2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Importantly, other molecules such as p16INK4 are probably also involved in the induction of permanent cell-cycle arrest. Because disruption of p16INK4 enables escape from RAS-induced senescence [60],",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2007 Jan 13(1) 4-11",
                "id": "17118707"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cdd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The dimerization of two EGFR family molecules leads to .... exchange of a GTP from the receptor complex for a GDP from the RAS protein to form activated RAS",
              "citation": {
                "type": "PubMed",
                "name": "Curr Cancer Drug Targets 2004 Aug 4(5) 403-24",
                "id": "15320717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cda"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "In response to stimulation with epidermal growth factor (EGF), the guanine nucleotide exchange factor human SOS1 (hSOS1) promotes the activation of Ras by forming a complex with Grb2 and the human EGF receptor (hEGFR)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Mar 8 271(10) 5871-7",
                "id": "8621459"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cc8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Epo has also been shown to stimulate activation of Ras and Raf-1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1994 Nov 25 269(47) 29962-9",
                "id": "7961995"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cc5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The sentence from ResnetDB These data suggest that Src, Raf, and H-Ras oncoproteins stimulate elevated ARF6 expression is translated to the assertions Activation of ARF6 (Homo sapiens) Gene Expression by Oncogene Activation of ARF6 (Homo sapiens) Gene Expression by RAF1 (Homo sapiens) Protein",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Jan 23(2) 645-54",
                "id": "12509462"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cc4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Ligation of this receptor by EGF activates Erk1 and Erk2, members of the mitogen-activated protein (MAP) kinase family, through a Ras-dependent signal transduction pathway. ",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1998 Oct 15 395(6703) 713-6",
                "id": "9790194"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ca9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "jubilant",
              "citation": {
                "type": "PubMed",
                "name": "Blood 1999 Feb 15 93(4) 1338-45",
                "id": "9949177"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ca5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Although both Rac and CDC42 are clearly activated by RAS",
              "citation": {
                "type": "PubMed",
                "name": "Prog Cell Cycle Res 2003 5 203-10",
                "id": "14593714"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c9c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 1997 Jan 6 185(1) 43-53",
                "id": "8996240"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c98"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "senescence was induced by replicative exhaustion, oncogenic RAS, p14(ARF), or hydrogen peroxide",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Oct 9 98(21) 12072-7",
                "id": "11593017"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c96"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The constitutive activation of Ras provokes premature senescence in vascular cells, which is associated with accumulation of the proteins p53 as well as p16 [20].",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 2004 Feb 36(2) 175-83",
                "id": "14871544"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c8e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We also found that NCK binds directly to the guanine nucleotide exchange factor SOS. This interaction is mediated by the SH3 domains of NCK. These findings suggest that NCK can regulate p21ras-dependent gene transcription through interaction with SOS protein.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1995 Mar 15(3) 1169-74",
                "id": "7862111"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c80"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We demonstrated that silencing of gelsolin expression by small interfering RNA sensitized cells to butyrate-induced apoptosis through amplification of the activation of caspase-9 and caspase-7. These data therefore demonstrate that gelsolin protects cells from butyrate-induced apoptosis and suggest that Ras promotes apoptosis, at least in part, through its ability to down-regulate the expression of gelsolin.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Aug 27 279(35) 36680-8",
                "id": "15213223"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c7f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We found that oncogenic ras promotes an increase in the intracellular level of ceramides together with an increase in the PPP1CA protein levels.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2008 Mar 29(3) 491-9",
                "id": "18204081"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c77"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We demonstrate that co-expression of DIP1/2 and the N-terminal domain of DOC-2/DAB2 (i.e. Delta B) has an additive effect on suppressing either TPA-induced SRE or TRE reporter gene activity (Fig. 6B and Table I). Therefore, we believe that the in vivo interaction of DIP1/2 with the N-terminal domain of DOC-2/DAB2 acts as a feedback mechanism to modulate PKC-induced gene activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 5 274(45) 31981-6",
                "id": "10542228"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c75"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "COX-2 is inducible by oncogenes ras and scr, interleukin-1, hypoxia, benzo[a]pyrene, ultraviolet light, epidermal growth factor, transforming growth factor beta, and tumor necrosis factor alpha.",
              "citation": {
                "type": "PubMed",
                "name": "Ann Clin Lab Sci 2000 Jan 30(1) 3-21",
                "id": "10678579"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c5e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Precancerous hyperproliferation and sustained activation of the Ras-MAPK cascade was recently found in skin with tissue-specific ablation of a-catenin [8].",
              "citation": {
                "type": "PubMed",
                "name": "Breast Cancer Res 2001 3(5) 289-93",
                "id": "11597316"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c5b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Each of these stimuli triggers a cell cycle arrest and the expression of a battery of senescence associated markers (e.g., SA-associated b-galactosidase). Other markers include the p16 and p21 CDK inhibitors, of which the latter is a new p38 MAPK target.",
              "citation": {
                "type": "PubMed",
                "name": "Gene 2004 Jul 7 336(1) 1-13",
                "id": "15225871"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c50"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Ras activation was decreased in RAGE null mouse lung exposed to chronic cigarette smoke.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2011 Aug 45(2) 411-8",
                "id": "21131443"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c44"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "calcimycin, a calcium mobilizer, activates the RAF/MEK/ERK pathway through RAS,",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2005 Sep 16(9) 4437-53",
                "id": "16000378"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c26"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We showed that the expression of Gro-1 is activated by RAS and is vital for cell survival and the malignant transformation of ovarian epithelial cells.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2006 Oct 31 103(44) 16472-7",
                "id": "17060621"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c1b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Gene 33 inhibits EGFR autophosphorylation and specifically blunts epidermal growth factor (EGF)-induced activation and/or phosphorylation of Ras, ERK, JNK, Akt/PKB, and retinoblastoma protein.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 28 280(4) 2924-33",
                "id": "15556944"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c11"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Rap-1 antagonizes Ras in T cells42 but activates the Raf-ERK cascade, as does Ras, in PC12 cells43 and contributes to the integrin-mediated adhesion of T lymphocytes and embryonic fibroblasts.44,45",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2002 Nov 1 91(9) 769-75",
                "id": "12411390"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Incubation of neutrophils in the presence of 25 nM IL-8 for 2 minutes resulted in the stimulation of Ras/GTP exchange followed by the rapid hydrolysis of GTP to GDP by Ras, identified by the Ras-bound GDP.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Feb 2 271(5) 2832-8",
                "id": "8576262"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070be3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "from full text - Figure 1 ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Jul 35(1) 3-9",
                "id": "16484682"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bda"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 15 276(24) 21039-45",
                "id": "11274196"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bcc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The LHR-mediated phosphorylation of the EGFR and Shc, the activation of Ras, and the phosphorylation of ERK1/2 are inhibited by expression of a dominant-negative mutant of Fyn, a member of the Src family kinases (SFKs) expressed in MA-10 cells and by PP2, a pharmacological inhibitor of the SFKs. ",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2006 Jul 147(7) 3419-27",
                "id": "16614081"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bb9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "In addition, the Y716(P) peptide significantly decreased the amount of GTP bound to Ras [Ras activation] in response to PDGF",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1994 Oct 14(10) 6715-26",
                "id": "7935391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bb3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We also examined the interaction between Oog1 and Ras by GST pull-down assay and revealed that Oog1 interacts with Ras in a GTP-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 May 19 343(4) 1105-12",
                "id": "16580637"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bab"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Reactive oxygen species (ROS) activate Ras",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jul 23 274(30) 21003-10",
                "id": "10409649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b92"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Thus, in addition to negatively regulating Src family kinases by recruiting Csk, PAG also negatively regulates Ras by recruiting RasGAP to the membrane. ",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2007 Jul 15 110(2) 596-625",
                "id": "17389760"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b8e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2003 Feb 28 302(1) 46-55",
                "id": "12593846"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b88"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "overexpression of either dominant negative Rac2 or the N-terminal regulatory domain of PAK1 inhibits Ras-mediated activation of ERK2",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Jul 16(7) 3707-13",
                "id": "8668187"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b74"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Expression of activated MEK completely blocked apoptosis induced by serum withdrawal (Fig. 5). In addition, the expression of active Ras and Raf-1, which also activate MEK, similarly inhibited cell death induced by growth factor deprivation",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Aug 19(8) 5308-15",
                "id": "10409722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b66"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "EphrinB2 not only increased the phosphorylation of EphB2 and EphB4 in a time-dependent manner but also increased recruitment of p120-Ras-GTPase-activating protein (p120-RasGAP) to EphB2 and EphB4. Accordingly, ephrinB2 inhibited VEGF- and Ang1-induced Ras-MAPK activities, whereas ephrinB2 did not alter VEGF-induced Flk phosphorylation or Ang1-induced Tie2 phosphorylation. ",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2002 Jul 16(9) 1126-8",
                "id": "12039842"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b4b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Cofilin has been identified as a key mediator of actin reorganization. Its activity is regulated via reversible phosphorylation of ser-3......Thus, stimulation of Ras through platelet-derived growth factor (PDGF) or transient expression of activated Ras-proteins induces the dephosphorylation of cofilin",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2004 Feb 16(2) 235-43",
                "id": "14636893"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b40"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 8 277(10) 8076-82",
                "id": "11779872"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b29"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "TNFalpha-induced Ras activation is important in hepatic proliferation in response to ethanol-induced liver injury.",
              "citation": {
                "type": "PubMed",
                "name": "Hepatology 2004 Mar 39(3) 721-31",
                "id": "14999690"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b1b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We show that p52Shc is phosphorylated on both YY239/240 and Y317 following TCR engagement. Mutation of either YY239/240 or Y317 results in impaired interaction with Grb2 and inhibition of Ras/MAP kinase activation and CD69 induction, supporting a role for both Grb2 binding sites in this function.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Mar 24 24(13) 2218-28",
                "id": "15688026"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b1a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "These findings suggest that inhibition of ICMT causes endothelial cell apoptosis by attenuation of Ras GTPase methylation and activation and its downstream antiapoptotic signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2003 Mar 14(3) 848-57",
                "id": "12631708"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b18"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Dominant-negative forms of Ras and/or Rac-1 significantly suppressed HIF-1 activation by muscarinic signaling. Signaling via M1- and M3- but not M2- or M4-AchRs promote accumulation and transcriptional activation of HIF-1alpha.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 1 279(40) 41521-8",
                "id": "15280370"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b0d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Apr 21(8) 2659-70",
                "id": "11283246"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b03"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Induction of SNT-1 PTB resulted in a significant decrease of FGF-1-dependent tyrosine phosphorylation of endogenous SNT-1, strong inhibition of complex formation between SNT-1, Gab-1 and Sos-1, and reduced activation of Ras, mitogen-activated protein kinase (MAP kinase), and Akt.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Sep 28 25(44) 6003-14",
                "id": "16682955"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ae5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of breast",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "RAF pull-down assays showed elevated levels of activated Ras-GTP in Lkb1 mutant SCC relative to papillomas and normal skin despite the absence of H-ras mutations in these tumors (Fig. 4A).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2008 Jan 1 68(1) 55-63",
                "id": "18172296"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ac4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Carcinoma, Squamous Cell",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "TNF- induced binding of Ras to beads conjugated to the Ras binding domain (RBD) of Raf, indicative of Ras activation (Figure 2A).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2003 Jun 28(6) 762-9",
                "id": "12600818"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070abf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "C2-ceramide-induced membrane association of p21Ras was reduced by 30-50% in PPT1-overexpressing cells compared with control.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2000 Apr 74(4) 1478-88",
                "id": "10737604"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070aa6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Protein kinase A-dependent phosphorylation of serine 43 within the regulatory domain of Raf-1 reciprocally potentiates its interaction with Rheb and decreases its interaction with H-Ras.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1997 Feb 17(2) 921-33",
                "id": "9001246"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070aa1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Genetic and biochemical analyses in Caenorhabditis elegans, Drosophila, Xenopus, and mammals support the notion that Shp2 promotes Ras activation by growth factors and cytokines......most functional analyses suggest that the catalytic activity of Shp2 is required for promotion of signaling through the Ras-Erk pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2007 Feb 1 109(3) 862-7",
                "id": "17053061"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a9c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Jul 20(13) 4494-504",
                "id": "10848576"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a9b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We conclude (i) that PP2A negatively regulates the Ras/MAP kinase pathway by binding to Shc, inhibiting tyrosine phosphorylation;",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Apr 22(7) 2375-87",
                "id": "11884620"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a95"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "high levels of Bcr-Abl activate a signaling cascade involving the sequential activation of Ras, phosphatidylinositol-3 kinase, atypical protein kinase C, Raf-1, and mitogen-activated protein kinase kinase, leading to the ultimate expression of OPN.",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2005 Jul 78(1) 289-300",
                "id": "15857938"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a8e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "PDGF-AA-induced activation of Ras, initiation of DNA synthesis, or growth of cells alphaPDGFR to activate Ras or initiate a proliferative response",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Dec 16(12) 6926-36",
                "id": "8943348"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a7b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Here we found that DOC-2/DAB2, a signaling molecule inhibiting the Ras cascade, binds to myosin VI at the globular tail domain.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2002 Mar 29 292(2) 300-7",
                "id": "11906161"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a66"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "At the same time, the ROS dependent activation of Ras is found to be one of the causes of development of atherosclerosis and restenosis [292]",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry (Mosc) 2008 Dec 73(13) 1493-510",
                "id": "19216714"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a5c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Thus, while p120 and NF1 (neurofibromatosis-related protein 1) are clearly Ras-specific and do not enhance the catalytic activity of Rap, RASA1 (p120-RASGAP)",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Soc Trans 2006 Nov 34(Pt 5) 846-50",
                "id": "17052212"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a57"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Sprouty (Spry) proteins were found to be endogenous inhibitors of the Ras/mitogen-activated protein kinase pathway that play an important role in the remodeling of branching tissues.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Sep 1 64(17) 6127-36",
                "id": "15342396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a4c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Ras activates several proteins to initiate human tumour growth, only PI3K, through activation of protein kinase B (PKB; also known as AKT), must remain activated by oncogenic Ras to maintain this growth",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2008 Apr 3 452(7187) 646-9",
                "id": "18344980"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a2b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Together, the results show that K/E-FR3 is transforming and that the Ras-ERK and the PI3K-Akt signaling pathways, which are positively regulated by SHP2, are important for K/E-FR3-induced transformation.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Oct 9 22(44) 6909-18",
                "id": "14534538"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a20"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We also provide evidence for the importance of the downregulation of RhoB in oncogenesis by demonstrating that RhoB antagonizes Ras/PI3K/Akt malignancy.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jun 24(12) 5565-76",
                "id": "15169915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a14"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Ras GTPase was activated by EGF, NGF, insulin and phorbolester in PC12 cells",
              "citation": {
                "type": "PubMed",
                "name": "Int J Oncol 2000 May 16(5) 1043-8",
                "id": "10762643"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a0a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "TNF? initiates the activation of ERK/mitogen-activated protein kinase through the adaptor protein, Grb2, binding to the TNF? receptor 1, leading to activation of the ras/mitogen-activated kinase kinase (MEK)/ERK signalling cascade",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Res Ther 2009 11(1) R8",
                "id": "19144181"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a08"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "chondrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Blood 1999 Oct 15 94(8) 2754-66",
                "id": "10515879"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a04"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The Dok-1 mutants having tyrosine-to-phenylalanine (YF) substitution(s) at Tyr-336 and/or Tyr-340 lost their inhibitory effect on Ras and Erk downstream of Src-like PTK, Lyn or Fyn, whereas the rasGAP-binding of each mutant remained intact. ",
              "citation": {
                "type": "PubMed",
                "name": "Genes Cells 2004 Jun 9(6) 601-7",
                "id": "15189452"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709fd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We previously showed that the cytoplasmic adapter 3BP2 (also known as SH3BP2) promotes NFAT/AP-1 transcriptional activities in T cells through the activation of Ras- and calcineurin-dependent pathways.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 28 278(9) 7146-53",
                "id": "12501243"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709f3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "inhibition of LPAAT-beta inhibits signaling in both the Ras/Raf/Erk and PI3K/Akt pathway",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2003 Oct 2(10) 1067-78",
                "id": "14578472"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709d9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We previously reported that Ras activation induced vascular cell senescence and inflammation, and we suggested that vascular cell senescence might contribute to human atherogenesis.19",
              "citation": {
                "type": "PubMed",
                "name": "Circulation 2006 Aug 29 114(9) 953-60",
                "id": "16908765"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We found that Pak directly associates with Raf-1 under both physiological and overexpressed conditions. The association is greatly stimulated by 4beta-12-O-tetradecanoylphorbol-13-acetate and nocodazole and by expression of the active mutants of Rac and Ras.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Feb 8 277(6) 4395-405",
                "id": "11733498"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709d0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Taken together, these findings suggest that IL-6 might activate the Ras signaling pathway via tyrosine phosphorylation of Shc and subsequent recruitment of Grb2.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Immunol 1996 Feb 26(2) 379-84",
                "id": "8617307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709cf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "These observations suggest that SR gene expression is regulated via a signal transduction pathway involving ras, AP-1, and ets domain proteins",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1994 Mar 14(3) 2129-39",
                "id": "8114743"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407098c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Using a physiological model of beta-cell expansion, we show that HNF-4alpha is required for beta-cell replication and the activation of the Ras/ERK signaling cascade in islets",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2007 Apr 1 21(7) 756-69",
                "id": "17403778"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407097c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "pancreatic beta cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Shc tyrosine phosphorylation and Ras activation by H(2)O(2) were also significantly reduced in Fyn-/- cells, but not altered in Src-/- cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jul 23 274(30) 21003-10",
                "id": "10409649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407096a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "In the second case, Fyn or Yes, activated by some b1 and aV integrins, recruit Shc through their SH3 domain and phosphorylates it, thus promoting Shc association with the Grb2-Sos complex [62,63].",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2004 Mar 4 1654(1) 51-67",
                "id": "14984767"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070961"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Thus HGF stimulation can trigger the Ras pathway by recruiting Grb2 both directly through the receptor, and indirectly, through Shc.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1995 Apr 20 10(8) 1631-8",
                "id": "7731718"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070956"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "This antiapoptotic effect is not mediated by an increase in H(+)-ATPase activity but through activation of the Ras-mitogen-activated protein kinase (MAPK)-signaling pathway that results in the serine phosphorylation of Bad at residues 112 and 155.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Death Differ 2006 Dec 13(12) 2109-17",
                "id": "16710359"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070948"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Moreover, the aFGF-induced Ras signaling pathway, which is essential for PC12 cell differentiation, is not affected by elimination of PI hydrolysis",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1994 May 20 269(20) 14419-23",
                "id": "7514169"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070947"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The phorbol ester PMA is a Ras agonist and, similar to Ras, inhibits Dicer protein expression in IMR-90 human fibroblasts (data not shown) and in JAR (Fig. 4).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Immunol 2009 Mar 46(6) 1222-8",
                "id": "19118902"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070924"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Of potential functional relevance, the expression of Par-4 allows TNFalpha to induce apoptosis in NIH-3T3 cells. In addition, the down-regulation of Par-4 levels by oncogenic Ras sensitizes cells to TNFalpha-induced NF-kappaB activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jul 9 274(28) 19606-12",
                "id": "10391896"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407091c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 1986 Jan 24 14(2) 843-52",
                "id": "3945555"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407090a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 20 277(38) 34679-91",
                "id": "12105209"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "On the other hand, prostate cancer cells LNCaP or normal prostatic epithelial cells that were resistant to apoptosis by Par-4 did not show Fas or FasL trafficking. Par-4 is down-regulated by oncogenic-Ras, -Raf, or -Src.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Oct 1 61(19) 7255-63",
                "id": "11585763"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708fc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Similarly, somatostatin receptor (Lahlou et al., 2003), as well as insulin and low doses of EGF (Wennstrom and Downward, 1999) can drive Ras activation through PI3K",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Sep 18 27(41) 5527-41",
                "id": "18794886"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708f6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The EGFR and ErbB2 suppression of RhoB promoter activity is mediated by Ras. Furthermore, Ras suppresses basal as well as 5-fluorouracil (5-FU)-induced RhoB promoter activity and RhoB protein levels.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Feb 5 23(5) 1136-45",
                "id": "14647415"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708f2"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Hematopoietic progenitors isolated from CML patients in the chronic phase contain a constitutively tyrosine-phosphorylated protein that migrates at 62 kDa by SDS-PAGE and associates with the p120 ras GTPase-activating protein (GAP). ",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1997 Jan 24 88(2) 197-204",
                "id": "9008160"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "U-87 MG cells treated with FTI-277 (farnesyltransferase inhibitor), which block the Ras activity, decreased VEGF mRNA expression to approximately 30% of baseline. Also, cells transfected with dominant negative form of Ras, showed a decreased VEGF promoter activity in U-87 and U87/T691cells MG cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Oct 15 60(20) 5879-86",
                "id": "11059786"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708e5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "In Fyn-/- fibroblasts, activation of Ras by H(2)O(2) was significantly attenuated.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jan 21 275(3) 1739-48",
                "id": "10636870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708e2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "hDAB2IP (human DAB2 (also known as DOC-2) interactive protein) is a novel GTPase-activating protein for modulating the Ras-mediated signal pathway",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 31 278(5) 3121-30",
                "id": "12446720"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "In this paper, we present a comprehensive pathway map of EGFR signaling and other related pathways. The map reveals that the overall architecture of the pathway is a bow-tie (or hourglass) structure with several feedback loops.  See figure 2: The bow-tie architecture of the EGFR signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Syst Biol 2005 1 2005.0010",
                "id": "16729045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708c0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "however, phosphorylation of Raf-1 was significantly lower in Hpca(-/-) slices. These results suggest that Hpca plays an important role in the activation of Raf conducted by Ras.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci Res 2007 Mar 85(4) 837-44",
                "id": "17279541"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708bd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Thus far, only a single Shc phosphorylation site, the tyrosine at position 317 (Y317) has been identified. Phosphorylation of Y317 has been implicated in Grb2 binding and activation of the Ras pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 1996 Nov 1 6(11) 1435-44",
                "id": "8939605"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708ad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The mechanism of action of farnesyltransferase inhibitors (FTIs) has not been fully clarified. We investigated the cytotoxic effects of various FTIs in chronic myeloid leukemia (CML)",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2003 Aug 15 102(4) 1490-8",
                "id": "12714496"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708a6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "(Figure 6B). The average of three experiments showed that 55.8+6.9% of ERK phosphorylation and 43.0+7.9% of IkBa degradation were reverted by the Ras inhibitor.",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2008 Aug 1 79(3) 537-44",
                "id": "18411230"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407089d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "These findings suggest that inhibition of ICMT causes endothelial cell apoptosis by attenuation of Ras GTPase methylation and activation and its downstream antiapoptotic signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2003 Mar 14(3) 848-57",
                "id": "12631708"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070898"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We previously showed that TESK1 interacts with Sprouty-4 (referred to as Spry4), an inhibitor of growth factor-induced Ras/MAP (mitogen-activated protein) kinase signalling, but the functional role of this interaction has remained unknown.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2005 May 1 387(Pt 3) 627-37",
                "id": "15584898"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070886"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "In turn, Grb2 stimulates a guanine nucleotide exchange protein, SOS, to convert Ras from the inactive GDP-bound state to the active GTP-bound form. ",
              "citation": {
                "type": "PubMed",
                "name": "Breast Cancer Res 2000 2(3) 211-6",
                "id": "11250712"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070885"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of breast",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Levels of AFP mRNA but not albumin mRNA were elevated by simvastatin in a dose-dependent manner (1-10 micromol/l).",
              "citation": {
                "type": "PubMed",
                "name": "J Hepatol 1999 May 30(5) 904-10",
                "id": "10365819"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407087a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Our results indicate that autocrine secretion of PRL stimulates tyrosine phosphorylation of ErbB-2 by Jak2, provides docking sites for Grb2 and stimulates Ras-MAP kinase cascade, thereby causing unrestricted cellular proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Oct 27 275(43) 33937-44",
                "id": "10938266"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070878"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of breast",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Reconstitution of PKCbetaI expression in these cells by retroviral transfection increased Ras/ERK activation by 3050%, indicating full restoration of Ras/ERK activation (Fig. 2 D and E). ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Aug 5 100(16) 9470-5",
                "id": "12881490"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407086c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "cyclic stretch causes AEC DNA damage and that FGF-10 attenuates these effects by mechanisms involving MAPK activation via the Grb2-SOS/Ras/RAF-1/ERK1/2 pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2003 Feb 284(2) L350-9",
                "id": "12533312"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070867"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "from full text - bombesin treatment significantly increased Ras activation (Fig. 2 C). The expression of KUZ, but not K MP, further elevated the increase of activated Ras.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Jul 22 158(2) 221-6",
                "id": "12119356"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070864"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Fig.1",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Nov 26 306(5701) 1506-7",
                "id": "15567848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070863"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "consistent with its role in tumor angiogenesis, expression of VEGF is upregulated by the common genetic events leading to malignant transformation, including loss of tumor suppressor genes, such as p53, and activation of oncogenes, such as ras, v-src and HER2",
              "citation": {
                "type": "PubMed",
                "name": "Oncologist 2004 9 Suppl 1 2-10",
                "id": "15178810"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407085e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "\\\"Phosphorylation of Raf-1 serine 338-serine 339 is an essential regulatory event for Ras-dependent activation and biological signaling.\\\"",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1997 Aug 17(8) 4509-16",
                "id": "9234708"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070851"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Here we report that oncogenic Ras inhibits TGFbeta signaling in mammary and lung epithelial cells by negatively regulating the TGFbeta mediators Smad2 and Smad3.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 Apr 1 13(7) 804-16",
                "id": "10197981"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070838"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "In addition to its role in cell proliferation, we have found that constitutive activation of Ras induces vascular cell senescence that is associated with vascular inflammation [20].",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 2004 Feb 36(2) 175-83",
                "id": "14871544"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407081f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Oncogenes which activate ras signal transduction pathways stimulate expression of the K18 gene through transcription factors including members of the AP-1 (jun and fos) and ETS families.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Metastasis Rev 1996 Dec 15(4) 445-71",
                "id": "9034603"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407081b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Thus, in addition to negatively regulating Src family kinases by recruiting Csk, PAG also negatively regulates Ras by recruiting RasGAP to the membrane. ",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2007 Jul 15 110(2) 596-625",
                "id": "17389760"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070800"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Under these circumstances activated RhoA is reported to prevent the expression of the CKI p21Cip1, a major mediator of RAS- or RAF-induced cell cycle arrest in mouse fibroblasts (43).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Dec 24(24) 10868-81",
                "id": "15572689"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707f0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "activation of Jnk was inhibited by dominant-negative Ras and Rac1 and by the phosphoinositide 3-kinase inhibitor",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 May 1 16(9) 2365-75",
                "id": "9171350"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Interestingly, VSMC lines stably expressing dominant negative Ras (Ras N17) or Rac (Rac N17) exhibited a marked decrease in MKP-1 expression; the inhibition of ERK kinases (MEK1/2) by PD 98059 or of p38 MAPKs by SB 202190 resulted in a down-regulation of MKP-1 induction.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Sep 3 274(36) 25273-80",
                "id": "10464250"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707c7"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "oncogenic mutations or amplification of ras leads to VEGF up-regulation",
              "citation": {
                "type": "PubMed",
                "name": "Endocr Rev 2004 Aug 25(4) 581-611",
                "id": "15294883"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707c0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "BMP-2 and TGF-beta stimulated Ras, MAPK, and AP-1 activities (note: Ras is upstream of the otehr two)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 3 277(18) 15514-22",
                "id": "11854297"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407079c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "osteoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Src inhibition leads to activation of the Ras pathway upon PDGF stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2005 Nov 16(11) 5418-32",
                "id": "16135530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070790"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "H2O2-dependent stimulation of HDC promoter activity was completely inhibited by kinase-deficient ERKs, dominant-negative (N17 and N15) Ras, and dominant-negative Raf, and partially blocked by a dominant-negative EGFR mutant.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Sep 4 273(36) 23046-54",
                "id": "9722530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070787"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Ras-GTP levels were elevated 2 days after infection and were suppressed to levels significantlylower than cycling vector-infected cells several days later (Figure 3B).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2006 Dec 10(6) 459-72",
                "id": "17157787"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407077b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": " The small guanine nucleotide (GTP)-binding protein Rac regulates mitogen-induced cytoskeletal changes and c-Jun amino-terminal kinase (JNK), and its activity is required for Ras-mediated cell transformation. Epistatic analysis placed Rac as a key downstream target in Ras signalling; however, the biochemical mechanism regulating the cross-talk among these small GTP-binding proteins remains to be elucidated.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1999 Sep 16 401(6750) 290-3",
                "id": "10499589"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070777"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "These events have been detected in primary scleroderma fibroblasts, which generate reactive oxygen species-Ras-ERK1/2",
              "citation": {
                "type": "PubMed",
                "name": "N Engl J Med 2009 May 7 360(19) 1989-2003",
                "id": "19420368"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407076e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Ang II is an important molecule that activates the Ras signaling pathway. Consistent with the influence of Ang II on senescence, constitutive activation of Ras has been found to induce vascular cell senescence and is associated with vascular inflammation.60",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2007 Jan 5 100(1) 15-26",
                "id": "17204661"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070751"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We show that wild-type B-RAF forms a complex with C-RAF in a RAS-dependent manner, whereas the mutants bind independently of RAS. Importantly, we show that wild-type B-RAF can also activate C-RAF.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2005 Dec 22 20(6) 963-9",
                "id": "16364920"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407073d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Helicobacter pylori infection, one of the risk factors for gastric cancer, can activate Ras through EGFR transactivation [13].",
              "citation": {
                "type": "PubMed",
                "name": "Am J Transl Res 2011 Feb 3(2) 209-18",
                "id": "21416062"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070720"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of gastrointestinal tract",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "we found that PGE2 stimulated the activation of Ras and ERK, but not Akt, and reduced matrix deprivation-induced apoptosis, in untransformed epithelial cells",
              "citation": {
                "type": "PubMed",
                "name": "Mol Carcinog 2007 Dec 46(12) 958-70",
                "id": "17477350"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070719"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Through its phosphorylated tyrosine residues, the activated VEGFR-2 associates with the adapter molecules Shc, Grb2 and Nck, to Ras GTPase activating protein, p59fyn, pp62yes and phospholipase Cg, and to the tyrosine phosphatases SHP-1 and SHP-2",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 Feb 15 18(4) 882-92",
                "id": "10022831"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070718"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Cortical OP (oligodendrocyte precursor) cells treated with 10 ng/ml of pDGF and 10 ng/ml of bFGF for 5 minutes showed significant increase in GTP-bound, active Ras.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 1997 Feb 15 17(4) 1291-301",
                "id": "9006973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070703"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Protein phosphatase 1alpha is a Ras-activated Bad phosphatase",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2000 May 15 19(10) 2237-46",
                "id": "10811615"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The RasRafMek pathway is involved in signaling downstream from EGFR and in other pathways leading to the growth of cancer cells and tumor progression (Fig. 2).",
              "citation": {
                "type": "PubMed",
                "name": "N Engl J Med 2008 Sep 25 359(13) 1367-80",
                "id": "18815398"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "In the presence of an inhibitor of farnesly transferase (Ftase-1), which prevent the maturation of Ras, both Estradiol and TGF alpha induced ERK activation was significantly inhibited.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 3 277(18) 15514-22",
                "id": "11854297"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Src inhibition leads to activation of the Ras pathway upon PDGF stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2005 Nov 16(11) 5418-32",
                "id": "16135530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706e5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We have previously shown in NIH 3T3 fibroblasts that treatment with 12-O-tetradecanoylphorbol 13-acetate (TPA) or fibroblast growth factor-2 (FGF-2) activates the Ras/Erk signaling pathway in NIH 3T3 fibroblasts, leading to the induction of the urokinase-type plasminogen activator (uPA) gene.",
              "citation": {
                "type": "PubMed",
                "name": "Gene 1997 Nov 12 201(1-2) 179-87",
                "id": "9409785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706de"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Co-transfection of the MAO B promoter with dominant negative forms of Ras, Raf-1, MEKK1, MEK1, MEK3, MEK7, ERK2, JNK1, and p38/RK inhibit the PMA-dependent activation of the MAO B promoter",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 21 277(25) 22222-30",
                "id": "11956220"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706dd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The activation of Ras by the guanine nucleotide-exchange factor Son of sevenless (Sos) constitutes the rate-limiting step in the transduction process that links receptor tyrosine kinases to Ras-triggered intracellular signalling pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2007 Jun 9(6) 706-12",
                "id": "17486115"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706db"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "growth factors, cytokines and other signalling molecules stimulate HIF-1a synthesis via activation of the phosphatidylinositol 3-kinase (PI3K) or mitogen- activated protein kinase (MAPK) pathways (FIG. 1).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2003 Oct 3(10) 721-32",
                "id": "13130303"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Expression of Cdo and Boc in myoblast cell lines is downregulated by the ras oncogene,",
              "citation": {
                "type": "PubMed",
                "name": "Mol Carcinog 2003 May 37(1) 1-4",
                "id": "12720294"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Consistent with these findings, inhibition of Ras activity has been demonstrated to suppress the release of proinflammatory molecules, thereby reducing lesion formation in apoE-deficient mice.125",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2007 Jan 5 100(1) 15-26",
                "id": "17204661"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706d5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Atherosclerosis",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "This results in sustained activation of Met Y1003F and downstream signals involving the Ras-mitogen-activated protein kinase pathway, cell transformation, and tumorigenesis.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Nov 25(21) 9632-45",
                "id": "16227611"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Figure 1 | The ErbB signalling network.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2001 Feb 2(2) 127-37",
                "id": "11252954"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "STAT3 inhibited myogenic differentiation induced by low serum or MyoD as efficiently as the Ras/mitogen-activated protein kinase cascade",
              "citation": {
                "type": "PubMed",
                "name": "Trends Immunol 2003 Dec 24(12) 659-66",
                "id": "14644140"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706ab"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Consistent with our findings, functional inhibition of Ras has been demonstrated to suppress pro-inflammatory molecules, thereby reducing lesion formation in ApoE-deficient mice [83].",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 2004 Feb 36(2) 175-83",
                "id": "14871544"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706a9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Atherosclerosis",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Lysyl oxidase (LOX) down-regulation induced an oncogenic phenotype in NRK-49F. This event was accompanied by a constitutive activation of ras oncogene and down-regulation of PDGF beta receptor, among other important phenotypic and molecular modifications.",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2003 Apr 11 1647(1-2) 239-44",
                "id": "12686140"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407069c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Ras acting via Erk MAP kinases causes phosphorylation of Smad2 and Smad3 at specific sites in the region linking the DNA-binding domain and the transcriptional activation domain.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 Apr 1 13(7) 804-16",
                "id": "10197981"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407069a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of breast",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Hyaluronan-CD44 binding  stimulated Ras-Mek1-Mapk pathway, which inturn stimulated MMP-2 secretion in a time and dose dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Jul 15 62(14) 3962-5",
                "id": "12124327"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070688"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "We show that JNK- but not p38-activating pathways regulate the DSE activity. Furthermore, the JNK/SAPK signaling pathway cooperates with the Raf-MEK-ERK cascade in TPA/ionomycin-induced DSE activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Apr 24 273(17) 10112-9",
                "id": "9553058"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407067a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The interaction of Ras with p110alpha is thus required in vivo for certain normal growth factor signaling and for Ras-driven tumor formation.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2007 Jun 1 129(5) 957-68",
                "id": "17540175"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070677"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1991 Aug 6(8) 1353-62",
                "id": "1679529"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407066f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 27 277(39) 36216-22",
                "id": "12147692"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070662"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "In the case of the Ras proteins, carboxyl methylation is important for targeting of the proteins to the plasma membrane.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2004 Feb 113(4) 539-50",
                "id": "14966563"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407065a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "A significant increase of alpha-D-mannosidase (up to 16-fold increase) activity, and a parallel increase of alpha-D-mannosidase transcript in fibroblasts overexpressing Ras with respect to those infected with the empty vector was observed.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 3 278(40) 38453-60",
                "id": "12878600"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070652"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "NF1, a tumor suppressor and negative regulator of Ras",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2010 Jun 29",
                "id": "20587590"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407064e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "wild-type AMs exposed to CSE had increased levels of active Ras, a small GTPase that perpetuates proinflammatory signaling. Conversely, RAGE KO AMs had less Ras activation compared with wild-type AMs after exposure to CSE.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2012 Jun 1 302(11) L1192-9",
                "id": "22505673"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070645"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages, Alveolar",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Tumour incidence in the Rasexpressing Par-4 KO lungs was significantly higher as compared with the Ras-expressing WT controls (Figure 2B).",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Jul 24",
                "id": "18650932"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070612"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "we demonstrate that Ras activity can be increased by tyrosine phosphorylated Vav upon cellular stimulation via the IL-2 receptor or the TCR/CD3-complex.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1995 Dec 26 217(3) 876-85",
                "id": "8554611"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705f7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "5PC-12 cells stimulated with 100 ng per ml NGF showed increase in Ras activation after 5 minutes, which was maintained after 45 minutes of NGF stimulation",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Mar 20(6) 1931-46",
                "id": "10688641"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705f2"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Expression of oncogenic Ras in thyroid cells results in loss of expression of several thyroid-specific genes and inactivation of TTF-1,",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Apr 20(8) 2783-93",
                "id": "10733581"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705f0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Overexpression of N17Ras completely eliminated ERK phosphorylation at 5 minutes and 24 hours following NGF treatment indicating that Ras plays a critical role in the apoptotic pathways that are induced by NGF-mediated activation of TrkA receptors in the cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jan 7 275(1) 565-70",
                "id": "10617652"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705a0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 21 277(25) 22558-65",
                "id": "11960991"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407058a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Ras is involved in CpG ODN signaling as an early event by associating with TLR9 and promoting IRAK1/TRAF6 complex formation, and MAPK and NF-kappaB activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 19 278(38) 36334-40",
                "id": "12867418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070588"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "In Fyn-/- fibroblasts, activation of Ras by H(2)O(2) was significantly attenuated.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jan 21 275(3) 1739-48",
                "id": "10636870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407057a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Necl-5, known as a poliovirus receptor and up-regulated in many cancer cells, enhances platelet-derived growth factor (PDGF)-induced activation of Ras-Raf-MEK-ERK signaling, but not PDGF-induced tyrosine phosphorylation of PDGF receptor, resulting in facilitation of cell proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Cells 2007 Mar 12(3) 345-57",
                "id": "17352739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070576"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "To examine the mechanism of Unc51.1 regulation of axon extension, we have identified two direct binding partners. The first, SynGAP, a negative regulator of Ras, is expressed within axons and growth cones of developing granule cells.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2004 Mar 1 18(5) 541-58",
                "id": "15014045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407056c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Moreover, mutation of Thr-133 in RasGRP3 alone severely impaired its ability to activate Ras in B cell receptor signaling. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Nov 23 101(47) 16612-7",
                "id": "15545601"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070569"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Following platelet-derived growth factor treatment, this receptor induces persistent activation of ectopically expressed PLC epsilon through activation of Ras and Rap1.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Nov 21 21(53) 8105-13",
                "id": "12444546"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070547"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The angiogenic switch can be induced at a predictable time and usually more rapidly, by introduction of oncogenes into the tumors. When the human non-angiogenic osteosarcoma was transfected with the ras oncogene, neovascularized tumors appeared within 2 weeks [7].",
              "citation": {
                "type": "PubMed",
                "name": "Semin Cancer Biol 2003 Apr 13(2) 159-67",
                "id": "12654259"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070529"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "The Son of Sevenless 1 protein (sos1) is a guanine nucleotide exchange factor (GEF) for either the ras or rac1 GTPase. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2006 Mar 13 172(6) 817-22",
                "id": "16520382"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070523"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"RAS Family\") actsIn gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Ras activation of Rac",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2002 Aug 4(8) 621-5",
                "id": "12134164"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407050a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:MAPK14)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:MAPK14))",
        "directed": false,
        "label": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526e2",
          "evidences": [
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Different agents activated the 5-LO kinase activities, including stimuli for cellular leukotriene biosynthesis (A23187, thapsigargin, N-formyl-leucyl-phenylalanine), compounds that up-regulate the capacity for leukotriene biosynthesis (phorbol 12-myristate 13-acetate, tumor necrosis factor alpha, granulocyte/macrophage colony-stimulating factor), and well known p38 stimuli as sodium arsenite and sorbitol. For all stimuli, 5-LO kinase activation was counteracted by SB203580 (3 microM or less), an inhibitor of p38 kinase",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 May 9 97(10) 5261-6",
                "id": "10779545"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070da5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "leukocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "All five cell lines did not express FADD by immunoblot analysis and were completely resistant to Fas-induced death. Complementation of the FADD mutant cell lines with wild-type FADD restored Fas-mediated apoptosis. Fas activation of caspase-2, caspase-3, caspase-7, and caspase-8 and the proteolytic cleavage of substrates such as BID, protein kinase Cdelta, and poly(ADP-ribose) polymerase were completely defective in the FADD mutant cell lines. In addition, Fas activation of the stress kinases p38 and c-Jun NH2 kinase and the generation of ceramide in response to Fas ligation were blocked in the FADD mutant cell lines",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1999 Dec 10(12) 797-804",
                "id": "10616904"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d96"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d94"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Hsp27 effectively protected the cells from cisplatin-induced DNA fragmentation. The p38 inhibitors obviously decreased whereas Akt inhibitors markedly increased the apoptotic fraction in cisplatin-treated cells. Overexpression of Hsp27 doubly enhanced the drug-induced Akt activation while substantially depressing the drug-induced activation of ASK1 and p38. Hsp27 endues cells with cisplatin resistance via depression of the drug-induced ASK1/p38 activation and enhancement of the drug-induced Akt activation.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2007 May 15 13(10) 2855-64",
                "id": "17504983"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d6e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "To see the phosphorylation of MAPK by ETS, the control and ETS-exposed brain tissues were extracted and 100 mg proteins were analyzed by 10% SDS-PAGE and phosphorylated form of MAPK was detected by Western blot using anti-phospho-MAPK antibody. The result shown in Fig. 4B indicates that phosphorylated MAPK was increased in all the regions of the brain exposed to ETS as compared to control brain tissue. The same extracts were probed with anti- ERK antibody and the level of ERK was unchanged in all the lanes indicating equal loading of proteins as well as specificity of the phosphorylation of the MAPK because ERK also undergoes phoshorylation but through different signaling pathway [31]. These results therefore strongly suggest that ETS induces MAPK phosphorylation and that the level of phosphorylation was similar across all the regions of the brain. We next examined the effect of ETS on p38MAP kinase in various regions of the brain. We found that ETS induced the phosphorylation of the p38MAP kinase in all the regions of the brain examined without altering the levels of the p38 MAP kinase protein expression (Fig. 4C).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2006 May 28 71(11) 1602-9",
                "id": "16569398"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d4e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "striatum"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The insulin/IGF-I signalling cascade in brown adipocytes differentiation Insulin and IGF-I initiate the biological effects in target cells by binding to, and activating its endogenous Tyr kinase receptors. These receptors are believed to transduce signals by phosphorylation on Tyr residues of several cellular substrates including insulin receptor substrate (IRS) proteins 1, 2, 3 and 4 (White 2003). A number of signalling pathways can be activated downstream of IRS proteins. Molecules containing Src homology 2 domain, including the regulatory subunits of phosphatidylinositol 3-kinase (PI3K), Grb-2, SHP2 and others, are recruited to the Tyr phosphorylated IRSs and transmit a cascade of signals, which consists in two major elements, i.e. Ras/Raf/p44-p42MAPK and PI3K/ Akt/p70S6K pathways (Virkamaki et al. 1999). More recently, p38MAPK, a parallel MAPK signal transduction pathway that becomes activated in response to cellular stresses (Nebreda & Porras 2000), has been shown to be stimulated by insulin in several cell systems including skeletal muscle (Conejo & Lorenzo 2001).",
              "citation": {
                "type": "PubMed",
                "name": "Mini Rev Med Chem 2005 Mar 5(3) 269-78",
                "id": "15777261"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cc6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c12"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "After establishing the role of p53 in cardiomyocyte apoptosis, we examined whether or not p53 activation was dependent on p38alpha MAPK, inhibition of which was essential in cytoprotection by E2.4 In order to block endogenous p38alpha MAPK, we expressed dominant negative p38alphaDN, via adenovirus infection, carrying a TGY180182 ? AGF mutation in the phosphorylation site of the kinase.9 This mutant prevents hypoxia-induced activation of endogenous p38alpha MAPK.4 We predicted that inactivating p38alpha MAPK would diminish the subsequent phosphorylation and activation of p53. Accordingly, little p-p53(S15) was observed in the presence of p38alphaDN during H/R, corrected for modest change in total p53 protein concentration (Figure 2). Similarly, the use of a chemical inhibitor of p38alpha MAPK, SB203580 (SB), also attenuated p-p53(S15). Although SB inhibits both p38alpha and p38beta MAPKs, the latter is not activated by H/R stress alone, whereas the former is significantly up-regulated by the same stimulus.4 Therefore, SB is likely to inhibit p38alpha MAPK to a much greater degree than p38beta in H/R. Overall, these results indicate that H/R-induced p53 depends on p38alpha MAPK. ",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2011 Jan 1 89(1) 119-28",
                "id": "20724307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c0f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "To see the phosphorylation of MAPK by ETS, the control and ETS-exposed brain tissues were extracted and 100 mg proteins were analyzed by 10% SDS-PAGE and phosphorylated form of MAPK was detected by Western blot using anti-phospho-MAPK antibody. The result shown in Fig. 4B indicates that phosphorylated MAPK was increased in all the regions of the brain exposed to ETS as compared to control brain tissue. The same extracts were probed with anti- ERK antibody and the level of ERK was unchanged in all the lanes indicating equal loading of proteins as well as specificity of the phosphorylation of the MAPK because ERK also undergoes phoshorylation but through different signaling pathway [31]. These results therefore strongly suggest that ETS induces MAPK phosphorylation and that the level of phosphorylation was similar across all the regions of the brain. We next examined the effect of ETS on p38MAP kinase in various regions of the brain. We found that ETS induced the phosphorylation of the p38MAP kinase in all the regions of the brain examined without altering the levels of the p38 MAP kinase protein expression (Fig. 4C).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2006 May 28 71(11) 1602-9",
                "id": "16569398"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bff"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Activation of RET, either by ligand or through specific mutations, results in phosphorylation of multiple tyrosine residues that, in turn, interact with specific adaptor molecules to trigger downstream signaling. Four of the tyrosines phosphorylated on RET activation, tyrosines 905, 1015, 1062, and 1096, have been well characterized, and are known to interact with a number of adaptor molecules to stimulate signaling through phosphatidylinositol kinase (PI3K)/AKT, PLC-gamma, RAS/extracellular signal-regulated kinase (ERK), p38MAPK, JNK and ERK5.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Jul 1 64(13) 4453-63",
                "id": "15231654"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b96"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b7f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b4f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Although alpha2-ARs (alpha2C >> alpha2A) were detected in aortas, alpha2C-ARs were localized by immunohistochemistry to VSMs of adventitial arterioles and not aortic media. In contrast with aortas, aortic arterioles constricted in response to alpha2-AR stimulation. Reporter constructs demonstrated higher activities for alpha2A- and alpha2C-AR gene promoters in arteriolar compared with aortic VSMs. Serum induction of alpha2C-ARs was reduced by inhibition of p38 mitogen-activated protein kinase (MAPK) with 2 microM SB-202190 or dominant-negative p38 MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2004 Jan 286(1) H59-67",
                "id": "12946937"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b47"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ac2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "MAP kinases help to mediate diverse processes ranging from transcription of protooncogenes to programmed cell death. More than a dozen mammalian MAP kinase family members have been discovered and include, among others, the well studied ERKs and several stress-sensitive enzymes. MAP kinases lie within protein kinase cascades. Each cascade consists of no fewer than three enzymes that are activated in series. Cascades convey information to effectors, coordinates incoming information from other signaling pathways, amplify signals, and allow for a variety of response patterns. Subcellular localization of enzymes in the cascades is an important aspect of their mechanisms of action and contributes to cell-type and ligand-specific responses. Recent findings on these properties of MAP kinase cascades are the major focus of this review.",
              "citation": {
                "type": "PubMed",
                "name": "Prog Biophys Mol Biol 1999 71(3-4) 479-500",
                "id": "10354710"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a8b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "3-Phosphoinositide- dependent protein kinase (PDK) 1 has been identified as a primary kinase that will phosphorylate Akt at Thr308. Kinases that activate Ser473 are known as PDK2, which include mitogen-activated protein kinase (MAPK)-activated protein kinase (PK)-2, integrin-linked kinase, p38 MAPK, PKCa, PKCbII, rictor-mTOR complex (mTORC2), double-stranded DNA-dependent PK, autophosphorylation, and ataxia telangiectasia- mutated gene product (Brazil et al., 2004; Manning and Cantley, 2007).",
              "citation": {
                "type": "PubMed",
                "name": "Dev Cell 2009 Dec 17(6) 800-10",
                "id": "20059950"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a64"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Ang II and H2O2 induced marked activation of extracellular signal-responsive kinase1/2 (ERK1/2), which was blocked by NAC. Ang II and H2O2 also activated p38MAPK, and they were blocked by pre-treatment with NAC. However, the level of activated p38MAPK was quite low in comparison with ERK1/2. Ang II- or H2O2 -induced Gax down-regulation was significantly inhibited by PD98059, an ERK1/2 inhibitor but not SB203580, a p38MAPK inhibitor",
              "citation": {
                "type": "PubMed",
                "name": "Regul Pept 2005 Apr 15 127(1-3) 159-67",
                "id": "15680482"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a63"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "MEKK3-dependent activation of an NF-kappaB reporter gene as well as ERK, JNK, and p38 MAP kinases correlated with a requirement for serine at position 526. Constitutively active mutants of MEKK3, consisting of S526D and S526E, were capable of activating a NF-kappaB luciferase reporter gene as well as ERK and MEK, suggesting that a negative charge at Ser526 was necessary for MEKK3 activity and implicating Ser526 as a phosphorylation site.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Mar 10 281(10) 6236-45",
                "id": "16407301"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a36"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We studied the response of porcine vascular smooth muscle cells (PVSMCs) to cyclic sinusoidal stretch at a frequency of 1 Hz. Cyclic stretch with an area change of 25% caused an increase in PVSMC apoptosis, which was accompanied by sustained activation of c-Jun NH(2)-terminal kinases (JNK) and the mitogen-activated protein kinase p38.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2002 May 282(5) H1709-16",
                "id": "11959635"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a2a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "p38MAPK inhibitor SB203580 could remarkably promote the apoptosis of A2780/Taxol cells, and the cell apoptosis was in a time-dependent manner. SB203580 down-regulated the activity of p38MAPK pathway, but up-regulated EGR-1 expression. SB203580 significantly increased the level of cellular phosphorylated p53 protein, but decreased the p-gp protein level and MDR1 mRNA level in A2780/Taxol cells. There existed a close relationship between p38MAPK pathway and the paclitaxel resistance of ovarian carcinoma cells. The expression of EGR-1 mediated by p38MAPK pathway plays a critical role in paclitaxel resistance of ovarian carcinoma cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Huazhong Univ Sci Technolog Med Sci 2008 Aug 28(4) 451-5",
                "id": "18704310"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709c5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "EGF stimulates the phosphorylation (activation) of the signaling intermediate p38 (MAPK11/14), and blocking phosphorylation pharmacologically with either SB203580 or SB202190 strongly inhibited spontaneous and EGF-stimulated secretion of CGB.  --From Materials and Methods: Primary antibodies to cyclin D1/CCND1and p21/CDKN1A (catalog numbers 2926 and 2946; mouse monoclonal) and phosphorylated (p)-MAPK11/14 (catalog number 9211; rabbit polyclonal) were obtained from Cell Signaling Technology (Beverley, MA) and used at a dilution of 1:500.  -- From Cell Signaling Technologies: Phospho-p38 MAP Kinase (Thr180/Tyr182) Antibody detects endogenous levels of p38 MAP kinase only when activated by phosphorylation at threonine 180 and tyrosine 182.",
              "citation": {
                "type": "PubMed",
                "name": "Biol Reprod 2005 Dec 73(6) 1282-8",
                "id": "16120828"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407099e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "trophoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "o clarify the intracellular downstream signaling cascades of alpha -synuclein, we measured the activity of endogenous mitogen-activated protein kinases, such as extracellular signal-regulated protein kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 kinase. When 10 M alpha -synuclein was added, a significant increase of JNK (Fig. 1B) and a lower but marked activation of ERK and p38 activity (data not shown) were observed using anti-phospho-ERK, anti-phospho-JNK, and anti-active p38 antibodies. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jul 20 276(29) 27441-8",
                "id": "11316809"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708f7"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We next examined whether p38 was required for serine phosphorylation. MAEC were treated with LPS and/or IFN?, and SB202190 or PD98059 (50 ?M, 30 min) and extracts were analyzed by blotting with a phospho-Ser727-specific antibody. SB202190 (Fig. 7, A and B), but not PD98059 (data not shown), greatly attenuated STAT1? serine phosphorylation in response to IFN? alone and more dramatically in response to the combination of LPS and IFN?. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2004 Aug 66(2) 302-11",
                "id": "15266021"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708da"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We showed previously that the transactivation activity of MEF2C is stimulated by p38 mitogen-activated protein (MAP) kinase. In this study, we examined the potential role of the p38 MAP kinase pathway in regulating the other MEF2 family members. We found that MEF2A, but not MEF2B or MEF2D, is a substrate for p38. Among the four p38 group members, p38 is the most potent kinase for MEF2A. Threonines 312 and 319 within the transcription activation domain of MEF2A are the regulatory sites phosphorylated by p38.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Jan 19(1) 21-30",
                "id": "9858528"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407087d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "MAP kinase kinases are activated by dual phosphorylation within subdomain VIII (3, 9, 12, 29, 38, 52, 64). These phosphorylation sites are conserved in MKK6 (Ser-207 and Thr- 211)....To test this hypothesis, we examined the effect of introducing a constitutive negative charge by replacing Ser-207 and Thr-211 with Glu....MKK6(Glu) caused activation of wild-type (Thr-Gly-Tyr) p38 MAP kinase but not activation of the phosphorylation-defective (Ala-Gly-Phe) mutant (Fig. 7B). In contrast, kinase-negative MKK6 did not activate p38 MAP kinase (Fig. 7B). Together, these data demonstrate that MKK6(Glu) is an activator of p38 MAP kinase in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Mar 16(3) 1247-55",
                "id": "8622669"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070874"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "increase in LDL oxidation enhances platelet activation via 2 independent pathways, 1 signaling via p38(MAPK) phosphorylation and 1 via Ca(2+) mobilization. Between 0% and 15% oxidation, the p38(MAPK) route enhances fibrinogen binding induced by thrombin receptor (PAR-1)-activating peptide (TRAP), and signaling via Ca(2+) is absent. At 30% oxidation, p38(MAPK) signaling increases further and is accompanied by Ca(2+) mobilization and platelet aggregation in the absence of a second agonist",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2005 Feb 3",
                "id": "15692097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070852"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070829"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "However, SB203580 pretreatment only inhibited p38 MAPK activation and had no effect on Akt activation (Fig. 2C, lane 5). These data indicated that the activation of p38 MAPK by CO is PI3K/Akt-dependent. We next tested whether CO modulated STAT1 and STAT3 via PI3K/Akt and p38 MAPK pathways. We pretreated PAEC with SB203580 and observed that CO can no longer modulate STAT1 or STAT3 activation (Fig. 2D, lane 5). Consistent with our data that PI3K/Akt activation is upstream of p38 MAPK activation by CO during A-R (Fig. 2C), when we blocked the PI3K/Akt pathway with LY294002, CO lost its ability to decrease STAT1 and increase STAT3 activation during A-R (Fig. 2D, lane 4). These data demonstrated that the opposing effect of CO on STAT1 and STAT3 activation is dependent upon PI3K/Akt and p38 MAPK pathways. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 11 280(10) 8714-21",
                "id": "15590660"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407076a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "HBECs were stimulated with pro-inflammatory cytokines tumor necrosis factor-alpha and interleukin (IL)-1beta or, because of their critical role in allergic diseases, IL-4 and IL-13. Each of these stimuli induced MIP-3alpha/CCL20 gene and protein expression. Moreover, these agents upregulated mitogen-activated protein kinase pathways in HBECs. Inhibition of the ERK1/2 pathway or p38 reduced cytokine-induced MIP-3alpha/CCL20 expression. These data suggest a mechanism by which AEC may facilitate recruitment of DC subsets to the airway.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2003 Jun 28(6) 648-54",
                "id": "12760962"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070752"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "TAK1, a member of the mitogen-activated kinase kinase kinase family, is activated in vivo by various cytokines, including interleukin-1 (IL-1), or when ectopically expressed together with the TAK1-binding protein TAB1. However, this molecular mechanism of activation is not yet understood. We show here that endogenous TAK1 is constitutively associated with TAB1 and phosphorylated following IL-1 stimulation. Furthermore, TAK1 is constitutively phosphorylated when ectopically overexpressed with TAB1. In both cases, dephosphorylation of TAK1 renders it inactive, but it can be reactivated by preincubation with ATP. A mutant of TAK1 that lacks kinase activity is not phosphorylated either following IL-1 treatment or when coexpressed with TAB1, indicating that TAK1 phosphorylation is due to autophosphorylation. Furthermore, mutation to alanine of a conserved serine residue (Ser-192) in the activation loop between kinase domains VII and VIII abolishes both phosphorylation and activation of TAK1. These results suggest that IL-1 and ectopic expression of TAB1 both activate TAK1 via autophosphorylation of Ser-192.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Mar 10 275(10) 7359-64",
                "id": "10702308"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070730"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Treating TMK-1 cells with IL-1beta increased VEGF mRNA levels and activated extracellular signal-regulated kinases 1 and 2 (Erk 1/2) and p38, but not Akt. Inhibitors of the Erk and p38 pathways blocked IL-1beta induction of VEGF mRNA. Treating TMK-1 cells with IL-1beta also increased VEGF promoter activity. VEGF transcriptional activity was found to depend on a 120-bp region just proximal to the transcription start site.",
              "citation": {
                "type": "PubMed",
                "name": "Surgery 2004 Sep 136(3) 686-92",
                "id": "15349119"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070726"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of gastrointestinal tract",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "deliberate activation of endogenous p38 stimulates muscle differentiation even in the presence of antimyogenic cues. Much evidence indicates that p38 is an activator of MyoD: (i) p38 kinase activity is required for the expression of MyoD-responsive genes, (ii) enforced induction of p38 stimulates the transcriptional activity of a Gal4-MyoD fusion protein and allows efficient activation of chromatin-integrated reporters by MyoD, and (iii) MyoD-dependent myogenic conversion is reduced in mouse embryonic fibroblasts derived from p38alpha(-/-) embryos.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Jun 20(11) 3951-64",
                "id": "10805738"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070707"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In addition, we found that MCP-1 has a novel function in airway epithelium, increasing the two major airway mucins MUC5AC and MUC5B, an effect mediated, at least in part, by a cascade of events initiated by interaction of its receptor CCR2B with G(q) subunits in caveolae, followed by PLC??, PKC, and (44/42)MAPK activation. We also have shown that MCP-1 is able to induce its own expression using the same receptor but through a different pathway that involves RhoA GTPase.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2011 Feb 300(2) L204-15",
                "id": "21097527"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "the mechanism by which P2RX5 receptor activation produced effects on satellite cell activity was also investigated we were able to demonstrate that ATP application to satellite cells produced a significant and rapid increase in the phosphorylation of p38 and to a lesser extent ERK1/2 however, only inhibition of p38 blocked the P2x-dependent effects on cell number these results are consistent with previous studies demonstrating the importance of the p38 MAPK signaling pathway in myogenesis",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Jul 22 158(2) 345-55",
                "id": "12135987"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070664"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Extracellular signal-regulated kinase (ERK) is critical for the expression of immediate-early genes in the striatum in response to cocaine and Delta9-tetrahydrocannabinol and for the rewarding properties of these drugs. Here we show that in mice a single injection of cocaine (10 mg/kg) activates mitogen- and stress-activated protein kinase 1 (MSK1) in dorsal striatum and nucleus accumbens. Cocaine-induced phosphorylation of MSK1 threonine 581 and cAMP response element-binding protein (CREB) serine 133 (Ser133) were blocked by SL327, a drug that prevents ERK activation. C",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2005 Dec 7 25(49) 11444-54",
                "id": "16339038"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407065b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "For these experiments, p38{alpha} (wt and mt) and p38{beta}2 (wt and mt) were transiently transfected into rat mesangial cells and the effects on the expression of Il-1{beta}-induced iNOS expression were assessed. It shows that transfection of p38{alpha} wt had virtually no effect on IL-1{beta}-induced iNOS expression, whereas the mutant p38{alpha} inhibited IL-1{beta}-induced iNOS expression. the p38{beta}2 mt was without effect, whereas the wt p38{beta}2 inhibited IL-1{beta}-induced iNOS expression. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2004 Jan 286(1) C145-52",
                "id": "14522818"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070635"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "As shown in Figure 2A, NECA-stimulated Akt, pan PKC, ERK, p38, JNK MAPKs, and NF-kB phosphorylation. Moreover, Cx43 phosphorylation was blocked by targeted inhibitors of PI3K (LY 294002), Akt (Akt inhibitor), PKC (bisindolylmaleimide I, staurosporine), p38 MAPK (SB 203580), ERK (PD 98059), c-Jun N-terminal kinase (JNK) (SP 600125), and NF-kB (Bay 11-7082, SN50) pathways, respectively (Fig. 2B?E).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2010 Jul 224(1) 187-94",
                "id": "20232318"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070614"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "embryonic stem cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PKB/ Akt-dependent signaling controls many essential cellular processes such as cellular metabolism, transcription, cell proliferation, migration and survival [37,73,74]. PKB/Akt is believed to promote endothelial cell survival and angiogenesis via the phosphorylation and inactivation of the pro-apoptotic molecules Bad, Bax, caspase 9, and the Forkhead (FRKH) transcription factor [75], the stimulation of nitric oxide (NO) production [76,77], and the inhibition of the stressactivated kinases p38 and JNK [78].",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2004 Mar 4 1654(1) 51-67",
                "id": "14984767"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407060a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In Rac2(-/-) T cells, proliferation was reduced upon stimulation with either plate-bound anti-CD3 or T cell receptor-specific antigen. This defect is accompanied with decreased activation of mitogen activated protein kinase extracellular signal-regulated kinase (ERK)1/2 and p38, and reduced Ca(2)+ mobilization. TCR stimulation-induced actin polymerization is also reduced",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2001 Oct 1 194(7) 915-26",
                "id": "11581314"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "It has recently been shown that inflammatory stimuli result in the activation of p38 MAPK, which may be responsible for the subsequent specific phosphorylation of serine 10 on H3 seen in vitro (12). To determine if this was the case in vivo in the rat smoking model, Western blot analysis was performed to assess p38 MAPK phosphorylation (activation). p38 MAPK phosphorylation remained unchanged in the lungs after 3 d of cigarette smoke exposure, but was increased significantly after 8 wk of smoke exposure (Figure 3). The increased p38 MAPK phosphorylation was positively correlated with the observed elevation in H3 phosphorylation. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2004 Dec 31(6) 633-42",
                "id": "15333327"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407057d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Overexpression of JNK1 or p38 was sufficient to induce HIF-1alpha and VEGF expression Hypoxia rapidly induced both JNK1 and p38 activity in these cells. This activation correlated with induction of HIF-1alpha expression and DNA binding activity which was blocked by the p38 inhibitor SB203580. Hypoxia also increased VEGF production by SCC lines, which was inhibited by treatment with SB203580. Overexpression of JNK1 or p38 was sufficient to induce HIF-1alpha and VEGF expression.",
              "citation": {
                "type": "PubMed",
                "name": "Oral Oncol 2002 Apr 38(3) 251-7",
                "id": "11978547"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d7f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "At the gene transcriptional level, both IL-6 and Stat3 mRNA levelswere up-regulated in response to MMP12 overexpression (Fig. 4C). Other intracellular oncogenic moleculeswere also analyzed (Supplementary Fig. S2). NFnB, extracellular signal-regulated kinase (ERK), p38, and AKT were all significantly activated in doxycycline-treated bitransgenic mice compared with untreated bitransgenic mice.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2009 Sep 15 69(18) 7252-61",
                "id": "19706765"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b69"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Alveolar type II cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "NMuMg mammary epithelial cells exposed to hyperosmotic stress induced by the organic osmolyte sorbitol, heat shock, ultraviolet irradiation, oxidative stress induced by hydrogen peroxide... The environmental stresses, but not dexamethasone, stimulatedSgk expression through a p38/MAPK-dependent pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 21 278(8) 5871-82",
                "id": "12488318"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070aea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "When MK2delta3B is expressed in E. coli with active p38alpha produced from this bicistronic plasmid, the kinase cascade was reconstituted. MK2delta3B was phosphorylated, demonstrated by reduced mobility of the protein in SDS-PAGE analysis (Fig. 1, A  and B) and increased peptide kinase activity (Fig. 1C). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Mar 12 279(11) 10176-84",
                "id": "14688255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ae6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We found upregulation of several genes, including CYR6 (IGFBP10), FGF2, IGF1, IGFBP7, PDGFA, and PTHLH. The induction of these genes was suppressed by SD-208, but not by SD-282. In addition, down-regulation of several antiproliferative genes, such as BTG1, CD164, and GAS1, was observed. The regulation of these genes was strongly suppressed by SD-208, and not by SD-282, except for GAS1, which showed modest reversal by SD-282",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2006 Aug 70(2) 518-31",
                "id": "16707625"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707fc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We show that exposure of NIH-3T3 and SV-40 transformed green monkey kidney (COS) cells to stress stimuli such as osmotic shock or UVC irradiation, but not to mitogenic activators such as PDGF or EGF, results in a marked cytoplasmic accumulation of hnRNP A1, concomitant with an increase in its phosphorylation. These effects are mediated by the MKK(3/6)-p38 pathway, and moreover, p38 activation is necessary and sufficient for the induction of hnRNP A1 cytoplasmic accumulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2000 Apr 17 149(2) 307-16",
                "id": "10769024"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707b8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "These were prohibitin (PHB), protein disulfide isomerase 3 (PDIA3), focal adhesion kinase 2 (FAK2), c-GMP dependent protein kinase 2 (KGP2), NADH-ubiquinone oxidoreductase 30 kDa subunit (NUGM) and translationally controlled tumor protein (TCTP). All these proteins were up-regulated in the membranes of H-RasV12-transformed p38alpha-/-cells, except for prohibitin, which was down-regulated",
              "citation": {
                "type": "PubMed",
                "name": "Proteomics 2006 Apr 6 Suppl 1 S262-71",
                "id": "16534743"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705d0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Figure 4A illustrates that CSE induces phosphorylation of both ERK and p38, although the magnitude of the early response was significantly less than that occurring with control DCs activated by Lps. We observed that LPS induces rapid phosphorylation of both ERK and p38 within 5-15 minutes of activation. CSE similarly induced phosphorylation of both ERK and p38 within 5-15 minutes of incubation (Figure 4A). ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2008 Jul 15 181(2) 1536-47",
                "id": "18606709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705bc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Ang II also induced the rapid formation of ROS, which could be inhibited by a specific antibody as well as by antisense against the p22phox subunit of the NAD(P)H oxidase. JNK and p38 MAPK, but not ERK, activation was inhibited by an inhibitor of NAD(P)H oxidase. Antisense against p22phox also solely inhibited p38 MAPK but did not affect ERK.",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2000 Apr 20(4) 940-8",
                "id": "10764657"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d87"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Fig. 7C and D shows that CSC at 0.1, 10 and 50 lg/ml concentration significantly induced the p38 kinase activity by 3.0, 3.78- and 4.92-fold, respectively. Effect of CSC on SAPK activity is shown in Fig. 7C and D. SAPK activity was significantly increased by 50 lg/ml of CSC concentration and this increase was found to be 5.0-fold with respect to control.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Lett 2008 Oct 18 270(1) 120-31",
                "id": "18550274"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d85"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "cross-talk and activation between the PI 3-kinase/Akt and p38 MAPK pathways that is essential for efficient myoblast differentiation. During myoblast differentiation, Akt kinase activity correlated with S473 but not T308 phosphorylation and occurred 24 h after p38 activation Akt2 promoter activity and protein levels were regulated by p38 activation, thus providing a mechanism for communication.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 May 24(9) 3607-22",
                "id": "15082758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d5c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In the present study, we investigated possible involvement of mitogen-activated protein (MAP) kinases; extracellular signal-regulated kinase (ERK), c-Jun amino-terminal kinase (JNK), and p38, in the chymase-induced eosinophil migration. Human chymase induced a rapid phosphorylation of ERK1/2 and p38 in human eosinophilic leukemia EoL-1 cells, while no phosphorylation was detected in JNK.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Jul 15 332(4) 969-75",
                "id": "15919053"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d2e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Phosphorylation of mitogen-activated protein kinases (MAPKs) such as p38 MAPK and ERK was markedly increased by the heat shock, and SB203580 (a p38 MAPK kinase inhibitor) and/or PD098059 (a MEK inhibitor) inhibited the phosphorylation of HSP25, indicating that p38 MAPK and ERK are upstream regulators of HSP25 phosphorylation in the heat shock condition",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 31 277(22) 19913-21",
                "id": "11912188"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cc9"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Treatment with SP600125, an inhibitor of JNK1, 2 and 3 Group 1 includes two transcripts, whose expression levels are increased at least twofold when compared with baseline by either of the SB203580 and SP600125 treatments.",
              "citation": {
                "type": "PubMed",
                "name": "Development 2005 Apr 132(8) 1773-83",
                "id": "15772134"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cb3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "embryo"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "As shown in Fig. 3A, in the control experiment where NIH 3T3 cells were co-transfected with ORE-SVLuc and pCMV-Script, hypertonicity resulted in a 19-fold increase in ORE reporter activity. Co-transfection with ORE-SVLuc and the p38DN (FLAG-p38alphaAF) resulted in a reduction in hypertonic induction of ORE reporter activity to 3.5-fold, confirming the results obtained by SB203580 to inhibit p38.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 29 277(48) 46085-92",
                "id": "12359721"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c99"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "SB203580, a specific p38 MAPK inhibitor, attenuated these effects, further confirming that both MMK6 and MMK3 act via p38 MAPK, whereas they had no effect on the increase in glucose transport induced by a constitutively active MAPK kinase 1 (MEK1) mutant or by myristoylated Akt.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 8 276(23) 19800-6",
                "id": "11279172"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c93"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "inhibition of p38 blocks the rapid initiation of the G2 checkpoint in both human and murine cells p38 binds and phosphorylates CDC25B at serines 309 and 361 and CDC25C at serine216, phosphorylation of these residues is required for binding to 14-3-3 proteins inhibition of p38 prevents both phosphorylation of CDC25B at serine 309 and 14-3-3 binding after ultraviolet radiation",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2001 May 3 411(6833) 102-7",
                "id": "11333986"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c4a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Yet, nothing is known about the molecular mechanisms that couple VEGFR2 to SAPK2/p38. Here, we found that VEGF increased by twofold the activity of the small GTPase Cdc42 and that the expression of two different constitutively active forms of Cdc42 (Cdc42 V12 and Cdc42 L61) led to a marked increase in the formation of stress fibers that was sensitive to SAPK2/p38 inhibition by SB203580.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Jan 15 23(2) 434-45",
                "id": "14724572"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c2b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "FGF-1-induced PN expression was blocked by the FGF-1 receptor antagonist PD-166866 and by inhibitors of phosphatidylinositol 3-kinase (PI3K) (LY-294002, wortmannin), p70S6K (rapamycin), MEK1/2 (U-0126, PD-98059), and p38MAPK (SB-203580) but not of JNK (SP-600125)",
              "citation": {
                "type": "PubMed",
                "name": "J Appl Physiol 2004 Oct 97(4) 1550-8; discussion 1549",
                "id": "15121739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c27"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We report here that inhibition of the p38alpha isoform suppressed the ability of Smad3 to mediate TGF-beta-induced transcriptional responses. The inhibition of p38 activity blocked TGF-beta-mediated phosphorylation of the MSK1 kinase, a substrate of p38 that plays an important role in the remodeling of chromatin.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 16 279(29) 30474-9",
                "id": "15133024"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c20"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "8-isoprostane significantly (P=0.03) activated ERK 1/2 and the peak of phosphorylation was reached after 15 min of stimulation (Fig. 4A). Similarly, 8-isoprostane induced significantly (P=0.03) p38 MAPK phosphorylation, but with a peak of phosphorylation after 30 min (Fig. 4B) and the 8-isoprostane induced phosphorylation of both MAP kinases sustained for up to 60 min. ",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2003 Oct 1 59(4) 945-54",
                "id": "14553834"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a24"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Glucose stimulates nuclear USF2 protein accumulation through protein kinase C, p38 MAPK, and extracellular signal-regulated kinase pathways. Increased PKG activity down-regulates USF2 protein levels and its DNA binding activity under high glucose conditions, resulting in inhibition of glucose-induced TSP1 transcription and TGF-beta",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Aug 13 279(33) 34311-22",
                "id": "15184388"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070981"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In this study, we showed that c-Abl-PKCdelta-Rac1-p38 MAPK signaling is required for the conformational changes of Bak and Bax during ionizing radiation-induced apoptotic cell death in human non-small cell lung cancer cells. Ionizing radiation induced conformational changes and subsequent oligomerizations of Bak and Bax, dissipation of mitochondrial membrane potential, and cytochrome c release from mitochondria.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Mar 17 281(11) 7049-59",
                "id": "16410245"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070921"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Here we demonstrate that NFATc4 is phosphorylated by p38 mitogen-activated protein (MAP) kinase but not by JNK. The p38 MAP kinase phosphorylates multiple residues, including Ser(168) and Ser(170), in the NFAT homology domain of NFATc4.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jun 22(11) 3892-904",
                "id": "11997522"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708ef"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Inhibition of AR by sorbinil or tolrestat prevented TNF-alpha-induced increase in Bax and Bak and the downregulation of Bcl-2. Inhibition of AR abrogated AP-1 DNA binding activity and prevented the activation of caspase-3, JNK, and p38 MAPK in cells stimulated by TNF-alpha. Exposure to TNF-alpha also induced apoptotic cell death, which was attenuated by AR inhibition or antisense ablation",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2004 Jul 16 570(1-3) 189-94",
                "id": "15251463"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407087f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The knockdown resulted in a significant decrease in the expression of phosphorylated p38 MAPK (p-p38), but the expression of total p38, ERK1/2, JNK, phosphorylated ERK1/2 (p-ERK1/2), and phosphorylated JNK (p-JNK) remained unchanged (Fig. 4).",
              "citation": {
                "type": "PubMed",
                "name": "Basic Res Cardiol 2009 Nov 104(6) 631-42",
                "id": "19377854"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070815"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "While inhibition of extracellular signal-related kinase and NF-kappaB activation suppressed the up-regulation of the expression of TLR2, TLR4 and TLR9 mRNA, inhibition of p38 kinase prevented the up-regulation of TLR2 and TLR4 mRNA expression but enhanced the up-regulation of TLR9 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Immunology 2002 May 106(1) 38-45",
                "id": "11972630"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070813"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "To examine directly the role of MKP-1 in the regulation of these protein kinases in vivo, we established a U937 cell line that conditionally expresses MKP-1 from the human metallothionein IIa promoter. Conditional expression of MKP-1 inhibited PMA-induced ERK2, SAPK, and p38 MAPK activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Jul 4 272(27) 16917-23",
                "id": "9202001"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070807"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "When HEMEC were exposed to acidic pH for various time periods, there was a rapid and significant activation of JNK which was seen as early as 1 min. Activation of p44/42 MAPK was first detected at 15 min and maximized by 30 min, while activation of p38 MAPK was delayed, appearing at 60 min (Fig. 3A).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2006 Nov 291(5) C931-45",
                "id": "16790501"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707f7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "N6-cyclopentyladenosine (CPA; an adenosine A1 receptor agonist)-induced PP2a translocation was blocked by p38 MAPK inhibition but not by JNK inhibition. CPA increased phosphorylation of p38 MAPK, and this effect was abolished by pertussis toxin and inhibitors of the cGMP pathway",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2003 Jul 285(1) H97-103",
                "id": "12649078"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707f2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PMA-induced galectin-3 overexpression was blocked by: protein kinase C inhibitors staurosporine, calphostin C, and apigenin; tyrosine-specific protein kinase inhibitors genistein and tyrphostin A25; PD 98059, a selective inhibitor of mitogen-activated protein kinase (MAPK) kinase 1 (MEK1 or MKK1); and SB 203580, a specific inhibitor of p38 MAPK",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2003 Jun 17 1641(1) 13-23",
                "id": "12788225"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070680"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Bacteria induced activation of p38 mitogen-activated protein kinase (MAPK) in keratinocytes, which was required for the induction of PGLYRP2 expression, because induction of PGLYRP2 transcription by bacteria was inhibited by SB203580 (a specific inhibitor of p38 MAPK) and by a dominant-negative p38 construct.",
              "citation": {
                "type": "PubMed",
                "name": "Infect Immun 2005 Nov 73(11) 7216-25",
                "id": "16239516"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "As shown in Fig. 1A, the phosphorylation level of type 1 and type 2 JNKs was significantly increased within 60 min after H2O2 treatment, peaking (?5.5-fold, compared with the no treatment sample) at 2 h. The p38 and ERK proteins were also phosphorylated and activated in response to oxidative stress but to a substantially lesser than was JNK (Fig. 1B).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Sep 28 282(39) 28395-407",
                "id": "17681939"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705de"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Oxidative stress induces in endothelial cells a quick and transient coactivation of both stress-activated protein kinase-2/p38 and extracellular signal-regulated kinase (ERK) mitogen-activated protein kinases. We found that inhibiting the ERK pathway resulted, within 5 min of oxidative stress, in a misassembly of focal adhesions characterized by mislocalization of key proteins such as paxillin.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2003 Apr 14(4) 1418-32",
                "id": "12686598"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070557"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Pretreatment of VSMC with IL-19 results in a significant reduction in fetal calf stimulated p44/42 and p38 MAPK activation in cultured human VSMC [38]. It was found that this inhibition was mediated by SOCS5 interaction with these MAP kinases, suggesting that in other cell types, other interleukins could inhibit MAPKs by induction of SOCS proteins.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Vasc Pharmacol 2009 Jul 7(3) 267-76",
                "id": "19601851"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070551"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In addition, JDP2 induced p38 activity in both C2 and RD cells programmed to differentiate.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 18 277(42) 40043-54",
                "id": "12171923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070dad"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "rhabdomyosarcoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "SB203580, a specific inhibitor of p38 MAP kinase, significantly inhibited IL-1beta-induced IL-6 and stromelysin-1 production by both parental FLSs and MH7A cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biochem (Tokyo) 1998 Dec 1 124(6) 1153-62",
                "id": "9832620"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070da8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We also show that p38 MAPK is able to directly associate with and modulate both casein kinase 2 (CK2) and protein kinase A (PKA)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 29 280(17) 17221-6",
                "id": "15649893"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070da3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In addition, a p38 MAPK inhibitor, but not ERK and JNK inhibitors, suppressed their expression in cultured astrocytes.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 7 278(45) 44525-34",
                "id": "12944406"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d9e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "astrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jun 11 279(24) 25898-904",
                "id": "15037619"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d9d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 1999 Oct 1 85(7) 565-74",
                "id": "10506481"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d99"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In cells stably transfected with empty vector, AVP rapidly stimulated ERK, JNK, and p38 activity (Fig. 7A), similar to what we have previously reported (11). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 10 278(41) 39830-8",
                "id": "12882977"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d93"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "SOCS6 reduced SCF-induced activation of ERK1/2 and p38",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jan 5",
                "id": "14707129"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d8d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "TNF activated p38 MAPK which peaked at 15 min and then returned to basal levels.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 May 15 168(10) 5342-51",
                "id": "11994493"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d83"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "These data indicate that phosphorylation of PPARalpha by p38 kinase on one or more of the serines at position 6, 12, or 21 is responsible for p38-mediated enhancement of PPARalpha transactivation function.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 30 276(48) 44495-501",
                "id": "11577087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d82"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "treatment of human mononuclear cells with leptin increased p38 MAP kinase phosphorylation Another study in L6 muscle cells suggested that leptin did not itself alter p38 MAP kinase phosphorylation but reduced insulin-stimulated p38 MAP kinase phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2002 Aug 14(8) 655-63",
                "id": "12020765"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d80"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "pp60(v-src) induction of CREB was blocked by the p38 inhibitor SB203580 or by mutation of CREB at Ser133.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Mar 12 274(11) 7341-50",
                "id": "10066798"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d73"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "activation of AKT2 inhibits UV- and TNF alpha-induced c-Jun N-terminal kinase and p38 activities that have been shown to be required for stress- and TNF alpha-induced programmed cell death",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 16 277(33) 29973-82",
                "id": "12048203"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d5d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Treatment of melanoma cells with SB203580, a selective inhibitor of the p38 mitogen-activated protein kinase (MAPK) pathway, effectively inhibited Ad.mda-7-induced apoptosis. Additional support for an involvement of the p38 MAPK pathway in Ad.mda-7-mediated apoptosis was documented by using an adenovirus expressing a dominant negative mutant of p38 MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Jul 23 99(15) 10054-9",
                "id": "12114539"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d51"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "melanoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Results show that stimulation of the CB2 receptor leads to p38 MAPK activation and that inhibition of this kinase attenuates CB2 receptor-induced caspase activation and apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2005 Sep 12 579(22) 5084-8",
                "id": "16139274"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d4d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "minimally modified LDL (mmLDL) mainly activated components involved in stress response and apoptotic cell death including p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase/stress-activated protein kinase (JNK) as well as neutral and acid sphingomyelinase",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2004 Oct 14 1690(2) 150-8",
                "id": "15469904"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d4c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Ang II dramatically increased the phosphorylation of ERK1/2, JNK1/2 and p38 (Figure 2 A-C).",
              "citation": {
                "type": "PubMed",
                "name": "Exp Mol Med 2006 Oct 31 38(5) 525-34",
                "id": "17079869"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d4b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "IL-1beta rapidly activates the c-Jun NH2-terminal/stress-activated protein kinases (JNK/SAPK) and p38 mitogen-activated protein kinase (MAPK) and also induces Cox-2 expression and prostaglandin E2 (PGE2) production.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Oct 30 273(44) 28670-6",
                "id": "9786861"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d43"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Histamine induced a time-dependent, H1 receptor-mediated activation of p38 MAP kinase (p38), p44/42 MAP kinase (ERK), and c-jun terminal NH2 kinase (JNK).",
              "citation": {
                "type": "PubMed",
                "name": "Circulation 2005 Jul 19 112(3) 341-9",
                "id": "16009787"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d41"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2002 Dec 12 420(6916) 691-5",
                "id": "12478298"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d38"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 22 279(43) 44294-302",
                "id": "15308641"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d37"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "These results imply that PPARb/d phosphorylation by p38 MAPK inhibits the transcriptional activity of the former.",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2009 Mar 1 81(4) 703-12",
                "id": "19038972"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d2a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Furthermore, inhibitors of p38 MAPK and cPLA2, but not NF-kB and JAK2, signaling pathways inhibited ADAM-9-induced IL-6 production by hOBs (p<0.01).",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2005 Dec 22",
                "id": "16373656"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d1d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "nhibition of the p38MAPK pathway, which in turn inhibits the transcription of IL-10 via Sp1. Inhibition of the IL-10 autocrine/paracrine loop results in the inhibition of STAT3 activity",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Apr 29 23(20) 3530-40",
                "id": "15077178"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d1b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Activated p38(MAPK) phosphorylated endogenous p53 at Ser(33) in living cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Oct 19 276(42) 39115-22",
                "id": "11495913"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d1a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "These data indicate that phosphorylation of PPARalpha by p38 kinase on one or more of the serines at position 6, 12, or 21 is responsible for p38-mediated enhancement of PPARalpha transactivation function.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 30 276(48) 44495-501",
                "id": "11577087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d11"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "ASK1 and Daxx act upstream of p38 in the Fas signaling pathway",
              "citation": {
                "type": "PubMed",
                "name": "Neuron 2002 Sep 12 35(6) 1067-83",
                "id": "12354397"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d0b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Inhibition of p160 rho kinase or p38 MAP kinase prevented the loss of epithelial morphology in response to TGFbeta, whereas only inhibition of p160 rho kinase blocked TGFbeta-stimulated caldesmon expression.",
              "citation": {
                "type": "PubMed",
                "name": "Dev Dyn 2006 Jan 235(1) 82-93",
                "id": "16258965"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cfe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "cardiac muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "It has been shown recently that sole activation of the p38 pathway can lead to hypertrophy of cultured cardiomyocytes (43, 47).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Jan 19(1) 21-30",
                "id": "9858528"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cfd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "rac2-/- neutrophils displayed significant defects in... and p38 and, unexpectedly, p42/p44 MAP kinase activation",
              "citation": {
                "type": "PubMed",
                "name": "Immunity 1999 Feb 10(2) 183-96",
                "id": "10072071"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ced"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Transfection of MLK-3 increased the MBP kinase activity of endogenous p38/RK by >6- fold over control (Figure 5).",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1996 Dec 16 15(24) 7026-35",
                "id": "9003778"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ce4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "activation of p38MAPK by IL-6",
              "citation": {
                "type": "PubMed",
                "name": "Biol Chem 2001 Oct 382(10) 1447-53",
                "id": "11727828"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ce3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "inhibition of MAPK14 activity also interfered with stabilization of EPO mRNA in human hepatoma cells undergoing hypoxic stress",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2000 Jul 21 102(2) 221-31",
                "id": "10943842"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cdf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "hepatocellular carcinoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We recently revealed that p38 MAPK-mediated serine phosphorylation of both Stat1 and Stat3 is required for the induction of 15-lipoxygenase (15-LO) expression by IL-13",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 16 279(16) 15954-60",
                "id": "14757756"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cd6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Ask1 constitutes the converging point of the heat shock and oxidative stress-sensing pathways that lead to p38 activation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 23 277(34) 30792-7",
                "id": "12077134"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ccf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Jul 23 99(15) 10054-9",
                "id": "12114539"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cc1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Here, we demonstrate that p38alpha-/- cells fail to activate HIF-1 under hypoxic conditions.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Jun 25(12) 4853-62",
                "id": "15923604"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cbe"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We show that both HSP60s activate the stress-activated protein kinases p38 and JNK1/2, the mitogen-activated protein kinases ERK1/2, and the I-kappaB kinase (IKK).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 17 276(33) 31332-9",
                "id": "11402040"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cb9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In addition, Tiam1 or Ras-GRF1 binding to IB2/JIP2 increases the association of the components of the p38 MAP kinase signaling cassette with IB2/JIP2 in cells and activates scaffold-associated p38. # note complex contains RAC,MAP3K11,MAP2K3,MAPK14 # IB2/JIP2 = mapk8ip2",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jun 22(12) 4073-85",
                "id": "12024021"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cb7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We find that RanBPM is phosphorylated on serine residues; phosphorylation of RanBPM is increased by stress stimuli and decreased by treatment with the p38 kinase inhibitor SB203580.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Mar 26 279(13) 13027-34",
                "id": "14722085"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cb5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "# Ariadne: Thus, our findings provide support for a signaling pathway in which Mekk3  activity leads to the activation of p38 MAPK, which in turn regulates MEF2C. [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Sep 12 97(19) 10454-9",
                "id": "10973481"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ca6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "JNK and p38 can be activated by phosphorylation at Thr183/Tyr185 and Thr180/Tyr182, respectively. As shown in Fig. 5A, palmitic acid induced both JNK and p38 phosphorylation, which were paralleled by a dose-dependent decrease in eNOS phosphorylation. ",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2006 Aug 55(8) 2301-10",
                "id": "16873694"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c9a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "These  results indicated that p38 MAPK regulates IL-12 p40 transcriptionally, at least  in part.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 Apr 1 18(7) 1845-57",
                "id": "10202148"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c97"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Hypertension 1998 Oct 32(4) 661-7",
                "id": "9774360"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c94"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Most surprisingly, although Rin was unable to stimulate MAP kinase activity in NIH 3T3 cells, it potently activated isoform-specific p38alpha MAP kinase signaling and weakly stimulated ERK signaling in pheochromocytoma (PC6) cells. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Nov 11 280(45) 37599-609",
                "id": "16157584"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c91"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Aug 22(16) 5835-45",
                "id": "12138194"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c87"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Interestingly, treatment with specific p38 mitogen-activated protein kinase inhibitors blocks both myotube formation and caveolin-3 expression,",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Oct 15 274(42) 30315-21",
                "id": "10514527"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c85"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "However, K8/19 tyrosine phosphorylation is independent of EGF signaling or ERK activation while inhibition of p38 kinase activity blocks pervanadate-induced K8/19 tyrosine phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 1999 Jul 112 ( Pt 13) 2081-90",
                "id": "10362538"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c72"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jun 27 278(26) 23432-40",
                "id": "12697749"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c69"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Moreover, in addition to JNK, ERK5, p38alpha, and p38gamma were found to stimulate the c-jun promoter by acting on distinct responsive elements.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Jun 19(6) 4289-301",
                "id": "10330170"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c60"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Sodium salicylate activated p38MAPK through phosphorylation at Thr 180/Tyr 182 and Akt/PKB at Ser 473, whereas it partially activated ERK1/2 through its phosphorylation at Thr 202/Tyr 204.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Oncol 2003 Aug 23(2) 503-8",
                "id": "12851702"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c5d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In addition, JDP2 induced p38 activity in both C2 and RD cells programmed to differentiate.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 18 277(42) 40043-54",
                "id": "12171923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c59"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "peroxynitrite. Indeed, the later is a powerful trigger of p38 phosphorylation and activation in a wide number of cell types, notably from cardiac (63), vascular (48,73,80) and neural origin (31,8185).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c48"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Recently, caveolin-1 was elucidated to be phosphorylated on tyrosine 14. However, it is not known how phosphorylation of caveolin-1 is controlled in endothelium. In this study, we found that caveolin-1 is phosphorylated by p38 mitogen-activated protein kinase (MAPK) under a static condition. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 Jan 20 339(3) 737-41",
                "id": "16325778"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c47"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "p38 kinase, a stress-activated kinase, becomes activated in response to hypoxia",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 14359-65",
                "id": "11278616"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c43"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "exercise leads to the activation of at least three MAPK signalling pathways, i.e. ERK1/2, p38 MAPK and JNK, in skeletal muscle (Zierath, 2002).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Nutr Soc 2004 May 63(2) 227-32",
                "id": "15294035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c3c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Silencing of p38alpha by isoform-specific small interfering RNAs increased claudin-4 and -8 mRNAs, whereas silencing of p38beta only increased claudin-4 mRNA.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2009 Sep 297(3) C775-87",
                "id": "19605737"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c39"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "# Ariadne: Activation of both JNK and p38 MAPK pathways was necessary for AVP-mediated induction of SM22 alpha promoter. [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2003 Oct 285(4) H1444-52",
                "id": "12829429"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c34"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Jul 15 163(2) 844-53",
                "id": "10395678"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c30"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Arch Biochem Biophys 2003 Jul 1 415(1) 117-25",
                "id": "12801520"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c2d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Inhibition of p38 MAPK by SB203580 in differentiating C2C12 myoblasts blocks MyoD expression, SHPS-1 tyrosyl phosphorylation and the association of SHPS-1 with SHP-2.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2001 Jun 114(Pt 11) 2187-98",
                "id": "11493654"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c19"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The mTOR inhibitor rapamycin reversed the dephosphorylation of eEF2 induced by CCK, as did treatment with the p38 MAPK inhibitor SB202190, the MEK inhibitor PD98059, and the phosphatase [PP2A] inhibitor calyculin A.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Jun 18 319(1) 144-51",
                "id": "15158453"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c15"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The p38 MAP kinase kinase MKK6 is identified as a common activator of p38 alpha, p38 beta 2, and p38 gamma MAP kinase isoforms, while MKK3 activates only p38 alpha and p38 gamma MAP kinase isoforms.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Jan 16 273(3) 1741-8",
                "id": "9430721"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c14"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2003 Nov 3 22(21) 5793-805",
                "id": "14592977"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c0e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Endocrinol 2003 Sep 149(3) 239-45",
                "id": "12943527"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c0c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "cAMP- and protein kinase A-dependent activation of p38 mitogen-activated protein kinase (MAPK) in brown adipocytes is an indispensable step in the transcription of the UCP1 gene in mice.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Apr 24(7) 3057-67",
                "id": "15024092"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c0b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "brown adipocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "inhibition of TNF-induced IkappaB alpha phosphorylation and degradation by NaSal is prevented by treatment of cells with SB203580, a highly specific p38 MAPK inhibitor.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1998 Jan 18(1) 78-84",
                "id": "9418855"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c07"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Mar 1 62(5) 1549-54",
                "id": "11888934"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c06"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Furthermore, TGF-beta1 rapidly activated the p38 mitogen-activated protein kinase (p38 MAPK) pathway in A549 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2002 Nov 283(5) L1094-102",
                "id": "12376363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bfe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "It was observed that p38 MAP kinase (MAPK) was activated soon after the treatment followed by over-expression of Bax protein in cells undergoing apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "Apoptosis 2003 Jan 8(1) 91-100",
                "id": "12510156"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070be1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We show that in CGCs, cAMP can activate Epac1 and Epac2, which in turn stimulates Rap and p38MAPK, but not p42/p44MAPK or JNK. This effect results in mobilization of ryanodine- and IP3- sensitive intracellular Ca2 stores and BK channel opening.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2007 Feb 13 104(7) 2519-24",
                "id": "17284589"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bc2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "granulocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "although all of these effects are far less substantial than those of the accepted activators AMP kinase kinase, phosphoinositide-dependent kinase 1, and CaMKK, respectively (24-26). Finally, Ras-independent activation of the mitogen-activated protein kinases ERK2, p38, and JNK1 was observed in cells transfected with constitutively active CaMKIV and further enhanced by cotransfection with CaMKK (27).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 2 276(5) 2975-8",
                "id": "11096122"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bb8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "By contrast, TNF primarily induces gene transcription through the inhibitor of kappaB kinase (IKK), c-Jun N-terminal kinase (JNK), and p38 mitogen-activated protein kinase pathways.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Dec 9 280(49) 40599-608",
                "id": "16227629"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "There was no significant increase in expression of p38 during H alone and early Re (1-2 h of Re). Enhanced p38 expression was detected after 4 h of Re. Postcon significantly reduced the p38 band density at 4 and 6 h of Re. Addition of anisomysin 5 min before Re also reversed inhibition of p38 with Postcon. Same patterns in change and modulation of p38 activity after H/Re with and without Postcon were also demonstrated as shown in Fig. 4. ",
              "citation": {
                "type": "PubMed",
                "name": "Apoptosis 2006 Sep 11(9) 1583-93",
                "id": "16820962"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ba5"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer 2003 Aug 15 98(4) 720-9",
                "id": "12910515"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ba3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In vitro kinase assays using the combined STAT1 proteins as substrates from immunoprecipitation and glutathione S-transferase pull down show that active ERK1, JNK1, p38 kinase, MEK1 and MSK1 stimulated phosphorylation of STAT1 (Ser727) indirectly through an unidentified factor or a downstream kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2004 Jul 25(7) 1165-75",
                "id": "14963018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b9e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2004 Feb 16 199(4) 449-58",
                "id": "14970175"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b91"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We demonstrate that p38 MAPK is able to not only enhance CK2 kinase activity but also suppress PKA kinase activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 29 280(17) 17221-6",
                "id": "15649893"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b8b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "SB203580, a specific inhibitor of p38MAPK, blocked arsenite-induced growth inhibition as well as the arsenite-induced p21(CIP1/WAF1) expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2002 Jan 190(1) 29-37",
                "id": "11807808"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b83"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In monocytic cells, mutation of these residues to alanine prevents MEF2C activation in response to either lipopolysaccharide stimulation or constitutive activation of the p38 kinase pathway [25].",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 1999 May 6 9(9) 449-59",
                "id": "10322110"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b7e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Furthermore, glucosamine inhibited the release of granule enzyme lysozyme from phagocytosing neutrophils and suppressed neutrophil chemotaxis toward zymosan-activated serum. In addition, glucosamine inhibited fMLP-induced up-regulation of CD11b significantly, polymerization of actin, and phosphorylation of p38 mitogen-activated protein kinase (MAPK)",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2002 Apr 71(4) 632-40",
                "id": "11927650"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b78"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We show that TTP mRNA is expressed in a biphasic manner following stimulation of cells with lipopolysaccharide and that the second phase of expression, like the first, is dependent on mitogen-activated protein kinase (MAPK) p38",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 30 279(31) 32393-400",
                "id": "15187092"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b70"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In ClC-3- deficient PMNs there was enhanced phosphorylation in ~27% of cells (Fig. 9B and D), but phosphorylation was diminished as compared with wild-type PMNs (Fig. 9C).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Nov 23 282(47) 33958-67",
                "id": "17908687"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b65"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "UV-induced activation of p38 MAP kinase, which suppressed the caspase-3 activity in NHK, was blocked by dominant negative PKC eta.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2003 Mar 28 303(1) 350-6",
                "id": "12646210"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b5b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "intracellular interaction of PKA, GMF, and p38 is supported by the phosphorylation of GMF upon cellular stimulation by forskolin (blocked by PKA inhibitor) and by the co-immunoprecipitation of p38 with GMF from cell lysates. Withdrawal of nerve growth factor from PC12 leads to increased GMF phosphorylation with a time course similar to that reported for p38 activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Sep 20 271(38) 22953-6",
                "id": "8798479"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b59"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2002 Nov 283(5) L1094-102",
                "id": "12376363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b52"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "nhibition of p38 MAPK signaling with the specific SB203580 inhibitor totally prevented the H2O2-mediated activation of the two Sp1 binding sites of the caveolin-1 promoter (?244/?222 and ?124/?101; Fig. 3B)",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Nov 15 66(22) 10805-14",
                "id": "17108117"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b4e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "m1 muscarinic acetylcholine receptor induces p38 MAPK activation mediated by MKK3 and MKK6",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 29 276(26) 23362-72",
                "id": "11304531"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b46"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cell Res 2001 Jun 11(2) 89-94",
                "id": "11453551"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b43"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We demonstrate that BMP2 induces activation of TGF-beta-activated kinase (TAK1) and subsequent phosphorylation of p38 stress-activated protein kinase.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jun 9 275(23) 17647-52",
                "id": "10748100"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b3f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "RNA interference (RNAi) demonstrates that MEKK3 and the scaffold protein are required for p38 activation in response to sorbitol-induced hyperosmolarity.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2003 Dec 5(12) 1104-10",
                "id": "14634666"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b3b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 12 279(46) 47912-28",
                "id": "15310753"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b3a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "VEGF also stimulated the mitogen activated protein (MAP) kinases ERK (extracellular signal-regulated kinase) and p38 (stress activated protein kinase-2)",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1997 Oct 15(18) 2169-77",
                "id": "9393975"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b34"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The specific p38 MAP kinase inhibitor, SB202190, significantly decreased the cytotoxicity and increased the survivin levels in NO donor-treated and inducible NOS-transfected cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 7 279(19) 20267-76",
                "id": "14988404"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b31"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We find that although pretreatment of BMMs with IL-4 does not alter M-CSF signaling, it reversibly blocks RANKL-dependent activation of the NF-kappa B, JNK, p38, and ERK signals.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Feb 22 277(8) 6622-30",
                "id": "11719504"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b2a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Studies with specific inhibitors and evaluation of protein phosphorylation indicated the involvement in PAF synthesis of two intracellular signaling pathways leading to cytosolic phospholipase A(2) activation: a phospholipase Cgamma-protein kinase C-Raf-p42/p44-mitogen-activated protein kinase (MAPK) and a MAPK kinase-3/6-dependent activation of p38 MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2003 Nov 15 171(10) 5489-97",
                "id": "14607955"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b28"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Interestingly, each of the individual MAPKs evaluated was found to promote Lox-1 expression to varying degrees. As we expected, CpG ODN treatment of macrophages increased three MAPKs phosphorylation, and each inhibitor of three MAPKs significantly attenuated the CpG ODN-induced phosphorylation of the MAPKs (Fig. 7A). ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2008 Dec 20(12) 2266-75",
                "id": "18817866"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b27"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The activation of the p38-MAPK was dependent on protein kinase-C.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetologia 2003 Apr 46(4) 531-7",
                "id": "12679868"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b26"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "inhibitor of p38-MAPK reversed the influence of IL-1beta on tau phosphorylation and synaptophysin",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2003 Mar 1 23(5) 1605-11",
                "id": "12629164"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b23"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Jun 15 19(26) 3003-12",
                "id": "10871852"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b19"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Nephrol Dial Transplant 2003 Apr 18(4) 670-6",
                "id": "12637634"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b14"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Acta Pharmacol Sin 2004 Apr 25(4) 485-9",
                "id": "15066218"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b12"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In addition, we present the evidence that Snn overexpression results in reduced extracellular regulated kinase activation and increased p38 activation.",
              "citation": {
                "type": "PubMed",
                "name": "Brain Res Mol Brain Res 2005 Aug 18 138(2) 256-63",
                "id": "15923056"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b0f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Apr 21(7) 2373-83",
                "id": "11259586"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070afd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jan 12 276(2) 999-1004",
                "id": "11029458"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070afb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Using specific inhibitors of MAPK pathways, we demonstrate that, in our experimental system, p38 signals survival, while ERK activity is required for apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 May 11 19(20) 2377-85",
                "id": "10828879"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070afa"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "calcineurin promotes down-regulation of p38 MAPK activity and enhances expression of the dual specificity phosphatase MAPK phosphatase-1 (MKP-1).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 11 276(19) 15913-9",
                "id": "11279073"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070af7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "cardiac muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Both PD98059 and SB203580, inhibitors of ERK1/ERK2 and p38 strongly suppressed IL-1beta induced COX-2 expression in a dose dependent manner, indicating that they mediate IL-1beta induced COX-2 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2002 Nov 62(5) 1112-8",
                "id": "12391274"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ae0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Jan 1 166(1) 466-72",
                "id": "11123325"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ade"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Table 1 Cluster B: mRNA transcripts stabilized by NO through p38 MAPK activation",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2006 34(10) 3044-56",
                "id": "16757573"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ace"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "p38 alpha and JNK1 phosphorylated p21 in vivo, and both p38 alpha and JNK1 phosphorylated p21 at Ser(130) in vitro.Peptide mapping demonstrated that both TGF-beta 1 and p38 alpha induced phosphorylation of p21 at Ser(130) in vivo, and mutation of Ser(130) to alanine rendered p21 less stable than wild-type p21. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 16 277(33) 29792-802",
                "id": "12058028"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070acb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Blockade of p38 activity did not affect inducible nuclear translocation and recruitment of NF-kappaB/RelA to the IL-8 promotor but did reduce the level of phosphorylated RelA (serine 536)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 17 279(51) 53241-7",
                "id": "15485852"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070aca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Unexpectedly, SB-203580, a p38 kinase antagonist, was found to block HSP60-induced expression of COX-2, but not NOS-2.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2002 Oct 283(4) C1267-77",
                "id": "12225989"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070abe"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PMNs treated with NFA, DPI (not shown), or N-Ac all displayed significantly enhanced levels of phosphorylated p38 in the absence of any other treatment and did not further increase p38 phosphorylation in response to LOS (Fig. 8).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Nov 23 282(47) 33958-67",
                "id": "17908687"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070abd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In human fibroblasts cultivated in floating collagen gels, the induction of MMP1 is mediated by PKC-zeta and p38 MAPK [96-98].",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Dermatol 11(6) 506-14",
                "id": "11701397"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070aae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Aug 4 275(31) 23549-58",
                "id": "10806207"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a91"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "we have cloned GAPR-1 from the human neutrophil, and confirmed that it is also LPS-responsive at the transcriptional level, as it undergoes LPS-induced, p38 MAPK-dependent downregulation",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2004 Aug 31(2 Suppl) S1-81",
                "id": "15269003"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a85"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PDGF-BB induces phosphorylation of alphaB-crystallin via p38 MAP kinase during myocardial infarction",
              "citation": {
                "type": "PubMed",
                "name": "Arch Biochem Biophys 2005 Jun 15 438(2) 111-8",
                "id": "15907784"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a80"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "cardiac muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Pyrrolidine dithiocarbamate (PDTC) induction of the human glutamate cysteine ligase modulatory (GCLM) gene is dependent on activation of the mitogen-activated protein kinases (MAPKs) extracellular regulated kinase (Erk) and p38",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Sci 2003 May 73(1) 124-34",
                "id": "12657749"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a7e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "MGSA/GROalpha in immortalized melanocytes enhances NF-kappaB activation, as well as mitogen-activated protein (MAP) kinase kinase kinase (MEKK) 1, MAP kinase kinase (MEK) 3/6, and p38 MAP kinase activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 2 276(5) 3650-9",
                "id": "11062239"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a76"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "melanocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "NMuMg mammary epithelial cells exposed to hyperosmotic stress induced by the organic osmolyte sorbitol, heat shock, ultraviolet irradiation, oxidative stress induced by hydrogen peroxide... The environmental stresses, but not dexamethasone, stimulatedSgk expression through a p38/MAPK-dependent pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 21 278(8) 5871-82",
                "id": "12488318"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a75"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Thapsigargin-induced mPer1 and mPer2 mRNA expressions took distinct signaling pathways from protein kinase C and cAMP, but were partially inhibited by inhibitors of MEK1 and p38 mitogen-activated protein kinase, respectively",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2002 Apr 10 516(1-3) 101-5",
                "id": "11959112"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a72"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PD98059 (MAPK/ERK1 inhibitor) and SB203580 (p38 MAPK inhibitor) respectively. In isolated rat skeletal muscle specific inhibition of ERK1/2 by PD98059 completely abolishes contraction-mediated p90rsk activity (Ryder et al. 2000).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Nutr Soc 2004 May 63(2) 227-32",
                "id": "15294035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a70"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "These results suggest that Fas-mediated inactivation of Rb is mediated via the p38 kinase, independent of cdks",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 Mar 15 18(6) 1559-70",
                "id": "10075927"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a6a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Transfection of HeLa cells with MKK6b(E), a constitutively active specific upstream activator of p38, led to a potent inhibition of GR activation of the MMTV promoter-driven luciferase construct.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 15 279(42) 43708-15",
                "id": "15292225"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a68"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Thus, p38alpha-induced re-localization of PP2A to caveolae can lead to dephosphorylation and inhibition of Akt, which in turn would contribute to the decreased survival observed in wild type cells",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2007 Jan 19(1) 62-74",
                "id": "16844343"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a67"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "p38, but not ERK or JNK, was found in a complex with Gadd45 proteins. The region of interaction was mapped to amino acids 71 to 96, and the central portion (amino acids 71 to 124) of Gadd45a was required for p38 MAPK activation in the presence of H-ras.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Jun 23(11) 3859-71",
                "id": "12748288"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a61"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The transfection of the TOPK gene to COS-7 cells up-regulated a phosphorylation of p38 MAPK but not ERK1/2 or SAPK/JNK.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jul 14 275(28) 21525-31",
                "id": "10781613"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a5f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 9 278(19) 16713-9",
                "id": "12609980"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a56"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Investigation into the downstream targets and mechanisms involved in ALK7-induced apoptosis revealed that the TGF-beta signaling intermediates, Smad2 and -3, were activated, as well as the MAPKs JNK and p38. In addition, caspase-3 and -9 were also activated, and cytochrome c release from the mitochondria was observed",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 2 279(27) 28458-65",
                "id": "15107418"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a52"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2006 Mar 20(3) 503-15",
                "id": "16282370"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a45"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Consistent with this finding, SB203580 and overexpression of a dominant-negative mutant of p38alpha or p38beta also inhibited NTHi-induced MUC5AC transcription as assessed using a human MUC5AC promoter-luciferase reporter construct ( Fig. 1 C ), thus confirming the requirement for p38 MAPK in MUC5AC induction.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 25 278(30) 27811-9",
                "id": "12734193"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a44"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Consistent with recent reports demonstrating the antagonistic actions of NF-kappaB and c-Jun amino-terminal kinase (JNK) signalling, we have found that Par4(-/-) cells show a reduced activation of the sustained phase of JNK and p38 stimulation by TNF-alpha and interleukin 1.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO Rep 2003 Mar 4(3) 307-12",
                "id": "12634851"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a42"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Activation of the tyrosine kinase receptor vascular endothelial growth factor receptor 2 (VEGFR2) by VEGF leads to the activation of stress-activated protein kinase (SAPK)2/p38 and then to actin polymerization and reorganization into stress fibers in endothelial cells.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Jan 15 23(2) 434-45",
                "id": "14724572"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a33"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In T cells CD137-induced signals lead to the recruitment of TRAF family members and activation of several kinases, including ASK-1, MKK, MAPK3/ MAPK4, p38, and JNK/SAPK  CD137 = TNFRSF9 ASK1 = MAP3K5",
              "citation": {
                "type": "PubMed",
                "name": "Immunol Res 2004 29(1-3) 197-208",
                "id": "15181282"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a32"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Specific inhibitors for p38 kinase inhibited BMP2-induced adipocytic differentiation and transcriptional activation of PPARgamma, whereas overexpression of Smad6 had no effect on transcriptional activity of PPARgamma.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2003 Feb 14(2) 545-55",
                "id": "12589053"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a31"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "p38 inhibitor SB 202190",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Crit Care Med 2002 Apr 15 165(8) 1161-71",
                "id": "11956062"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a2f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "contraction increases both GLUT4 translocation to the cell surface and p38 mitogen-activated protein kinase (p38 MAPK) activity.",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2003 Sep 17(12) 1658-65",
                "id": "12958172"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a27"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Rac2D57N also inhibited lipopolysaccharide-stimulated p38 kinase activation. # Rac2D57N described as dominant inhibitory",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2004 Jan 15 117(Pt 2) 243-55",
                "id": "14676277"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a25"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "IL13 in combination with IL1beta, caused synergistic increase in eotaxin release. There was 16 fold increase in eotaxin production when 100 ng/ml of IL13 and IL1beta were used. Treatment of cells with inhibitors of p38, ERK1/2 attenuated the eotaxin release.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2000 Nov 75(5) 2020-8",
                "id": "11032891"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a21"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2001 Jul 78(2) 374-83",
                "id": "11461973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a1f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2003 Jul 1 171(1) 106-14",
                "id": "12816988"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a11"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Here we demonstrate that NFATc4 is phosphorylated by p38 mitogen-activated protein (MAP) kinase but not by JNK. The p38 MAP kinase phosphorylates multiple residues, including Ser(168) and Ser(170), in the NFAT homology domain of NFATc4.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jun 22(11) 3892-904",
                "id": "11997522"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a0d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "preadipocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Overexpression of LAX in Jurkat cells specifically inhibits T cell receptor-mediated p38 MAPK activation and NFAT/AP-1 transcriptional activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 29 277(48) 46151-8",
                "id": "12359715"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a03"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Interestingly, VSMC lines stably expressing dominant negative Ras (Ras N17) or Rac (Rac N17) exhibited a marked decrease in MKP-1 expression; the inhibition of ERK kinases (MEK1/2) by PD 98059 or of p38 MAPKs by SB 202190 resulted in a down-regulation of MKP-1 induction.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Sep 3 274(36) 25273-80",
                "id": "10464250"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709f7"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Erk and p38 phosphorylate MNK1 and MNK2, which stimulates their in vitro kinase activity towards a substrate, EIF-4E",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Apr 15 16(8) 1909-20",
                "id": "9155017"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709f0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Inhibition of p38 MAP kinase by SB203580 also partially suppressed the H2O2-initiated AR induction",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2001 Jul 15 31(2) 205-16",
                "id": "11440832"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709ec"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Kit and other RTKs will activate the MAP kinase signaling pathway and has been reported both to increase the transcriptional activity of Mitf as well as down-regulate Mitf protein levels.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Jul 15 14(14) 1712-28",
                "id": "10898786"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709ea"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Thus with a GST fusion protein of MAPKAP kinase-2 that lacks the N-terminal proline-rich domain both RK and p42 MAP kinase phosphorylate Thr222 and Ser272, but only p42 MAP kinase phosphorylates Thr334 efficiently.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1995 Dec 1 14(23) 5920-30",
                "id": "8846784"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709e8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Feb 15 166(4) 2342-7",
                "id": "11160291"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "ERK and p38 activities are essential for maximal c-Jun and Fra-2 expression, and AP-1 DNA binding activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 3 277(18) 15992-6001",
                "id": "11884386"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709dd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "As shown in Fig. 1a, p38 MAPK was strongly phosphorylated by E. coli DNA stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2006 Sep 15 177(6) 4037-46",
                "id": "16951367"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Co-transfection of the MAO B promoter with dominant negative forms of Ras, Raf-1, MEKK1, MEK1, MEK3, MEK7, ERK2, JNK1, and p38/RK inhibit the PMA-dependent activation of the MAO B promoter",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 21 277(25) 22222-30",
                "id": "11956220"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709d5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Aug 30 20(38) 5359-65",
                "id": "11536048"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "p38 phosphorylates and activates MAPKAPK5",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1998 Jun 15 17(12) 3372-84",
                "id": "9628874"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709ca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "MKNK1 was phosphorylated and activated by ERK1 and p38 MAP kinases but not by JNK/SAPK MNK1 was activated upon stimulation of HeLa cells with 12-o-tetradecanoylphorbol-13-acetate",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Apr 15 16(8) 1921-33",
                "id": "9155018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709c8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "coexpression of TAB1 and p38 enhanced autophosphorylation of p38",
              "citation": {
                "type": "PubMed",
                "name": "Science 2002 Feb 15 295(5558) 1291-4",
                "id": "11847341"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709b4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2003 Jul 285(1) C39-47",
                "id": "12606313"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709b2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Western blot analysis of phospho-p38 MAPK gave similar results: combination treatment markedly increased phosphorylation of p38 compared with either IGF-I or TGF-beta1 treatment alone (Figure 7b).",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2003 Jun 120(6) 956-62",
                "id": "12787120"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "This induction was in part dependent on the MEK1/2 and p38 components of the MAPK signal transduction pathway. Addition of either U0126, a specific and potent inhibitor of MEK1/2, or SB203580, a specific and potent inhibitor of p38, nearly abolished induction of ESE-3 mRNA (Figure 6B). Addition of both reagents inhibited induction at lower doses.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2002 Dec 27(6) 697-704",
                "id": "12444029"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709a9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Inhibition of p38 MAP kinase, which blocks ezrin phosphorylation, also prevents Akt activation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 14 280(2) 1688-95",
                "id": "15531580"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Table 1 Cluster B: mRNA transcripts stabilized by NO through p38 MAPK activation",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2006 34(10) 3044-56",
                "id": "16757573"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407099f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Nat Immunol 2002 Apr 3(4) 392-8",
                "id": "11896392"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070996"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Western analysis demonstrated that phospho-p38, but not phospho-ERK or phospho-JNK (data not shown), was activated after stimulation with both IL-1 and NE in bronchial epithelial cells (Fig. 2C).  ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Dec 1 175(11) 7594-601",
                "id": "16301669"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070992"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "stimulation of p38 MAPK isoforms phosphorylated purified Nrf2 protein and caused an increase in the interaction between Nrf2 and Keap1 in vitro and the suppression of Nrf2 translocation into the nucleus.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Sep 1 66(17) 8804-13",
                "id": "16951197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407098f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Interestingly, phospho-acceptor site mutations of MEF2 that render it unresponsive to p38 MAP kinase signalling abrogate the cooperativity with the Smads suggesting that p38 MAP Kinase-catalysed phosphorylation of MEF2 is a prerequisite for the Smad-MEF2 interaction.",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2001 Feb 1 29(3) 732-42",
                "id": "11160896"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070989"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "IL-1beta rapidly activates the c-Jun NH2-terminal/stress-activated protein kinases (JNK/SAPK) and p38 mitogen-activated protein kinase (MAPK) and also induces Cox-2 expression and prostaglandin E2 (PGE2) production.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Oct 30 273(44) 28670-6",
                "id": "9786861"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070977"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "insulin-dependent p38 alpha and p38 beta MAPK activities were also markedly reduced by wortmannin",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 7 276(49) 46079-87",
                "id": "11598141"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070973"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Therefore, once recruited at the promoter, active p38 is able to induce gene expression. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 Oct 8 285(41) 31819-28",
                "id": "20682780"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407096b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Here we show that hyperglycemia inhibits thioredoxin ROS-scavenging function through p38 MAPK-mediated induction of Txnip.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 16 279(29) 30369-74",
                "id": "15128745"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070966"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "TPA stimulates increased generation of ROS and initiates the stress-activated protein kinase (SAPK) pathway via protein kinase C (PKC) bII activation (Datta et al., 2000), representing typical characteristics of STASIS...Activation of stress kinases (JNK, MAPK, p38) (Day 2008;  Gao et al., 2008; Kirkham and Rahman, 2006;  Kliment et al., 2008; Koli et al., 2008) ",
              "citation": {
                "type": "PubMed",
                "name": "Biol Chem 2008 Mar 389(3) 211-20",
                "id": "18208352"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407095f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "the p38 inhibitor SB203580 (SB) produced additive increases in StAR expression",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Endocrinol 2005 Feb 28 231(1-2) 95-107",
                "id": "15713539"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407095b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2003 Jun 1 372(Pt 2) 631-41",
                "id": "12646044"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070959"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2000 Dec 141(12) 4637-46",
                "id": "11108278"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070951"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "jubilant",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Crit Care Med 2002 Apr 15 165(8) 1161-71",
                "id": "11956062"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407094f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Furthermore, CK2 activity toward IkappaB is UV inducible through a mechanism that depends on activation of p38 MAP kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2003 Oct 12(4) 829-39",
                "id": "14580335"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070942"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Feb 15 61(4) 1727-32",
                "id": "11245489"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407093c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In addition to NF-?B, among the known pathways that can be activated by RAGE are phosphoinositide 3-kinases (PI3K)/Akt (also termed as protein kinase B), and mitogen-activated protein kinase members (MAPKs) (52,53). The latter group includes Jun-N-terminal kinase (JNK), p38, and extracellular signal-regulated kinases (ERK) (54,55) (Figure 2).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 1403-13",
                "id": "19273137"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407093b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "However, inhibition of the p38 pathway prevented the insulin-stimulated decrease in GLUT4 protein levels.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2003 Mar 52(3) 634-41",
                "id": "12606502"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070935"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The sentence (ResnetDB) CREB and ATF-1 were phosphorylated upon UVB treatment, and SB202190, a p38 MAPK inhibitor, decreased the phosphorylation of CREB/ATF-1 and suppressed COX-2 promoter activity.  is translated to Activation of ATF1 (Homo sapiens) Gene Expression by MAPK14 (Homo sapiens) Protein  The following edits have been made already none  Links Doc Sourcerer for 11526505 ATF1 (Homo sapiens) Gene Expression MAPK14 (Homo sapiens) Protein",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Mar 1 61(5) 1862-8",
                "id": "11280739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070933"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "TGF-beta1 failed to induce phosphorylation of either MKK3 or p38 MAPK in MKK3-deficient (Mkk3-/-) mouse mesangial cells, indicating that MKK3 is required for TGF-beta1-induced p38 MAPK activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 6 277(49) 47257-62",
                "id": "12374793"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070927"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Production of interleukin-1 and tumour necrosis factor from stimulated human monocytes is inhibited by a new series of pyridinyl-imidazole compounds. Using radiolabelled and radio-photoaffinity-labelled chemical probes, the target of these compounds was identified as a pair of closely related mitogen-activated protein kinase homologues, termed CSBPs.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 372(6508) 739-46",
                "id": "7997261"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407091e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Here we show that CXCL12, complement factor 5a (C5a), hepatocyte growth factor (HGF) and platelet-derived growth factor (PDGF)-BB, which stimulate cell migration, also activate p38alpha MAPK. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2006 Nov 18(11) 1897-905",
                "id": "16574378"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070919"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "p38 and MK2 were phosphorylated in CD-cholesterol-loaded macrophages. Early activation of p38 by CD-cholesterol (i.e., at 5?8 h) was observed independently of ACAT inhibition.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2005 Oct 10 171(1) 61-73",
                "id": "16203857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070911"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Apr 1 60(7) 2007-17",
                "id": "10766192"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407090c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2002 Apr 118(4) 704-11",
                "id": "11918720"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070909"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Mar 1 61(5) 1855-61",
                "id": "11280738"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070902"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "9829964;7958915;11969286;8887554;15733869;12356771;9687510;9528766",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In contrast, p38 activation by PPARalpha and gamma ligands occurred independently of Src, oxidative stress, the EGFR, and Ras.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 21 278(47) 46261-9",
                "id": "12966092"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708f9"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PKA-phosphorylated GMF strongly enhances the activity of a related but distinct subfamily of MAP kinase, the p38 MAP kinase, showing an increase of 60-fold over baseline and an EC50 of 7 nM.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Sep 20 271(38) 22953-6",
                "id": "8798479"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708f8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "astrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Jul 15 21(14) 3749-59",
                "id": "12110587"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708f5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "TGF-beta1 failed to induce phosphorylation of either MKK3 or p38 MAPK in MKK3-deficient (Mkk3-/-) mouse mesangial cells, indicating that MKK3 is required for TGF-beta1-induced p38 MAPK activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 6 277(49) 47257-62",
                "id": "12374793"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708f4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "TNF-activated p38alpha kinase promotes the interaction between YY1 and PRC2, via threonine 372 phosphorylation of EZH2, the enzymatic subunit of the complex, leading to the formation of repressive chromatin on Pax7 promoter. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Stem Cell 2010 Oct 8 7(4) 455-69",
                "id": "20887952"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708f3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The p38 kinase inhibitor, SB 203580, and the NF-kappaB inhibitor, MG-132, inhibited the induction of mob-1 mRNA",
              "citation": {
                "type": "PubMed",
                "name": "Cytokine 2003 Aug 7 23(3) 64-75",
                "id": "12906869"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708eb"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Ezrin, a member of the ezrin/radixin/moesin (ERM) family, seems to be involved in the formation and stabilization of the apical microvilli. We found that phosphorylation of ezrin caused elongation of microvilli via a p38 MAP-kinase signaling pathway in an immortalized mouse hepatic cell line.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2006 Jan 15 312(2) 111-20",
                "id": "16274688"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708dc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Jpn J Pharmacol 2000 Aug 83(4) 351-4",
                "id": "11001183"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708db"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In these cells, FGF-BP was up-regulated by treatment with epidermal growth factor (EGF), dependent on protein kinase C and p38 mitogen-activated protein kinase signaling.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Apr 1 63(7) 1696-705",
                "id": "12670924"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708d9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The alkylating agent methylmethanesulfonate (MMS) activates the c-jun N-terminal kinase (JNK)/stress-activated protein kinase (SAPK) and the p38 mitogen-activated protein kinase (p38MAPK) pathways via different mechanisms of action.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Carcinog 2001 Jun 31(2) 63-7",
                "id": "11429782"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PPARgamma ligands not only activated calcium/calmodulin-dependent kinase II (CaMKII) 2-fold over control, but the selective CaMKII inhibitor, KN-93, attenuated MKK3/6 and p38 as well as PKR and eIF2alpha phosphorylation. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 18 280(11) 10109-18",
                "id": "15649892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Stimulation of TLRs leads to activation of NF-?B, MAPKs, JuN N-terminal kinases (JNKs), p38 and ERKs, and interferon regulatory factor (IRF3, IRF5 and IRF7) signalling pathways5.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2009 Jan 9(1) 57-63",
                "id": "19052556"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708b9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "a part of the phosphorylation of Sap-1a upon stimulation with H2O2 is due to p38 MAPK, while the rest can most likely be attributed to JNKs that are also inducible by H2O2.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Apr 1 16(7) 1620-7",
                "id": "9130707"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708b7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "IFN-dependent activation of the downstream effectors of p38, MAPKAPK-2 and MAPKAPK-3, is not detectable in cells lacking Mkk3 and Mkk6",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 18 280(11) 10001-10",
                "id": "15644321"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708b3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "p38 protein interacts with MAX protein p38 phosphorylates MAX in both in vitro and in vivo",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1995 Nov 7 92(23) 10531-4",
                "id": "7479834"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708b0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "As shown in Fig. 2A, THP-1 cells transfected with siRNAs for p38 MAPK and p47phox showed complete inhibition in ET-1?mediated MIP-1b mRNA expression, whereas control scRNA had no effect.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Oct 15",
                "id": "20952681"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708af"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "p38 can directly activate the MEF2 transcription factors in skeletal muscle and together with the myod family, mef2 transcription factors are necessary for the differentiation of myoblasts",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Jul 22 158(2) 345-55",
                "id": "12135987"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Transforming growth factor-beta-activated kinase 1 (TAK1) is a member of the MAPK kinase kinase (MAPKKK) family and can activate JNK and p38.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Sep 29 281(39) 28802-10",
                "id": "16893890"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708a8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Next, we incubated the cells with p38 MAP kinase inhibitor SB 203580. SB 203580 at concentration of 5 ?M inhibited the IL-8 generation by macrophages. The amounts of IL-8 produced and released by the cells were diminished by 42% (from ~52.5  7 ng/ml to ~22.0  5.1 ng/ml).",
              "citation": {
                "type": "PubMed",
                "name": "Respir Res 2006 7 66",
                "id": "16620395"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages, Alveolar",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "treatment with SB203580, a specific inhibitor of p38 alpha and beta MAPKs",
              "citation": {
                "type": "PubMed",
                "name": "Development 2005 Apr 132(8) 1773-83",
                "id": "15772134"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070895"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Moreover, the phosphatidylinositol 3 (PI3)-kinase inhibitor (wortmannin) and p38(MAPK) inhibitor (SB203580) inhibited the EGF-induced CREB phosphorylation and the expression of NF-IL6beta gene in cells.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2005 Jul 16(7) 3365-76",
                "id": "15901830"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407088e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "the protein kinase TAO2 activates MAP/ERK kinases (MEKs) 3, 4, and 6 toward their substrates p38 MAP kinase and c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 11 276(19) 16070-5",
                "id": "11279118"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407088c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "IFN-dependent activation of the downstream effectors of p38, MAPKAPK-2 and MAPKAPK-3, is not detectable in cells lacking Mkk3 and Mkk6",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 18 280(11) 10001-10",
                "id": "15644321"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070889"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We found that BPDE transiently increased the phosphorylation of p38 and Hdm2, and increased total p53 protein levels after 4 h of BPDE exposure (Figure 2A).",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2006 Nov 27(11) 2331-40",
                "id": "16774943"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070880"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PPM1A inhibited the activation of the p38 and JNK cascades induced by environmental stresses PPM1A dephosphorylated and inactivates MAPKKs (MKK6 and SEK1) and p38 in the stress-responsive MAPK cascades",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1998 Aug 17 17(16) 4744-52",
                "id": "9707433"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407087e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Res Ther 2003 5(4) R186-92",
                "id": "12823853"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407087b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": "synovium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "p38 mitogen activating protein kinase (MAPK) can be activated by stressors such as hypoxia, hypertonicity, UV light, oxidative radicals and protein synthesis inhibitors, some hormones and growth factors (e.g. insulin, IGF-1 and FGF), and by muscle contraction.",
              "citation": {
                "type": "PubMed",
                "name": "Acta Physiol Scand 2003 Aug 178(4) 287-96",
                "id": "12864733"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070871"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Antioxid Redox Signal 2002 Aug 4(4) 587-92",
                "id": "12230870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407086a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "reversed by suppressing p38 mitogen-activated protein kinase activity.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2006 May 5(5) 1126-35",
                "id": "16731744"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070868"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "p38alpha, rather than p38beta, MAPK activity is essential for uPA/uPAR expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 21 275(16) 12266-72",
                "id": "10766865"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070861"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Inhibition of heat shock protein (HSP) 27 activity by p38 mitogen-activated protein kinase (MAPK)-catalyzed phosphorylation induces actin stress fiber formation,",
              "citation": {
                "type": "PubMed",
                "name": "J Appl Physiol 2001 Oct 91(4) 1487-500",
                "id": "11568129"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407085f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Finally, either inhibition or disruption of p38MAPK increased peroxisome proliferator-activated receptor (PPAR)gamma expression and transactivation.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2006 Feb 55(2) 281-9",
                "id": "16443758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407085a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "preadipocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Oct 1 62(19) 5611-7",
                "id": "12359775"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070855"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Treatment of cells with cisplatin induces a sustained activation of the stress activated protein kinase SAPK/JNK and the mitogen-activated protein kinase p38.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Oct 26 19(45) 5142-52",
                "id": "11064451"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070840"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In the present study, we show that Fas receptor ligation or cellular treatment with synthetic C6-ceramide results in activation or phosphorylation, respectively, of the small G-protein Rac1, Jun N-terminal kinase (JNK)/p38 kinases (p38-K), and the transcription factor GADD153",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Aug 29 272(35) 22173-81",
                "id": "9268362"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407083e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Recombinant human (rh) CyPA activated ERK1/2, p38MAPK, SAPKs, and Akt in cultured cardiac myocytes. Furthermore, CyPA significantly increased Bcl-2 in cardiac myocytes.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Apr 23 317(1) 162-8",
                "id": "15047162"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407083a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "# Ariadne: Activation of both JNK and p38 MAPK pathways was necessary for AVP-mediated induction of SM22 alpha promoter. [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2003 Oct 285(4) H1444-52",
                "id": "12829429"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070828"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We show that p38alpha MAP kinase, in a phosphorylation-dependent manner, can directly interact with the alpha and beta subunits of CK2 to activate the holoenzyme through what appears to be an allosteric mechanism.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jun 2 275(22) 16569-73",
                "id": "10747897"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070825"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "p38 is one of the substrates of MEKs. MEK3 and MEK6 both strongly activate p38 kinase, however MEK3 is more active on p38?, while MEK6 activates all p38 isoforms",
              "citation": {
                "type": "PubMed",
                "name": "J Mammary Gland Biol Neoplasia 2003 Jan 8(1) 45-73",
                "id": "14587863"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070822"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "N6-cyclopentyladenosine (CPA; an adenosine A1 receptor agonist)-induced PP2a translocation was blocked by p38 MAPK inhibition but not by JNK inhibition. CPA increased phosphorylation of p38 MAPK, and this effect was abolished by pertussis toxin and inhibitors of the cGMP pathway",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2003 Jul 285(1) H97-103",
                "id": "12649078"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070821"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580 diminished Ang II-induced Smad2 phosphorylation. ",
              "citation": {
                "type": "PubMed",
                "name": "Exp Dermatol 2009 Nov 18(11) 947-53",
                "id": "19397700"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070819"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Perfusion of hearts with 100 microM PE caused a rapid (maximal at 10 min) 12-fold activation of twop38-MAPK isoforms",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1998 Jun 1 332 ( Pt 2) 459-65",
                "id": "9601075"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070802"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Nov 8(5) 971-82",
                "id": "11741533"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "blocking TGF-beta-induced p38 activity with SB202190",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Mar 28 278(13) 11041-9",
                "id": "12538652"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707f6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Phorbol ester-dependent activation of peroxiredoxin I gene expression via a protein kinase C, Ras, p38 mitogen-activated protein kinase signaling pathway. The data indicate that a protein kinase C, Ras, MEKK1, p38 MAPK signaling pathway plays a major role for the transcriptional up-regulation of Prx I gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 14 278(46) 45419-34",
                "id": "12960165"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In this report we demonstrate that IL-12 activates mitogen-activated protein kinase kinase 3/6 (MKK) and p38 mitogen-activated protein kinase (MAPK), but not p44/42 (ERK) or stress-activated protein kinase/c-Jun N-terminal kinase MAPK. The activation of p38 MAPK is required for normal induction of IFN-gamma mRNA and IFN-gamma secretion by IL-12 in activated T cells and Th1 cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2000 Aug 1 165(3) 1374-80",
                "id": "10903740"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707e1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": " Knockdown of Brk by stable expression of short hairpin RNA (shRNA) in T47D breast cancer cells decreases proliferation and blocks epidermal growth factor (EGF)- and heregulin-induced activation of Rac GTPase, extracellular signal-regulated kinase (ERK) 5, and p38 mitogen-activated protein kinase (MAPK)",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2007 May 1 67(9) 4199-209",
                "id": "17483331"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Id3 is induced by X/XO via superoxide, calcium, p38, and p42/44 MAP kinase.",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2002 Jul 16(9) 1077-86",
                "id": "12087069"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In human DLD-1 cells, inhibition of p38 MAPK by the compound 4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole (SB203580) or by overexpression of a dominant-negative p38 MAPKalpha protein resulted in a reduction of human iNOS mRNA and protein expression",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2005 Jun 67(6) 2148-61",
                "id": "15778452"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707d4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Further analysis reveals that expression of beta-arrestin2 strengthened CXCR4-mediated activation of both p38 MAPK and ERK, and the suppression of beta-arrestin2 expression blocked the activation of two kinases",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 20 277(51) 49212-9",
                "id": "12370187"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707d3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Addition of SB203580, transforming growth factor-beta1 (TGF-beta1) monoclonal antibody, p38 small interfering RNA (siRNA), and c-myc siRNA 30 minutes before stretch inhibited the induction of DDR2 protein and abolished the DNA-protein binding activity induced by cyclic stretch.",
              "citation": {
                "type": "PubMed",
                "name": "Hypertension 2005 Sep 46(3) 614-21",
                "id": "16087782"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707d0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 9 277(32) 29294-303",
                "id": "12034736"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Gal-9 induced phosphorylation of the MAPK p38 and ERK1/2 in DCs, and an inhibitor of p38 signaling, but not inhibitors of signaling by either ERK1/2 or PI3K, blocked Gal-9-induced up-regulation of costimulatory molecule expression and IL-12 production.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Sep 1 175(5) 2974-81",
                "id": "16116184"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707ca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Of interest, activation of PAR1 resulted in the phosphorylation of caveolin-1, a principal component of caveolae, on tyrosine 14 by a Gi-linked Src kinase pathway and p38 mitogen-activated protein kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2006 Nov 18(11) 1977-87",
                "id": "16678999"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707b6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In the present study, we found that blocking alpha(v) integrin functionality with a function-blocking monoclonal antibody or down-regulating alpha(v) integrin expression with alpha(v)-specific antisense oligonucleotides significantly decreased the levels of active p38 MAPK and inhibited cell-associated uPA expression in invasive breast cancer MDA-MB-231 cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 21 276(51) 47901-5",
                "id": "11606583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707b2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "peroxynitrite. Indeed, the later is a powerful trigger of p38 phosphorylation and activation in a wide number of cell types, notably from cardiac (63), vascular (48,73,80) and neural origin (31,8185).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707ab"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Our data demonstrate that increased intracellular cAMP concentration in endothelial cells prevents thrombin-induced ICAM-1 expression by inhibiting p38 MAPK activation, which in turn prevents phosphorylation of RelA/p65 and transcriptional activity of the bound NF-kappaB.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2004 Nov 287(5) L1017-24",
                "id": "15246972"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Nov 21(22) 7545-57",
                "id": "11604491"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407079f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We demonstrate that purified SCG10 can be phosphorylated by two subclasses of mitogen-activated protein (MAP) kinases, c-Jun N-terminal/stress-activated protein kinase (JNK/SAPK) and p38 MAP kinase. Moreover, SCG10 was found to bind tightly and specifically to JNK3/SAPKbeta. JNK3/SAPKbeta phosphorylation occurs at Ser-62 and Ser-73, residues that result in reduced microtubule-destabilizing activity for SCG10",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2001 Nov 16 508(2) 259-64",
                "id": "11718727"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070795"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PMA and granulocyte/macrophage colony-stimulating factor induce Egr-1 expression through ERK and p38 activation, respectively.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 23 278(21) 18859-67",
                "id": "12618431"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070793"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Stem Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Besides binding to specific elements in the ucp-1 enhancer, rosiglitazone has extragenic effects activating p38 mitogen-activated protein kinase (MAPK), a necessary signal for UCP-1 induction (Teruel et al. 2003).",
              "citation": {
                "type": "PubMed",
                "name": "Mini Rev Med Chem 2005 Mar 5(3) 269-78",
                "id": "15777261"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407078f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "TNF-alpha represses the promoter activity of the 250-bp region, and the repression is mediated by p38 MAP kinase independent of NF-kappaB",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 1998 Jun 139(6) 3030-3",
                "id": "9607817"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407078a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In contrast, USF1/2 activates the hTERT promoter exclusively in hTERT-positive cells in a manner that is enhanced by the coactivator p300 and attenuated upon inhibiting p38-MAP kinase, a known modulator of USF activity.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Sep 11 22(39) 8042-7",
                "id": "12970752"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070770"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "MSK1 induction requires simultaneous activation of both ERK and p38 MAPK. Other downstream targets of p38 MAPK include transcription factors such as Elk1 and myocyte-enhancing factor (MEF) 2, whereby p38 MAPK directly phosphorylates nuclear substrates and augments their activity (Chen et al. 2001).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Nutr Soc 2004 May 63(2) 227-32",
                "id": "15294035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070762"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "CK1-a, which has been shown to rephosphorylate and deactivate NFAT4 transcription factor (18, 19), and p38 MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2004 Jun 18(9) 1025-7",
                "id": "15084522"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407075b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "At a high glucose concentration, O-glycosylation of p53 occurred between 10 and 20 min, reached its peak at 1 h, and then decreased with time. Angiotensin II synthesis increased at 45 min and 1 h, resulting in p38 mitogen-activated protein (MAP) kinase-driven p53 phosphorylation at Ser 390.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2001 Oct 50(10) 2363-75",
                "id": "11574421"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407073e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscles"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Pretreatment of LNCaP cells with SB202190, PD98059, or tyrphostin AG879 [p38 mitogen-activated protein kinase (MAPK), MAP/extracellular signal-regulated protein kinase kinase 1/2, and ErbB2 MAPK inhibitors, respectively) but not wortmannin (PI3-kinase inhibitor) blocked IL-6-mediated induction of the PSA promoter, which demonstrates that IL-6 activity is dependent on a MAPK pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2001 Jun 7(6) 1773-81",
                "id": "11410519"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407073b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "From Cell Signaling Technologies Pathway Maps for p38 and JNK signaling.",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2001 Apr 81(2) 807-69",
                "id": "11274345"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070739"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2005 Apr 15 387(Pt 2) 507-17",
                "id": "15568999"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070738"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In contrast, p38 activation by PPARalpha and gamma ligands occurred independently of Src, oxidative stress, the EGFR, and Ras.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 21 278(47) 46261-9",
                "id": "12966092"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070735"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Co-exposure to C75 and Taxol induced a remarkable nuclear accumulation of activated p38 mitogen-activated protein kinase (p38 MAPK), which was accompanied by a synergistic nuclear accumulation of the p53 tumor-suppressor protein that was phosphorylated at Ser46, a p38 MAPK-regulated pro-apoptotic modification of p53",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2005 May 20 115(1) 19-35",
                "id": "15657900"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070734"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Similarly, the p150Glued siRNA could also specifically reduce the tumor necrosis factor -induced phosphorylation of MKK3/6 and p38 MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 29 279(44) 45308-11",
                "id": "15375157"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070729"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "deletion of p38alpha mitogen-activated protein (MAP) kinase in adult mice results in increased proliferation",
              "citation": {
                "type": "PubMed",
                "name": "Nat Genet 2007 Jun 39(6) 750-8",
                "id": "17468755"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070721"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "U0126 also completely abolished the insulin-stimulated increase of the activated (phosphorylated) ERK1/2. it was shown that MAPKp38 inhibits MEK1/2",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2003 May 52(5) 1073-80",
                "id": "12716735"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407071d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Circulation 2002 Apr 30 105(17) 2030-6",
                "id": "11980681"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070715"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "peroxynitrite. Indeed, the later is a powerful trigger of p38 phosphorylation and activation in a wide number of cell types, notably from cardiac (63), vascular (48,73,80) and neural origin (31,8185).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070712"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "DUSP8, DUSP10 and DUSP16 make up the third subgroup as they preferentially recognize JNK, p38 or both, respectively",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Drug Discov 2007 May 6(5) 391-403",
                "id": "17473844"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070705"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "These effects were markedly attenuated in Rat2-Rac(N17) cells expressing a dominant negative Rac1 mutant. Pretreatment with SB203580, a specific inhibitor of p38 MAP kinase",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2001 Jun 1 284(1) 126-32",
                "id": "11374881"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706ff"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "treatment of human mononuclear cells with leptin increased p38 MAP kinase phosphorylation Another study in L6 muscle cells suggested that leptin did not itself alter p38 MAP kinase phosphorylation but reduced insulin-stimulated p38 MAP kinase phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2002 Aug 14(8) 655-63",
                "id": "12020765"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706fd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "the in vitro phosphorylation of GSTElk and GSTSap by immunoprecipitated p38 MAPK was abolished in the presence of the inhibitor SB202190, whereas the ability of the MAPK ERK-1 to phosphorylate these two TCFs was unaffected (Figure 1B).",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Apr 1 16(7) 1620-7",
                "id": "9130707"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706f7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In an effort to support this hypothesis, we studied the effects of P38 pharmacologic inhibition on cell growth in the epidermal growth factor receptor mutant (delE746_A750) adenocarcinoma cell line HCC827, which is derived from a nonsmoking patient and does not harbor K-Ras mutations (20). We showed that P38 activity does not inhibit, but rather, contributes to cell growth in the HCC827 model.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2008 Jul 1 14(13) 4096-102",
                "id": "18593986"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706e2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Although p38 phosphorylated LIMK1 at Ser-310, it failed to activate LIMK1 directly; however, MK2 activated LIMK1 by phosphorylation at Ser-323.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Feb 22 25(4) 713-26",
                "id": "16456544"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706c8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "# Ariadne: Collectively, these results support the concept that p38 kinase targets MEF2C  at a unique site (Thr293), whose phosphorylation is required to stimulate MEF2- dependent transcription during muscle differentiation. [MolTransport]",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Jun 20(11) 3942-50",
                "id": "10805737"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706ba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The p38 mitogen-activated protein kinase (MAPK) inhibitors SB202190 and SB203580 suppressed IL-4-induced TIMP-2 expression, suggesting the involvement of p38 MAP kinase in the signaling of IL-4 leading to TIMP-2 expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Feb 15 168(4) 1895-902",
                "id": "11823524"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706b8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2002 Dec 15 368(Pt 3) 939-45",
                "id": "12225289"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "a p38 MAP kinase phosphorylation site (serine 401) were identified in the HBP1 protein. Furthermore, the docking and phosphorylation sites on HBP1 were specific for p38 MAP kinase",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Dec 23(23) 8890-901",
                "id": "14612426"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407069b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "human endostatin binding to alpha 5 beta 1 integrin leads to the inhibition of focal adhesion kinase/c-Raf/MEK1/2/p38/ERK1 mitogen-activated protein kinase pathway",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Apr 15 100(8) 4766-71",
                "id": "12682293"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070690"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Wy-L4,643 increases phosphorylation of ERK and p38",
              "citation": {
                "type": "PubMed",
                "name": "Thromb Haemost 2003 Oct 90(4) 611-9",
                "id": "14515181"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407068b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "...p38 MAPK alpha and beta are rapidly activated by insulin in both L6 myotubes and mature skeletal muscle...",
              "citation": {
                "type": "PubMed",
                "name": "Acta Physiol Scand 2003 Aug 178(4) 287-96",
                "id": "12864733"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407068a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Unexpectedly, in tumors induced by the K12D oncogene, the K-Ras mutant protein does not interact with Raf-1 nor activates the Erk canonical pathway. Instead, it transduces signals through the PI3K/Akt, JNK, p38 and FAK pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2006 Nov 27(11) 2190-200",
                "id": "16679305"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070689"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The association between HBP1 and p38 MAPK was initially defined by a two-hybrid interaction. Like the p21 results, the apparent mechanism was that p38 MAPK-mediated phosphorylation of the HBP1 led to increased protein stability and a G1 arrest.",
              "citation": {
                "type": "PubMed",
                "name": "Gene 2004 Jul 7 336(1) 1-13",
                "id": "15225871"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070684"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Thus, we conclude that RELT does not rely on the canonical TRAF pathways for its function, but instead uses a kinase, SPAK, to mediate p38 and JNK activation  RELT = TNFRSF19L SPAK = STK39",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 Apr 28 343(1) 125-34",
                "id": "16530727"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070679"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jun 6 278(23) 20593-602",
                "id": "12663665"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070676"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "S100A8/A9 complexes, as well as S100A9 homodimers, stimulated the production of proinflammatory cytokines, such as tumor necrosis factor alpha, by purified monocytes and in vitro-differentiated macrophages.",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Res Ther 2006 Apr 13 8(3) R69",
                "id": "16613612"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407066b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Insulin-induced VEGF expression requires p38 MAPK and PI 3-kinase, whereas hyperglycemia-induced VEGF expression is HIF-1alpha-independent and requires PKC and p42/p44 MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2002 Mar 109(6) 805-15",
                "id": "11901189"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070669"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Treatment with palmitate rapidly induced the association of myeloid differentiation factor 88 (MyD88) with the TLR2 receptor, activated the stress-linked kinases p38, JNK, and protein kinase C, induced degradation of IkappaBalpha, and increased NF-kappaB DNA binding...TLR2 mediates the initial events of fatty acid-induced insulin resistance in muscle",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Sep 15 281(37) 26865-75",
                "id": "16798732"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070663"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Furthermore, anisomycin, a potent stimulus of SAPK and p38 MAP kinase, also induced MKP-1 mRNA expression.",
              "citation": {
                "type": "PubMed",
                "name": "Hypertension 1998 Oct 32(4) 661-7",
                "id": "9774360"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070661"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Over-expression of Hsp105alpha enhanced hydrogen peroxide-induced apoptosis by enhancing the activation of caspase-3, poly(ADP-ribose)polymerase cleavage, cytochrome c release and activation of p38 mitogen-activated protein kinase (p38).",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2002 Aug 269(16) 4143-51",
                "id": "12180991"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070656"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Apr 1 61(7) 3084-91",
                "id": "11306491"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070654"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "S100-A9 binds the transcription factors NF-kB and P53, and activates the P38 and ERK MAPK kinases and the receptor for advanced glycated end products (RAGE) (50).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2008 May 38(5) 541-50",
                "id": "18079489"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070643"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "% We previously showed that MKP-7 suppresses MAPK activation in COS-7 cells in the order of selectivity, JNK >> p38 > ERK, but interacts with ERK as well as JNK and p38.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 22 278(34) 32448-56",
                "id": "12794087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070641"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1998 Jun 4 16(22) 2915-26",
                "id": "9671412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407063a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "beta 2 receptors can also couple to Gi proteins, resulting in stimulation of of the ERK and p38 MAPK pathways.  Activation of this pathway by the beta 2 receptor requires that the receptor be phosphorylated by PKA",
              "citation": {
                "type": "PubMed",
                "name": "J Allergy Clin Immunol 2006 Jan 117(1) 18-24; quiz 25",
                "id": "16387578"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070639"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Ectopic expression of PP2Cbeta-1 inhibited the TAK1-mediated mitogen-activated protein kinase kinase 4-c-Jun amino-terminal kinase and mitogen-activated protein kinase kinase 6-p38 signaling pathways.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 23 276(8) 5753-9",
                "id": "11104763"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070632"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "MEHP also induced phosphorylation of MAPK p38, while the p38 inhibitor SB 202190 reduced MEHP-induced TNF-alpha, suggesting a p38-dependent cytokine production.",
              "citation": {
                "type": "PubMed",
                "name": "Inhal Toxicol 2010 Feb 22(2) 140-50",
                "id": "19938896"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407062e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Furthermore, we demonstrate that anisomycin- and tumor necrosis factor-alpha-induced phosphorylation of p53 at Ser-392, which is important for the transcriptional activity of this growth suppressor protein, requires p38 MAP kinase and CK2 activities.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jun 2 275(22) 16569-73",
                "id": "10747897"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070628"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "We also show that p38 mitogen-activated protein kinase is activated within 10 min of DA treatment, which precedes the onset of apoptosis because the potent p38 kinase inhibitor SB203580 protects against DA-induced cell death as well as against caspase-9 and caspase-3 activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2001 Jul 78(2) 374-83",
                "id": "11461973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070623"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of brain",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Here, we have shown that MKK7, but not SEK1/ MKK4, is activated by Fas as an activator for JNK/ SAPK and that MKK6 is a major activator for p38 in Fas signaling",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 1997 Nov 17 139(4) 1005-15",
                "id": "9362518"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070621"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Immunology 2002 May 106(1) 38-45",
                "id": "11972630"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407061f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Immunol 2001 Nov 31(11) 3218-27",
                "id": "11745338"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407061d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "MAPK-activated protein kinase 2 (MAPKAPK2), one of several kinases directly phosphorylated and activated by p38 MAPK, plays a central role in the inflammatory response.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 4 277(40) 37401-5",
                "id": "12171911"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070611"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In this study, we identify, by using mass spectrometry techniques and specific anti-phosphopeptide antibodies, Ser(87) and Thr(56) as the Bcl-2 residues phosphorylated by p38 MAPK and show that phosphorylation of these residues is always associated with a decrease in the antiapoptotic potential of Bcl-2 protein.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Jul 28 281(30) 21353-61",
                "id": "16714293"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070610"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "LPS-induced IL-8 production also depends on CS-induced phosphorylation and activation of ERK-1, ERK-2 and P38MAPK. CS has been found to have a profound modulatory effect on ERK-1 and ERK-2. Both basal and LPS induced phosphorylation of ERK-2 was higher in AM from healthy smokers than those from non-smokers. CS has been shown to enhance mitogenactivated protein-kinase activation more than NF-kB activation to increase LPS-induced IL-8 production in AM [76].",
              "citation": {
                "type": "PubMed",
                "name": "Exp Lung Res 2009 Aug 35(6) 439-85",
                "id": "19842832"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407060e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1997 Mar 20 386(6622) 296-9",
                "id": "9069290"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407060c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jun 22(11) 3892-904",
                "id": "11997522"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070608"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Recent in vitro studies by Saccani and colleagues (12) showed that specific phosphorylation of H3 at serine 10, indirectly resulting from activation of p38 mitogen-activated protein kinase (MAPK),",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2004 Dec 31(6) 633-42",
                "id": "15333327"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070607"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Haematologica 2004 May 89(5) 578-85",
                "id": "15136221"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070602"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "The vegf gene encodes a multifunctional cytokine that is crucial in angiogenesis during the development of cancer and activates p38 Kinase, which in turn, mediates actin reorganization and cell migration in human endothelial cells. p38 may thus also be an important regulator of angiogenesis [70]. ",
              "citation": {
                "type": "PubMed",
                "name": "Curr Genomics 2007 Sep 8(6) 379-97",
                "id": "19412438"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of gastrointestinal tract",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2000 Sep 1 96(5) 1844-52",
                "id": "10961885"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705d3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2003 Jul 2 23(13) 5877-86",
                "id": "12843292"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705d2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Feb 15 162(4) 2087-94",
                "id": "9973482"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705c8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Inhibition of AR also attenuated the increase in p38 mitogen-activated protein kinase and c-Jun N-terminal kinase phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2003 Feb 17(2) 315-7",
                "id": "12490536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Chemical p38 inhibitors and a dominant negative allele of p38 decrease fat cell differentiation, and overexpression of constitutively active MKK6, an activator of p38, enhance the process.35,36",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2002 Dec 979 143-58; discussion 188-96",
                "id": "12543724"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705bb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Thus, Fer is required for maximal p38 kinase activation to promote the chemotaxis of activated mast cells.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Sep 22(18) 6363-74",
                "id": "12192036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705b4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Here we demonstrate that cAMP- and protein kinase A-dependent activation of p38 mitogen-activated protein kinase (MAPK) in brown adipocytes is an indispensable step in the transcription of the UCP1 gene in mice.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Apr 24(7) 3057-67",
                "id": "15024092"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705b1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "stimulation ofalpha(2)-adrenoceptor by their agonists triggered the activation of the p38 mitogen-activated protein kinase (MAPK) signaling pathway",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Pharmacol 2003 Apr 25 467(1-3) 223-31",
                "id": "12706479"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705b0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "these statements are all true for murine cells as well",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2001 May 3 411(6833) 102-7",
                "id": "11333986"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705af"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Substitution of either YY239/240 or Y317 also results in a defective activation of Rac and the coupled stress kinases JNK and p38. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Mar 24 24(13) 2218-28",
                "id": "15688026"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705ae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Thus, both p38 and SAPK/Jun N-terminal kinase mitogen-activated protein kinases (MAPKs) are activated on stimulation of these cells with either T- or M-tropic gp120, as well as with SDF-1alpha or MIP-1beta.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2001 Aug 1 98(3) 541-7",
                "id": "11468147"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705aa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Active mutants of p38alpha induced AP-1-driven reporter genes, as well as the c-jun and c-fos promoters. An active variant of p38gamma suppressed AP-1-mediated transcription",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jan 5 282(1) 91-9",
                "id": "17088247"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705a8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "p38 MAPK has been associated with reduced GR function",
              "citation": {
                "type": "PubMed",
                "name": "Mol Psychiatry 2004 9(1) 65-75",
                "id": "14699442"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407059b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Exposure of cells to alpha2M* (50 pM) induced phosphatidylinositol 3-kinase-dependent activation of Akt by phosphorylation at Thr-308 and Ser-473 with a concomitant 60-80% increase in Akt-associated kinase activity. ERK1/2 and p38 MAPK were also activated",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 May 12 281(19) 13694-707",
                "id": "16543232"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070593"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Prostatic Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 13 277(50) 48764-70",
                "id": "12351630"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070590"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Thrombin induced the phosphorylation of HSP27 and the phosphorylation was suppressed by SB-203580. These results indicate that thrombin stimulates not only the dissociation of HSP27 but also the induction of HSP27 via p38 MAPK activation in aortic smooth muscle cells.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2002 Sep 283(3) H941-8",
                "id": "12181122"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407058f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Treatment of cortical neurons with sodium arsenite activated p38 and JNK3 but not JNK1 or JNK2",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2000 Sep 1 20(17) 6442-51",
                "id": "10964950"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407058c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Nov 3 275(44) 34424-32",
                "id": "10896679"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407056f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In the absence of p38 activity, EGF fails to stimulate the ubiquitin ligase Cbl or ubiquitinylation of EGFR, and internalized EGFR accumulates in intracellular vesicles containing caveolin-1. These effects are accompanied by loss of EGFR phosphorylation on Y1045, a phosphorylation site required for Cbl activation.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Dec 13 25(24) 5683-92",
                "id": "17139251"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070556"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "In both dietary and genetically (ob/ob) obese mice, adipose tissues displayed a marked decrease in p38MAPK activity compared with the same tissues from lean mice.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2006 Feb 55(2) 281-9",
                "id": "16443758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407054a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Treatment with the p38 MAPK inhibitor, SB202190, decreased interleukin-1beta stimulated MAPKAP-K2 activity, GIIa PLA(2) mRNA expression, GIIa PLA(2) protein synthesis, and the release of extracellular PLA(2) activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 23 276(47) 43842-9",
                "id": "11571275"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407053c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Mar 26 279(13) 12300-11",
                "id": "14711826"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070539"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "CREB-1 expression is dramatically up-regulated during macrophage differentiation and phosphorylation of CREB-1 and the related factor CREM-1 are stimulated by M-CSF in a SAPK2/p38-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 23 279(17) 17772-84",
                "id": "14754893"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070535"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2004 Feb 198(2) 310-23",
                "id": "14603533"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070534"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "aldosterone induces CTGF expression via both p38 MAPK cascade and mineralocorticoid receptor and that cross-talk exists between the two pathways",
              "citation": {
                "type": "PubMed",
                "name": "J Korean Med Sci 2004 Dec 19(6) 805-11",
                "id": "15608389"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070531"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Surprisingly, SB203580, an inhibitor of p38 MAPK, and PD98059, an inhibitor of mitogen-activated protein kinase kinase (MEK1), strongly enhanced hypoxia-induced HO-1 mRNA expression in PAEC.",
              "citation": {
                "type": "PubMed",
                "name": "Antioxid Redox Signal 2002 Aug 4(4) 587-92",
                "id": "12230870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407052a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Figure 1. Pathways to MUC5AC expression in COPD",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82",
                "id": "17615396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070524"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Apr 3 22(13) 2034-44",
                "id": "12673208"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407051e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "basal PAK6 kinase activity was repressed by a p38 mitogen-activated protein (MAP) kinase antagonist and could be strongly stimulated by constitutively active MAP kinase kinase 6 (MKK6), an upstream activator of p38 MAP kinases.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Feb 4 280(5) 3323-30",
                "id": "15550393"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070518"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "CD40 lacks intrinsic catalytic activity, but the cytoplasmic domain of CD40 has two binding sites for TRAF...TRAFs 1, 2, 3, 5, and 6 have been found in association with CD40, and these adaptors couple CD40 to the phosphoinositide 3-kinase (PI3K), phospholipase C (PLC-), mitogen-activated protein kinase (MAPK-ERK, p38, and JNK), and nuclear factor B (NF-B) signaling pathways",
              "citation": {
                "type": "PubMed",
                "name": "Sci STKE 2004 Jun 15 2004(237) pe25",
                "id": "15199223"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070516"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "An inhibition of p38 with PD169316 impairs the upregulation of involucrin mRNAs by a treatment with MbetaCD, but not by a p38delta-activating TPA treatment, which might suggest that cholesterol depletion alters involucrin gene expression through activation of p38alpha/beta.",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2004 Sep 123(3) 564-73",
                "id": "15304097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407050d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MAPK14) actsIn kin(p(HGNC:MAPK14))",
              "summary_text": "Calcimycin also activates p38 kinase and JNK2, which are not involved in calcium-induced apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2005 Sep 16(9) 4437-53",
                "id": "16000378"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070509"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:EGFR)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:EGFR))",
        "directed": false,
        "label": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526cd",
          "evidences": [
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "we pre-incubated NHBE cells with AG1478 (1 ?M) a specific inhibitor of phosphorylation in Tyr residues, or with cetuximab (10 ?g/mL), a monoclonal antibody raised against the ligand binding portion of EGFR, 60 min before each nicotine treatment. As shown in Fig. 4A and B, pre-incubation with either AG1478 or cetuximab prevented EGFR phosphorylation and filopodia extensions in primary human bronchial epithelial cells, showing that nicotine-induced filopodia protrusion was dependent on ligand binding and phosphorylation of EGFR.",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Appl Pharmacol 2008 May 1 228(3) 334-42",
                "id": "18262213"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070dae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The dimerization of two EGFR family molecules leads to phosphorylation of C-terminal tyrosine residues either by autophosphorylation or by a SRC-related kinase followed by binding of GRB2, a RAS adaptor protein, at the SH2 domain of the receptor; binding of the proline-rich C-terminus of SOS, a guanine nucleotide exchange factor, to the SH3 domain of the receptor; exchange of a GTP from the receptor complex for a GDP from the RAS protein to form activated RAS; activation of phosphatidylinositol-3-kinase (PI-3 kinase) to initiate signaling by the biochemical pathways that are triggered by diacylglycerol production and protein kinase C activation; and activation of the series of cytoplasmic serine and threonine kinases beginning with RAF to initiate signaling by the biochemical pathways that are triggered by members of the MAPK family (e.g. ERK 1 and 2). EGFR signaling also activates other pathways in the cell including the Janus kinase (JAK)/signal transduction activators of transcription (STAT) pathways [80, 81].",
              "citation": {
                "type": "PubMed",
                "name": "Curr Cancer Drug Targets 2004 Aug 4(5) 403-24",
                "id": "15320717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070da7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Macrophages in COPD. Macrophages may play a pivotal role in COPD as they are activated by cigarette smoke extract and secrete many inflammatory proteins that may orchestrate the inflammatory process in COPD. Neutrophils may be attracted by IL-8, GRO-{alpha}, LTB4, MCP-1, and CD8+ lymphocytes by IP-10, Mig, and I-TAC. Release of elastolytic enzymes including MMPs and cathepsins causes elastolysis and release of TGF-{beta}1 and CTGF. Release of TGF-{alpha} activates EGFR, which stimulates mucus hypersecretion. Macrophages also generate ROS and NO, which together form peroxynitrite and may contribute to steroid resistance.",
              "citation": {
                "type": "PubMed",
                "name": "Pharmacol Rev 2004 Dec 56(4) 515-48",
                "id": "15602009"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d67"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Finally, recent studies have shown that paclitaxel-resistant ovarian cancer cell lines show an abnormal increase of STAT3 activity and that the RNAi mediated downregulation of the transcription factor reduced paclitaxel resistance [77]. Importantly, a higher activation of STAT3 was correlated with a drugresistant profile of recurrent ovarian tumors Extending these results to lung cancers, it has been recently shown that STAT3 activity is downregulated by small molecule inhibitors of the epidermal growth factor (EGF) receptor such as gefitinib (Iressa) [79]. The EGF receptor STAT3 signaling pathway probably limits the efficiency of current chemotherapeutic treatments, and the inhibition of STAT3 is likely to be involved in the improved therapeutic effects of gefitinib.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2007 Jan 13(1) 4-11",
                "id": "17118707"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d22"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "wt BRCA1 also inhibited epidermal growth factor and insulin-like growth factor I-induced ERK and cell proliferation. Breast cancer growth factors such as epidermal growth factor (EGF) or insulin-like growth factor I (IGF-I) utilize similar signaling pathways to stimulate cell proliferation, which results from the activation of their membrane tyrosine kinase receptors (44, 52). Furthermore, membrane ER signaling to ERK in breast cancer results from cross talk to EGF receptor (EGFR) transactivation (8).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jul 24(13) 5900-13",
                "id": "15199145"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d17"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Previous studies have indicated a direct relationship between levels of p190 tyrosine phosphorylation, the extent and kinetics of epidermal growth factor (EGF)-induced actin rearrangements, and EGF-induced cell cycle progression, suggesting that p190 links Ras-mediated mitogenic signaling with signaling through the actin cytoskeleton. Phosphorylation of Y1105, but not the minor site, was modulated in vivo to a greater extent by overexpression of c-Src than by the EGF receptor and was efficiently catalyzed by c-Src in vitro, indicating that Y1105 is a selective and preferential target of c-Src both in vitro and in vivo. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1998 Dec 18(12) 7052-63",
                "id": "9819392"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cd9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "For these experiments, E19 type II epithelial cells were incubated with different recombinant EGFR ligands for 16 h. Samples were processed by Northern blot to analyse SP-B and SP-C mRNA expression. As shown in Fig. 1A, incubation with amphiregulin (AR), epiregulin (EPR) or betacellulin (BTC) did not change SP-B/SP-C gene expression when compared to vehicle samples. In contrast, the addition of HB-EGF or TGF-? clearly increased SP-B and SP-C mRNA expression. ",
              "citation": {
                "type": "PubMed",
                "name": "J Physiol 2009 Apr 15 587(Pt 8) 1739-53",
                "id": "19237431"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cd0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Alveolar type II cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "To determine the mechanisms linking MMP-12 and inflammation, we examined the effect of recombinant human MMP-12 (rhMMP-12) catalytic domain on IL-8/CXCL8 production in cultured human airway epithelial (A549) cells. Stimulation with rhMMP-12 resulted in a concentration-dependent IL-8/CXCL8 synthesis 6 h later.. rhMMP-12 induced transient, peaking at 5 min, activation of ERK1/2. Selective MEK inhibitors (U0126 and PD-98059) blocked both IL-8/CXCL8 release and ERK1/2 phosphorylation. IL-8/CXCL8 induction and ERK1/2 activation were preceded by EGF receptor (EGFR) tyrosine phosphorylation, within 2 min, and reduced by selective EGFR tyrosine kinase inhibitors (AG-1478 and PD168393) by a neutralizing EGFR antibody and by small interfering RNA oligonucleotides directed against EGFR, implicating EGFR activation.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2008 Jun 294(6) L1076-84",
                "id": "18390828"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "As expected, EGFR was highly phosphorylated upon EGF stimulation, whereas ErbB2 and ErbB3 were not phosphorylated (Fig. 10  A). When TE-8 cells were cultured in medium supplemented with 10% serum, protein-protein interactions between EGFR, ErbB2, and ErbB3 and between ErbB3 and p85, the regulatory subunit of PI3K, were clearly demonstrated (Fig.10  B). On the contrary, when cells were stimulated by 10 ng/ml EGF for 30 min in serum-free medium, protein-protein interactions among the ErbB family members or between p85 and the ErbB family members were not observed (Fig. 10  B and data not shown). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Oct 6 275(40) 30934-42",
                "id": "10908564"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c7a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of esophagus",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Epidermal growth factor (EGF) binding to its receptor causes rapid phosphorylation of the clathrin heavy chain at tyrosine 1477, which lies in a domain controlling clathrin assembly. EGF-mediated clathrin phosphorylation is followed by clathrin redistribution to the cell periphery and is the product of downstream activation of SRC kinase by EGF receptor (EGFR) signaling. In cells lacking SRC kinase, or cells treated with a specific SRC family kinase inhibitor, EGF stimulation of clathrin phosphorylation and redistribution does not occur, and EGF endocytosis is delayed.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1999 Mar 5 96(5) 677-87",
                "id": "10089883"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c1f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Treatment of the GRP78-underglycosylated EGFR complex with ATP resulted in a release of the underglycosylated EGFR from GRP78, indicating that the complex could be formed through the chaperone function of GRP78. In accordance with the complex formation with endoplasmic reticulum-resident GRP78, the underglycosylated EGFR could not be translocated to the cell surface. As a result, EGF could not induce expression of cyclin D3, a G1 cyclin, in the stressed cells, whereas it did in non-stressed cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 1998 Nov 177(2) 282-8",
                "id": "9766525"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bf4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "he interaction of cytohesin 2 and IPCEF1 in mammalian cells was demonstrated by immunoprecipitation. Immunofluorescence analysis revealed that IPCEF1 co-localizes with cytohesin 2 to the cytosol in unstimulated cells and translocates to the plasma membrane via binding to cytohesin 2 in epidermal growth factor-stimulated cells. The functional significance of the IPCEF1-cytohesin 2 interaction is demonstrated by showing that IPCEF1 increases the in vitro and in vivo stimulation of ARFGTP formation by cytohesin 2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 31 278(44) 43460-9",
                "id": "12920129"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bc7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "TNF-? enhances the expression of epidermal growth factor receptor (EGF-R), which co-localizes with MUC-5 AC protein [28]. Hegab et al. found that cigarette smoke induced the expression of EGF-R mRNA, as well as those of rCLCA1 and MUC5AC [18]. They also reported that a selective EGF-R tyrosine kinase inhibitor, AG- 1478, and a CLCA1 inhibitor, niflumic acid, blocked EGF-induced MUC5AC expression and mucus staining in the human airway epithelial cell line NCI-H292. These studies suggest that cigarette smoke activation of EGF-R signaling may be involved in CLCA1 expression and mucus overproduction.",
              "citation": {
                "type": "PubMed",
                "name": "Respir Res 2012 Jun 25 13(1) 55",
                "id": "22731784"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070baf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "respiratory epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "he interaction of cytohesin 2 and IPCEF1 in mammalian cells was demonstrated by immunoprecipitation. Immunofluorescence analysis revealed that IPCEF1 co-localizes with cytohesin 2 to the cytosol in unstimulated cells and translocates to the plasma membrane via binding to cytohesin 2 in epidermal growth factor-stimulated cells. The functional significance of the IPCEF1-cytohesin 2 interaction is demonstrated by showing that IPCEF1 increases the in vitro and in vivo stimulation of ARFGTP formation by cytohesin 2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 31 278(44) 43460-9",
                "id": "12920129"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b81"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Among microtubule proteins examined, MAP2 was the best substrate for the EGF receptor kinase. By contrast, src kinase favored phosphorylation of tubulin as compared to MAP2. The peptide mapping of MAP2 phosphorylated by the EGF receptor kinase and by the insulin receptor kinase produced very similar patterns of phosphopeptides, while that of MAP2 phosphorylated by the src kinase gave a distinctly different pattern. When the phosphorylation of the tubulin subunits was examined, the EGF receptor kinase preferred beta subunit to alpha subunit, but the src kinase phosphorylated both alpha and beta subunits to a similar extent. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1986 Nov 5 261(31) 14797-803",
                "id": "3771552"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b72"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "GRP induced Akt activation primarily through c-Src-mediated transactivation of EGFR. Transfection of dominant-negative c-Src abolished GRP-induced EGFR and Akt activation. GRP induced release of amphiregulin, and pre-incubation with human amphiregulin neutralizing antibody eliminated GRP-induced Akt phosphorylation. Pretreatment with phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 completely blocked GRP-initiated Akt phosphorylation. These results suggest that GRP stimulates Akt activation primarily via c-Src activation, followed by extracellular release of the EGFR ligand amphiregulin, leading to the activation of EGFR and PI3K.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2007 Apr 15 313(7) 1361-72",
                "id": "17349623"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b68"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b64"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "More recently, ERBB transactivation has been shown to involve other physiological ligands (FIG. 2). The binding of WNT to its seven-pass membrane receptor Frizzled (FZD) transactivates EGFR. The mechanism seems to be similar to that described for GPCRs, as it is rapid and blocked by metalloproteinase inhibitors; however, the target ligand has not been identified. WNT?FZD-mediated transactivation has been observed in normal mammary cells43 and in breast cancer cells (T. Schlange and N.E.H., unpublished observations). Oestradiol (E2) bindingto plasma-membrane-associated oestrogen receptor (ER) has also been shown to rapidly transactivate ERBBs. According to one report, E2-stimulated activation of MMP2 and MMP9 leads to the release of HB-EGF. Tamoxifen, a selective ER modifier (SERM) was shown to transactivate EGFR and ERBB2, and in ERBB2-overexpressing breast cancer cells this reduced the antiproliferative activity of the SERM",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2005 May 5(5) 341-54",
                "id": "15864276"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b5d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Angiotensin II (Ang II)-mediated signals are transmitted via heparin binding epidermal growth factor (EGF)-like growth factor (HB-EGF) release followed by transactivation of EGF receptor (EGFR). Although Ang II and HB-EGF induce angiogenesis, their link to the angiopoietin (Ang)-Tie2 system remains undefined. We tested the effects of Ang II on Ang1, Ang2, or Tie2 expression in cardiac microvascular endothelial cells expressing the Ang II receptors AT(1) and AT(2). Ang II significantly induced Ang2 mRNA accumulations without affecting Ang1 or Tie2 expression, which was inhibited by protein kinase C inhibitors and by intracellular Ca(2+) chelating agents. Ang II transactivated EGFR via AT(1), and inhibition of EGFR abolished the induction of Ang2. Ang II caused processing of pro-HB-EGF in a metalloproteinase-dependent manner to stimulate maturation and release of HB-EGF. Neutralizing anti-HB-EGF antibody blocked EGFR phosphorylation by Ang II. Ang II also upregulated vascular endothelial growth factor (VEGF) expression in an HB-EGF/EGFR-dependent manner. AT(2) inhibited AT(1)-mediated Ang2 expression and phosphorylation of EGFR. In an in vivo corneal assay, AT(1) induced angiogenesis in an HB-EGF-dependent manner and enhanced the angiogenic activity of VEGF. Although neither Ang2 nor Ang1 alone induced angiogenesis, soluble Tie2-Fc that binds to angiopoietins attenuated AT(1)-mediated angiogenesis. These findings suggested that (1) Ang II induces Ang2 and VEGF expression without affecting Ang1 or Tie2 and (2) AT(1) stimulates processing of pro-HB-EGF by metalloproteinases, and the released HB-EGF transactivates EGFR to induce angiogenesis via the combined effect of Ang2 and VEGF, whereas AT(2) attenuates them by blocking EGFR phosphorylation. Thus, Ang II is involved in the VEGF-Ang-Tie2 system via HB-EGF-mediated EGFR transactivation, and this link should be considerable in pathological conditions in which collateral blood flow is required.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2001 Jan 19 88(1) 22-9",
                "id": "11139469"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b5a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Table 1 Small molecule inhibitors of ErbB tyrosine kinases in clinical development EGFR IC50 HER2 IC50 HER4 IC50 Agent (umol/l) (umol/l) (umol/l) Reversible/irreversible Source Gefitinib (Iressa, ZD1839) 0.02 3.7 NR Reversible AstraZeneca Erlotinib (Tarceva, OSI-774) 0.02 3.5 NR Reversible Genentech/Roche EKB-569 0.038 1.2 NR Irreversible Wyeth-Ayerst TAK-165 NR 0.006 NR NR Takeda GW572016 0.011 0.009 NR Reversible GlaxoSmithKline PKI-166 0.02 0.1 NR Reversible Novartis AEE-788 0.002 0.006 0.16 Reversible Novartis CI-1033 0.0008 0.019 0.007 Irreversible Pfizer AEE-788 also inhibits KDR with a 50% inhibitory concentration (IC50) of 0.077 umol/l. NR, not reported. EGFR, epidermal growth factor receptor; HER, human epidermal growth factor receptor.",
              "citation": {
                "type": "PubMed",
                "name": "Breast Cancer Res 2004 6(5) 204-10",
                "id": "15318926"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ae7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Studies to date suggest that, in these cancers, several (if not all) of the critical downstream signaling pathways, including the phosphoinositide 3-kinase (PI3K)/Akt, signal transducers and activators of transcription, and extracellular signal-regulated kinase 1 and 2 pathways, are solely controlled by EGFR. Thus, when the tumors are exposed to EGFR inhibitors, these intracellular pathways are turned off and the cancer cells undergo apoptosis (21, 22, 24, 25).",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2008 May 15 14(10) 2895-9",
                "id": "18483355"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070aa2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Table E1. Differentially expressed genes from microarray analysis.  Statistical Analysis: For microarray data analysis, we used an approach that allowed us to estimate differential gene transcript expression using linear models (23). We used a 2 x 2 factorial model, with two factors representing the IL-13 and the anti-EGFR effects, and a two-way interaction term for the interaction of IL-13 and anti-EGFR. The interaction term was used to identify transcripts that had a different response to IL-13 when anti-EGFR was present than when anti-EGFR was not present. We calculated estimated log ratios, moderated t statistics, log odds ratios of differential expression, and P values for each contrast of interest using functions in the Bioconductor package limma (24). P values were adjusted for multiple testing using the Bonferroni correction.  [Took FC 1.5 (log2 1.5=.585) and P<0.05 -JP]",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Sep 15",
                "id": "16980555"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a84"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Treatment of mice with rapamycin 4 weeks after the induction of TGF-alpha prevented additional weight loss, increases in total collagen, and changes in pulmonary mechanics. Rapamycin prevented further increases in established pulmonary fibrosis induced by EGFR activation. This study demonstrates that mammalian target of rapamycin (mTOR) is a major effector of EGFR-induced pulmonary fibrosis, providing support for further studies to determine the role of mTOR in the pathogenesis and treatment of pulmonary fibrosis.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2009 Nov 41(5) 562-72",
                "id": "19244201"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a7a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The functional ramifications of EGFR/ERK1/2 signaling by asbestos include the initiation of cell cycling in a murine alveolar type II epithelial cell line (C10), suggesting that EGFR-initiated ERK1/2 signaling may play a role in aberrant proliferation induced by asbestos in lung epithelial cells in vitro and after inhalation (26, 27). [From primary paper: In both control and asbestos-exposed cells, the percentage of phosphorylated ERK-positive cells was greatest in cells in the G2/M and S phases of the cell cycle. All stimuli caused increased proportions of cells in G2/M at 24 h that were inhibited by PD98059 (30 M).]",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Jun 34(6) 666-9",
                "id": "16484683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a6d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Autocrine pathways were blocked with suramin, a general inhibitor of growth factor receptor binding, and resulted in more than a 10-fold increase in lysyl oxidase expression and proenzyme production. This regulation was found to be reversible and occurred at the transcriptional level determined using lysyl oxidase promoter/reporter gene assays. from NCI NCI04 A polysulphonated naphthylurea with potential antineoplastic activity. Suramin blocks the binding of various growth factors, including insulin-like growth factor I (IGF-I), epidermal growth factor (EGF), platelet-derived growth factor (PDGF), and tumor growth factor-beta (TGF-beta), to their receptors, thereby inhibiting endothelial cell proliferation and migration. This agent also inhibits vascular endothelial growth factor (VEGF)- and basic fibroblast growth factor (bFGF)-induced angiogenesis; retroviral reverse transcriptase; uncoupling of G-proteins from receptors; topoisomerases; cellular folate transport; and Steroidogenesis.(NCI04)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 15 278(33) 30781-7",
                "id": "12788924"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a4f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Cholesterol has been recently suggested to regulate the early steps of keratinocyte differentiation through lipid rafts. In many cell types, depletion of cholesterol activates signaling proteins like epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), or extracellular signal-regulated kinase (ERK) known to affect cell differentiation",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2004 Sep 123(3) 564-73",
                "id": "15304097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a2c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "show a good clinical response to EGFR TKIs such as gefitinib, but they almost invariably develop drug resistance after an average of 12 months5. A secondary mutation in exon 20 (T790M) is found in about half of patients with a primary mutation that have grown resistant after an initial response to EGFR TKIs68. More recently, a new secondary mutation (D761Y) was found in a brain metastasis of a lung cancer initially responsive to gefitinib9. So far, T790M and D761Y are the only acquired alterations identified in the EGFR associated with escape from TKI therapy.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2007 Jun 13(6) 675-677",
                "id": "17554333"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709fb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Prostaglandin E(2) (PGE(2)), a major product of cyclooxygenase enzymes, is implicated in colorectal carcinogenesis and has been shown to stimulate the growth of human colorectal carcinoma cells. Here, we show that PGE(2) activated the cyclic AMP/protein kinase A pathway, which induced the expression of amphiregulin (AR), an epidermal growth factor family member, through activation of a cyclic AMP-responsive element in the AR promoter. AR exerted a mitogenic effect on LS-174 cells and partially mediated the PGE(2)-induced growth stimulation. In addition, PGE(2), in collaboration with transforming growth factor-alpha or K-Ras oncogene, synergistically induced AR expression and activated receptor tyrosine kinase-dependent signaling pathways. Our results provide novel mechanisms for cyclooxygenase-2 pro-oncogenic activity and suggest that PGE(2) may act with major oncogenic pathways in a synergistic fashion to activate the epidermal growth factor receptor signaling system through a ligand-dependent autocrine pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Sep 1 63(17) 5218-23",
                "id": "14500348"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070987"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "An epidermal-growth-factor(EGF)-receptor preparation isolated by calmodulin-affinity chromatography from rat liver plasma membranes is able to phosphorylate calmodulin. Calmodulin phosphorylation was enhanced 3-8-fold by EGF, was dependent on the presence of a polycation or basic protein and was inhibited by micromolar concentrations of Ca2+. Phosphate incorporation into calmodulin occurs predominantly on tyrosine residues. Partial proteolysis of phosphocalmodulin by thrombin identifies Tyr99, located in the third calcium-binding domain of calmodulin, as the phosphorylated residue. ",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 1994 Sep 15 224(3) 909-16",
                "id": "7925415"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070983"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Treatment of the GRP78-underglycosylated EGFR complex with ATP resulted in a release of the underglycosylated EGFR from GRP78, indicating that the complex could be formed through the chaperone function of GRP78. In accordance with the complex formation with endoplasmic reticulum-resident GRP78, the underglycosylated EGFR could not be translocated to the cell surface. As a result, EGF could not induce expression of cyclin D3, a G1 cyclin, in the stressed cells, whereas it did in non-stressed cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 1998 Nov 177(2) 282-8",
                "id": "9766525"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407095a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The response to C5a was blocked by inhibitors of phosphatidylinositol-3-kinase, src kinase, and of the epidermal growth factor (EGF) receptor (EGFR) as well as by neutralizing Abs against the EGFR and heparin-binding EGF-like factor. Furthermore, immune precipitations showed that the EGFR was phosphorylated following stimulation with C5a. The C5aR in endothelial cells thus uses a signaling cascade-transactivation of the EGFR-that does not exist in leukocytes",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Aug 15 169(4) 2102-10",
                "id": "12165538"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Proper H(2)O to mucin ratio of airway mucus is important for mucociliary clearance. Recent studies suggest that decreased aquaporin 5 (AQP5) is correlated with increased staining of MUC5AC in submucosal glands of COPD patients. Lipopolysaccharide (LPS) is one of the major insults in airway mucin secretion in COPD. In this study, changes in both AQP5 and MUC5AC expression levels in SPC-A1, a human airway submucosal gland cell line, were quantified after exposure of the cells to LPS. AQP5 transcription and protein expression were decreased while MUC5AC expression was increased by LPS exposure in SPC-A1 cells. Further studies revealed that AQP5 expression was down-regulated via the p38/JNK signaling pathway, while MUC5AC was up-regulated through the EGFR-p38/JNK pathway. Therefore, p38 and JNK may become promising targets to preserve AQP5 expression and prevent MUC5AC over-expression to restore proper H(2)O to mucin ratio of the airway mucus, which may be beneficial to the clinical management of COPD patients.",
              "citation": {
                "type": "PubMed",
                "name": "Respir Physiol Neurobiol 2010 May 31 171(3) 212-7",
                "id": "20362698"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070884"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Chronic Obstructive Pulmonary Disease",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "E2-stimulated ERK required ER in breast cancer and endothelial cells and was substantially prevented by expression of a dominant negative EGFR or by tyrphostin AG1478, a specific inhibitor for EGFR tyrosine kinase activity. Transactivation/phosphorylation of EGFR by E2 was dependent on the rapid liberation of heparin-binding EGF (HB-EGF) from cultured MCF-7 cells and was blocked by antibodies to this ligand for EGFR. Expression of dominant negative mini-genes for Galpha(q) and Galpha(i) blocked E2-induced, EGFR-dependent ERK activation, and Gbetagamma also contributed. G protein activation led to activation of matrix metalloproteinases (MMP)-2 and -9. This resulted from Src-induced MMP activation, implicated using PP2 (Src family kinase inhibitor) or the expression of a dominant negative Src protein.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 24 278(4) 2701-12",
                "id": "12421825"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070816"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Here, we report that EGF-stimulation-induced Cbp tyrosine phosphorylation followed by Cbp-Csk association, in a SFK-dependent manner. Expression of wild-type (wt) Cbp remarkably suppressed EGF-induced activation of Src, ERK1/2, and Akt-1 enzymes, and NIH3T3 cell transformation, as well as colony formation of a breast cancer cell line (MDA-MB-468) in soft agar. In contrast, expression of CbpY317F or knockdown endogenous Cbp in NIH3T3 cells by RNA interference significantly enhanced EGF-induced activation of these enzymes and cell transformation. In addition, overexpression of multiple receptor tyrosine kinases (RTKs)-induced Cbp tyrosine phosphorylation. These results demonstrate that Cbp functions as a negative regulator of cell transformation and tumor cell growth through downregulation of Src activation, suggesting that Cbp might be broadly involved in RTKs-activated signaling pathways and tumorigenesis.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Sep 7 25(40) 5495-506",
                "id": "16636672"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707e8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Recently, we and others (8, 9) have identified a transmembrane phosphoprotein, known as Csk-binding protein (Cbp) or phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), which binds tightly to the SH2 domain of Csk. Cbp is located exclusively in so-called lipid rafts in which cholesterol, glycosphingolipid, and a variety of membrane-anchored signaling molecules including SFK accumulate. Lipid rafts are thus viewed as platforms for signaling across the membrane. The interaction of Cbp with Csk is also dependent upon the phosphorylation of its Tyr-314 by SFK (8-10). Based on these lines of evidence, a model of feedback regulation of SFK has been presented according to which activation of SFK by an extracellular stimulus leads to the phosphorylation of Cbp; this results in recruitment of Csk to lipid rafts and is followed by termination of SFK function (11-13).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Feb 13 279(7) 5975-83",
                "id": "14613929"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707c6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Furthermore, this up-regulation of COX-2 mRNA and protein was blocked by selective inhibitors of AP-1 and NF-kappaB, curcumin and helenalin, respectively. Moreover, thrombin-stimulated activation of NF-kappaB, AP-1, and COX-2 promoter activity was blocked by the inhibitors of c-Src, PKC, EGFR, MEK1/2, AP-1 and NF-kappaB, suggesting that thrombin induces COX-2 promoter activity mediated through PKC(delta)/c-Src-dependent EGFR transactivation, MEK-ERK1/2, AP-1, and NF-kappaB. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2008 Sep 1783(9) 1563-75",
                "id": "18452714"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707b1"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Activated Yes rapidly associated with the epidermal growth factor receptor (EGFR), which became phosphorylated at Tyr845 and Tyr1173 but not at Tyr1045. Activated EGFR then triggered an AG1478-sensitive CD95-tyrosine phosphorylation, which was a signal for membrane targeting of the EGFR/CD95 complex, subsequent recruitment of Fas-associated death domain and caspase 8, and apoptosis induction. All of these events were significantly blunted by inhibitors of sphingomyelinase, PKCzeta, NADPH oxidases, Yes, or EGFR-tyrosine kinase activity and after protein knockdown of either p47phox, Yes, or EGFR. The data suggest that CD95L-induced apoptosis involves a sphingomyelinase- and PKCzeta-dependent activation of NADPH oxidase isoforms, which is required for Yes/EGFR/CD95 interactions as upstream events of CD95 activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jul 22 280(29) 27179-94",
                "id": "15917250"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407076f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "We show that continuous expression of epidermal growth factor in hair follicles of transgenic mice arrested follicular development at the final stage of morphogenesis (catagen). Data from immunoprecipitation and immunoblotting showed that epidermal growth factor signals through EGFR/ErbB2 heterodimers in skin. Furthermore, topical application of tyrphostin AG1478 or AG825, specific inhibitors of EGFR and ErbB2, respectively, completely inhibited new hair growth in wild type mice but not in transgenic mice. When the transgenic mice were crossed with waved-2 mice, which possess a lower kinase activity of EGFR, the hair phenotype was rescued in the offspring. Taken together, these data suggest that EGFR signaling is indispensable for the initiation of hair growth (anagen phase). On the other hand, continuous expression of epidermal growth factor prevents entry into the catagen phase",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 11 278(28) 26120-6",
                "id": "12714603"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070753"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Table 1 Small molecule inhibitors of ErbB tyrosine kinases in clinical development EGFR IC50 HER2 IC50 HER4 IC50 Agent (umol/l) (umol/l) (umol/l) Reversible/irreversible Source Gefitinib (Iressa, ZD1839) 0.02 3.7 NR Reversible AstraZeneca Erlotinib (Tarceva, OSI-774) 0.02 3.5 NR Reversible Genentech/Roche EKB-569 0.038 1.2 NR Irreversible Wyeth-Ayerst TAK-165 NR 0.006 NR NR Takeda GW572016 0.011 0.009 NR Reversible GlaxoSmithKline PKI-166 0.02 0.1 NR Reversible Novartis AEE-788 0.002 0.006 0.16 Reversible Novartis CI-1033 0.0008 0.019 0.007 Irreversible Pfizer AEE-788 also inhibits KDR with a 50% inhibitory concentration (IC50) of 0.077 umol/l. NR, not reported. EGFR, epidermal growth factor receptor; HER, human epidermal growth factor receptor.",
              "citation": {
                "type": "PubMed",
                "name": "Breast Cancer Res 2004 6(5) 204-10",
                "id": "15318926"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407072c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Although it has been clearly established that negative feedback loops have a fundamental role in the regulation of epidermal growth factor receptor (EGFR) signalling in flies, their role in the regulation of mammalian EGFR has been inferred only recently from in vitro studies. Here, we report on the forced expression of RALT/MIG-6, a negative feedback regulator of ErbB receptors, in mouse skin. Conversely, knockdown of RALT by RNA interference enhanced ErbB mitogenic signalling. Thus, RALT behaves as a suppressor of EGFR signalling in mouse skin.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO Rep 2005 Aug 6(8) 755-61",
                "id": "16007071"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407070e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "To explore this further, we have blocked endogenous ErbB3 transcription, thereby engineering tumor cells with overexpressed, fully active ErbB2 but lacking ErbB3 (T. Holbro and N.E. Hynes, unpublished data). As a consequence, these cells have decreased PI-3K/PKB signaling, a reduction in D-type cyclin levels, and show an increase in the G1 phase of the cell cycle. A main effector of ErbB signaling, the PI-3K/PKB pathway, is particularly important in mediating cell survival 103 T. Holbro et al. / Experimental Cell Research 284 (2003) 99-110 since several PKB substrates directly control various apoptotic processes. The proapoptotic Bcl family member Bad, when phosphorylated by PKB [93], is retained in the cytosol where it is unable to inhibit survival proteins like Bcl-XL on the mitochondria [94]. In normal mammary cells, blocking ErbB1 activity leads to apoptosis by lowering phospho-Bad levels, [95], a characteristic that would be extremely desirable to retain in cancer cells. Another PKB target is caspase-9, whose activation is blocked by phosphorylation [96] Members of the forkhead family of transcription factors, when phosphorylated by PKB, are retained in the cytoplasm and are unable to stimulate expression of several critical genes for apoptosis, including FasL, BIM, and others (reviewed by Brunet et al. [97]). Moreover, PKB phosphorylates IKK-alpha, which in turn inactivates IkappaB, thus leading to activation of NF-kappaB. This transcription factor upregulates levels of the prosurvival Bcl-XL protein and several inhibitors of apoptosis (IAPs) (reviewed by Datta et al. [98]). In this regard, it has been reported that cell lines overexpressing ErbB2 are resistant to TNF-induced apoptosis through a PKB/NF-B pathway [99]. Another ErbB effector protein, signal transducer, and activator of transcription (Stat) has been implicated in survival of squamous cell carcinomas of the head and neck. ErbB1, activated as a result of autocrine TGF-alpha expression in tumor cells, constitutively activates Stat3 [100]. Blocking Stat3 in vivo is associated with decreased level of the antiapoptotic Bcl-XL and increased tumor cell death [101].",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2003 Mar 10 284(1) 99-110",
                "id": "12648469"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070704"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "squamous cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Western blot analysis showed that the primary antibodies used were specific for their epitopes. We found that VEGF, FGF-2, EGF and their receptors were all expressed, especially in and/or around blood vessels, thus supporting the hypothesis that these peptides contribute to the regulation of angiogenesis and blood vessel function in the human endometrium. The receptors VEGFR-1, VEGFR-2, FGFR-2 and EGFR were co-expressed and exhibited their strongest expression during the beginning of the secretory phase, coinciding with the developing endometrial oedema and formation of a complex subepithelial capillary plexus.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Hum Reprod 2001 Jan 7(1) 65-72",
                "id": "11134362"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "A class of high-affinity inhibitors is disclosed that selectively target and irreversibly inactivate the epidermal growth factor receptor tyrosine kinase through specific, covalent modification of a cysteine residue present in the ATP binding pocket. ..Evidence is also presented to indicate that the compounds interact in an analogous fashion with erbB2 but have no activity against the other receptor tyrosine kinases or intracellular tyrosine kinases that were tested in this study. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1998 Sep 29 95(20) 12022-7",
                "id": "9751783"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070626"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The GnRHR is also expressed in non-pituitary cells and was found to be involved in the inhibition of cell proliferation in certain cells. Therefore, GnRHR represents a potential target for GnRH-analogs used for cancer treatment. Interestingly, the signaling mechanism of the GnRHR in other cell types significantly differs from that in pituitary cells. Studies conducted in GnRHR-expressing COS7 cells have shown that GnRHR transmits its signals mainly via Gi, EGF receptor, c-Src, and is not dependent on PKC.",
              "citation": {
                "type": "PubMed",
                "name": "Arch Med Res 32(6) 499-509",
                "id": "11750725"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705ba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The receptors for insulin, plateletderived growth factor (PDGF), epidermal growth factor (EGF), and vascular endothelial growth factor (VEGF) are optimally activated by their ligands only under appropriate cell attachment conditions (24-28). Although a systematic analysis has not been conducted, certain integrins appear to be preferentially associated with specific growth factor receptors. Thus, the avb3 integrin can be immunoprecipitated in complexes with the insulin, PDGF, and VEGF receptors (26, 28), whereas a5b1 and perhaps other b1 integrins associate with the EGF receptor (25, 27).",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Aug 13 285(5430) 1028-32",
                "id": "10446041"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070581"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "From Fig. 4: Using the same time and dose strategies as before, a mean 6.2-fold induction of PLC{gamma} phosphorylation was observed following radiation treatment (Fig. 4). Increases in phosphorylation of Shc family members were observed following irradiation; the mean -fold changes (n = 3) were 2.3, 3.0, and 3.5 for the 66-, 52-, and 46-kDa isoforms, respectively. For both PLC{gamma} and Shc, EGF at 10 ng/ml induced a significantly greater increase in phosphorylation than IR (p < 0.05). Pretreatment of cells with 500 nM AG1478, a specific inhibitor of EGFR Tyr phosphorylation (29), abolished the radiation- and EGF-induced activation of both PLC{gamma} and Shc in A431 cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 15 280(15) 14597-604",
                "id": "15708852"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407055e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The relationship between NOX-mediated oxidant signaling and tyrosine phosphorylation was first indicated by pioneering studies by Finkel and Rhee and their co-workers (39,40), who demonstrated that the activation of receptor tyrosine kinases by growth factors, such as epidermal growth factor (EGF) or platelet-derived growth factor (PDGF), is associated with transient and regulated cellular production of H2O2, which amplifies tyrosine kinase signaling by temporally inactivating a protein tyrosine phosphatase (PTP).",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2008 Mar 15 44(6) 938-55",
                "id": "18164271"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070554"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Here, we describe that COX-2 induction is dependent on PKCalpha/c-Src/EGFR, PDGFR/PI3K/Akt/NF-kappaB signaling in HTSMCs. CSE stimulated the phosphorylation of c-Src, EGFR, PDGFR, and Akt, which were inhibited by pretreatment with the inhibitor of PKCalpha (G?6976 or G?6983), c-Src (PP1), EGFR (AG1478), PDGFR (AG1296), or PI3K (LY294002). Moreover, CSE induced a significant increase in COX-2 expression, which was reduced by pretreatment with these inhibitors or transfection with siRNA of PKCalpha, Src, or Akt. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2009 Nov 297(5) L892-902",
                "id": "19717552"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070552"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "down-regulation of GAK by small hairpin RNA has two pronounced effects on EGF receptor signaling: (i) the levels of receptor expression and tyrosine kinase activity go up by >50-fold; and (ii) the spectrum of downstream signaling is significantly changed. One very obvious result is a large increase in the levels of activated extracellular signal-regulated kinase 5 and Akt. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Jul 13 101(28) 10296-301",
                "id": "15240878"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d31"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Here, we describe a previously unrecognized pathway for the PH domain-dependent membrane recruitment of Sos that is initiated by the growth factor-induced generation of phosphatidic acid via the signalling enzyme phospholipase D2 (PLD2). Phosphatidic acid interacts with a defined site in the Sos PH domain with high affinity and specificity. This interaction is essential for epidermal growth factor (EGF)-induced Sos membrane recruitment and Ras activation. ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2007 Jun 9(6) 706-12",
                "id": "17486115"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c1e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "In this study, we describe the specific interaction of PAK1 with the Grb2 adapter protein both in vitro and in vivo. We identify the site of this interaction as the second proline-rich SH3 binding domain of PAK1. Stimulation of the epidermal growth factor receptor (EGFR) in HaCaT cells enhances the level of EGFR-associated PAK1 and Grb2, although the PAK1-Grb2 association is itself independent of this stimulation. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Mar 14 278(11) 9388-93",
                "id": "12522133"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a7d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Using this system, we could show that EphB4 activation leads to the inhibition of cell migration. Furthermore we identified PP2, a known inhibitor of kinases of the Src family, and PD 153035, a known inhibitor of EGF receptor kinase, as inhibitors of EphB4 kinase activity. Using PP2, the inhibition of cell migration by ephrinB2 could be relieved, demonstrating that the kinase function of EphB4 is of prominent importance in this process.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Jan 2 313(1) 80-8",
                "id": "14672701"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The ErbB family of four receptor tyrosine kinases occupies a central role in a wide variety of biological processes from neuronal development to breast cancer. New information continues to expand their biologic significance and to unravel the molecular mechanisms that underlie the signaling capacity of these receptors. Here, we review several aspects of ErbB receptor physiology for which new and significant information is available.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Cell Biol 2006 Dec 16(12) 649-56",
                "id": "17085050"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070596"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "To determine the requirement of EGFR tyrosine kinase activity for DNA synthesis, we employed AG-1478, a specific EGFR tyrosine kinase inhibitor. AG-1478 inhibited EGF-induced DNA synthesis in a dose-dependent manner with half-maximal inhibitory concentration of 70 nM (Fig. 1B). # from full text",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Renal Physiol 2005 Jul 289(1) F72-82",
                "id": "15701816"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d8b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "DCA (50 microM) rapidly stimulated phosphorylation of the epidermal growth factor receptor (EGFr) and both ERK and p38 MAPKs (mitogen-activated protein kinases). The EGFr inhibitor, AG1478, and the protein synthesis inhibitor, cycloheximide, reversed the antisecretory effects of DCA, while the MAPK inhibitors, PD98059 and SB203580, did not.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Mol Med 2009 Aug 13(8B) 2293-303",
                "id": "19583809"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d69"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "colon epithelium",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "In an airway epithelial cell line (NCI-H292), TNF-alpha-converting enzyme (TACE) small interfering RNA (siRNA) was used to confirm that TACE is the MP involved in TLR (2,3,5,6)-ligand-induced IL-8 and VEGF production. We show that transforming growth factor (TGF)-alpha is the EGFR ligand in this signaling cascade by using TGF-alpha neutralizing antibody and by showing that epithelial production of TGF-alpha occurs in response to TLR ligands. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2008 Jun 294(6) L1068-75",
                "id": "18375743"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d52"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Blocking phosphatidylinositol trisphosphate kinase (PI3K) or alternatively, EGF-R of suspension cells, induces apoptosis. Inversely, if integrins are cross-linked, proliferation is maintained (Adams and Watt, 1989; Watt et al., 1993; Rodeck et al., 1997; Nikolopoulos et al., 2005).",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2008 Mar 128(3) 501-16",
                "id": "18268536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ccd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "However, EGFR inhibitor, AG1478, treatment significantly induced the redistribution of ZO-1 protein to the sites of cell-cell junction and the cell aggregation, as well as simultaneous suppression of EGFR activation in both the dissociated and the non-dissociated pancreatic cancer cells.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Oncol 2005 Sep 27(3) 645-51",
                "id": "16077912"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cb2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Here we show that in human airway epithelial cells HNE increases TGF-alpha release, EGFR phosphorylation, and MUC5AC mucin expression, effects that were attenuated by TACE inhibitor TAPI-1 and by specific knockdown of TACE expression with small interfering RNA, implicating TACE in HNE-induced responses.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Sep 15 175(6) 4009-16",
                "id": "16148149"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ca4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "we looked at EGFR phosphorylation in response to fMLP in cells pre-treated by the TrkA inhibitor (Fig. 5C) and TrkA phosphorylation in response to fMLP in cells pre-treated by the EGFR inhibitor (Fig. 5D). In both cases, fMLP-induced receptor heterologous phosphorylation was decreased.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2010 Oct 22(10) 1437-47",
                "id": "20566383"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ca1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "observations that inhibition of PI3K or EGF-R is sufficient to prevent terminal differentiation in keratinocytes in suspension (Rodeck et al., 1997; Nikolopoulos et al., 2005), and that function disrupting antibodies to E-cadherin abrogate Akt phosphorylation inducing growth arrest and terminal differentiation in conventional submerged mouse keratinocyte cultures at confluency (Calautti et al., 2005).",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2008 Mar 128(3) 501-16",
                "id": "18268536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c9f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The regulation of protein biosynthesis and of eukaryotic initiation factor eIF2B was studied in PC12 cells. An increase in protein biosynthesis was observed after nerve growth factor (NGF) and epidermal growth factor (EGF) treatment of PC12 cells, and this increase coincided with activation of eIF2B.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Mar 6 273(10) 5536-41",
                "id": "9488678"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c9d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Furthermore, when EGF receptor signalling was evaluated, by examination of mRNA expression for several EGF-responsive genes (EGF receptor, EGR-1, Fos and Jun), it was observed that induced expression of REPS2 exerts an inhibiting effect on this signalling.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2005 Feb 10 113(4) 561-7",
                "id": "15455380"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bc6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "We show that cigarette smoke activates metalloprotease TACE, cleaving pro-TGF-, leading to shedding of soluble TGF-, resulting in EGFR hosphorylation and mucin overproduction in NCI-H292 cells. The study suggests that oxygen free radicals are responsible for the activation of TACE by cigarette smoke.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2004 Aug 287(2) L420-7",
                "id": "15121636"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b32"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Chronic Obstructive Pulmonary Disease",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The effects of hCG were reduced by inhibitors of protein kinase A, MAPK kinase, or p38 kinase, indicating that Runx1 expression is regulated by the LH-initiated activation of these signaling mediators. In addition, hCG-induced Runx1 mRNA expression was inhibited by a progesterone receptor antagonist and an epidermal growth factor receptor tyrosine kinase inhibitor, whereas amphiregulin stimulated Runx1 mRNA expression",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2006 Sep 20(9) 2156-72",
                "id": "16675540"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a1d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Furthermore, although epiregulin stimulated tyrosine phosphorylation of all four ErbB receptors, the main intracellular signal was mediated by ErbB-4 and/or EGFR. The pattern of activation of ErbB family receptors was different from that of other EGF-related ligands. Our findings indicate that ErbB-4 and EGFR are receptors for epiregulin, and suggest that EGF-related ligands transduce signals for different biological responses by the hierarchical mechanism.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1997 Dec 4 15(23) 2841-8",
                "id": "9419975"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709f6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "activated neutrophils secrete TNF, which induces EGFR expression in airway epithelial cells, activated neutrophils release reactive oxygen species, which activate EGFR , neutrophil elastase cleaves the EGFR proligand, pro-transforming growth factor (TGF)-alpha, releasing mature TGF alpha which activates EGFR in a ligand-dependent fashion , neutrophil elastase causes potent goblet cell degranulation ",
              "citation": {
                "type": "PubMed",
                "name": "Treat Respir Med 2004 3(3) 147-59",
                "id": "15219174"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709e5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Goblet Cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "This is taken from supplemental table 2 from PMID 15951569 Cut-offs were 2.25 for increase and 0.5 for decrease LLID were found by converting from GI assession numbers in DAVID Spreadsheet is saved in the project folder for Cell Signaling Project # bduckworth",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Proteomics 2005 Sep 4(9) 1240-50",
                "id": "15951569"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "ErbB4-stimulated COX-2 induction was associated with an increase in mRNA half-life and was blocked by inhibition of Src, phosphatidylinositol (PI) 3-kinase, or epidermal growth factor receptor (EGFR). Furthermore, ErbB4 expression promoted EGFR phosphorylation in the presence of heregulin, implicating ErbB4-EGFR heterodimerization in these responses.",
              "citation": {
                "type": "PubMed",
                "name": "Lab Invest 2010 Oct 90(10) 1415-24",
                "id": "20585313"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709cb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "colon epithelium",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Reactive oxygen species can activate the epidermal growth factor receptor to promote mucus secretion and this is one of the potential mechanisms by which an increase in reactive oxygen species could lead to a worsening of an acute exacerbation. ",
              "citation": {
                "type": "PubMed",
                "name": "BMC Pulm Med 2004 Dec 6 4 13",
                "id": "15581425"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709c6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Chronic Obstructive Pulmonary Disease",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "PK1 induced a time-dependent increase in expression of IL-8 and COX-2, which was significantly reduced by inhibitors of Gq, cSrc, epidermal growth factor receptor (EGFR), and MAPK kinase. Treatment of third-trimester placenta with 40 nm PK1 induced a rapid phosphorylation of cSrc, EGFR, and ERK1/2. Phosphorylation of ERK1/2 in response to PK1 was dependent on sequential phosphorylation of cSrc and EGFR.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2008 Jul 149(7) 3470-7",
                "id": "18372330"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "TGF-alpha (0.17 nM) irreversibly inhibited ClC-2 current in nystatin-perforated whole cell patch-clamp experiments, whereas a superimposed reversible activation of the current was observed at 8.3 nM TGF-alpha. Both effects required activation of the intrinsic epidermal growth factor receptor (EGFR) tyrosine kinase activity, of phosphoinositide 3-kinase, and of protein kinase C. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2001 Jun 280(6) C1588-98",
                "id": "11350754"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070995"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "HGF also induced EGFR tyrosine phosphorylation. CONCLUSIONS: EGFR modulates HGF/c-Met activity by inducing c-Met ectodomain shedding, and HGF/c-Met transactivates EGFR, leading to an enhanced activation of downstream signaling pathways. Cross talk between EGFR and c-Met may play a key role in regulating RPE cell migration, proliferation, and wound healing.",
              "citation": {
                "type": "PubMed",
                "name": "Invest Ophthalmol Vis Sci 2007 May 48(5) 2242-8",
                "id": "17460286"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070984"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "We show that treatment of A431 cells with 10 nM EGF induced a 15-fold increase in EGF-R autophosphorylation, leading to inhibition of cell proliferation and morphological features of apoptosis. However, at a lower concentration of EGF (0.01 nM), there is a 2-fold increase in EGF-R autophosphorylation and increased cell proliferation when compared to untreated cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1996 Feb 7(2) 173-8",
                "id": "8822200"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070854"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Additionally, KLF6 inhibits cellular transformation induced by several oncogenes (c-sis/PDGF-B, v-src, H-Ras, and EGFR) that are components of signaling cascades implicated in GBM.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Jun 24 23(29) 5077-83",
                "id": "15064720"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070803"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Constitutive activation of STAT3 has been shown in human cancers and transformed cell lines. We report that STAT3, but not STAT1 and STAT5, becomes phosphorylated in response to epidermal growth factor (EGF) and achieves maximal induction of collagenase-1 (MMP-1) transcription by interacting with c-JUN",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Feb 23 25(8) 1195-204",
                "id": "16205632"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707f5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Using anti-phosphotyrosine antibodies for immunoprecipitation and one-dimensional gel electrophoresis, we have identified 10 proteins in the epidermal growth factor receptor signaling pathway, of which 8 have been shown previously to be involved in epidermal growth factor signaling. Most importantly, in addition to several known tyrosine phosphorylation sites, we have identified five novel sites on SHIP-2, Hrs, Cbl, STAM, and STAM2, most of which were not predicted to be phosphorylated.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jan 11 277(2) 1031-9",
                "id": "11687594"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070773"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "To address this, we reduced endogenous AIB1 levels using RNA interference in lung, breast, and pancreatic cancer cell lines. We found that a knockdown of AIB1 levels resulted in a loss of the growth response of these cell lines to EGF. Further analysis revealed that the depletion of AIB1 reduced tyrosine phosphorylation of EGFR at multiple residues both at autophosphorylation and Src kinase phosphorylation sites.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2007 Aug 1 67(15) 7256-65",
                "id": "17671194"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706ca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "We postulated that phosphorylation could provide the stimulus for caveolae assembly. To this end, we transfected cells with mutant forms of Cav1 that could not be phosphorylated (Cav1Y14F) and tested if this altered protein reduced the number of EGF-induced caveolae. We observed that EGF-stimulated PANC-1 cells expressing the mutant Cav1Y14F protein exhibited a 90-95% reduction in caveolae number compared with cells expressing wild type Cav1. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Feb 24 281(8) 4570-9",
                "id": "16332692"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407064c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Transactivation of EGFR is a major mechanism by which ANG II influences growth-related signaling pathways. ANG II-mediated EGFR activation occurs in the cholesterol-rich domains of caveolae in a Src-dependent and redox-sensitive manner (58, 203). ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2007 Jan 292(1) C82-97",
                "id": "16870827"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407064a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Treatment of cells with GPCR agonists such as endothelin- 1 (ET-1), thrombin, bombesin, and lysophosphatidic acid (LPA) transactivates ErbB1 (reviewed by Zwick et al. [48]). Mechanistically, the process involves rapid stimulation of metalloproteinases followed by cleavage of an ErbB1 ligand precursor, e.g., pro-HB-EGF [49], whose binding activates ErbB1 and downstream signaling pathways",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2003 Mar 10 284(1) 99-110",
                "id": "12648469"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "beta1AR stimulation and EGF ligand can each induce equivalent EGFR phosphorylation, internalization, and downstream activation of ERK1/2, but only EGF ligand causes translocation of activated ERK to the nucleus, whereas beta1AR-stimulated/EGFR-transactivated ERK is restricted to the cytoplasm.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jul 24 284(30) 20375-86",
                "id": "19509284"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "After activating Ras using EGF, the GTP-bound form of Ras was precipitated with GST-RBD (GST-Raf containing Ras binding domain). Precipitated Ras was detected using the HA-antibody. As shown in Fig. 5D, in the presence of EGF, the amount of GTP-bound Ras increased over that of the control. Levels of the GTP-bound Ras significantly decreased in cells expressing DIP1/2; however, DIP1/2m failed to stimulate Ras GTPase in cells treated with EGF.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Apr 12 277(15) 12622-31",
                "id": "11812785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407059f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Here we show that keratinocyte TRPV3, a member of the transient receptor potential (TRP) family of Ca(2+)-permeant channels, forms a signaling complex with TGF-alpha/EGFR. Activation of EGFR leads to increased TRPV3 channel activity, which in turn stimulates TGF-alpha release. TRPV3 is also required for the formation of the skin barrier",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2010 Apr 16 141(2) 331-43",
                "id": "20403327"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407057f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "More recently, it has been shown that a pool of ERalpha resides in or associates with the plasma membrane as a cytoplasmic protein. These ERs utilize the membrane EGFR to rapidly signal through various kinase cascades that influence both transcriptional and nontranscriptional actions of estrogen in breast cancer cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2003 Mar 17(3) 309-17",
                "id": "12554774"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407057b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Figure 4 shows the inhibitory effect of gefitinib on EGFinduced autophosphorylation of EGFR, and phophorylation of Akt and ERK1/2 in three of the NSCLC cell lines. EGF stimulated EGFR autophosphorylation and activation of Akt and ERK1/2 in PC9 (A), A549 (B), and QG56 (C) cells, and activation was blocked to different extents by gefitinib.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2004 Apr 3(4) 465-72",
                "id": "15078990"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070572"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "DOC-2/DAB2 and DIP1/2 complex represent a negative feedback machinery for several exogenous stimuli-elicited signal cascade. PKC can phosphorylate the N-terminal domain of DOC-2/DAB2 (serine 24) that recruits DIP1/2 to inactivate Ras protein. On the other hand, shortly after the treatment of peptide growth factors, the C terminus of DOC-2/DAB2 (proline-rich domain) competes with SOS for Grb 2 binding, which leads to the inactivation of the MAP pathway. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 5 274(45) 31981-6",
                "id": "10542228"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070541"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "studies of MCF-7 breast cancer cells stimulated with heregulin showed increased HIF-1a protein synthesis that was inhibited by treatment with rapamycin a macrolide antibiotic that inhibits mammalian target of rapamycin (mTOR; a kinase that functions downstream of PI3K and AKT). The effect of heregulin was mediated via the 5-untranslated region of HIF-1a mRNA47. The known targets for phosphorylation by mTOR are regulators of protein synthesis (FIG. 1).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2003 Oct 3(10) 721-32",
                "id": "13130303"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070526"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "This result indicates that centaurin-{alpha}1 is required for the EGF-dependent activation of Elk-1 in T-REx 293 cells.  This result indicates that centaurin-{alpha}1 contributes to the phosphorylation of ERK in the EGF signaling pathway.  ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Jan 20 281(3) 1332-7",
                "id": "16287813"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407051d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "cultures, EGF activates the IGFR via an intracellular pathway involving the EGFR and the cytoplasmic tyrosine kinase, c-src (Hallak et al., 2002). Following EGF-induced tyrosine phosphorylation, c-src forms a complex with the IGF-1R.",
              "citation": {
                "type": "PubMed",
                "name": "Growth Factors 2004 Jun 22(2) 89-95",
                "id": "15253384"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407051a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Upon exposure of J774A.1 cells to acrolein, EGFR phosphorylation increased significantly within minutes, and further increased up to 10 min (Fig. 6A), confirming a direct effect of acrolein on the activation of the EGFR pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Appl Pharmacol 2010 May 15 245(1) 76-82",
                "id": "20153347"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070506"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Analysis of phosphotyrosine proteins from transforming growth factor alpha (TGF-a) triggered phosphotyrosine proteome permitted the identification of novel downstream substrates of the epidermal growth factor receptor (EGFR)",
              "citation": {
                "type": "PubMed",
                "name": "Med Oncol 2010 Dec 27(4) 1407-14",
                "id": "20049563"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070daa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma Of nasopharynx",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Reduced LAR levels also resulted in increases of over 300% and 250% in epidermal growth factor (EGF)- and hepatocyte growth factor (HGF)-dependent receptor autophosphorylation, respectively, as well as a severalfold increase in substrate tyrosine phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Jan 12 271(2) 748-54",
                "id": "8557682"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070da6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Sep 15 60(18) 5310-7",
                "id": "11016663"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d9b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "We and others recently reported that EGFR transactivation is important for activation of cultured SMCs by thrombin, angiotensin II, and endothelin I.4446",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2001 Dec 947 42-54; discussion 54-5",
                "id": "11795306"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d95"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "EGF rapidly increases the level of tyrosine phosphorylation of EGFR.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2004 Sep 2(9) 514-22",
                "id": "15383630"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d8c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The SH2-mediated association of Grb2 with the EGFR was increased following EGF stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 31 277(22) 19382-8",
                "id": "11896055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d8a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Phospholipase C gamma 1 (PLC gamma 1) and p21ras guanosine triphosphatase (GTPase) activating protein (GAP) bind to and are phosphorylated by activated growth factor receptors",
              "citation": {
                "type": "PubMed",
                "name": "Science 1990 Nov 16 250(4983) 979-82",
                "id": "2173144"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d7a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Different signalling molecules such as the ?-subunit of G-proteins, Ha-Ras, Src-kinases, eNOS, EGF receptors and some protein kinase-C isoenzymes bind directly to the scaffolding domain of caveolins. This binding results in the inactivation of these molecules (Casey, 1994, Feron et al., 1998 and Li et al., 1996);",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Endocrinol 2005 Dec 21 245(1-2) 128-37",
                "id": "16368181"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d76"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Treatment with both tamoxifen and the small molecule HER1/2 kinase inhibitor AG1478 reduced mitogen-activated protein kinase activity and markedly reduced growth of established MCF-7/HER2 xenografts in athymic nude mice.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2001 Dec 7(12 Suppl) 4436s-4442s; discussion 4411s-4412s",
                "id": "11916237"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d74"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Apr 1 62(7) 1996-2003",
                "id": "11929816"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d64"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Phospholipase Cgamma1 is expressed ubiquitously, especially in the brain, thymus and lungs. PLCgamma1 can be activated by receptor tyrosine kinases (i.e.: PDGFR, EGFR, FGFR, Trk), as well as non-receptor protein kinases (Src, Syk, Tec)",
              "citation": {
                "type": "PubMed",
                "name": "Postepy Hig Med Dosw (Online) 2011 65 470-7",
                "id": "21918248"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d5a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Interleukin 8 was recently reported to transactivate the EGFR via the alpha chemokine receptors CXCR-1 and CXCR-2 in ovarian cancer cells.67",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2001 Dec 947 42-54; discussion 54-5",
                "id": "11795306"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d48"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Treatment of keratinocytes with epidermal growth factor results in an increase in Delta Np63 alpha expression at the mRNA level, which is abrogated by inhibition of PI3K but not mitogen-activated protein kinase signaling.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 19 278(51) 51408-14",
                "id": "14555649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d46"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "These results suggest that integrin alpha5/beta1 mediates fibronectin-induced epithelial cell proliferation through activation of the EGFR.  \t ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2000 Jul 11(7) 2485-96",
                "id": "10888683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d44"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Several receptor tyrosine kinases exhibit stimulated activity upon peroxynitrite exposure, triggering downstream phosphotyrosine-dependent signalling, as shown for the platelet-derived growth factor receptor (PDGFR) and the receptor for brain-derived neurotrophic factor (TrkB) in murine fibroblasts (24,25), as well as the Epidermal Growth Factor Receptor (EGFR) in rat lung myofibroblasts (26).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d42"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "myofibroblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "from full text - ZD6474 is a low MW inhibitor of the TK domain of EGFR and VEGFR-2 (57)",
              "citation": {
                "type": "PubMed",
                "name": "Ann Thorac Cardiovasc Surg 2009 Aug 15(4) 213-20",
                "id": "19763051"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d3e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "To further confirm the contribution of EGF and TGF-a to IL-1b-induced alveolar epithelial repair, the signaling of the EGFR was blocked with a specific tyrosine kinase inhibitor, tyrphostin AG-1478. The IL- 1b-induced increase in epithelial repair of rat alveolar epithelial cells was inhibited by AG-1478 in a concentration- dependent manner (",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2000 Dec 279(6) L1184-90",
                "id": "11076808"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d36"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Mar 16 19(12) 1509-18",
                "id": "10734310"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d2c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "We designed oligopeptides consisting of amino-acid sequences of the major (Y1068, Y1148, and Y1173) and minor (Y992) autophosphorylation sites of EGFR.",
              "citation": {
                "type": "PubMed",
                "name": "Br J Pharmacol 2006 Feb 147(4) 402-11",
                "id": "16402038"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d19"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Phosphorylation of cortactin tyrosine 421 and 466 was elevated in response to Src, epidermal growth factor receptor and Rac1 activation, and tyrosine 421 phosphorylated cortactin localized with F-actin in lamellipodia and podosomes.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2003 Aug 14(8) 3216-29",
                "id": "12925758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d07"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Stimulation of T47D cells with epidermal growth factor (EGF) results in the activation of the intrinsic tyrosine kinases of the receptor and the phosphorylation of multiple cellular proteins including the receptor, scaffold molecules such as c-Cbl, adapter molecules such as Shc, and the serine/threonine protein kinase Akt. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jul 12 277(28) 24967-75",
                "id": "11994282"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cf3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 May 15 63(10) 2379-87",
                "id": "12750255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cf0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "For this purpose, we developed an antibody that specifically recognizes Tyr221-phosphorylated CrkII, and we demonstrated that CrkII was phosphorylated on Tyr221 upon EGF stimulation. Moreover, recombinant CrkII protein was phosphorylated in vitro by EGF receptor.  These results strongly suggest that EGF receptor directly phosphorylates CrkII.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Jul 3 273(27) 17186-91",
                "id": "9642287"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ce8"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Consistent with this, PPAR agonists increased tyrosine autophosphorylation of the EGFR as well as phosphorylation at a putative Src-specific site, Tyr845.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 21 278(47) 46261-9",
                "id": "12966092"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ce7"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Eps8 protein, which contains an SH3 domain, is coupled functionally and physically to the EGFR and is tyrosine phosphorylated by this receptor",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1997 Oct 16 15(16) 1929-36",
                "id": "9365239"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cd5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Epidermal growth factor (EGF) stimulates recruitment of RN-tre to the EGF receptor (EGFR) in a Grb2-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 27 277(52) 50996-1002",
                "id": "12399475"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cd3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Alternatively, this integrin complex can interact with tenascin-C, thus favoring the clustering of EGF receptors and EGF-dependent growth (Jones et al., 1997).",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 Feb 15 18(4) 882-92",
                "id": "10022831"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cc7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "# Ariadne: In turn, the addition of EGF , HB-EGF ,  amphiregulin, and TGF-alpha increased epiregulin mRNA levels. [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Feb 25 275(8) 5748-53",
                "id": "10681561"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cb8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "We show that TGF-beta1 activates the epidermal growth factor receptor (EGFR) and phosphorylates c-Src.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Jun 30 24(28) 4580-7",
                "id": "15856020"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cb6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "A431 cells expressing annexin VI are defective in their ability to sustain elevated levels of cytosolic Ca(2+) following stimulation with EGF.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1999 Jul 5 260(2) 540-6",
                "id": "10403803"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cb0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "These data demonstrate that in vivo, the mechanism for beta1AR-mediated EGFR transactivation requires GRK5/6 and ?-arrestin recruitment to agonist-stimulated beta1ARs. ",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2007 Sep 117(9) 2445-58",
                "id": "17786238"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c9e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "NE regulates IL-8 production from airway epithelial cells and can activate both EGFR and TLR4. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Sep 4",
                "id": "18772136"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c95"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "N-acetyl-L-cysteine [Cys(Ac)] and dithiothreitol markedly suppressed EGF-induced dimerization and activation of the EGF receptor in cells.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2000 Apr 267(7) 1933-44",
                "id": "10727932"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c8d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "On treatment with epidermal growth factor (EGF), NIH3T3 cells expressed EGFR/Tyro3 (a fusion receptor with the extracellular domain from epidermal growth factor receptor and the transmembrane and cytoplasmic domains from Tyro3), and EGFR/Tyro3 was rapidly phosphorylated on tyrosine residues",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2000 Jan 15 95(2) 633-8",
                "id": "10627473"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c81"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "In addition, treatment of AGS-B cells with H2O2 resulted in increased c-fos/c-jun mRNA expression and AP-1 activity, and also led to increased phosphorylation of epidermal growth factor receptor (EGFR) and Shc.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Sep 4 273(36) 23046-54",
                "id": "9722530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c6b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "reatments of cells with ERRP or Iressa (an EGFR tyrosine kinase inhibitor) results in elevated CARP-1 levels, whereas antisense-dependent depletion of CARP-1 causes inhibition of apoptosis by ERRP.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 May 12 281(19) 13188-98",
                "id": "16543231"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c64"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1991 May 11(5) 2511-6",
                "id": "1850098"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c61"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "In the LNCaP cell model, OPN stimulates cell proliferation in serum-free medium and colony growth at high dilution but this effect is visible only in presence of epidermal growth factor (EGF). Proliferation induced by OPN is accompanied by a sustained activation of EGF receptor (EGFR)",
              "citation": {
                "type": "PubMed",
                "name": "Prostate 2004 May 1 59(2) 157-66",
                "id": "15042616"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c56"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Src, as a mediator of receptor transactivation, can uniquely activate EGFR in the absence of EGFR ligand",
              "citation": {
                "type": "PubMed",
                "name": "Gastrointest Cancer Res 2007 1(4 Suppl 2) S37-41",
                "id": "19360146"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c55"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Moreover, addition of the anti-EGFR inhibitory MAb in the culture medium significantly diminished the subcellular localizations of these TJ proteins at cell-cell contact sites, indicating disruption of TJs",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2011 Jan 300(1) L56-63",
                "id": "21036915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c4d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Shc phosphorylation and Ras activity were inhibited by expression of PTEN, whereas EGF receptor autophosphorylation was unaffected. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 1998 Nov 30 143(5) 1375-83",
                "id": "9832564"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c4b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on hyaluronan depolymerization and epidermal growth factor receptor (EGFR)/mitogen-activated protein kinase (MAPK) activation (ERK activation).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2009 Mar 40(3) 277-85",
                "id": "18757307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c49"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 1996 Jul 17 67(2) 264-8",
                "id": "8760597"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c46"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Sep 10(9) 2861-78",
                "id": "10473632"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c3e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": ": In vitro, gefitinib inhibited cell proliferation with differing IC(50), and suppressed activation of EGFR and downstream signaling molecules protein kinase B (AKT), extracellular signal-regulated kinase 1/2, signal transducer and activator of transcription 3 (STAT3), and nuclear factor kappaB. ",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2009 Apr 1 15(7) 2361-72",
                "id": "19318490"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c3b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "from full text - Transfection of KUZ further augmented GPCR-induced EGFR phosphorylation. The enhancement of EGFR phosphorylation in the presence of transfected KUZ was moderate but significant, ranging from a 1.5- to 3.2-fold increase over the transactivation mediated by the endogenous protease (Fig. 1 C).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Jul 22 158(2) 221-6",
                "id": "12119356"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c37"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "In vivo, b4-integrin amplifies proproliferative signals in basal epidermal keratinocytes (Nikolopoulos et al., 2005), where STAT3 is expressed and can be activated by EGF/EGF-R (Nishio et al., 2001; Chan et al., 2004; Li et al., 2007)",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2008 Mar 128(3) 501-16",
                "id": "18268536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c36"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "We studied the impact of ADAM inhibitors on the functional release and activation of EGFR ligands from NCI-H1666 cells, which express TGFa, AR, and EPR (Figure 2A), using an A431 reporter cell assay. As shown in Figure 7A, INCB3619 inhibits EGFR ligand activation, as measured by EGFR phosphorylation on Tyr-1173 in A431.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2006 Jul 10(1) 39-50",
                "id": "16843264"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c32"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "ATP-?-S activates EGFR signaling in corneal and airway epithelial cells. (AC) ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2007 Mar 1 120(Pt 5) 815-25",
                "id": "17284517"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c31"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Figure 1 | The ErbB signalling network.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2001 Feb 2(2) 127-37",
                "id": "11252954"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c28"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "They first showed that increased mucin transcription by cigarette smoke was mediated through activation of the EGFR via cleavage of amphiregulin by the MMP ADAM 17 (7).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Jun 34(6) 666-9",
                "id": "16484683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c23"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Cyclooxygenase-2 (COX-2) antagonists, by blocking prostaglandin production, might inhibit this pathway 149.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Feb 2(2) 101-12",
                "id": "12635173"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c1d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "We now report that RALT binds to ligand-activated epidermal growth factor receptor (EGFR), ErbB-4 and ErbB-2.ErbB-3 dimers. When ectopically expressed in 32D cells reconstituted with the above ErbB receptor tyrosine kinases (RTKs) RALT behaved as a pan-ErbB inhibitor.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Jul 3 22(27) 4221-34",
                "id": "12833145"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c03"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Heparin-binding epidermal growth factor-like growth factor (HB-EGF), a mitogen and chemotactic factor, binds to two receptor tyrosine kinases, erbB1 and erbB4",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2001 Jul 2 20(13) 3342-50",
                "id": "11432822"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bfa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Interaction of tenascin-C, an ECM glycoprotein induced in pulmonary vascular disease, with ?v?3 integrins induces EGFR phosphorylation in pulmonary vascular SMCs.75",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2001 Dec 947 42-54; discussion 54-5",
                "id": "11795306"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bef"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Finally, disruption of microtubule polymerization by 2-methoxyoestradiol (2ME2) has also been shown to result in decreased HIF-1a levels and decreased VEGF mRNA expression in cultured cells88.In vivo, 2ME2 decreases tumour-xenograft growth and vascularization.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2003 Oct 3(10) 721-32",
                "id": "13130303"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bec"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "These effects (TLR2,3,5,6 activation of VEGF and IL8) were prevented by treatment with a selective inhibitor of EGFR phosphorylation (AG-1478), a metalloprotease (MP) inhibitor, a reactive oxygen species (ROS) scavenger, and an NADPH oxidase inhibitor. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2008 Jun 294(6) L1068-75",
                "id": "18375743"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070be5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "EGF also induces SCAMP-EGFR association, as detected by coimmunoprecipitation, and phosphorylation of SCAMP3 is stimulated by the EGFR in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1998 Jul 9(7) 1661-74",
                "id": "9658162"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bde"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 21 275(16) 12353-9",
                "id": "10766877"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bdd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The Src inhibitor PP1 and the EGFR inhibitor AG-1478 completely inhibited carbachol-stimulated MAPK activation. AG-1478 also inhibited goblet cell secretion. (Fig. 8) We conclude that carbachol transactivates the EGFR to activate MAPK, leading to conjunctival goblet cell secretion.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2003 Apr 284(4) C988-98",
                "id": "12620895"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bd9"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "We also observed that UV radiation induced activation of EGFR in a time- and dose-dependent manner",
              "citation": {
                "type": "PubMed",
                "name": "Int J Mol Med 2006 Oct 18(4) 713-9",
                "id": "16964427"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bd8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "These results indicate that Pyk2 facilitates EGFR- and c-Src-mediated Stat3 activation, thereby implicating Pyk2 activation as a potential co-mediator in triggering Stat3-induced oncogenesis.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 23 279(17) 17224-31",
                "id": "14963038"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bd6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Dec 15 275(50) 39451-7",
                "id": "10967114"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bd5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "ultraviolet, ionizing radiation, membrane depolarization, and oxidative stress (53?57) also led to EGFR transactivation. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 24 277(21) 18938-46",
                "id": "11889128"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bd2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 13822-9",
                "id": "11278817"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bd1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "H2O2 induces Scr-family kinase-dependent phospohrylation of caveolin-1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Jan 3",
                "id": "16407214"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bcb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Additionally, KLF6 inhibits cellular transformation induced by several oncogenes (c-sis/PDGF-B, v-src, H-Ras, and EGFR) that are components of signaling cascades implicated in GBM.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Jun 24 23(29) 5077-83",
                "id": "15064720"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bc1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Finally, we showed that the interaction between PLC-gamma1 and Akt enhanced EGF-stimulated cell motility.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2006 May 17(5) 2267-77",
                "id": "16525023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bb7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "RNF11 is capable of degrading AMSH, a positive regulator of both TGFbeta and EGFR signalling pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Cancer 2005 Nov 41(16) 2549-60",
                "id": "16226459"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bb5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "CaM kinase II phosphorylation of the EGFR might regulate receptor autokinase activity and show that this modification can hinder association of the cytoplasmic tail with the kinase domain to prevent an enzyme-substrate interaction.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jun 4 274(23) 16168-73",
                "id": "10347170"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bb1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "To identify the specific EGFR phosphorylation sites, hGab-1-C was sequenced by Edman degradation and mass spectrometry. The entire protein was phosphorylated by rEGFR at eight tyrosine residues (Y285, Y373, Y406, Y447, Y472, Y619, Y657, and Y689). ",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 1999 Jan 5 38(1) 151-9",
                "id": "9890893"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bb0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 10 279(50) 52191-9",
                "id": "15469938"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ba7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Here, using rat pheochromocytoma PC12 cells transiently transfected with a plasmid expressing a chimera of green fluorescent protein fused to GAP1(m) (GFP-GAP1(m)), we show that epidermal growth factor (EGF) induces a rapid (less than 60 seconds) recruitment of GFP-GAP1(m) from the cytosol to the plasma membrane.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 1999 Mar 11 9(5) 265-8",
                "id": "10074452"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b9c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "EGF and thrombin triggered a rapid activation of the EGF receptor, followed by the phosphorylation and activation of the extracellular signal-regulated protein kinase (ERK)",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2002 85(2) 381-91",
                "id": "11948693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b99"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jan 30 279(5) 3543-52",
                "id": "14593119"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b94"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Hyperosmotic exposure of rat hepatocytes triggers epidermal growth factor receptor (EGFR) activation, which results in an activation of the CD95 system and sensitizes the cells toward apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jun 4 279(23) 23977-87",
                "id": "15039424"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b8a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Upon stimulation with epidermal growth factor, similar translocation of ectopically expressed PLCepsilon is observed, which is inhibited by coexpression of dominant negative Ha Ras.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jan 26 276(4) 2752-7",
                "id": "11022048"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b85"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Ang II transactivated EGFR via AT(1), and inhibition of EGFR abolished the induction of Ang2.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2001 Jan 19 88(1) 22-9",
                "id": "11139469"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b7d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "EGF-R causes disassembly of hemidesmosomes by activating Fyn, which in turn phosphorylates the beta4 cytoplasmic domain. Neoplastic cells expressing dominant negative Fyn display increased hemidesmosomes and migrate poorly in vitro in response to EGF.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2001 Oct 29 155(3) 447-58",
                "id": "11684709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b79"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Treatment of Caco-2 and LoVo cells with PGE2 (10 micromolar, 5 mins) significantly increased c-met-R phosphorylation. when these cells were treated with a specific inhibitor Tryphostin AG 1478 of EGFR, PGE2 almost completely inhibited PGE2-induced c-met-R phosphorylation, indicating that functional EGFR is required for PGE2-induced c-Met-R activation.",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2003 Sep 17(12) 1640-7",
                "id": "12958170"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b77"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The administration of gefitinib showed potent preventive effects on BaP-induced lung tumorigenesis",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2006 Dec 4(12) 971-81",
                "id": "17189387"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b73"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Apr 19 271(16) 9185-8",
                "id": "8621573"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b6f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "activation of the epidermal growth factor receptor (EGFR) triggers mitogenic signaling in gastrointestinal mucosa, and its expression is also upregulated in colonic cancers and most neoplasms",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2002 Mar 8(3) 289-93",
                "id": "11875501"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b57"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Moreover, autocrine TGF-alpha-mediated epidermal growth factor receptor activation was shown to control the constitutive activation of the ERK/MAPK pathway,",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 30 278(22) 19861-9",
                "id": "12657625"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b48"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2001 Sep 281(3) C886-98",
                "id": "11502566"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b44"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Significant and specific knockdown of endogenous M-BAR mRNA levels was observed (Fig. 3b), and the cells treated with M-BAR siRNAs also showed potent suppression of DC-induced EGFR tyrosine phosphorylation and ERK1/2 activation (Fig. 3c). These results suggest that DC-induced activation of EGFR in AGS cells involves the activity of M-BAR/TGR5.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2007 Mar 2 354(1) 154-9",
                "id": "17214962"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b3c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "ZD1839 (\\\"Iressa\\\") is an adenosine triphosphate-competitive inhibitor specific to the EGFR tyrosine kinase currently under evaluation as a chemotherapeutic agent in HNSCC.",
              "citation": {
                "type": "PubMed",
                "name": "Laryngoscope 2003 Jun 113(6) 936-9",
                "id": "12782800"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b2f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Gene 33 is a physiological feedback inhibitor of the EGFR, functioning to inhibit EGFR phosphorylation and all events induced by EGFR activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 28 280(4) 2924-33",
                "id": "15556944"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b24"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "In cultured HC11 cells, epidermal growth factor (EGF) treatment rapidly induces Stra13 protein accumulation, which is blocked by the synthetic glucocorticoid, dexamethasone. Neither the induction of Stra13 by EGF nor its repression by dexamethasone correlates with changes in Stra13 mRNA levels.",
              "citation": {
                "type": "PubMed",
                "name": "Dev Dyn 2004 May 230(1) 124-30",
                "id": "15108316"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b22"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Immunoprecipitation studies demonstrated a reduction of EGF-induced tyrosine phosphorylation of EGFR in PC3-AR cells.",
              "citation": {
                "type": "PubMed",
                "name": "Steroids 2004 Aug 69(8-9) 549-52",
                "id": "15288768"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b10"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 14 279(20) 20927-34",
                "id": "15010475"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b0c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "PTPD1 activates src tyrosine kinase and increases the magnitude and duration of epidermal growth factor (EGF) signaling. EGF receptor phosphorylation and downstream activation of ERK 1/2 and Elk1-dependent gene transcription are enhanced by PTPD1.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jun 24(11) 4613-26",
                "id": "15143158"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b0b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Gefitinib, an EGFR small-molecule antagonist, recently won approval as thirdline treatment for NSCLC [66]. Small molecule Erlotinib is also an EGFR antagonist, and has shown a statistically significant survival benefit in a randomized phase 3 NSCLC [66].",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Agents Med Chem 2009 Sep 1",
                "id": "19663788"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b0a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "EGFR Iressa (ZD1839) Phase III treatment (182) Preclinical prevention (183,184) Tarceva OSI774) Phase III treatment (185,186) PKI-166 Phase I treatment (187, 188) CI-1033 Phase II treatment (189-192) EKB-569 Phase I treatment (189-192) GW502016 Phase I treatment (187, 188) Way177-820 Preclinical development (193) GW572016 Preclinical development (193)",
              "citation": {
                "type": "PubMed",
                "name": "J Mammary Gland Biol Neoplasia 2003 Jan 8(1) 45-73",
                "id": "14587863"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b07"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "In a human colorectal carcinoma cell line, b-arrestin1-mediated Src activation was necessary for transactivation of the EGFR and downstream Akt activation and also for the migration of the cells in vitro (Buchanan et al., 2006).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2006 Dec 8 24(5) 643-52",
                "id": "17157248"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b06"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "EGF induced rapid and sustained GTP loading of Rap2B, binding of Rap2B to PLC-epsilon, and Rap2B-dependent translocation of PLC-epsilon to the plasma membrane.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jun 24(11) 4664-76",
                "id": "15143162"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b05"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "EGF-R activation was significantly blocked by therapy with PKI166 and was associated with significant reduction in tumor cell production of VEGF and IL-8, which in turn correlated with a significant decrease in microvessel density and an increase in apoptotic endothelial cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Jun 1 60(11) 2926-35",
                "id": "10850439"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070aff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2001 Nov 21(11) 1759-63",
                "id": "11701462"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ae9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The EGF effect depended on activation of its receptor tyrosine kinase but not on that of protein kinase C, mitogen-activated protein kinases, or phosphoinositide-3 kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Renal Physiol 2001 Aug 281(2) F244-54",
                "id": "11457715"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ae8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "In the EGFR bearing lines, the receptor was phosphorylated at tyrosine 992 under basal conditions, and the addition of 100 nM amphiregulin did not lead to the phosphorylation of other tyrosine residues typically phosphorylated by the prototypical ligand EGF. Treatment of the EGFR positive lines with the EGFR inhibitor PD153035 and amphiregulin-neutralizing antibodies reduced PTHrP mRNA levels by 50-70%.",
              "citation": {
                "type": "PubMed",
                "name": "Breast Cancer Res Treat 2007 Sep 20",
                "id": "17882547"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ae2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Significantly, challenge of Tam-R cells with the EGFR-selective tyrosine kinase inhibitor gefitinib, for 7 days, reduces IRS-1/EGFR association",
              "citation": {
                "type": "PubMed",
                "name": "Breast Cancer Res Treat 2007 Sep 28",
                "id": "17902048"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070adb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of breast",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Epidermal growth factor (EGF) receptor activation resulted in Tyr phosphorylation of PG, which was accompanied by a loss of desmoplakin from desmosomes and decreased adhesive strength following 18-h EGF treatment. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Dec 2 280(48) 40355-63",
                "id": "16183992"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ad8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Interestingly, pharmacological inhibition of the kinase activities of EGFR, erbB2, and src and activation of mitogen-activated protein kinase, but not phosphatidylinositol 3'-kinase, significantly up-regulated SIRPalpha1 promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Sep 15 64(18) 6444-52",
                "id": "15374953"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ad7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Glioma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "We also observed that MEKK1 interacted with Grb2 and Grb2-MEKK1 complex was recruited to epidermal growth factor receptor (EGFR) after UVC irradiation",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2007 Mar 19(3) 563-72",
                "id": "17029735"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ad6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "activation of EGF-R by EGF triggers signaling through the MAP kinase pathway during in vitro maturation",
              "citation": {
                "type": "PubMed",
                "name": "Mol Reprod Dev 2005 Aug 71(4) 489-94",
                "id": "15858794"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ad0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "ATP-?-S activates EGFR signaling in corneal and airway epithelial cells. (AC) ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2007 Mar 1 120(Pt 5) 815-25",
                "id": "17284517"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070acd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Inhibition of the EGFR kinase prevented EGF-induced steroidogenesis in these in vitro systems and blocked LH-induced steroidogenesis in intact follicles primed with pregnant mare serum gonadotropin.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Nov 8 102(45) 16257-62",
                "id": "16260720"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070abc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "ovarian follicle cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The EGF-induced increase of Ugrp2 occurred at the transcriptional level that required the EGF receptor and the activation of the ERK-MAPK and phosphoinositide-3 kinase pathways.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2005 Apr 11 579(10) 2221-5",
                "id": "15811345"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070abb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "# Ariadne: Ullrich  Reactive Oxygen Species Mediate Met Receptor Transactivation by G Protein- coupled Receptors and the Epidermal Growth Factor Receptor in Human Carcinoma  Cells  J. [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Nov 1 62(21) 6329-36",
                "id": "12414665"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070aad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Stimulation of EGFR and mitogen-activated protein kinase signaling by GM3 depletion involves the phosphorylation of EGFR at tyrosine residues 845, 1068, and 1148 but not 1086 or 1173. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 5 278(49) 48770-8",
                "id": "14512423"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070aa9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "squamous cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2001 Dec 3 20(23) 6793-804",
                "id": "11726515"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070aa7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "AG 1478 (EGF receptor tyrosine kinase inhibitor), PD 98059 (ERK1/2 inhibitor), and SB 203580 (p38 inhibitor) significantly inhibited EGF-induced p11 expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 11 277(41) 38431-40",
                "id": "12163506"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a9e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "HB- EGF is a member of the EGF family that binds to and induces the activation of two of the four members of the EGF receptor family: ErbB1 and ErbB4",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Apr 11 21(16) 2584-92",
                "id": "11971193"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a99"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "in HEK-293 cells, the agonists insulin, insulin-like growth factor-1 and epidermal growth factor induce the phosphorylation of DAPP1 at Tyr(139). ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2000 Jul 15 349(Pt 2) 605-10",
                "id": "10880360"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a97"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "We report that two tyrosine residues in the C terminus of human TRPC4 (hTRPC4), Tyr-959 and Tyr-972, are phosphorylated following epidermal growth factor (EGF) receptor stimulation of COS-7 cells. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Nov 11 280(45) 37974-87",
                "id": "16144838"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a94"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 1999 Aug 5(8) 2251-60",
                "id": "10473113"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a90"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "\\\"Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs).\\\"",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Aug 17 19(35) 3999-4010",
                "id": "10962556"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a86"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Recently, we identified a similar cohort of tyrosine phosphorylation sites for the epidermal growth factor receptor (EGFR) with a predominant phosphorylation of tyrosine residue Y657 and binding of Syp [Lehr, S. et al. (1999) Biochemistry 38, 151-159].",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 2000 Sep 5 39(35) 10898-907",
                "id": "10978177"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a7c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The binding of beta-catenin to these partners is regulated by phosphorylation of at least three critical tyrosine residues. Each of these residues is targeted by one or more specific kinases: Y142 by Fyn, Fer and cMet; Y489 by Abl; and Y654 by Src and the epidermal growth factor receptor.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Opin Cell Biol 2005 Oct 17(5) 459-65",
                "id": "16099633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a6e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The pathophysiology of Helicobacter pylori-associated gastroduodenal diseases, ulcerogenesis, and carcinogenesis is intimately linked to activation of epidermal growth factor receptor (EGFR) and production of vascular endothelial growth factor (VEGF)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Nov 21 283(47) 32369-76",
                "id": "18806258"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a6b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Phosphorylation of Pyk2 at Tyr881 is known to link Pyk2 with growth factor receptor-bound protein 2 (Grb2), leading to the activation of ERK1/2 (29). Additionally, Pyk2 has been associated with the activation of the EGFR (30,31) and PDK1 (32).",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2006 Nov 27(11) 2331-40",
                "id": "16774943"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a69"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "transactivation of the EGF receptor by IGF1 is blocked by ZD1839",
              "citation": {
                "type": "PubMed",
                "name": "Breast Cancer Res 2002 4(6) 231-9",
                "id": "12473169"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a4e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Inhibition of EGFR blocked the effects of HP on GJIC and HP-induced Cx43 tyrosine phosphorylation. ",
              "citation": {
                "type": "PubMed",
                "name": "Glia 2007 Aug 1 55(10) 1085-98",
                "id": "17551925"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a47"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "astrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Hrs undergoes ligand-induced tyrosine phosphorylation on residues Y329 and Y334 downstream of epidermal growth factor receptor (EGFR) activation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 Feb 27(3) 888-98",
                "id": "17101784"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a41"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The treatment of NCI-N87 cells with EGF resulted in increases in phosphorylation of Erk1/2, Akt, and P38. Blockade of the Erk, phosphatidylinositol-3 kinase/Akt, or P38 pathways in this cell line",
              "citation": {
                "type": "PubMed",
                "name": "Br J Cancer 2003 Mar 10 88(5) 796-802",
                "id": "12618892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a40"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Using dominant-negative mutants of c-Src and Fyn and Src-deficient SYF cells as well as by co-immunoprecipitation studies, we can demonstrate that the M2R-mediated transactivation of EGFR specifically involves Fyn but not c-Src or Yes. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2006 Aug 18(8) 1338-49",
                "id": "16337776"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a3e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 1999 Mar 5(3) 681-6",
                "id": "10100722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a3d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The hypoxic induction of arginase II protein was prevented by treatment with AG-1478. Proliferation assays were performed in the presence of arginase inhibitors, and hypoxia-induced proliferation was also prevented by arginase inhibition.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2010 Apr 298(4) L600-6",
                "id": "20139181"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a23"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Furthermore, EGFR, activated by amphiregulin but not epidermal growth factor, results in the prompt activation of the transcription factor nuclear factor-kappaB (NF-kappaB)",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2007 Aug 5(8) 847-61",
                "id": "17670913"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a17"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Figure 1. Pathways to MUC5AC expression in COPD",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82",
                "id": "17615396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a0e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 May 30 21(24) 3934-8",
                "id": "12032832"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a0b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "In fact, batimastat, a potent inhibitor of zinc-dependent metalloproteinases was found to block autocrine-activated ErbB1 and the proliferation of prostate carcinoma cells [49] and breast epithelial cells",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2003 Mar 10 284(1) 99-110",
                "id": "12648469"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Here we report that epidermal growth factor (EGF) stimulated SphK2 in HEK 293 cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Aug 19 280(33) 29462-9",
                "id": "15951439"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The induction of EMMPRIN by AR was mediated by epidermal growth factor receptor (EGFR) tyrosine kinase activation and inhibited by ZD1839.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Nov 15 63(22) 7575-80",
                "id": "14633669"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709f5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Bile acids transactivate the EGF receptor (EGFR) in cholangiocytes",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Gastrointest Liver Physiol 2003 Jul 285(1) G31-6",
                "id": "12606307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709f1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "cholangiocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "A search for SCAMP kinase activities has shown that SCAMPs 1 and 3, but not SCAMP2, are tyrosine phosphorylated in EGF-stimulated murine fibroblasts overexpressing the EGF receptor (EGFR). ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1998 Jul 9(7) 1661-74",
                "id": "9658162"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709e9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "In this paper, we present a comprehensive pathway map of EGFR signaling and other related pathways. The map reveals that the overall architecture of the pathway is a bow-tie (or hourglass) structure with several feedback loops.  See figure 2: The bow-tie architecture of the EGFR signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Syst Biol 2005 1 2005.0010",
                "id": "16729045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709e2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The results demonstrate that EGF-R-mediated phosphorylation of MUC1 induces binding of MUC1 to c-Src in cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Sep 21 276(38) 35239-42",
                "id": "11483589"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709e1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "EGFR and its ligands EREG, AREG, DTR (HB-EGF), and TGFA",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Prev Res (Phila Pa) 2008 Jul 1(2) 100-11",
                "id": "19138943"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709db"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "from full text - overexpression of WT-ADAM12 slightly enhanced EGFR transactivation when compared with LacZ-overexpressing cardiomyocytes (Fig. 2d).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2002 Jan 8(1) 35-40",
                "id": "11786904"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709da"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "A reversible EGFR and HER2 TKI, lapatinib, decreased Stat3 activation by blocking heterodimerization of EGFR and HER2",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2008 Mar 7(3) 607-15",
                "id": "18347147"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709c7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "In this report, we demonstrate that class II phosphoinositide 3-kinase C2beta (PI3KC2beta) associates with the Eps8/Abi1/Sos1 complex and is recruited to the EGF receptor as part of a multiprotein signaling complex also involving Shc and Grb2. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2006 Sep 17(9) 3729-44",
                "id": "16775008"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "A genetic screen for regulators of EGFR signaling has led to the identification of Sprouty, a cell autonomous inhibitor of EGF signaling that is transcriptionally induced by the pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Apr 30 99(9) 6041-6",
                "id": "11983899"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "After cell stimulation by growth factors (epidermal growth factor (EGF) and transforming growth factor-beta1 (TGF-beta1) for NHKs and NHFs, respectively), a significant up-regulation of the VEGF family member proteins was observed in normal human fibroblasts NHFs but not in NHKs.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Dermatol 2004 Feb 13(2) 98-105",
                "id": "15009103"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709ba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "from full text - Figure 1 ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Jul 35(1) 3-9",
                "id": "16484682"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709b9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The oxidized LDL-induced rise of active beta-catenin required metalloproteinase activation, as well as epidermal growth factor receptor and Src signaling, as assessed by the use of pharmacological inhibitors and cells overexpressing a SrcK-inactive form.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2008 Sep 26 103(7) 694-701",
                "id": "18703780"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "RT-PCR analysis revealed high IL-6 mRNA expression in ?EGFRMCF-10A cells relative to expression in control MCF 10A cells (Figure 7B).",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2007 Dec 117(12) 3846-56",
                "id": "18060032"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709b3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "A disintegrin and metalloprotease 12 (ADAM12/meltrin alpha) is a key enzyme implicated in the ectodomain shedding of membrane-anchored heparin-binding epidermal growth factor (EGF)-like growth factor (proHB-EGF)-dependent epidermal growth factor receptor (EGFR) transactivation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 14 278(46) 46029-34",
                "id": "12952982"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709ad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The stimulatory EGFR signal is insensitive to inhibition of JAKs and appears to involve Src kinases and STAT proteins as shown by inhibition through overexpression of C-terminal Src kinase (Csk) and transdominant negative STAT3, respectively",
              "citation": {
                "type": "PubMed",
                "name": "Hepatology 1999 Sep 30(3) 682-97",
                "id": "10462375"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709a8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 8 277(10) 8693-701",
                "id": "11751923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709a0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 2 279(14) 14287-93",
                "id": "14742435"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070994"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "In ezrin, two tyrosine residues, corresponding to amino acids 145 and 353, are phosphorylated by the epidermal growth factor receptor",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1999 Jun 22 96(13) 7300-5",
                "id": "10377409"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070991"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "kidney epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Pharmacol 2000 Apr 57(4) 667-78",
                "id": "10727511"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070990"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "AR activation by IGF-I, KGF, and EGF was completely inhibited by the pure AR antagonist casodex, showing that these effects are AR mediated.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1994 Oct 15 54(20) 5474-8",
                "id": "7522959"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407098a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The endogenous Gene 33 polypeptide is induced by EGF, platelet-derived growth factor, serum, and dexamethasone (Dex) in Rat 2 rat fibroblasts",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 28 280(4) 2924-33",
                "id": "15556944"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070986"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "From mutations file",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Jul 15 65(14) 6401-8",
                "id": "16024644"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407097d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "p120(ctn) forms a complex with E-cadherin at the adherens junction and is phosphorylated by ligands such as epidermal growth factor receptor as well as pp60 src",
              "citation": {
                "type": "PubMed",
                "name": "J Pathol 1999 Oct 189(2) 180-5",
                "id": "10547572"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070976"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The increase in tyrosine phosphorylation was reduced by pretreating the cells with AG1478, an EGFR tyrosine kinase inhibitor (Figure 2A). Pretreatment with AG1478 decreased the levels of MUC5AC mRNAinduced by acrolein or EGF (Figures 2B and 2C).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Crit Care Med 2005 Feb 15 171(4) 305-14",
                "id": "15531749"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070974"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "These results suggest that exogenous hsp60 released from bacteria or inflammatory cells may promote epithelial cell migration through activation of EGFR and MAP kinases",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Jul 9 319(4) 1088-95",
                "id": "15194479"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407096e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Besides being activated by ligand binding, the EGFR can be transactivated by a growing number of different pathways, including G-protein-coupled receptors (GPCRs), cytokine receptors, ion channels, integrins, and other RTKs.37",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2001 Dec 947 42-54; discussion 54-5",
                "id": "11795306"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070967"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "A previous study demonstrated EGFR activation in lung cells at very high levels of arsenite (500lM) (Wu et al. 1999).",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Sci 2009 Jun 109(2) 350-7",
                "id": "19168569"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070965"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "TGF-, which also binds to EGFR, also increased glucose transport to the same extent as insulin and with a similar affinity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 27 277(39) 36045-51",
                "id": "12138086"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070962"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": " In addition, EGFR activation in vitro induced Egr-1 protein expression in both human pulmonary artery smooth muscle cells and human lung fibroblasts within one hour (see Figure E1 in the online supplement).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2009 Oct 41(4) 415-25",
                "id": "19188657"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407095e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Besides being activated by ligand binding, the EGFR can be transactivated by a growing number of different pathways, including G-protein-coupled receptors (GPCRs), cytokine receptors, ion channels, integrins, and other RTKs.37",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2001 Dec 947 42-54; discussion 54-5",
                "id": "11795306"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407095d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Mig-6 overexpression results in reduced activation of the mitogenactivated protein kinase ERK2 in response to EGF,",
              "citation": {
                "type": "PubMed",
                "name": "Biol Chem 2001 Dec 382(12) 1649-62",
                "id": "11843178"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070957"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Interestingly, in airway epithelial cells, NE was shown to release TGF--like polypeptides followed by EGFR transactivation and signaling to increase expression of a major respiratory mucin, Muc5ac (14).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2006 Aug 291(2) L232-43",
                "id": "16473861"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407094e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "In response to stimulation with epidermal growth factor (EGF), the guanine nucleotide exchange factor human SOS1 (hSOS1) promotes the activation of Ras by forming a complex with Grb2 and the human EGF receptor (hEGFR)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Mar 8 271(10) 5871-7",
                "id": "8621459"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407094d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Finally, ErbB-1 activated by all EGF-related peptides (EGF, HB-EGF, BTC and NDF) couples to SHC, whereas only ErbB-1 activated by its own ligands associates with and phosphorylates Cbl.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Apr 1 16(7) 1647-55",
                "id": "9130710"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407094a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1998 Oct 29 251(3) 907-13",
                "id": "9791009"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070944"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 22 276(25) 22685-98",
                "id": "11297548"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407093f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Here, we demonstrate that the PGM of Sts-1, but not of Sts-2, dephosphorylates the EGFR at multiple tyrosines thereby terminating its signalling and endocytosis. ",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2007 Oct 2 581(24) 4767-72",
                "id": "17880946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070937"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Pulse-chase experiments indicated that EGF stimulated the degradation of the wild type EGF receptor but had no effect on the rate of degradation of the EGFR/RET receptor.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Jan 24 272(4) 2199-206",
                "id": "8999923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070934"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Ligation of this receptor by EGF activates Erk1 and Erk2, members of the mitogen-activated protein (MAP) kinase family, through a Ras-dependent signal transduction pathway. ",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1998 Oct 15 395(6703) 713-6",
                "id": "9790194"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407092d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Mar 23(6) 2213-24",
                "id": "12612091"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407092a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "we reported that RLPs from hypertriglyceridemic patients stimulated SMC proliferation via epidermal growth factor receptor transactivation and heparin-binding EGF like growth factor shedding",
              "citation": {
                "type": "PubMed",
                "name": "J Atheroscler Thromb 2005 12(2) 73-6",
                "id": "15942116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070928"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Gastrin-releasing peptide receptor mediates activation of the epidermal growth factor receptor in lung cancer cells",
              "citation": {
                "type": "PubMed",
                "name": "Neoplasia 2005 Apr 7(4) 426-31",
                "id": "15967120"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070926"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Non-Small-Cell Lung",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 30 277(35) 32258-67",
                "id": "12077147"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070922"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "HNE increased phosphorylated EGFR, an effect that was most prominent after 30 min of incubation with HNE (Fig. 3 A), and this induction after 30 min of incubation with HNE was prevented by a selective inhibitor of EGFR tyrosine kinase",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2002 Sep 283(3) L531-40",
                "id": "12169572"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407091b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "activation of ERK depended on EGFR, Src tyrosine kinase and calcium calmodulin in PC12 cells (31), while requiring ras/Raf-1/MEK activation in human neutrophils (58).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070917"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Studies using inhibitors of the EGF receptor tyrosine kinase, phosphatidylinositol 3-kinase (PI3-kinase) and protein kinase C (PKC) revealed that all of the cell surface agonists could activate PAK1 through pathways independent of PKC, that EGF stimulated a PI3-kinase dependent pathway to stimulate PAK1, and that muscarinic receptor stimulation of PAK1 was predominantly mediated through this EGF-R-dependent mechanism",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2003 Dec 15(12) 1099-109",
                "id": "14575865"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070916"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The RasRafMek pathway is involved in signaling downstream from EGFR and in other pathways leading to the growth of cancer cells and tumor progression (Fig. 2).",
              "citation": {
                "type": "PubMed",
                "name": "N Engl J Med 2008 Sep 25 359(13) 1367-80",
                "id": "18815398"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407090f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2000 Sep 18 150(6) 1385-98",
                "id": "10995443"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070904"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "We demonstrate here that integrin-dependent EGFR activation is also essential for adhesion-induced formation of actin stress fibers, focal adhesion localization and tyrosine phosphorylation of the adapter protein paxillin, as well as transcriptional activation of the serum response factor.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2005 Nov 17(11) 1449-55",
                "id": "16125057"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070901"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "A role for the actin-binding protein gelsolin has been demonstrated in fibroblast motility.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2005 Jul 1 307(1) 153-63",
                "id": "15922735"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070900"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Following smoke exposure, we observed oligomerization and internalization of EGFR (Fig. 2C)...Oligomerization implies that smoke induces autophosphorylation of the receptor, a mode of activation inhibitable by AG 1478.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 11 278(28) 26202-7",
                "id": "12711607"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708f1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Brain Res Mol Brain Res 2001 Feb 19 87(1) 12-21",
                "id": "11223155"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Pharmacologic inhibitors of PI3K, Akt, or the EGFR decreased Akt activity and increased apoptosis of BEAS-2B and BEAS-2B/NNK cells, with the greatest relative induction of apoptosis observed with BEAS-2B/NNK cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Chest 2004 May 125(5 Suppl) 101S-2S",
                "id": "15136436"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708e8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Serum starvation promoted tyrosine phosphorylation of a 145-kDa protein and activation of the tyrosine kinase Src and the receptor for epidermal growth factor (EGFR) over a slow time course (>8 hours). The phosphorylated 145-kDa protein was identified as the beta-subunit of c-Met/hepatocyte growth factor (HGF) receptor, p145(met), in which tyrosine residues 1003, 1234, and 1235 were phosphorylated.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2006 Nov 15 119(Pt 22) 4623-33",
                "id": "17062641"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Ang II-induced EGF-R transactivation is mediated through cSrc, a proximal target of reactive oxygen species (ROS) derived from NAD(P)H oxidase (NOX) and is dependent on AT(1)R trafficking through caveolin1 (Cav1)-enriched lipid rafts.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2005 Oct 14 97(8) 829-36",
                "id": "16151024"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708ce"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer 2004 May 13 3 15",
                "id": "15140260"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708ca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Oct 1 62(19) 5611-7",
                "id": "12359775"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708c9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Besides being activated by ligand binding, the EGFR can be transactivated by a growing number of different pathways, including G-protein-coupled receptors (GPCRs), cytokine receptors, ion channels, integrins, and other RTKs.37",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2001 Dec 947 42-54; discussion 54-5",
                "id": "11795306"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708b6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "astrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 11 278(28) 25591-9",
                "id": "12724312"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Alternatively, bile acids prevent Mcl-1 turnover through an EGFRdependent pathway, again enhancing protection (Yoon et al., 2002).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2007 Sep 13 26(42) 6133-40",
                "id": "17404574"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "EGF stabilizes the short-lived Smad transcriptional corepressor TG-interacting factor (TGIF) via EGFR",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2008 Jul 295(1) L143-51",
                "id": "18441095"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708a3"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "TNF-? elicited 1.6- and 1.3-fold increases in the pEGFR/EGFR ratio in NuLi and CuFi cells, respectively (Fig. 6A, n = 9, P < 0.03), similarly to positive control EGF stimulation (Fig. 6A). ",
              "citation": {
                "type": "PubMed",
                "name": "Antioxid Redox Signal 2009 Oct 11(10) 2453-65",
                "id": "19358684"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407089f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "phosphorylation of c-Cbl on tyrosine 371 by the activated EGFR",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Sep 14 276(37) 35185-93",
                "id": "11448952"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407089b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Autocrine amphiregulin signaling maintains EGFR in a constitutively active state in HBECs, allowing for COX-2 induction by TGF-?1.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2007 Nov 37(5) 578-88",
                "id": "17600311"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070899"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Apr 1 63(7) 1696-705",
                "id": "12670924"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070897"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "In contrast to p42IP4, which was distributed throughout the cell, centaurin alpha2 was concentrated at the plasma membrane already in unstimulated cells. The protein centaurin alpha2 was released from the membrane upon addition of wortmannin, which inhibits PI3-kinase. p42IP4, however, translocated to plasma membrane upon growth factor stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2004 Jan 88(2) 326-36",
                "id": "14690521"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070893"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Jul 1 63(13) 3764-74",
                "id": "12839972"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070892"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Jan 17 21(3) 460-74",
                "id": "11821958"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407087c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "in vivo, that cbl-b, like c-cbl, is phosphorylated and recruited to the EGFR upon EGF stimulation and both cbl proteins can bind to the Grb2 adaptor protein",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Mar 11 18(10) 1855-66",
                "id": "10086340"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070876"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "9890893;10753869;10734310",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070875"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Within 1 minute, the proapoptotic bile salts taurolithocholate-3-sulfate and glycochenodeoxycholate induced oxidative stress and EGF receptor (EGF-R) tyrosine phosphorylation followed by rapid c-Jun-N-terminal kinase (JNK) activation.",
              "citation": {
                "type": "PubMed",
                "name": "Gastroenterology 2003 Sep 125(3) 839-53",
                "id": "12949729"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070869"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "These studies show that EGF receptor activation is necessary but not sufficient for ANP and MLC2 responses to activation of G(q)-coupled receptors in ventricular myocytes, because inhibitory mechanisms can oppose such stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Mar 5 279(10) 8740-6",
                "id": "14676212"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407085c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Table 2. Targets and their Inhibitors Target Drug Form Stage References EGFR IMC-225 ZD-1839 EGFR-AS monoclonal antibodies kinase inhibitor antisense oligonucleotide Phase II and III Phase I and II preclinical Ciardiello and Tortora 2001 (91) Johnston et al. 2003 (94) Li et al. 2002 (95)",
              "citation": {
                "type": "PubMed",
                "name": "Curr Cancer Drug Targets 2004 Jun 4(4) 327-36",
                "id": "15180498"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070845"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The resulting mice called ADAM17(ex/ex) were viable, showed compromised shedding of ADAM17 substrates from the cell surface, and developed eye, heart, and skin defects as a consequence of impaired EGF-R signaling caused by failure of shedding of EGF-R ligands.",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 2010 Jul 5",
                "id": "20603312"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070843"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1999 Dec 9 266(1) 216-21",
                "id": "10581192"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407083f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Annexin V did not inhibit epidermal growth factor receptor/kinase phosphorylation of annexin I or cAMP-dependent protein kinase phosphorylation of the Kemptide peptide substrate.",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 1992 Feb 18 31(6) 1886-91",
                "id": "1310621"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407083b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "In these cells, FGF-BP was up-regulated by treatment with epidermal growth factor (EGF), dependent on protein kinase C and p38 mitogen-activated protein kinase signaling.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Apr 1 63(7) 1696-705",
                "id": "12670924"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070839"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of breast",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The smoke-triggered mechanism includes the generation of oxygen radicals, which in turn stimulate tumor necrosis factor alpha-converting enzyme (a disintegrin and metalloproteinase (ADAM) 17) to cleave transmembrane amphiregulin, a ligand for the epidermal growth factor receptor (EGFR).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 11 278(28) 26202-7",
                "id": "12711607"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070830"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "In addition, p38alpha controls self-renewal of the lung stem and progenitor cell population by inhibiting proliferation-inducing signals, most notably epidermal growth factor receptor",
              "citation": {
                "type": "PubMed",
                "name": "Nat Genet 2007 Jun 39(6) 750-8",
                "id": "17468755"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407082d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Inhibition of EGF receptor (EGFR) tyrosine kinase activity by PD168393 (1nM) blocked the stimulatory effects of EGF on SERT promoters. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Gastrointest Liver Physiol 2011 Jan 27",
                "id": "21273531"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407082b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Renal Physiol 2004 Feb 286(2) F385-93",
                "id": "14559717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070824"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Neuregulin-induced activation of CDK2 also depended on the ErbB receptor (EGFR), MAPK (MEK), and PI3K, all of which have previously been shown to be required for AChRepsilon expression. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jun 10 280(23) 21731-8",
                "id": "15824106"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070820"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "We previously reported that MAPK activation by GRP occurs via EGFR phosphorylation in HNSCC (15).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Sep 1 64(17) 6166-73",
                "id": "15342401"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407081a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Head and Neck Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "These results suggest that IL-8 increases cell proliferation in NSCLC cell lines via transactivation of the EGFR and that this mechanism involves metalloproteinase activity.",
              "citation": {
                "type": "PubMed",
                "name": "Lung Cancer 2007 Apr 56(1) 25-33",
                "id": "17175059"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070811"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "We investigated the effect of highly specific EGFR inhibitors PD153035 (IC50 = 25 pmol/L) and Erlotinib (IC50 = 2 nmol/L) that rapidly suppress EGFR autophosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Jul 15 65(14) 6275-81",
                "id": "16024629"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407080e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Epidermal growth factor receptor (EGFR) signaling has long been implicated downstream of ERalpha signaling",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2007 Mar 27 104(13) 5455-60",
                "id": "17369357"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070809"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "we showed that epidermal growth factor receptor (EGFR) activation causes mucin expression in airway epithelium in vivo and in human NCI-H292 airway epithelial cells and normal human bronchial epithelial (NHBE) cells in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2005 Dec 289(6) L1049-60",
                "id": "16055478"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707fb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Conversely, EGFR signaling blockade produces opposite effects, with increased CCL2, CCL5, and CXCL10, and reduced CXCL8 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Pathol 2003 Jul 163(1) 303-12",
                "id": "12819035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707fa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Treatment of keratinocytes with epidermal growth factor results in an increase in Delta Np63 alpha expression at the mRNA level, which is abrogated by inhibition of PI3K but not mitogen-activated protein kinase signaling.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 19 278(51) 51408-14",
                "id": "14555649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "MMP-7 activates the epidermal growth factor (EGF) receptor by releasing an EGF ligand, tumor growth factor (TGF)-alpha. ",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2004 Dec 15 10(24) 8243-9",
                "id": "15623600"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "EGF diminished NDRG1 expression, and this effect was abolished by the EGF receptor inhibitor AG1478",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Feb 3 281(5) 2764-72",
                "id": "16314423"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "trophoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2002 Nov 8(11) 3570-8",
                "id": "12429648"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707ae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "We show that EGF-induced EGFR autotransphosphorylation is reduced in PC3-AR cells compared to PC3 cells transfected only with the vector (PC3-Neo).",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2004 Oct 20 112(1) 78-86",
                "id": "15305378"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1992 Sep 25 267(27) 19258-65",
                "id": "1382070"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707a3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Treatment of keratinocytes expressing a normal epidermal growth factor receptor (EGFR) with TGFalpha or epidermal growth factor for 5 min induced PKCdelta tyrosine phosphorylation. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Mar 8 271(10) 5325-31",
                "id": "8621384"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707a2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Nicotine has been shown to induce transactivation of the epidermal growth factor receptor (EGFR) through an increase in intracellular Ca2+ and Ltype voltage-sensitive Ca2+ channels.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Pharmacol Sci 2008 Mar 29(3) 151-8",
                "id": "18262664"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "we demonstrate that EGF (i) increased the binding affinity of EGFR to Gab1 Tyr-627 and Shc Tyr-317 sites in purified GST fusion proteins approximately 4-6-fold, and (ii) EGF significantly enhanced the phosphorylation of these sites, relative to EGFR autophosphorylation, in cell lysates containing the full-length Gab1 and Shc proteins.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Sep 10 279(37) 38143-50",
                "id": "15231819"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707a0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Mar 28 272(13) 8739-43",
                "id": "9079708"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070796"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The Src inhibitor PP1 and the EGFR inhibitor AG-1478 completely inhibited carbachol-stimulated MAPK activation. AG-1478 also inhibited goblet cell secretion. (Fig. 8) We conclude that carbachol transactivates the EGFR to activate MAPK, leading to conjunctival goblet cell secretion.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2003 Apr 284(4) C988-98",
                "id": "12620895"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070789"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Goblet Cell",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Jun 15 62(12) 3402-7",
                "id": "12067982"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070780"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Exogenous OPN increased EGFR mRNA expression, as well as EGFR kinase activity.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Feb 27 22(8) 1198-205",
                "id": "12606946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407077e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "First, PEA-15 blocks nuclear accumulation of RSK2 after epidermal growth factor stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 22 278(34) 32367-72",
                "id": "12796492"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407077d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Although Ymer and EGF receptors are associated in an EGF-dependent manner, their interaction is required not only for MIU domains but also for the tyrosine phosphorylation of Ymer.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Aug 25 281(34) 24612-22",
                "id": "16803894"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407077c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "in A431 cells, high concentrations of HNE induces also EGFR signaling and receptor clustering but trigger apoptosis of A431 cells (Liu et al., 1999).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Aspects Med 24(4-5) 251-61",
                "id": "12893003"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070778"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "EGF strongly inhibited the expression of WDNM1 and SGP-2 genes. Our recent results are reviewed and discussed.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Mol Med 1998 Jul 2(1) 39-44",
                "id": "9854140"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070775"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Here we show that purified EGF (epidermal growth factor)-receptor kinase phosphorylates the enzymes PGM and enolase and also the key regulatory enzymes of the glycolytic pathway, phosphofructokinase and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), in an EGF-dependent manner.  (From Results: Tyrosine is the only amino acid in these enzyme substrates that was phosphorylated by purified EGFreceptor kinase (Fig. 2).)",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1986 Nov 1 239(3) 691-7",
                "id": "3030270"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070768"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "We report here that the activated GTP-bound form of RhoB is increased rapidly within 5 min of exposure to UVB, and then RhoB  protein levels increased concomitantly with EGF receptor (EGFR) activation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Dec 30 280(52) 43257-63",
                "id": "16278215"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407075f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The interaction of ACK1 with EGFR was dependent on the kinase activity or tyrosine phosphorylation of EGFR. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2007 Mar 18(3) 732-42",
                "id": "17182860"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407075a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Pretreatment with Triptorelin or [d-Lys(6)]GnRH-II blocked EGF-induced autophosphoryla-tion of EGF receptor and activation of mitogen-activated protein kinase (extracellular-signal-regulated kinase 1/2 (ERK1/2)) in these cells.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Endocrinol 2005 Oct 153(4) 613-25",
                "id": "16189183"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070759"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2002 Feb 15 115(Pt 4) 839-48",
                "id": "11865039"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070754"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "we show that in normal rat ovarian surface epithelial cells Lot1 gene expression is responsive to growth factor stimulation. Its mRNA is strongly down-regulated by epidermal growth factor receptor (EGFR) ligands, namely EGF and TGF-alpha",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Nov 11 18(47) 6477-87",
                "id": "10597250"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070744"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "CCh also induced association of FAK with the EGFr and FAK phosphorylation was attenuated by an EGFr inhibitor, tyrphostin AG1478, and an inhibitor of Src family kinases, PP2. The actin cytoskeleton disruptor, cytochalasin D (20 microM), abolished FAK phosphorylation in response to CCh but did not alter CCh-induced EGFr or ERK MAPK activation. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2005 Apr 203(1) 103-10",
                "id": "15389641"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070742"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "we showed that epidermal growth factor receptor (EGFR) activation causes mucin expression in airway epithelium in vivo and in human NCI-H292 airway epithelial cells and normal human bronchial epithelial (NHBE) cells in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2005 Dec 289(6) L1049-60",
                "id": "16055478"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070740"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "endogenous P-Rex1 was involved in cell migration of PC12 cells and primary cultured neurons from the embryonic day 14 cerebral cortices, induced by extracellular stimuli (NGF, BDNF, and epidermal growth factor).",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2005 Apr 27 25(17) 4406-19",
                "id": "15858067"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407073c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "These results suggest that EGF-induced H2O2 formation requires the kinase activity but probably not the autophosphorylation sites of the EGF receptor",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Jan 3 272(1) 217-21",
                "id": "8995250"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070736"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Autocrine Wnt signalling through the GPCR frizzled 1 contributes to breast cancer cell proliferation in part through EGFR transactivation92. To add another layer of complexity, progesterone receptor signalling through WnT1 induced EGFR transactivation and SRCdependent sustained activation of ErkMAPK signalling in breast cancer cells93",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2008 Dec 8(12) 929-41",
                "id": "19005493"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407072e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "STAG1 is induced by EGF and other growth factors at the transcript and protein levels",
              "citation": {
                "type": "PubMed",
                "name": "Mol Carcinog 2003 Dec 38(4) 188-200",
                "id": "14639658"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407072b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "EGFR inhibition resulted in diminished HIF-1a levels.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2010 May 6 29(18) 2616-27",
                "id": "20154724"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407071e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "b1-integrin phosphorylation by Src results in EGF-R activation (Miranti and Brugge, 2002), and b1-integrin expression is required for the initiation of mouse mammary tumors expressing the polyoma virus middle T antigen (White et al., 2004).",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2008 Mar 128(3) 501-16",
                "id": "18268536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070717"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Stem Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Arch Dermatol Res 2002 Feb 293(12) 634-41",
                "id": "11875647"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070716"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "inhibition of EGFR tyrosine kinase activity using AG1478 (1 ?m) markedly decreased IL-8 production induced by ATP, LPS, or ?-ASGM1 (Table 1)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jun 26 284(26) 17858-67",
                "id": "19386603"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407070c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "EGF treatment caused the association of SHC with Grb2 and Gab2 with phospho-SHC, phospho-Gab1, Grb2, and p85",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2006 Dec 147(12) 6027-35",
                "id": "16990343"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070706"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of breast",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 1997 Apr 4 53(7) 937-42",
                "id": "9174106"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "We used this approach to examine 13 xenografts of human tumors implanted into nude mice for sensitivity to an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), ZD1839 (Iressa).",
              "citation": {
                "type": "PubMed",
                "name": "Int J Oncol 2003 Jul 23(1) 29-39",
                "id": "12792773"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706fb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2000 Aug 21 150(4) 905-12",
                "id": "10953014"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706f0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Bacterial lipoteichoic acid activates the platelet-activating factor receptor, which is G protein-coupled. This results in activation of a disintegrin and metalloproteinase (ADAM10), kuzbanian, cleavage of pro heparin-binding epidermal growth factor and activation of the epidermal growth factor receptor. ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2002 Jan 8(1) 41-6",
                "id": "11786905"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706ef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "BMS-690514 is a novel specific inhibitor of EGFR, exhibiting an in vitro IC50 of ~5 nmol/L.11 At higher concentrations, it acts also on other members of the EGFR family (i.e., Erb-B2 and Erb-B4, with an IC50 of ~20 and ~60 nmol/L, respectively) as well as on VEGFR2 (IC50 of ~50 nmol/L).11 ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2007 Jul 1 67(13) 6253-62",
                "id": "17616683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "EGF receptor (EGFR) inhibition, neutralizing antibody against amphiregulin, or mitogen-activated protein kinase kinase (MEK) inhibition blocked TGF-beta1-mediated COX-2 induction.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2007 Nov 37(5) 578-88",
                "id": "17600311"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706e1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Shc products are phosphorylated on tyrosine by the activated epidermal growth factor receptor (EGFR) and become physically associated with EGFR via their SH2 domain. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1993 Aug 8(8) 2105-12",
                "id": "8101647"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706df"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "EGFR induction occurred during TAM response, as measured by immunocytochemistry and Western blotting, with EGFR-positive, highly proliferative resistant growth subsequently emerging.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2003 Nov 144(11) 5105-17",
                "id": "12960029"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706dc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of breast",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "the expression of SOCS5 and its closest homolog SOCS4 is elevated in cells following treatment with EGF,",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Feb 25 280(8) 7038-48",
                "id": "15590694"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706da"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2004 Jul 15 10(14) 4670-9",
                "id": "15269139"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "ligand (PDGF and EGF) binding to RTKs stimulates the production of H2O2 which reinforces RTK autophosphorylation and subsequent signaling, that may be independent or dependent on autocrine secretion of ligands (Bae et al., 1997)  ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Aspects Med 24(4-5) 251-61",
                "id": "12893003"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706cb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of epithelium",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "This is consistent with our finding that EGF, an upstream activator of MAPK, enhances the effect of SRC-1 on PR-dependent gene transcription (50).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Dec 20(23) 8720-30",
                "id": "11073973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706c6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "EGF induces tyrosine phosphorylation of tensin3 in MDA-MB-468 cells in a time- and dose-dependent manner, but it is independent of an intact actin cytoskeleton or phosphatidylinositol 3-kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2004 Apr 2(4) 225-32",
                "id": "15140944"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706c0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Amphiregulin, an EGF receptor (EGFR) ligand, is essential for epithelial development in various organs. A recent report suggested that amphiregulin acts as a protective factor in a liver injury model. Little is known about the roles of amphiregulin in lung injury and pulmonary fibrosis.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2010 Feb 298(2) L131-8",
                "id": "19915156"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706b9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "from full text Results - Fig. 2. AG1478 represses miR-21 expression   (AG1478 = EGFR TKI)",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2009 Jul 21 106(29) 12085-90",
                "id": "19597153"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706b3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The EGFR-dependent NSCLC cell lines HCC827 and H3255 had increased phosphorylation of SFKs, and treatment of these cells with an SFK inhibitor (PP1 or SKI-606) induced apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Pathol 2007 Jan 170(1) 366-76",
                "id": "17200208"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706af"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Apr 24(7) 2923-31",
                "id": "15024080"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706ae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Interestingly, the AR level was also decreased in EGF-treated LNCaP C-81 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 Mar 31 342(1) 92-100",
                "id": "16472761"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Here, we show that deletion of the mouse gene encoding Mig6 (designated Errfi1, which stands for ERBB receptor feedback inhibitor 1) causes hyperactivation of endogenous epidermal growth factor receptor (EGFR) and sustained signaling through the mitogen-activated protein kinase (MAPK) pathway, resulting in overproliferation and impaired differentiation of epidermal keratinocytes.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2006 May 12(5) 568-73",
                "id": "16648858"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706a3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "In addition, the scaffolding domains of caveolins 1 and 3 both functionally inhibit the autophosphorylation of the EGF-R kinase in vitro",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Nov 28 272(48) 30429-38",
                "id": "9374534"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706a2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "H322 cells express wild-type EGFR and have no EGFR gene amplification. EGF led to the expected EGFR activation and later to increased levels of EphA2 protein (Fig. 5); both were significantly decreased by the use of the EGFR inhibitor erlotinib.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2009 Jul 1 15(13) 4423-30",
                "id": "19531623"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407069d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Pubmed:gene: alpha-Hemolysin-induced dephosphorylation of EGF receptor of A431 cells is carried out by rPTPsigma.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Dec 3 325(1) 344-52",
                "id": "15522239"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070699"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "erbB kinase inhibitor CI1033 has been demonstrated to have potent inhibitory activity against the entire erbB family",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Jan 1 63(1) 132-9",
                "id": "12517789"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407068d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Gefitinib (Iressa) and erlotinib (Tarceva) inhibit the epidermal growth factor receptor (EGFR) kinase",
              "citation": {
                "type": "PubMed",
                "name": "Science 2007 May 18 316(5827) 1039-43",
                "id": "17463250"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070681"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Previously we found that short peptides surrounding major autophosphorylation sites of EGFR (VPEY(1068)INQ, DY(1148)QQD, and ENAEY(1173)LR) suppress phosphorylation of purified EGFR to 30-50% at 4000 muM",
              "citation": {
                "type": "PubMed",
                "name": "Biopolymers 2007 Sep 11",
                "id": "17849478"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070674"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "As shown in Fig. 3A, Ang II phosphorylated EGF receptor at its tyrosine residue indicating that Ang II activates EGF receptor.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Mar 19 315(4) 905-11",
                "id": "14985098"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070673"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "H. pylori up-regulates VEGF expression in gastric epithelial cells; and (b) this effect is specifically related to VacA toxin and seems to depend on the activation of an EGFR-, MAP kinase-, and COX-2-mediated pathway",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2003 Jun 9(6) 2015-21",
                "id": "12796363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407066e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The treatment of NCI-N87 cells with EGF resulted in increases in phosphorylation of Erk1/2, Akt, and P38. Blockade of the Erk, phosphatidylinositol-3 kinase/Akt, or P38 pathways in this cell line",
              "citation": {
                "type": "PubMed",
                "name": "Br J Cancer 2003 Mar 10 88(5) 796-802",
                "id": "12618892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407066d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The EGF effect depended on activation of its receptor tyrosine kinase but not on that of protein kinase C, mitogen-activated protein kinases, or phosphoinositide-3 kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Renal Physiol 2001 Aug 281(2) F244-54",
                "id": "11457715"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070668"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "that lipocortin I and the 35 kd substrate for the EGF-receptor/kinase from A431 cells are the same protein.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1986 Jul 18 46(2) 191-9",
                "id": "3013422"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070666"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "endogenous P-Rex1 was involved in cell migration of PC12 cells and primary cultured neurons from the embryonic day 14 cerebral cortices, induced by extracellular stimuli (NGF, BDNF, and epidermal growth factor).",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2005 Apr 27 25(17) 4406-19",
                "id": "15858067"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070660"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Pretreatment with selective EGFR inhibitors AG1478 or BIBX1522 or the MEK inhibitor PD-98059 significantly reduced PMA-induced IL-8 gene expression (Fig. 2A) ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2007 May 292(5) L1289-96",
                "id": "17220369"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407065e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Fig.1",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Nov 26 306(5701) 1506-7",
                "id": "15567848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407065d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Gab-1 is heavily phosphorylated by the epidermal growth factor receptor, but poorly by the insulin receptor",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 1999 Apr 103(7) 931-43",
                "id": "10194465"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407064b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "We could demonstrate in serum-starved cells that endogenous TNK2 binding to endogenous EGFR was enhanced by EGFR activation (Figure ?(Figure2b),2bFigure 2), although the ability of TNK2 to bind EGFR in normal serum, without EGF stimulation, was also evident (Figure ?(Figure2c,2cFigure 2, lane 1). ",
              "citation": {
                "type": "PubMed",
                "name": "Breast Cancer Res 2008 10(2) R36",
                "id": "18435854"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407063f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Jun 24 100(13) 7626-31",
                "id": "12802020"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407063e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "In this study, we demonstrate that PI3K-C2alpha and PI3K-C2beta represent two downstream targets of the activated epidermal growth factor (EGF) receptor in human carcinoma-derived A431 cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Jun 20(11) 3817-30",
                "id": "10805725"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070637"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1991 Jun 15 88(12) 5222-6",
                "id": "1647028"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070620"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Besides being activated by ligand binding, the EGFR can be transactivated by a growing number of different pathways, including G-protein-coupled receptors (GPCRs), cytokine receptors, ion channels, integrins, and other RTKs.37",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2001 Dec 947 42-54; discussion 54-5",
                "id": "11795306"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407061e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Hydrophobic bile acids induce CD95 (Fas, APO-1)-dependent hepatocyte apoptosis, which involves epidermal growth factor receptor (EGFR)-catalyzed CD95 tyrosine phosphorylation. The mechanisms underlying bile salt-induced EGFR activation remain unclear. METHODS: Bile acid-induced EGFR activation was studied in 24-hour cultured rat hepatocytes and perfused rat liver. ",
              "citation": {
                "type": "PubMed",
                "name": "Gastroenterology 2004 Nov 127(5) 1540-57",
                "id": "15521021"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407061c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1998 Dec 18(12) 7192-204",
                "id": "9819406"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407061b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "EGF increased the expression of OPN mRNA and protein in a dose- and time-dependent manners. Pretreatment of Wortmannin significantly reduced the EGF-induced OPN expression",
              "citation": {
                "type": "PubMed",
                "name": "Zhonghua Yi Xue Za Zhi 2003 Nov 25 83(22) 1980-3",
                "id": "14703434"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407061a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 1988 May 17 27(10) 3682-90",
                "id": "2457390"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407060f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "In conclusion, bile acids activate EGFR via a TGF-alpha-dependent mechanism, and this EGFR activation promotes cellular growth.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Gastrointest Liver Physiol 2003 Jul 285(1) G31-6",
                "id": "12606307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407060b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Exp Dermatol 2003 Aug 12(4) 445-52",
                "id": "12930301"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070603"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Down-regulation of ErbB-3 by means of short hairpin RNA leads to decreased phospho-Akt levels in the gefitinib-sensitive NSCLC cell lines, Calu-3 (WT EGFR) and H3255 (L858R EGFR), but has no effect on Akt activation in the gefitinib-resistant cell lines, A549 and H522.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Mar 8 102(10) 3788-93",
                "id": "15731348"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Exp Ther 2004 Jan 308(1) 66-72",
                "id": "14569062"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705fb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "In addition, heme-induced IL-8 expression utilizes a novel pathway involving meprin, EGF receptor, and MyD88.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2011 Mar 4 286(9) 7692-704",
                "id": "21193404"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705f5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Here we show that EGFR activation stimulates the formation of H-Ras.GTP- Galectin-1 (Gal-1) complexes on the plasma membrane that are then assembled into transient nanoclusters. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2008 Jan 30",
                "id": "18234837"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "EphA2 expression was found to be positively correlated with activated EGFR (Y1086)in patient tumors (SCC = 0.21; P = 0.01) using SCC.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2009 Jul 1 15(13) 4423-30",
                "id": "19531623"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Small Cell",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 21 276(51) 48532-8",
                "id": "11602604"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2003 Oct 15 116(Pt 20) 4169-79",
                "id": "12953068"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705e1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "We have also established that EGF receptor activation, which is known to function upstream of HD disassembly, results in the phosphorylation of only one or more of these three residues and the partial disassembly of HDs in keratinocytes. Additionally, we show that S1360 and S1364 of beta4 are the only residues phosphorylated by PKC and PKA in cells, respectively. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2007 Jul 5",
                "id": "17615294"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705dd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The effects of IL-13 were mediated through the epidermal growth factor receptor (EGFR), as proliferation was attenuated by AG1478, an EGFR tyrosine kinase inhibitor. Proliferation appeared to be mediated by transforming growth factor (TGF)-alpha, a potent ligand for EGFR, which was released rapidly from NHBE cells in response to IL-13.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2001 Dec 25(6) 739-43",
                "id": "11726400"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 16 279(16) 16452-62",
                "id": "14679213"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705d5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2003 Jun 3(6) 565-76",
                "id": "12842085"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705d4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "EphB4 expression was also reduced by inhibition of both the EGFR and IGF-IR pathways",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Jun 1 65(11) 4623-32",
                "id": "15930280"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Pretreating the cells with EGF receptor specific antibody, mAb 528 or with the EGF receptor specific inhibitor CGP59326 resulted in decreased phosphorylation of GAB1, and also decreased association with the other members of the immune complex including the EGF receptor.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Jan 1 61(1) 383-91",
                "id": "11196191"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705b9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Dec 24 274(52) 37285-91",
                "id": "10601294"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Dok-R has previously been shown to associate with the epidermal growth factor receptor (EGFR) and become tyrosine phosphorylated in response to EGF stimulation. Dok-R is constitutively associated with c-Src and upon recruitment to the EGFR Dok-R becomes tyrosine phosphorylated on tyrosine residue 402, which serves to recruit the negative regulator kinase, Csk. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 May 25(9) 3831-41",
                "id": "15831486"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705a4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": " While wild-type EGFR induced rapid and sustained Eps15 tyrosine phosphorylation, the capacity of the Y1045F EGFR mutant to do so was impaired, even when c-Cbl was co-expressed (Fig. 2B).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2004 Oct 1 117(Pt 21) 5001-12",
                "id": "15383614"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705a2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "We show that epidermal growth factor (EGF) represses PGDH expression in colorectal cancer cells. EGF receptor (EGFR) signaling induces Snail, which binds conserved E-box elements in the PGDH promoter to repress transcription.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Jul 1 66(13) 6649-56",
                "id": "16818638"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407059a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1993 Jan 4(1) 9-15",
                "id": "8424907"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407058d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "gp130 can transduce signals upon IL6 stimulation, which result in EGFR phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 15 279(42) 44093-100",
                "id": "15292206"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070575"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "# Ariadne: Ubiquitin- conjugated keratin 8 fragments appear to accumulate in colorectal carcinomas (  16 ). [Binding]",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Sep 1 275(35) 27075-83",
                "id": "10801882"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070573"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "In rodent pleural mesothelial cells, asbestos fibers preferentially activate the ERK1/2 pathway, in contrast to the JNK1/2 and p38 MAPK pathways (21), via phosphorylation of the EGFR (22). ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Jun 34(6) 666-9",
                "id": "16484683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070571"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "pleural mesothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Ariadne: In this study, we show that H-Ras, N-Ras, K-Ras, EGFR and ErbB2 but not v-Src suppress RhoB promoter transcriptional activity in NIH3T3 cells and human cancer cell lines derived from lung (A-549), pancreatic (Panc-1) and cervical (C33A) tumors. [Expression]",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Feb 5 23(5) 1136-45",
                "id": "14647415"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407055d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Both EGF and heregulin-beta1 induced expression of hnRNP K mRNA and protein in human breast cancer cells. This growth factor-mediated hnRNP K expression was effectively blocked by pretreatment of cultures with humanized anti-EGF receptor (EGFR) antibody C225, or anti-human epidermal growth factor receptor-2 (HER2) antibody.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Mar 30 276(13) 9699-704",
                "id": "11121407"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407054d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "RNAi depletion of beta2-chimaerin significantly extended the duration of Rac activation by EGF, suggesting that beta2-chimaerin serves as a mechanism that self-limits Rac activity in response to EGFR activation.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 May 17 25(10) 2062-74",
                "id": "16628218"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070549"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 1999 Apr 112(4) 443-9",
                "id": "10201527"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070548"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "We recently showed that IGF1R gene silencing led to EGFR hyper-phosphorylation in human breast cancer cells",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2007 Apr 13 355(3) 707-14",
                "id": "17307140"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070546"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of breast",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Ravid and co-workers found that hydrogen peroxide prolonged EGFR activation.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Aug 35(2) 165-74",
                "id": "16543607"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070542"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Moreover, AR gene silencing by siRNA or inhibition of AR biological activity by neutralizing antibodies and heparin prevents GPCR-induced EGFR tyrosine phosphorylation, downstream mitogenic signalling events, cell proliferation, migration and activation of the survival mediator Akt/PKB.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2003 May 15 22(10) 2411-21",
                "id": "12743035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407053a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 14 278(7) 5163-71",
                "id": "12454019"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070538"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "Besides being activated by ligand binding, the EGFR can be transactivated by a growing number of different pathways, including G-protein-coupled receptors (GPCRs), cytokine receptors, ion channels, integrins, and other RTKs.37",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2001 Dec 947 42-54; discussion 54-5",
                "id": "11795306"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070537"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "hSpry2 was shown to abrogate EGFR ubiquitylation and endocytosis, and sustain EGF-induced ERK signalling",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Sep 16 21(18) 4796-808",
                "id": "12234920"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070530"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:EGFR) actsIn kin(p(HGNC:EGFR))",
              "summary_text": "The tyrosine kinase JAK1 and the transcription factors STAT1 and STAT3 are phosphorylated in response to epidermal growth factor (EGF) and other growth factors",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Jan 16(1) 369-75",
                "id": "8524316"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407050c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:GGPS1)",
        "relation": "increases",
        "target": "kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
        "directed": false,
        "label": "p(HGNC:GGPS1) increases kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "edwardsanders",
          "edgeId": "52cbf83bbf21ca064401f294",
          "evidences": [
            {
              "bel_statement": "p(HGNC:GGPS1) increases kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
              "summary_text": "\"Taken together, our data suggest that MAPK Erk 1/2 might be positively regulated by EGR-1 through increasing Ras prenylation by promoting GGPPS [GGPS1] transcription.\" (p. 2747)",
              "citation": {
                "type": "Other",
                "name": "Shen N, Shao Y, Lai SS, \"GGPPS, a new EGR-1 target gene, reactivates ERK 1/2 signaling through increasing Ras prenylation,\" Am J Pathol, 2011, 179:2740-50.",
                "id": "21983072"
              },
              "metadata": {
                "created_by": "edwardsanders",
                "id": "52cbf83bbf21ca064401f222"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "Beas-2B cells",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:MAPK14))",
        "relation": "decreases",
        "target": "bp(GOBP:\"cell proliferation\")",
        "directed": false,
        "label": "kin(p(HGNC:MAPK14)) decreases bp(GOBP:\"cell proliferation\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526dd",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:MAPK14)) decreases bp(GOBP:\"cell proliferation\")",
              "summary_text": "deletion of p38mitogen-activated protein (MAP) kinase in adult mice results in increased proliferation and defective differentiation of lung stem and progenitor cells both in vivo and in vitro",
              "citation": {
                "type": "Other",
                "name": "Nat Genet. 2007 Jun;39(6):750-8. Epub 2007 Apr 29.\np38alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation.\nVentura JJ, Tenbaum S, Perdiguero E, Huth M, Guerra C, Barbacid M, Pasparakis M, Nebreda AR.",
                "id": "17468755"
              },
              "metadata": {
                "created_by": "jaguzova",
                "id": "52e726b4bf21ca0b18f661c6"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "stem cells"
              }
            },
            {
              "bel_statement": "kin(p(HGNC:MAPK14)) decreases bp(GOBP:\"cell proliferation\")",
              "summary_text": "deletion of p38alpha mitogen-activated protein (MAP) kinase in adult mice results in increased proliferation",
              "citation": {
                "type": "PubMed",
                "name": "Nat Genet 2007 Jun 39(6) 750-8",
                "id": "17468755"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a89"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "path(SDIS:\"cell senescence\")",
        "relation": "increases",
        "target": "kin(p(SFAM:\"MAPK p38 Family\"))",
        "directed": false,
        "label": "path(SDIS:\"cell senescence\") increases kin(p(SFAM:\"MAPK p38 Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526d0",
          "evidences": [
            {
              "bel_statement": "path(SDIS:\"cell senescence\") increases kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Exposure to high doses of IR can cause long-term hematopoietic\ninjury in part via induction of HSC senescence...In a preliminary study, we found that IR and G-CSF can\nactivate p38 in BM Lin- cells enriched with HSCs and HPCs and\nthe activation can be abrogated by incubation of the cells with SB,\na specific p38 inhibitor (Fig.S1)",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "23646161"
              },
              "metadata": {
                "created_by": "jaguzova",
                "id": "52e56be7bf21ca0a080aea24"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "hematopoietic stem cells"
              }
            },
            {
              "bel_statement": "path(SDIS:\"cell senescence\") increases kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "High Intensity ras Signaling Induces Premature Senescence by Activating p38 Pathway in Primary Human Fibroblasts",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "14593117"
              },
              "metadata": {
                "created_by": "jaguzova",
                "id": "52f647bf89e36207c803ba11"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": "fibroblasts"
              }
            },
            {
              "bel_statement": "path(SDIS:\"cell senescence\") increases kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "p38(MAPK) activation and increased DNA binding activities of ATF-2 and p53 are shown to mediate cyclooxygenase-2 overexpression in premature senescence",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "19082758"
              },
              "metadata": {
                "created_by": "jaguzova",
                "id": "52f6476389e36207c803b8cd"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": "fibroblasts"
              }
            },
            {
              "bel_statement": "path(SDIS:\"cell senescence\") increases kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Activation of p38MAPK in DNA-damage-induced senescence contributes to suppression of HSR",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "22510478"
              },
              "metadata": {
                "created_by": "jaguzova",
                "id": "52e569c6bf21ca0a080ae8a2"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": "fibroblast"
              }
            },
            {
              "bel_statement": "path(SDIS:\"cell senescence\") increases kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a1c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:EGR1)",
        "relation": "increases",
        "target": "r(HGNC:GGPS1)",
        "directed": false,
        "label": "p(HGNC:EGR1) increases r(HGNC:GGPS1)",
        "metadata": {
          "casual": false,
          "createdBy": "edwardsanders",
          "edgeId": "52cbf05ebf21ca0644010b31",
          "evidences": [
            {
              "bel_statement": "p(HGNC:EGR1) increases r(HGNC:GGPS1)",
              "summary_text": "\"When we overexpressed EGR1 with an adenovirus to mimic elevated EGR under CSE [cigarette smoke extract] stress, we found that GGPPS [GGPS1] mRNA and protein were also significantly increased.\" (p. 2744)",
              "citation": {
                "type": "Other",
                "name": "Shen N, Shao Y, Lai SS, et al., \"GGPPS, a new EGR-1 target gene, reactivates ERK 1/2 signaling through increasing Ras prenylation,\" Am J Pathol, 2011, 179:2740-50.",
                "id": "21983072"
              },
              "metadata": {
                "created_by": "edwardsanders",
                "id": "52cbf05ebf21ca0644010ac1"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "Beas-2B cells",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RASSF1)",
        "relation": "decreases",
        "target": "p(HGNC:CCND1)",
        "directed": false,
        "label": "p(HGNC:RASSF1) decreases p(HGNC:CCND1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526c8",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RASSF1) decreases p(HGNC:CCND1)",
              "summary_text": "RNA interference-mediated downregulation of endogenous RASSF1A expression in human epithelial cells results in abnormal accumulation of cyclin D1 protein",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jun 22(12) 4309-18",
                "id": "12024041"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b60"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(HGNC:RASSF1) decreases p(HGNC:CCND1)",
              "summary_text": "The exogenous expression of RASSF1A suppressed JNK phosphorylation, and cells stably transfected with RASSF1A showed reduced JNK and c-Jun phosphorylation and Cyclin D1 down-regulation. An in vitro kinase assay showed that the exogenous expression of RASSF1A inhibited JNK activity and that JNK activity suppression due to ectopically expressed RASSF1A was revived by RASSF1A siRNA treatment.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 May 1 65(9) 3682-90",
                "id": "15867363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ac8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RASSF1) decreases p(HGNC:CCND1)",
              "summary_text": "As shown in Fig. 1B, the exogenous expression of RASSF1A inhibited the phosphorylation of c-Jun and reduced the expression of Cyclin D1.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 May 1 65(9) 3682-90",
                "id": "15867363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407086b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RASSF1)",
        "relation": "decreases",
        "target": "p(HGNC:JUN,pmod(P))",
        "directed": false,
        "label": "p(HGNC:RASSF1) decreases p(HGNC:JUN,pmod(P))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526c9",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RASSF1) decreases p(HGNC:JUN,pmod(P))",
              "summary_text": "The exogenous expression of RASSF1A suppressed JNK phosphorylation, and cells stably transfected with RASSF1A showed reduced JNK and c-Jun phosphorylation and Cyclin D1 down-regulation. An in vitro kinase assay showed that the exogenous expression of RASSF1A inhibited JNK activity and that JNK activity suppression due to ectopically expressed RASSF1A was revived by RASSF1A siRNA treatment. Based on our data, we suggest that RASSF1A exerts a tumor-suppressing effect by blocking oncogene-mediated JNK activation in lung cells.",
              "citation": {
                "type": "Other",
                "name": "cancer res 2005 may 1 65(9) 3682-90",
                "id": "15867363"
              },
              "metadata": {
                "created_by": "davidgaralf",
                "id": "54e11b5589e3620a34acab92"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "lung neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RASSF1) decreases p(HGNC:JUN,pmod(P))",
              "summary_text": "The exogenous expression of RASSF1A suppressed JNK phosphorylation, and cells stably transfected with RASSF1A showed reduced JNK and c-Jun phosphorylation and Cyclin D1 down-regulation. An in vitro kinase assay showed that the exogenous expression of RASSF1A inhibited JNK activity and that JNK activity suppression due to ectopically expressed RASSF1A was revived by RASSF1A siRNA treatment. Based on our data, we suggest that RASSF1A exerts a tumor-suppressing effect by blocking oncogene-mediated JNK activation in lung cells.",
              "citation": {
                "type": "Other",
                "name": "cancer res 2005 may 1 65(9) 3682-90",
                "id": "15867363"
              },
              "metadata": {
                "created_by": "davidgaralf",
                "id": "54e110f689e3620a34a9de0d"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "lung neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RASSF1) decreases p(HGNC:JUN,pmod(P))",
              "summary_text": "The exogenous expression of RASSF1A suppressed JNK phosphorylation, and cells stably transfected with RASSF1A showed reduced JNK and c-Jun phosphorylation and Cyclin D1 down-regulation. An in vitro kinase assay showed that the exogenous expression of RASSF1A inhibited JNK activity and that JNK activity suppression due to ectopically expressed RASSF1A was revived by RASSF1A siRNA treatment.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 May 1 65(9) 3682-90",
                "id": "15867363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070779"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RASSF1) decreases p(HGNC:JUN,pmod(P))",
              "summary_text": "JNK phosphorylation was inhibited in cells stably expressing RASSF1A, and the phosphorylation inhibition of JNK substrates, such as c-Jun and ATF-2, was then accompanied (H1299 cells transiently transfected with RASSF1A)",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "15867363"
              },
              "metadata": {
                "created_by": "jaguzova",
                "id": "52e5653bbf21ca0a080ae2fd"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "h1299",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"MAPK p38 Family\",pmod(P,T,180))",
        "relation": "directlyIncreases",
        "target": "kin(p(SFAM:\"MAPK p38 Family\"))",
        "directed": false,
        "label": "p(SFAM:\"MAPK p38 Family\",pmod(P,T,180)) directlyIncreases kin(p(SFAM:\"MAPK p38 Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526e9",
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\",pmod(P,T,180)) directlyIncreases kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In pilot experiments we found that both TGF1-induced Smad3 and p38 MAPK phosphorylation was still detectable after 18 h and correlated with the increased levels of3 and5 integrins (supplemental Fig. 4S and Fig. 1C).....Smad3 phosphorylation was determined using rabbit mAb against phospho-Src (Tyr-416)...p38MAPKphosphorylation was determined using mousemAb against human phosphorylated p38MAPK(Thr180/Tyr182)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 May 9 283(19) 12898-908",
                "id": "18353785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070beb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"MAPK p38 Family\")",
        "relation": "actsIn",
        "target": "kin(p(SFAM:\"MAPK p38 Family\"))",
        "directed": false,
        "label": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526e8",
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "It is known that LPS stimulation leads to increased activation of three subgroups of MAPKs, i.e., ERK, JNK, and p38, in murine macrophages and human monocytes (38, 39).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Aug 1 169(3) 1401-9",
                "id": "12133965"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407050f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Pre-incubation with U0126, SB203580, SP600125, cyclosporin A and FK506 attenuated the A 1242-induced respiratory burst, measured by DCF-fluorescence, and luminol-amplified chemiluminescence.....Our results show that the Erk1/2 kinases and p38MAPK/JNK are involved in ROS formation in neutrophils exposed to A 1242.",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Lett 2009 Jun 22 187(3) 144-8",
                "id": "19429257"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070517"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Interestingly, recent in vitro kinetic studies using recombinant active p38a expressed in Escherichia coli showed that p38 phosphorylates GST-ATF2 (amino acids 1-115) via a two-step (double collision) mechanism, involving the dissociation of mono-phosphorylated ATF2 Thr71 or Thr69 from the enzyme after the first phosphorylation step (Waas et al., 2001). Moreover, these authors found that mono-phosphorylation of ATF2 Thr69 strongly reduces the phosphorylation rate of Thr71, whereas, in contrast, mono-phosphorylation of Thr71 does not reduce the rate of Thr69 phosphorylation. Thus, efficient phosphorylation of ATF2 by recombinant E.coli-expressed active p38 only occurs in the order Thr71-> Thr69 + 71 (Figure 7). ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Jul 15 21(14) 3782-93",
                "id": "12110590"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070da1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "n addition, in vitro stimulation of PMN with recombinant HMGB1 caused TLR4-dependent activation of NAD(P)H oxidase as well as increased ROS production through both MyD88-IRAK4-p38 MAPK and MyD88-IRAK4-Akt signaling pathways. Thus, PMN NAD(P)H oxidase activation, induced by HS/R and as mediated by HMGB1/TLR4 signaling, is an important mechanism responsible for PMN-mediated inflammation and organ injury after hemorrhage...PMN isolated from the mice ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2007 May 15 178(10) 6573-80",
                "id": "17475888"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d88"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The recent observation that diesel exhaust, a known source of particles and other agents that induce oxidative stress, activates redox-sensitive transcription factors and kinases in human airways (31) [From primary paper: DE induced a significant increase in the nuclear translocation of NF-{kappa}B (P = 0.02), AP-1 (P = 0.02), phosphorylated JNK (P = 0.04), and phosphorylated p38 (P = 0.01), as well as an increase in total (cytoplasmic + nuclear) immunostaining of phosphorylated p38 (P = 0.03). ]",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Jun 34(6) 666-9",
                "id": "16484683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d5b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Alveolar type II cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Proliferation of retinal endothelial cells in situ and in vitro migration of lung endothelial cells isolated from Rap1b-deficient mice were inhibited. At the molecular level, activation of 2 MAP kinases, p38 MAPK and p42/44 ERK, important regulators of endothelial migration and proliferation, was decreased in Rap1b-deficient endothelial cells in response to VEGF stimulation. These studies provide evidence that Rap1b is required for normal angiogenesis",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2008 Mar 1 111(5) 2647-56",
                "id": "17993608"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d28"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "HNE was able to induce phosphorylation of ERK and p38 MAPK, but not JNK, in a time-dependent manner up to 120min (Fig. 3). Moreover, nuclear translocation of 5-LO induced by HNE was markedly attenuated by PD98059, an ERK inhibitor as well as by SB203580, a p38 MAPK inhibitor, but not by SP600125, a JNK inhibitor (Fig. 4A?D). Linked to these results, LTB4 production by HNE was also significantly attenuated by PD98059 as well as by SB203580 in a dose-dependent manner, but not by SP600125 (Fig. 4E). ",
              "citation": {
                "type": "PubMed",
                "name": "Atherosclerosis 2010 Jan 208(1) 56-61",
                "id": "19586628"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d02"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "myogenin as an important transcriptional target under the control of three intracellular signaling pathways, namely, the p38 mitogen-activated protein kinase- (MAPK), calcium-calmodulin-dependent protein kinase- (CaMK), and calcineurin-mediated pathways,... Three cis-elements (i.e., the E box, myocyte enhancer factor [MEF] 2, and MEF3 sites) in the proximal myogenin promoter in response to these three pathways are defined. MyoD, MEF2s, and Six proteins, the trans-activators bound to these cis-elements, are shown to be activated by these signaling pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2002 Jun 13(6) 1940-52",
                "id": "12058061"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d01"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The PTEN gene (phosphatase and tensin homologous on chromosome 10) is frequently mutated or deleted in a number of malignancies including human hepatocellular carcinoma (HCC). We reported previously that the hepatitis B virus X (HBx) protein, known to be a causative agent in the formation of HCC, activates insulin-like growth factor II (IGF-II) expression through Sp1 phosphorylation by protein kinase C (PKC) or mitogen-activated protein kinase (MAPK) signaling. In this report we demonstrate that the PTEN effect on HBx induced IGF-II activation in a hepatoma cell line. Expression of PTEN and IGF-II was inversely related in different hepatoma cell lines. PTEN expression induced decreased Sp1 DNA binding by dephosphorylating Sp1 and interfered with transcriptional transactivation of IGF-II by HBx in hepatoma cells. The protein phosphatase activity was involved in PTEN downregulation of IGF-II transcription through downregulation of MAPK, MAPK kinase phosphorylation and PKC translocation. Our data suggest that PTEN blocks Sp1 phosphorylation in response to HBx, by inactivating PKC, MAPK and MAPK kinase which eventually downregulate IGF-II expression, during the formation of HCC.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2003 Jun 19 545(2-3) 203-8",
                "id": "12804776"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Here, we demonstrate that the HBP1 transcriptional repressor participates in RAS- and p38 MAPK-induced premature senescence. In cell lines, we had previously isolated HBP1 as a retinoblastoma (RB) target but have determined that it functions as a proliferation regulator by inhibiting oncogenic pathways as a transcriptional repressor. In primary cells, the results indicate that HBP1 is a necessary component of premature senescence by RAS and p38 MAPK. Similarly, a knockdown of WIP1 (a p38 MAPK phosphatase) induced premature senescence that also required HBP1.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Nov 26(22) 8252-66",
                "id": "16966377"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cc2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Our data further demonstrated that AMs exposed to CSE trigger an intracellular signaling pathway mediated by MAPKs and NF-B. Specifically, p38 MAPK activity peaked in AMs from wild-type mice after just 30 min of CSE exposure (Fig. 4). Whereas p38 MAPK activation was also observed in RAGE KO AMs, there was a significant decrease in p38 MAPK activity after 60 min of CSE exposure compared with wild-type AMs (Fig. 4).We also demonstrated that, after 4 h, nuclear translocation of active NF-B was significantly diminished in smoke-exposed RAGE KO AMs compared with smoke-exposed AMs from control mice (Fig. 5).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2012 Jun 1 302(11) L1192-9",
                "id": "22505673"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c1a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages, Alveolar",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": " In the present investigation, we find that SB203580, a specific inhibitor of p38, blocks oxLDL-exposed J774 cells from becoming foam cells. Inhibition of foam cell formation by blockade of the p38 pathway is, at least in part, due to inhibition of oxLDL-induced up-regulation of the scavenger receptor CD36. Using pharmaceutical inhibitors and dominant active MAP kinase kinases, we demonstrated that activation of the p38 pathway, but not the ERK or JNK pathways, is necessary and sufficient to transactivate PPARgamma, a nuclear receptor that has recently been shown to play a pivotal role in oxLDL-induced CD36 expression. Our results for the first time demonstrate a regulation of CD36 by p38, and the importance of the p38 pathway in regulation of foam cell formation.",
              "citation": {
                "type": "PubMed",
                "name": "APMIS 2002 Jun 110(6) 458-68",
                "id": "12193207"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bbf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In parallel with the upregulation of TGF-{beta}1, the protein levels of TAK1 were significantly increased 1.66  0.14-, 1.97  0.16-, and 1.57  0.07-fold (P < 0.01) at 1, 3, and 7 days post-MI compared with sham-operated rats (Fig. 2, A and B). Although there was no change in the protein levels of MKK3/6 and p38 MAPK levels throughout the time course, P-MKK3/6 and P-p38 MAPK were increased significantly (P-MKK3/6: 2.20  0.19-, 2.55  0.47-, and 3.29  0.32-fold; P-p38 MAPK: 1.90  0.03-, 2.03  0.06-, and 2.35  0.06-fold at 1, 3, and 7 days after MI), indicating the activation of the TGF-{beta}1-TAK1-MKK3/6-p38 MAPK pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Heart Circ Physiol 2006 Feb 290(2) H709-15",
                "id": "16183734"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b86"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We show that Crry increases early TCR-dependent activation signals, including p56lck-, zeta-associated protein-70 (ZAP-70), Vav-1, Akt, and extracellular signal-regulated kinase (ERK) phosphorylation but also costimulation-dependent mitogen-activated protein kinases (MAPK), such as the stress-activated c-Jun N-terminal kinase (JNK). It is intriguing that Crry costimulus enhanced p38 MAPK activation in T helper cell type 1 (Th1) but not in Th2 cells. ",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2005 Dec 78(6) 1386-96",
                "id": "16301324"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b5f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Th1 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "DCs isolated from E-FABP-null spleen showed enhanced production of IL-12p70, a key cytokine for innate immune responses, in response to appropriate stimuli as compared with wild-type. In real-time PCR, the expression level of IL-12p35 mRNA after LPS stimuli was much higher in mutant DCs when compared with wild-type, while no apparent change of IL-12p40 mRNA level was detected. Phosphorylated forms of p38 mitogen-activated protein kinase (p38MAPK) and IkappaB-alpha, molecules critical for IL-12 production, were detected at higher levels in E-FABP-null-mutant DCs after LPS stimuli when compared with wild-type counterparts",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 Jun 23 345(1) 459-66",
                "id": "16684508"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b53"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "HeLa S3 cells were radiolabeled with 32Pi in the presence and absence of 1,000 units/ml interferon-a. HeLa cells were also stimulated with sodium arsenite, which is a known activator of stress-activated protein kinases such as p38mapk. As shown in Fig. 8A, two radioactive tryptic peptides were detected with both stimulants. The earlier peak eluted with the S727-PP standard, and the later peak eluted in the region expected for the Ser-505 phosphopeptide.....Interferon-a treatment led to a 2-fold increase in phosphorylation at Ser-727 and a 1.6-fold increase in phosphorylation at Ser-505, and the corresponding increases with arsenite treatment were 6.5-fold for Ser-727 and 1.9-fold for Ser-505 (Fig. 8A).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Feb 20 273(8) 4449-58",
                "id": "9468497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b21"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "control and Sod2-overexpressing cells were treated with the specific inhibitors of ERK1/2 (PD98059) and p38 (SB203580) (Fig. 4B, inset). Northern blotting demonstrated that the ERK1/2 inhibitor blocked basal MMP-1 expression and dramatically decreased MMP-1 mRNA levels in the HT15 cell lines. The p38 inhibitor increased MMP-1 expression in both control and HT15 cell lines......the inductive properties of SB203580 could be blocked by PD98059.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 14264-70",
                "id": "11297530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a88"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "fibrosarcoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "These effects of high glucose were blocked by antioxidants (taurine and tiron), inhibitors of mitochondrial electron transport chain complex I (rotenone) and II (thenoyltrifluoroacetone), an inhibitor of glycolysis-derived pyruvate transport into mitochondria (alpha-cyano-4-hydroxycinnamic acid), an uncoupler of oxidative phosphorylation (carbonyl cyanide m-chlorophenylhydrazone), a manganese superoxide dismutase mimetic, catalase, and a specific inhibitor of p38 MAPK (SB 203580), but were not affected by an inhibitor of the malate-aspartate shuttle (aminooxyacetate acid). Hydrogen peroxide (>/=10(-5) M) also stimulated p38 MAPK phosphorylation, ANG secretion, and ANG mRNA gene expression, but its stimulatory effect was blocked by catalase and SB 203580.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2002 Aug 143(8) 2975-85",
                "id": "12130563"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a4d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Tube Cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In vitro treatment with activin A increased VEGF secretion, as well as p38 and p42/44 MAPK activity in corneal epithelial cells, whereas concurrent administration of specific inhibitors of p38 or p42/44 MAPK abolished the stimulatory effect of activin A on VEGF production. We conclude that activin A stimulates inflammatory corneal angiogenesis by increasing VEGF levels through a p38 and p42/44 MAPK-dependent mechanism.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Pathol 2004 Apr 164(4) 1293-302",
                "id": "15039217"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a30"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "p38 MAPK can positively and negatively modulate NFAT activity by several mechanisms. p38 MAPK can induce NFAT expression at the transcriptional and post-transcriptional levels and can promote the interaction of NFAT with the coactivator CREB-binding protein (CBP). In contrast, p38 MAPK can inhibit NFAT transcriptional activity by phosphorylation of NFAT and by activation of NFAT nuclear export [73,74].",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Res Ther 2006 8(2) 205",
                "id": "16542479"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a07"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The effects of hCG were reduced by inhibitors of protein kinase A, MAPK kinase, or p38 kinase, indicating that Runx1 expression is regulated by the LH-initiated activation of these signaling mediators. In addition, hCG-induced Runx1 mRNA expression was inhibited by a progesterone receptor antagonist and an epidermal growth factor receptor tyrosine kinase inhibitor, whereas amphiregulin stimulated Runx1 mRNA expression",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2006 Sep 20(9) 2156-72",
                "id": "16675540"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709d4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "To determine whether this activation by NE was mediated by the TGF-beta1 receptor, we used a dominant negative vector of the TGF-beta1 type II receptor, and the synergistic effects were inhibited. Furthermore, this synergistic effect was attenuated by a specific inhibitor of p38, SB203680. These data indicate that NE enhances cardiac fibrosis through TGF-beta1 post-receptor signaling, predominantly via the p38 MAP kinase pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Hypertension 2002 Aug 40(2) 148-54",
                "id": "12154105"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407096c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "To determine whether the p38MAPK was involved in HSP70-induced phagocytosis, RAW264.7 macrophages were treated with either SB203580 (a specific p38MAPK-inhibitor) at the dose of 20 mM in DMEM for 20 h or cultured in medium alone. Further, the vehicle in which the SB203580 was suspended (DMSO) was mixed in equivalent volume of medium (as for SB203580) and used as a control.As seen in Fig. 5C, SB203580 is able to abrogate HSP70-induced phagocytosis whereas controls were unable to do so (P  0.05). Together, these data indicate that HSP70-induced phagocytosis is mediated via involvement of p38MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "J Surg Res 2006 Nov 136(1) 58-69",
                "id": "16979664"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070881"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Here we describe a role for PRAK in tumor suppression by demonstrating that PRAK mediates senescence upon activation by p38 in response to oncogenic ras ... Furthermore, we show that PRAK activates p53 by direct phosphorylation. We propose that phosphorylation of p53 by PRAK following activation of p38 MAPK by ras plays an important role in ras-induced senescence and tumor suppression ... from full text, oncogenic ras is HRAS G12V and TP53 is phosphorylated at S37 ... human primary BJ fibroblasts",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2007 Jan 26 128(2) 295-308",
                "id": "17254968"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070827"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "IL-18 treatment markedly increased phospho-ATF-2 (Thr71) levels in HCMEC, and this effect was blocked by the IL-18BPa/Fc chimera (Fig. 5A). Furthermore, treatment with the p38PMAPK inhibitor SB203580 strongly inhibited IL-18-mediated ATF-2 phosphorylation (Fig. 5B). Inhibition of p38MAPK also attenuated p65 phosphorylation (Fig. 5C) and NF-?B-driven reporter gene activity (Fig. 5D). Together, these results demonstrate that IL-18 induced NF-?B activation via p38MAPK activation (Fig. 5).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2006 Jan 20 339(3) 956-63",
                "id": "16325763"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707fd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Transfection studies with luciferase reporter gene constructs indicate that increased HO-1 gene expression via inhibition of p38 was mediated by the transcription factor Nrf2, which is a central regulator of the cellular oxidative stress response. Accordingly, inhibitors of p38 induced binding of nuclear proteins to a Nrf2 target sequence of the HO-1 promoter, but did not affect HO-1 protein expression and promoter activity in Nrf2(-/-) MEF.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2009 Jun 1 182(11) 7048-57",
                "id": "19454702"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707bc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "periodically stretched them for 6 h (15% elongation, 0.5 Hz). The cells responded with an increase both in ET(B)-R mRNA (12-fold compared with control) and protein (4-fold). Among various kinase pathways, Rho kinase (ROCK) and p38 mitogen-activated protein kinase (p38 MAPK) mediated part of the deformation-induced increase in ET(B)-R expression, as judged by the inhibitory effect of Y27632 (1 microm, 38% inhibition) and SB202190 (10 microm, 44% inhibition), respectively.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Oct 5 276(40) 36999-7003",
                "id": "11457849"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707a4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Proper H(2)O to mucin ratio of airway mucus is important for mucociliary clearance. Recent studies suggest that decreased aquaporin 5 (AQP5) is correlated with increased staining of MUC5AC in submucosal glands of COPD patients. Lipopolysaccharide (LPS) is one of the major insults in airway mucin secretion in COPD. In this study, changes in both AQP5 and MUC5AC expression levels in SPC-A1, a human airway submucosal gland cell line, were quantified after exposure of the cells to LPS. AQP5 transcription and protein expression were decreased while MUC5AC expression was increased by LPS exposure in SPC-A1 cells. Further studies revealed that AQP5 expression was down-regulated via the p38/JNK signaling pathway, while MUC5AC was up-regulated through the EGFR-p38/JNK pathway. Therefore, p38 and JNK may become promising targets to preserve AQP5 expression and prevent MUC5AC over-expression to restore proper H(2)O to mucin ratio of the airway mucus, which may be beneficial to the clinical management of COPD patients.",
              "citation": {
                "type": "PubMed",
                "name": "Respir Physiol Neurobiol 2010 May 31 171(3) 212-7",
                "id": "20362698"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407079e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Chronic Obstructive Pulmonary Disease",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Using isolated human platelets, we report that PKCdelta, but not PKCalpha or PKCbeta, is required for collagen-induced phospholipase C-dependent signaling, activation of alpha(IIb)beta(3), and platelet aggregation. Analysis of PKCdelta phosphorylation and translocation to the membrane following activation by both collagen and thrombin indicates that it is positively regulated by alpha(IIb)beta(3) outside-in signaling. Moreover, PKCdelta triggers activation of the mitogen-activated protein kinase-kinase (MEK)/extracellular-signal regulated kinase (ERK) and the p38 MAPK signaling. This leads to the subsequent release of thromboxane A(2), ##Phospho-specific antibodies for PKC?, MEK1/2, ERK1/2, and p38 MAPK came from Cell Signaling Technologies (Beverly, MA) and Santa Cruz Biotechnologies (Santa Cruz, CA).##",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Oct 6 281(40) 30024-35",
                "id": "16895913"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070798"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Recent studies show that TLR4 serves as a previously unrecognized environmental sensor for autophagy. The studies defined a new molecular pathway in which LPS induces autophagy in human and murine macrophages by a pathway regulated through a TRIF-dependent, myeloid differentiation factor 88 (MyD88)-independent TLR4 signaling. Receptor-interacting protein 1 and p38 mitogen-activated protein kinase are downstream components of this pathway (Figure 1).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Am Thorac Soc 2010 Feb 7(1) 22-8",
                "id": "20160145"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070763"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In order to investigate the role of IRAK-4 kinase function in vivo, we generated \\\"knock-in\\\" mice where the wild-type IRAK-4 gene is replaced with a mutant gene encoding kinase-deficient IRAK-4 protein (IRAK-4 KD). IRAK-4 kinase is rendered inactive by mutating the conserved lysine residues in the ATP pocket essential for coordinating ATP. Analyses of embryonic fibroblasts and macrophages obtained from IRAK-4 KD mice demonstrated lack of cellular responsiveness to stimulation with IL-1beta or Toll-like receptor 4 (TLR4) and TLR7 agonists. IRAK-4 KD cells were severely impaired in NF-kappaB, JNK, and p38 activation in response to IL-1beta or TLR7 ligand.",
              "citation": {
                "type": "PubMed",
                "name": "Ernst Schering Found Symp Proc 2007 (3) 63-82",
                "id": "18510099"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070755"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In 1F6-18kD and 1F6-ALL clones VEGF mRNA was increased 4- to 5-fold and VEGF protein secretion was highly stimulated due to activation of the VEGF promotor. PI-3K, p38 MAPK and ERK1/2 MAPK pathways were activated, while inhibition of PI-3K or p38 resulted in, respectively, 55% and up to 70% reduction of VEGF mRNA overexpression. A concurrent 60% decrease in VEGF protein secretion was mostly apparent upon inhibition of PI-3K. Inhibition of ERK1/2 hardly affected VEGF mRNA or protein secretion. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Oncol 2009 31(3) 179-90",
                "id": "19478386"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407070a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "melanoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In the present study, we show that besides STAT1 also the tyrosine phosphatase SHP2 became tyrosine-phosphorylated upon hyperosmolarity. SB 202190 and SB 203580 (specific inhibitors of p38) inhibited both STAT activation and tyrosine phosphorylation of SHP2 induced by hyperosmotic stress. Overexpression of wild-type p38 mitogen-activated protein kinase and its upstream activator mitogen-activated protein kinase kinase 6 (MKK6) resulted in an enhanced STAT1 tyrosine phosphorylation upon osmotic shock.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Oct 15 274(42) 30222-7",
                "id": "10514514"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "from full text - We previously showed that TL1A is induced by the Fc?R signaling pathway [45]. Recently, the potential interaction of TL1A in microbial-host interaction was illustrated by a report showing microbial organisms can induce TL1A in APCs [46]. Microbial-activated TL1A was in part mediated by TLR 1, 2, 4, and 9 signaling pathways and dependent on downstream p38 MAP kinase and NF-kappaB activation (Fig. 1) [46]. Negative regulators of the TL1A signaling pathway also exist and may serve to maintain gut immune homeostasis. Our group showed that TLR8 or TLR7/8 ligand (R848) can inhibit TL1A production in a dose dependent manner [47].",
              "citation": {
                "type": "PubMed",
                "name": "Curr Gastroenterol Rep 2009 Dec 11(6) 473-80",
                "id": "19903423"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706a6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "antigen presenting cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "TGF-beta led to activation of Smad2/3, p38, p42/44, and c-Jun NH2-terminal kinase (JNK) pathways, assessed by phosphorylation, immunofluorescence, and reporter gene analysis. TGF-beta-dependent growth inhibition was specifically attenuated by pharmacological blockade of the TGF-beta type I receptor (TbetaRI) kinase or p38 mitogen-activated protein kinase pathways, whereas blockade of p42/44 or JNK kinases did not influence the effect of TGF-beta. TbetaRI kinase inhibition blocked all downstream pathways including Smad and p38 phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Exp Ther 2005 Dec 315(3) 1005-12",
                "id": "16120811"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "we show here that there exists a dynamic feedback loop that is triggered by a DNA damage response (DDR) and, which after a delay of several days, locks the cell into an actively maintained state of 'deep' cellular senescence. The essential feature of the loop is that long-term activation of the checkpoint gene CDKN1A (p21) induces mitochondrial dysfunction and production of reactive oxygen species (ROS) through serial signalling through GADD45-MAPK14(p38MAPK)-GRB2-TGFBR2-TGFbeta. These ROS in turn replenish short-lived DNA damage foci and maintain an ongoing DDR.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Syst Biol 2010 6 347",
                "id": "20160708"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070697"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In order to investigate the role of IRAK-4 kinase function in vivo, we generated \\\"knock-in\\\" mice where the wild-type IRAK-4 gene is replaced with a mutant gene encoding kinase-deficient IRAK-4 protein (IRAK-4 KD). IRAK-4 kinase is rendered inactive by mutating the conserved lysine residues in the ATP pocket essential for coordinating ATP. Analyses of embryonic fibroblasts and macrophages obtained from IRAK-4 KD mice demonstrated lack of cellular responsiveness to stimulation with IL-1beta or Toll-like receptor 4 (TLR4) and TLR7 agonists. IRAK-4 KD cells were severely impaired in NF-kappaB, JNK, and p38 activation in response to IL-1beta or TLR7 ligand.",
              "citation": {
                "type": "PubMed",
                "name": "Ernst Schering Found Symp Proc 2007 (3) 63-82",
                "id": "18510099"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407068f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In this study, we demonstrated that high glucose significantly increased intracellular ROS levels in human aortic endothelial cells (HAECs). Additionally, high glucose reduced the antioxidant activity of thioredoxin. To investigate the mechanisms involved, we found that glucose enhanced the expression of thioredoxin interacting protein (Txnip), a Trx inhibitory protein, through p38 mitogen-activated protein kinase (MAPK). We also showed that glucose regulated Txnip at transcription level and p38 MAPK and forkhead box O1 transcriptional factor (FOXO1) were involved in the process.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2009 Apr 17 381(4) 660-5",
                "id": "19254690"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070633"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We have observed that activation of p38 kinase accompanies receptor-mediated events in platelets and coincides with cPLA2 phosphorylation. Furthermore, in the presence of inhibitors of p38 kinase, the proline-directed phosphorylation of cPLA2 was completely blocked in platelets stimulated with the thrombin receptor agonist peptide SFLLRN and was suppressed during the early (up to 2 min) phase of platelet stimulation caused by thrombin.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Nov 1 271(44) 27723-9",
                "id": "8910365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705e9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "ERK1/2-phosphorylation peaked around 3 minutes after Pam3CSK4-activation and then abated, while thrombin-activation caused a quick increase, which remained constant after 10 minutes (Figure 2B). For p38, thrombin caused an almost immediate increase in phosphorylation, reaching a plateau after 3 minutes, while Pam3CSK4  led to only 60-70% of phosphorylation relative to thrombin (Figure 2C). (anti-phospho-ERK1/2(Thr202/Tyr204))",
              "citation": {
                "type": "PubMed",
                "name": "Thromb Haemost 2009 Jul 102(1) 97-110",
                "id": "19572074"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407052e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In pilot experiments we found that both TGF1-induced Smad3 and p38 MAPK phosphorylation was still detectable after 18 h and correlated with the increased levels of3 and5 integrins (supplemental Fig. 4S and Fig. 1C).....Smad3 phosphorylation was determined using rabbit mAb against phospho-Src (Tyr-416)...p38MAPKphosphorylation was determined using mousemAb against human phosphorylated p38MAPK(Thr180/Tyr182)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 May 9 283(19) 12898-908",
                "id": "18353785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c21"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "With HBP1 expression and the subsequent increase of p16(INK4A) gene expression, Ras induces premature senescence in primary cells. The data suggest a model in which Ras and p38 MAPK signaling engage HBP1 and p16(INK4A) to trigger premature senescence. In addition, we report that HBP1 knockdown is also required for Ras-induced transformation. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2010 Sep 9 29(36) 5083-94",
                "id": "20581871"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070568"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Although phosphatidylinositol 3-kinase pathway inhibition by LY294004 blocked both PHAS-1 Ser-65 and Thr-70 phosphorylation (3.8 +/- 0.1 versus 0.8 +/- 0.1 and 3.2 +/- 0.2 versus 1.0 +/- 0.01, respectively), protein phosphatase 2A inhibition by okadaic acid selectively increased (3.3 +/- 0.1 versus 5.2 +/- 0.1) and p38 mitogen-activated protein kinase inhibition by SB203580 selectively decreased (3.8 +/- 0.1 versus 1.4 +/- 0.3) Ser-65 phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 19 278(38) 36973-9",
                "id": "12860993"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070566"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "we incubated NIH-3T3 cells in amino acid-deficient medium with increasing concentrations of SB203580. As shown in Fig. 7Go, inclusion of the p38MAPK inhibitor was able to block CA-VI expression by amino acid deprivation, with partial inhibition occurring at 1020 M and full inhibition at 100 M.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2001 Jan 142(1) 221-8",
                "id": "11145585"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d68"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "SWCNTs induce fibrogenesis through reactive oxygen species-regulated phosphorylation of p38 mitogen-activated protein kinase (MAPK). Activation of p38 MAPK by SWCNTs led to the induction of transforming growth factor (TGF)-??1 as well as vascular endothelial growth factor (VEGF). Both TGF-??1 and VEGF contributed significantly to the fibroproliferative and collagen-inducing effects of SWCNTs. ",
              "citation": {
                "type": "PubMed",
                "name": "Nanotoxicology 2012 Jan 20",
                "id": "22263913"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cd2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In the absence of p38 activity, EGF fails to stimulate the ubiquitin ligase Cbl or ubiquitinylation of EGFR, and internalized EGFR accumulates in intracellular vesicles containing caveolin-1. These effects are accompanied by loss of EGFR phosphorylation on Y1045, a phosphorylation site required for Cbl activation.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Dec 13 25(24) 5683-92",
                "id": "17139251"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ccc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "At this time point only polyI:C and polyI:C+R848 stimulated cells showed enhanced IFN gene expression (Fig. 7). SB202190 and LY294002, the inhibitors of MAPK p38 and PI3K, respectively, completely blocked TLR ligand-induced IFN-B and IFN-L1 gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Immunol 2011 Jan 48(4) 505-15",
                "id": "21040977"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c8f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "HGF activates P42/P44MAPK (extracellular signal regulated kinase 2/1) and P38 MAPK two and three-fold respectively compared to basal level in a PKC independent manner. The phosphorylation level peaked within 5-10 minutes of HGF treatment.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Dec 6 20(56) 8125-35",
                "id": "11781826"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c84"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "melanocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The ATF2 transcription factor is phosphorylated by the stress-activated mitogen-activated protein kinases (MAPKs) JNK and p38. We show that this phosphorylation is essential for ATF2 function in vivo, since a mouse carrying mutations in the critical phosphorylation sites has a strong phenotype identical to that seen upon deletion of the DNA-binding domain",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2007 Aug 15 21(16) 2069-82",
                "id": "17699753"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c2e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Omeprazole is able to inhibit neutrophil chemotaxis to fMLP and IL-8... The addition of a potassium ionophore, nigericin, restored the migratory ability, as well as the intracellular calcium levels. The activity of p38 MAP Kinase was decreased in neutrophils pretreated with omeprazole.",
              "citation": {
                "type": "PubMed",
                "name": "Inflamm Res 2007 Mar 56(3) 105-11",
                "id": "17406807"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c05"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "neutrophils predominantly migrated toward end target chemoattractants via p38 MAPK, whereas intermediary chemoattractant-induced migration was phosphoinositide 3-kinase (PI3K)/Akt dependent. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2002 Oct 14 159(1) 91-102",
                "id": "12370241"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bc8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "suppression of AdipoR2 expression by siRNA in hepatocytes significantly reduced full-length adiponectin binding (Supplementary Fig. 3h) as well as increases in PPAR-a ligand activity by full-length adiponectin In mock-transfected C2C12 myocytes both globular and fulllength adiponectin increased the amount of phosphorylation of AMP kinase (AMPK), acetyl coenzyme A carboxylase (ACC)10,11 and p38 mitogen-activated protein kinase (MAPK)",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2003 Jun 12 423(6941) 762-9",
                "id": "12802337"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b3e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "As shown in Fig. 1A, the phosphorylation of p38 and ERK was decreased in Traf2-/- cells, indicating that TRAF2 also functions in the TNF-induced activation of p38 and ERK. Consistent with a previous study (Yeh et al., 1997), JNK activation by TNF in Traf2-/- cells was also decreased.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO Rep 2003 Jun 4(6) 623-7",
                "id": "12776182"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a5a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "TTP can be phosphorylated in vitro by p38 MAPK itself (8, 10) or by MK2 (47). Two major sites of MK2-mediated phosphorylation of mouse TTP in vitro and in vivo were identified as serines 52 and 178 (15; T. Santalucia, M. Brook, E. Hitti, G. Sully, R. Wait, C. R. Tchen, C. J. A. Asensio, M. Gaestel, J. Saklavala, and A. R. Clark, unpublished data). ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Mar 26(6) 2408-18",
                "id": "16508015"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a3f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We confirmed p38 MAPK activity activation by PM in a time-dependent manner (Cell Signaling) (Figure E3A) and subsequently determined that a prominent p38 MAPK target, the Ser/Thr kinase MAPKAP2, is also activated by PM, as evidenced by phosphorylation of the actin-binding protein, HSP27.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2010 Apr 42(4) 442-9",
                "id": "19520919"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709f2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In C3H/HeOuJ mice treated with ETX, activation of p38 MAP kinase was also evident in macrophages and endothelial cells, and JNK kinase in macrophages. In contrast, reduced protein kinase B (AKT) was noted in macrophages.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Mol Pathol 2007 Dec 83(3) 311-26",
                "id": "17996232"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709cd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Finally, the activation levels of extracellular signal-regulated kinase (ERK), p38, and Rac, which are important signaling molecules in angiogenesis, were all reduced in response to FGF2 when either of the Rap1 proteins was depleted. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2008 Sep 28(18) 5803-10",
                "id": "18625726"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Intraperitoneal administration of rottlerin or SB-203580 at least 1 h before TNF-? clearly diminished the level of VCAM-1 expression in lung tissue, suggesting that PKC? and p38 kinase do indeed play a role in the TNF-? signaling to VCAM-1 expression in vivo",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2005 Feb 288(2) L307-16",
                "id": "15489375"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709bb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In this paper, we present a comprehensive pathway map of EGFR signaling and other related pathways. The map reveals that the overall architecture of the pathway is a bow-tie (or hourglass) structure with several feedback loops.  See figure 2: The bow-tie architecture of the EGFR signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Syst Biol 2005 1 2005.0010",
                "id": "16729045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Treatment with pharmacological inhibitors of p38 MAPK or with a dominant negative form of MKK3, an upstream regulator of p38 MAPK, significantly reduced or ablated the sorbitol induction of sgk promoter activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Aug 18 275(33) 25262-72",
                "id": "10842172"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407084f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Stable over-expression of Smad7 in K562 cells (K562/7) prevented activation of Smad2/3 and MAPK (ERK1/2, p38 and JNK1/2) proteins by activin-A/TGF-beta1 and subsequent induction of erythroid differentiation.",
              "citation": {
                "type": "PubMed",
                "name": "Platelets 2007 Dec 18(8) 566-78",
                "id": "18041647"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407084d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Stem Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Here we have shown that UV-induced activation of the POMC and MC1R promoters is mediated by p38 stress-activated kinase signaling to the transcription factor, upstream stimulating factor-1 (USF-1).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 3 279(49) 51226-33",
                "id": "15358786"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407084b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "melanocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Treatment with roflumilast significantly suppressed LPS-induced activation of JNK and p38 MAP kinase concentration dependently (Fig. 6)",
              "citation": {
                "type": "PubMed",
                "name": "J Pharmacol Exp Ther 2005 Dec 315(3) 1188-95",
                "id": "16126838"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407080c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The mRNA and protein levels of VEGF in CRH-treated HaCaT cells were significantly attenuated. However, this downregulation was abrogated by pretreatment with antalarmin, SB203580 and SP600125; pretreatment with PD98059 did not attenuate the effects of CRH on the expression of VEGF. In addition, CRH treatment induced rapid phosphorylation of p38 MAPK and JNK1/2, and antalarmin, SB203580 and SP600125 inhibited CRH-induced phosphorylation of p38 MAPK and JNK1/2. ",
              "citation": {
                "type": "PubMed",
                "name": "Regul Pept 2010 Feb 25 160(1-3) 115-20",
                "id": "19852986"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070723"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Analysis of ubiquitination and degradation of the constitutively dimerized ATF2 mutant (ATF2(Delta150-248)) showed that activation of JNK or p38 kinase renders ATF2 resistant to ubiquitination and degradation. This effect is mediated by JNK/p38-dependent phosphorylation of ATF2 at Thr-69 and Thr-71, because the phosphorylation-deficient mutant (ATF2(Delta150-248-T69A,T71A)) was not protected from ubiquitination and degradation by the activation of SAPK.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 28 275(17) 12560-4",
                "id": "10777545"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070685"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "p38 MAPK and its substrate, activating transcription factor (ATF)-2, in bronchoalveolar lavage fluid cells were phosphorylated by intratracheal exposure of bleomycin, and the phosphorylation of ATF-2 was inhibited by subcutaneous administration of a specific inhibitor of p38 MAPK, FR-167653.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2002 Jul 283(1) L103-12",
                "id": "12060566"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070658"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We show that initially exposure of fibroblasts to Cr (III) induced membrane-dependent signaling including activation of Rac1 GTPase, Src and apoptosis signal-regulating kinase 1 (ASK-1) kinases leading to increased activities of p38 and particularly Jun N-terminal kinase (JNK) and subsequent activation of caspase-3. ",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Lett 2009 Aug 10 188(3) 236-42",
                "id": "19406221"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407064f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "However, TNF treatment did result in activation of the transcription factor, ATF-2, a primary downstream target of p38 MAP kinase. Use of the p38 MAP kinase inhibitors SB202190 and SB203580 did not interfere with the ability of TNF to activate ATF-2, suggesting that either the gamma isoform of p38 MAP kinase or a p38-independent pathway was utilized by TNF to increase the phosphorylated fraction of ATF-2.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 1999 Apr 179(1) 58-66",
                "id": "10082133"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070601"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Since Txnip is involved in ceramide-induced ASK1 activation, the regulation of ASK1 on ceramide-activated p38 MAPK and JNK was subsequently determined. In ASK1 siRNA-transfected EGFP+ Jurkat T cells, ceramide-induced phosphorylation of p38 MAPK and JNK was inhibited (Figures 6B,S4E,F).",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2008 Apr 15 111(8) 4365-74",
                "id": "18270325"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070600"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "p38 activity was required to enhance the accessibility of the cryptic NF-kappa B binding sites contained in H3 phosphorylated promoters, which indicated that p38-dependent H3 phosphorylation may mark promoters for increased NF-kappa B recruitment.  ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Immunol 2002 Jan 3(1) 69-75",
                "id": "11743587"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407058b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Activation of the tyrosine kinase receptor vascular endothelial growth factor receptor 2 (VEGFR2) by VEGF leads to the activation of stress-activated protein kinase (SAPK)2/p38 and then to actin polymerization and reorganization into stress fibers in endothelial cells. In turn, this triggers endothelial cell migration",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Jan 15 23(2) 434-45",
                "id": "14724572"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407056d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Heparin-DOCA inhibited capillary-like tubular structures of endothelial cells and bFGF-induced neovascularizations in Matrigel plug assays. Signaling experiments showed that heparin-DOCA significantly inhibited angiogenesis by suppressing the phosphorylation of FGFR and its downstream signal pathways (ERK and p38 MAPK activities)",
              "citation": {
                "type": "PubMed",
                "name": "Pharm Res 2007 Jan 24(1) 176-85",
                "id": "17109210"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070558"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Katz et al. (2000) presented evidence that overexpression of mammalian tensin activates both the JNK (601158) and p38 MAPK (600289) pathways. Tensin-mediated JNK activation was independent of the activities of Rac (602048) and Cdc42 (116952), but did depend on Sek (601335).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Jan 22 99(2) 733-8",
                "id": "11792844"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070527"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Pretreatment of NHBECs with the MEK-1 inhibitor PD98059 abolished the V2O5-induced increase in HB-EGF mRNA expression, whereas pretreatment with the p38 MAP kinase inhibitor SB203580 blocked the V2O5-induced increase in HB-EGF mRNA by ~ 80% (Figure 8 ).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2001 Feb 24(2) 123-31",
                "id": "11159045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070513"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "To verify the effect of SB 203580 on p38mapk activity in platelets, the activity of MAPKAP-K2, an in vivo substrate of p38mapk, was determined. SB 203580 inhibited activation of MAPKAP-K2 by thrombin in a concentration dependent manner with an IC50 of 0.2 mM, and inhibition was complete with 10 mM inhibitor (not shown).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Feb 20 273(8) 4449-58",
                "id": "9468497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070512"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Collagen I did not affect p38 phosphorylation compared with control (data not shown); however, thrombin led to a modest increase in activated p38 between 30 min and 2 h.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2007 Apr 292(4) L1030-8",
                "id": "17189319"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070dac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "p38 activation is necessary for shear stress-dependent angiogenesis.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2010 Jan 222(1) 120-6",
                "id": "19774558"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d9c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Phospho-Y705-STAT3, phospho-S727-STAT1, and phospho-p38 protein levels were also significantly higher in IRF-2(-/-) than control macrophages. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2007 Mar 15 178(6) 3602-11",
                "id": "17339457"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d97"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "IL-18 activated p38 MAP kinase, jun kinase, and beta casein kinase (TIP kinase), an apparently novel kinase previously thought to be specifically activated by IL-1 and tumor necrosis factor (TNF)",
              "citation": {
                "type": "PubMed",
                "name": "J Interferon Cytokine Res 1998 Dec 18(12) 1077-88",
                "id": "9877452"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d92"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "proliferate in response to TGF-beta1 indirectly by the release of FGF-2, which induces phosphorylation of p38 MAPK and JNK.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Dec 30 280(52) 43000-9",
                "id": "16246848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d90"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Blocking ERK1/2 with PD98059 or p38 MAPK with SB203580 reduced BK-induced IL-6 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2003 Mar 28(3) 330-8",
                "id": "12594059"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d86"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Inhibition of ERKs with PD98059 or of p38 with SB203580 significantly inhibited silica-induced AP-1 activation....These findings demonstrate for the first time that freshly fractured silica induces AP-1 activation, which may be mediated through p38 MAPK and ERK pathways.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Oct 22 274(43) 30611-6",
                "id": "10521445"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d84"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The molecular signature response to perceived hyperoxia included (1) induction of p21, cyclin D1, cyclin D2, cyclin G1, Fos-related antigen-2, and transforming growth factor-beta1, (2) lowered telomerase activity, and (3) activation of transforming growth factor-beta1 and p38 mitogen-activated protein kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2003 Feb 21 92(3) 264-71",
                "id": "12595337"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d7e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Therefore, TetaR signaling appears to be involved in NTHi-induced MKP-1  expression, which in turn leads to down-regulation of p38-dependent MUC5AC  transcription.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 25 278(30) 27811-9",
                "id": "12734193"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d7d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Other protein synthesis inhibitors, such as anisomycin and emetine, also enhanced CD40 mRNA expression, which was significantly blocked by a NF-kappaB antagonist and a p38 MAP kinase antagonist",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2004 Feb 1 91(2) 410-22",
                "id": "14743399"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d75"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In addition, CRH treatment induced rapid phosphorylation of p38 MAPK. SB203580 were able to inhibit CRH-induced p38 MAPK phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "J Invest Dermatol 2005 Apr 124(4) 751-5",
                "id": "15816833"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d70"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Oxidants also activate mitogen-activated protein (MAP) kinase pathways. H2O2 is a potent activator of extracellular regulated kinases (ERK) and p38 MAP kinase",
              "citation": {
                "type": "PubMed",
                "name": "Pharmacol Rev 2004 Dec 56(4) 515-48",
                "id": "15602009"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d66"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We find that although pretreatment of BMMs with IL-4 does not alter M-CSF signaling, it reversibly blocks RANKL-dependent activation of the NF-kappa B, JNK, p38, and ERK signals.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Feb 22 277(8) 6622-30",
                "id": "11719504"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d63"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We found that IL-17 increased the transmigration of neutrophils through the endothelium and that this could be reversed by a p38 MAPK inhibitor",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Apr 15 184(8) 4531-7",
                "id": "20228195"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d5f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Activation of c-Jun N-terminal kinase (JNK) by TNF-? was also diminished by depletion of SphK1 (Fig. 1a) or its inhibition (Supplementary Fig. 3b). Likewise, SK1-I reduced activation of p38 (Supplementary Fig. 3a).",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2010 Jun 24 465(7301) 1084-8",
                "id": "20577214"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d5e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Elafin prevented lipopolysaccharide-induced phosphorylation of AP-1, c-Jun, and JNK but had no effect on phosphorylation of p38. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Nov 17 281(46) 34730-5",
                "id": "16980310"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d59"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "For instance, stress-activated protein kinases, such as p38, which are activated by cellular stress and involved in the acute-phase reaction, cause C/EBPB phosphorylation on Ser105, inducing the transactivation potential (23).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2003 Oct 285(4) L773-81",
                "id": "12959923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d56"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "LPS induces autophagy through TRIF/RIP1/p38MAPK dependent TLR4 signaling pathway that maintains cell survival.",
              "citation": {
                "type": "PubMed",
                "name": "Immunity 2007 Jul 27(1) 135-44",
                "id": "17658277"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d4f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "cyclosporin A blocks angiotensin II-induced mitogen-activated protein kinase activation in cultured primary cardiomyocytes and in the heart of hypertensive mice.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Dec 29 275(52) 40867-73",
                "id": "11016940"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d3d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "when the cells were incubated with two structurally unrelated p38 MAPK inhibitors prestimulation with IL-17, namely SB203580 and BIRB0796 (26, 27), this upregulation was essentially abolished",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Apr 15 184(8) 4531-7",
                "id": "20228195"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d3a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The phosphorylation of p38 mitogen-activated protein kinase (p38 MAPK), which mediates signaling that leads to senescence, was also detected in both IR- or H(2)O(2)-treated AT and normal fibroblasts expressing hTERT.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jan 16 279(3) 2030-7",
                "id": "14570874"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d1e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We demonstrate that induction of IL-23 p19 gene expression by LPS depends on the TLR4 and MyD88 pathways. All three MAPK pathways (ERK, JNK, and p38) that are activated by lipopolysaccharide (LPS) stimulation were shown to exert a positive effect on p19 expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Sep 4 284(36) 24006-16",
                "id": "19592489"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d15"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "These results suggest a role for MEK2 and p38 in IFN-gamma-mediated signal transduction and induction of C/EBP beta expression and activity associated with interleukin-6 (IL-6) secretion in colon epithelial cells.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2003 May 284(5) C1133-9",
                "id": "12505790"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d0d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "This proapoptotic effect was blocked by inhibition of the p38 MAPK kinase signaling with the inhibitor SB-203580 and was associated with an increase in p38 activity as measured by a kinase assay.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2004 Sep 287(3) L515-24",
                "id": "15132952"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d08"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The PDE4 inhibitor Rp, but not the PDE3 inhibitor lixazinone, significantly suppressed TGF-b1-induced ERK and p38 activity (Fig. 6B).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2005 Oct 289(4) C959-70",
                "id": "15930146"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d06"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Here we show that untimely proteolysis of cyclin B1 following p38 activation contributes to G(2) checkpoint. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2007 Aug 212(2) 481-8",
                "id": "17373649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cfa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Western blotting showed enhanced phosphorylation of p38 MAPK in the cremasteric tissue after stimulation with KC but not with MIP-2.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2012 Jul 6 423(3) 484-9",
                "id": "22683630"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cee"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": "Muscles"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "cells exposed to 10 J/m2 of UV showed phosphorylation of not only ERK1 and ERK2 but also JNK1/2 and p38 (Fig. 3).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Jul 15 61(14) 5396-401",
                "id": "11454682"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ce0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Anthocyanins also decreased activation of JNK and p38 induced by CD40.",
              "citation": {
                "type": "PubMed",
                "name": "Atherosclerosis 2009 Jan 202(1) 41-7",
                "id": "18495129"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cbb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "SB203580 (20 or 40 um) effectively enhanced cell survival (3.1- or 4.0-fold) (Fig. 4A)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jun 17 280(24) 23122-9",
                "id": "15826945"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ca2"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The cytoplasmic tail of the endothelin B receptor was found to be required for activation of all three mitogen-activated protein kinases and stimulation of intracellular calcium levels.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Dec 6 271(49) 31572-9",
                "id": "8940174"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c92"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Figure 4.  p38 MAPK and its downstream effector, MAPKAPK2, regulates MMP-2 and MMP-9 by stabilizing their mRNA transcripts in bladder cancer cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2010 Jan 15 70(2) 832-41",
                "id": "20068172"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c90"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Selective p38 mitogen-activated protein kinase (p38 MAPK) inhibition reduces OA and IgE-mediated IL-6 production.",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2004 Nov 76(5) 1075-81",
                "id": "15316034"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c8a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "This mechanism requires signaling through MyD88",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2005 Sep 9 122(5) 707-21",
                "id": "16143103"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c88"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We show that Siah2 is subject to phosphorylation by p38 MAPK, which increases Siah2-mediated degradation of PHD3. .... Phosphopeptide mapping identified T24 and S29 as the primary phospho-acceptor sites.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Nov 17 281(46) 35316-26",
                "id": "17003045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c74"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Endostatin blocked VEGF-induced tyrosine phosphorylation of KDR/Flk-1 and activation of ERK, p38 MAPK, and p125(FAK) in human umbilical vein endothelial cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 2 277(31) 27872-9",
                "id": "12029087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c70"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Treatment of the cells concurrently with SB203580, a specific p38MAPK inhibitor, robustly blocked activation of NFkappaB transcriptional activity",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2007 Mar 1773(3) 367-74",
                "id": "17196679"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c54"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Next, we incubated the cells with p38 MAP kinase inhibitor SB 203580. SB 203580 at concentration of 5 ?M inhibited the IL-8 generation by macrophages. The amounts of IL-8 produced and released by the cells were diminished by 42% (from ~52.5  7 ng/ml to ~22.0  5.1 ng/ml).",
              "citation": {
                "type": "PubMed",
                "name": "Respir Res 2006 7 66",
                "id": "16620395"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c2c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages, Alveolar",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In the present study, we demonstrate that 5'-AMP-activated protein kinase (AMPK) and p38 mitogen-activated protein kinase (MAPK) are involved in the activation of peroxisome proliferator-activated receptor (PPAR)alpha by adiponectin in muscle cells.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2006 Sep 55(9) 2562-70",
                "id": "16936205"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c25"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Inhibition of NF-kappaB activation and p38 MAPK activity decreased the TNF-induced release of eotaxin from eosinophils.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Exp Immunol 2002 Jun 128(3) 483-9",
                "id": "12067303"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c13"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "eosinophil",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "However, addition of the p38 MAPK inhibitor SB202190 abrogates the enhancement of ERbeta activity by Brx, showing that p38 MAPK activity is required for the enhancement of ERbeta function by Brx.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 14 276(50) 46792-7",
                "id": "11579095"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c09"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "p38MAPK inhibition markedly reduced the secretion of most SASP factors, constitutive p38MAPK activation was sufficient to induce an SASP, and p53 restrained p38MAPK activation.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2011 Apr 20 30(8) 1536-48",
                "id": "21399611"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bf1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Mobilization of receptors to the cell surface and phosphorylation of p38 MAPK by LOS were both impaired in PMN with the NADPH oxidase chemically inhibited or genetically absent and in cells lacking functional ClC-3.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Nov 23 282(47) 33958-67",
                "id": "17908687"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070be0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Moreover, uPAR is known to take part in the release of both inflammatory cytokines TNF-a, IL-1b, and IL-6 and chemokines IL-8 and monocyte chemoattractant protein (MCP)-1 from human blood mononuclear cells through p38, c-Jun N-terminal kinases (JNKs), and NF-kB activation (Khan et al. 2006; Del Rosso et al. 2008).",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2009 Apr 50 Suppl S189-94",
                "id": "19064999"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bdc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "peripheral blood mononuclear cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Figure 1C shows that LPS activates and phosphorylates p38 by 15 min (lane 2), which returns toward control (lane 1)  at 2 h (lane 3).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2004 Jan 286(1) C145-52",
                "id": "14522818"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bd7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We found that CCR7 induced a Gi-dependent activation of MAPK members ERK1/2, JNK, and p38, with ERK1/2 and p38 controlling JNK. MAPK members regulated chemotaxis, but not the migratory speed, of DCs.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Apr 1 174(7) 4070-80",
                "id": "15778365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bc5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We conclude that in neutrophils, proapoptotic pathways after TNFR1 stimulation are initiated by p38 and PI3K, but not by caspase-8, a finding that should be considered in anti-inflammatory drug-development strategies.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2011 Jun 2 117(22) 5953-62",
                "id": "21478427"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bbd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "hus, suppression of p38 activity using SB203580 and siRNA transfection resulted in the significant reduction of IKK activity, DC maturation, and CXCL2 upregulation by toxin A. ",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Med 2009 Feb 87(2) 169-80",
                "id": "18985311"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bbb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "inhibition of extracellular signal regulated kinase (ERK) phosphorylation and p38 mitogen-activated protein kinase (MAPK) activation in response to fMLP by CYL-26z up to 30microM was obtained",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Pharmacol 2006 Sep 14 72(6) 749-60",
                "id": "16887102"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bba"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "This loading of macrophages with free cholesterol activates NF-?B and the MAPKs p38, extracellular-signal-regulated kinase 1 (ERK1) and ERK2, and JNK, thereby inducing the expression of genes encoding inflammatory cytokines (including TNF-? and IL-6)66",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2008 Jul 24 454(7203) 455-62",
                "id": "18650916"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ba9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "BMP-2 and TGF-beta stimulated Ras, MAPK, and AP-1 activities (note: Ras is upstream of the otehr two)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 3 277(18) 15514-22",
                "id": "11854297"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ba8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We found increased Erk-1/2 and p38 MAP kinase activities to be important components of ROS-mediated signaling. The pro-oxidant state also contributed to constitutive elevation of AP-1, NFkappaB and cAMP response element transactivation in the malignant phenotype. ",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 1999 Nov 20(11) 2063-73",
                "id": "10545407"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ba0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The astroglial-derived S100beta protein stimulates the expression of nitric oxide synthase in rodent macrophages through p38 MAP kinase activation",
              "citation": {
                "type": "PubMed",
                "name": "Life Sci 2006 May 1 78(23) 2707-15",
                "id": "16376947"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b9d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Exposure of rats to the smoke from 5 to 15 cigarettes produced a marked increase in phosphorylation of p38, JNK and ERK2 (maximal inductions of ~2.4-fold, ~2.5-fold and ~1.6-fold, respectively).",
              "citation": {
                "type": "PubMed",
                "name": "Chem Biol Interact 2005 Jun 30 155(1-2) 31-42",
                "id": "15970277"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b8f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The induction of Lox-1 and Nox1 by CpG ODN was regulated via the TLR9-p38 MAPK signaling pathway",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2008 Dec 20(12) 2266-75",
                "id": "18817866"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b87"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "peritoneal macrophage",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "As shown in Figure 6A, the basal level of phospho-p38 MAPK was elevated in cav-1/- mice but not detectable in wild-type mice.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2008 Aug 39(2) 171-9",
                "id": "18323531"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b76"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "These results suggest that in keratinocytes, p38 activity is crucial for the induction of SKALP gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "Arch Dermatol Res 2000 Apr 292(4) 180-7",
                "id": "10836611"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b71"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "p38 mitogen-activated protein kinase was activated by HSA and was involved in NF-kappaB-dependent transcription of fractalkine.",
              "citation": {
                "type": "PubMed",
                "name": "J Am Soc Nephrol 2003 Oct 14(10) 2436-46",
                "id": "14514721"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b6d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Figure 1. Pathways to MUC5AC expression in COPD",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82",
                "id": "17615396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b6b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In 2005, Yuan and colleagues identified necrostatin 1 and necrostatin 3, small molecules that allosterically block the kinase activity of RIP1, thereby inhibiting necroptosis but leaving RIP1-mediated activation of NF-kB, mitogen-activated protein kinase p38 and JUN N-terminal kinase 1 (JNK1) unaffected7,63.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2010 Oct 11(10) 700-14",
                "id": "20823910"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b62"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Signal transduction pathway inhibitors (SB203580, curcumin, and PD98059) implicated p38 and JNK",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2005 Mar 19(3) 443-5",
                "id": "15640282"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b5c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We found that the activation of JNK and p38 MAPK by UV, anisomycin and TNF-a was very similar between Perk+/+ and Perk-/- MEFs (Figure 5).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2006 Jan 1 393(Pt 1) 201-9",
                "id": "16124869"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b4d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "PD98059, a selective MEK inhibitor and SB202190, a p38 MAPK inhibitor, attenuated the MMP-1 mRNA expression enhanced by NO.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2003 Jan 10 103(2) 161-8",
                "id": "12455029"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b39"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Angiotensin II (Ang II), a proinflammatory mediator implicated in atherosclerosis, restenosis, and hypertension,13 leads to the hypertrophic response in SMCs via the production of both superoxide and H2O2 and activation of p38 MAPK.14,15",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2000 Aug 4 87(3) 179-83",
                "id": "10926866"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b2e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Further results showed that VEGFA induced the activation of JNK/SAPK, p38 kinase and extracellular signal-regulated kinases 1 and 2 (ERK1/2), while JNK/SAPK inhibitor SP600125 and specific siRNA both blocked all those angiogenic effects induced by VEGFA. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Biochem Biophys 2012 May 17",
                "id": "22592917"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b2b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Kumagai et al. [40] examined the relation between COX-2 mRNA stability and HNE-activated p38 MAPK pathway and found that the p38 MAPKspecific inhibitor accelerated COX-2 mRNA degradation [15,43].",
              "citation": {
                "type": "PubMed",
                "name": "Curr Atheroscler Rep 2007 Sep 9(3) 216-21",
                "id": "18241616"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b1e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "TAK1-induced iNOS-Luc activity was substantially inhibited by pharmacological inhibitors of the known downstream kinases, p38 MAPK and JNK (SB203580 and SP620125), and was almost completely blocked by co-expression of a phosphorylation mutant of IkappaB. TAK1/TAB1 also induced the production of NO and the expression of iNOS in microglial cells in a p38 MAPK-, JNK- and NFkappaB-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurochem 2003 Oct 87(1) 238-47",
                "id": "12969270"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b1c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "glial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We generated Card9(-/-) mice and found that CARD9-deficient macrophages had defects in activation of the kinases p38 and Jnk but not of transcription factor NF-kappaB after bacterial and viral infection. ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Immunol 2007 Feb 8(2) 198-205",
                "id": "17187069"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b11"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "IL-22 induces the activation of the ERK, JNK, and p38 MAPK pathways that are not activated by IL-10 ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 13 277(37) 33676-82",
                "id": "12087100"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b0e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatoblastoma cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "BMP-2 and TGF-beta stimulated Ras, MAPK, and AP-1 activities (note: Ras is upstream of the otehr two)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 3 277(18) 15514-22",
                "id": "11854297"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070af9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "osteoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In the case of TNF-alpha-treated cells, activation of ERK1/2 was transient, with a maximum at 10-20 min and decreasing to the baseline at 30 min, whereas strong activation of p38 kinase was sustained up to 60 min. Activation of JNK was transient, with maximum levels detected at 10 min. ",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2001 Jan 15(1) 230-242",
                "id": "11149911"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070af0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "blocking p38 MAPK decreased C-reactive protein release.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Apr 15 168(8) 4070-7",
                "id": "11937566"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070aed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "leukocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-kappaB and C/EBPbeta activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Sep 14 282(37) 27229-38",
                "id": "17652082"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070aeb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Neutrophils stimulated with FMLP exhibited phosphorylation of the cAMP response element binding protein (CREB), and this reaction was inhibited by SB 203580 and PD 98059.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Oct 15 163(8) 4527-36",
                "id": "10510396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ae4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Exposure to SB202190 (p38 MAPK), U0126 (ERK1/2) and NF-kB III inhibitor revealed that OA induced MMP-9 activity through p38 MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "Br J Pharmacol 2012 Jan 165(1) 274-88",
                "id": "21718298"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070adf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "These demonstrate that Ang II is capable of inducing CRP generation in macrophages via AT(1)-ROS-ERK1/2/p38MAPK-NF-kB signal pathway, which contributes to better understanding of the proinflammatory and proatherosclerotic actions of Ang II.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Physiol Biochem 2011 27(1) 63-70",
                "id": "21325823"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070adc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "senescence-like growth arrest was accompanied by impaired activation of mitogen-activated protein kinase (MAPK) pathways, namely, extracellular-regulated protein kinase, c-jun N-terminal kinase and p38 MAPK, in response to epidermal growth factor (EGF) and insulin-like growth factor-I (IGF-I)",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Jan 12 25(2) 176-85",
                "id": "16170353"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ad9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "CaMKIV, and p38 MAPK were also the kinases involved in CREB Ser(133) phosphorylation induced by CD3/CD28.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Jan 1 166(1) 284-92",
                "id": "11123304"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ad5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We also show that overexpression of BCMA in 293 cells activates NF-kappa B, Elk-1, the c-Jun N-terminal kinase, and the p38 mitogen-activated protein kinase.  ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2000 Aug 1 165(3) 1322-30",
                "id": "10903733"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ad4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Figure 1A shows that IL-1{beta} induces the phosphorylation of p38 in renal mesangial cells at 15 min (lane 2),",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2004 Jan 286(1) C145-52",
                "id": "14522818"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ac7"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "from full text - blockade of p38 MAPK suppresses TNF production. 73,74",
              "citation": {
                "type": "PubMed",
                "name": "Inflamm Bowel Dis 2006 Nov 12(11) 1068-83",
                "id": "17075348"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ac6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "jubilant",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Jul 1 63(13) 3632-6",
                "id": "12839952"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ac3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "ER81 is not only activated by ERK MAPK but also by p38 MAPK (42, 68). TAK1 is an MAPK kinase kinase that is capable of activating the p38 MAPK pathway (39, 69-73),",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 7 278(45) 44377-84",
                "id": "12947087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ac1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Of the LPS-regulated proteins identified by peptide mass fingerprinting for which probes were present on the oligonucleotide microarray... Similarly, CAP1, Rho-GAP1, and ficolin 1 were down-regulated at both the mRNA transcript and protein levels",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 30 277(35) 31291-302",
                "id": "11943771"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ac0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "IL-1 beta up-regulated GCLC expression (10 ng/ml IL-1 beta, 3.76 +/- 0.86; 100 ng/ml IL-1 beta, 4.22 +/- 0.68-fold control) via the p38 form of mitogen-activated protein kinase and NF kappa B and also increased reactive oxygen species levels (10 ng/ml IL-1 beta, 5.41 +/- 1.8-fold control).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 24 279(52) 53988-93",
                "id": "15485876"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ab6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "A signaling cascade from the Fas receptor via ceramide, Ras, Rac1, and JNK/p38-K to GADD153 is demonstrated employing transfection of transdominant inhibitory N17Ras, N17Rac1, c-Jun, or treatment with a specific p38-K inhibitor. The critical function of this signaling cascade is indicated by prevention of Fas- or C6-ceramide-induced apoptosis after inhibition of Ras, Rac1, or JNK/p38-K.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Aug 29 272(35) 22173-81",
                "id": "9268362"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ab3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "When HEMEC were exposed to acidic pH for various time periods, there was a rapid and significant activation of JNK which was seen as early as 1 min. Activation of p44/42 MAPK was first detected at 15 min and maximized by 30 min, while activation of p38 MAPK was delayed, appearing at 60 min (Fig. 3A).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2006 Nov 291(5) C931-45",
                "id": "16790501"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ab1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "NO* dose dependently activated p38 MAPK, and p38 MAPK inhibition with SB202190 or knockdown with siRNA was shown to block NO* activation of PPARgamma.",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2007 Mar 21(3) 950-61",
                "id": "17197391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070aa8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Duan et al. reported that these mice develop cardiac hypertrophy through elevated NF-KB activity [75], and unexpectedly, rosiglitazone-induced cardiac hypertrophy in both the WT mice and cardiomyocyt specific PPARG knockout mice through activation of p38 MAP kinase independent of PPARG.",
              "citation": {
                "type": "PubMed",
                "name": "PPAR Res 2010 2010",
                "id": "20814542"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a9f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Table S3 - TNF-inducible endothelial genes that are increased by and requiring p38 MAPK kinase, as they are repressed by SB202190 - bw",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2004 May 1 103(9) 3365-73",
                "id": "14715628"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a98"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Here, we show that ADP secreted from platelet-dense granules, and subsequent activation of P2Y12 receptors, as well as TxA2 release are important upstream mediators of p38 MAP kinase activation by thrombin.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2007 Jan 15 109(2) 616-8",
                "id": "16990590"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a96"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Pretreatment of THP-1 cells with pharmacological inhibitors of PI3K (LY294002), MAPK (PD98059), p38 MAPK (SB203580), and JNK (SP600125) inhibited ET-1-mediated MIP-1b mRNA expression by 89 6 5%, 104 6 7%, 102 6 8%, and 118 6 1%, respectively, when compared with that of untreated cells (Fig.1B).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Oct 15",
                "id": "20952681"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a81"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "insulin-dependent p38 MAPK phosphorylation was efficiently reduced in cells pretreated with wortmannin",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 7 276(49) 46079-87",
                "id": "11598141"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a77"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "These results suggest that p38 mitogen-activated protein kinase regulates LPS-induced activation of Sp1, which in turn regulates transcription of the hIL-10 gene",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 13664-74",
                "id": "11278848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a74"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In contrast, the p38 inhibitor SB 20358 (36) completely abrogated I-TAC-induced chemotaxis in a concentration-dependent manner (0.033 M) (P 0.05 by ANOVA) (Fig. 5B).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2006 Jul 291(1) C34-9",
                "id": "16467404"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a60"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Phosphorylation status of the three key MAPKs (ERK, JNK, and p38) and AKT in FIZZ2-treated MLFs were analyzed by Western blotting. The results showed rapid (10 min) marked activation of ERK by FIZZ2, with lesser effects on AKT and p38 (Fig. 5B). JNK was not activated by FIZZ2 treatment. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2011 Jul 1 187(1) 450-61",
                "id": "21602491"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a58"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "p38 MAPK inhibition affects the expression of MAPKAP-2, the direct molecular target of p38 MAPK (Figure 3)",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Rheum 2006 Feb 54(2) 463-72",
                "id": "16447221"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a51"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Rheumatoid Arthritis",
                "cell": "",
                "tissue": "synovium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We inhibited p38alpha MAPK by mating beta(1)-AR Tg and beta(2)-AR Tg mice with DNp38alpha MAPK mice, which rescued the depressed LVEF and reduced apoptosis and fibrosis in bigenic beta(2)-AR x DNp38alpha MAPK mice",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2007 May 117(5) 1335-43",
                "id": "17446930"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a49"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "One report has claimed that phosphorylation of GATA-3 occurs in Th2 cells and that this phosphorylation was mediated by p38 MAPK [66].",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Res Ther 2006 8(2) 205",
                "id": "16542479"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a46"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Th2 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Co-stimulation of TF1-KDR cells with both GM-CSF and VEGF-A resulted in massive migration of both the common GM-CSFR beta-chain and VEGF-R2 to lipid rafts and sustained p38 mitogen-activated protein kinase activation.",
              "citation": {
                "type": "PubMed",
                "name": "Br J Haematol 2009 May 145(3) 399-411",
                "id": "19245429"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a3c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "leukemia",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "many cytokines activate the transcriptional PPAR gamma coactivator-1 (PGC-1) through phosphorylation by p38 kinase, resulting in stabilization and activation of PGC-1 protein.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Nov 8(5) 971-82",
                "id": "11741533"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a3a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "BMP-2 also induced p38 mitogen-activated protein kinase (MAPK)",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2003 Aug 9(8) 1033-8",
                "id": "12872164"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a34"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "It has been demonstrated that IL-1alpha activates p38 MAPK and that this event is associated with StAR expression and testosterone synthesis in immature rat Leydig cells",
              "citation": {
                "type": "PubMed",
                "name": "J Signal Transduct 2011 2011 821615",
                "id": "21637381"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a1e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Leydig Cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The effects of TNF-alpha on plasma apoB48 levels could be blocked by the p38 inhibitor SB203580.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2007 Feb 56(2) 450-61",
                "id": "17259391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a1a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "IL-4 induces p38 MAPK activation in human dermal fibroblasts Since inhibition  of p38 MAPK significantly decreased IL-4-induced TIMP-2 expression, we  determined the activation of p38 MAPK by immunoblotting using Abs specific for  phosphorylated, activated forms of p38 MAPK (Thr 180 /Tyr 182 ).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Feb 15 168(4) 1895-902",
                "id": "11823524"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a16"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "IgE triggers the activation of three members of the mitogen-activated protein (MAP) kinase family, c-Jun amino-terminal kinase (JNK), p38 MAP kinase (p38), and extracellular signal-regulated kinases. SCF similarly activates all three MAP kinases.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Feb 15 162(4) 2087-94",
                "id": "9973482"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a12"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "the transcriptional activity of the ATF-2 transcription factor, as a direct p38 and JNK target in syndecan-4-null and wild type cells. In the absence of syndecan-4, both ATF-2 phosphorylation and transcriptional activity were significantly more elevated compared with wild type cells, and both activities were decreased either by the re-expression of syndecan-4 or by the expression of RacN17.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Nov 5 279(45) 47172-6",
                "id": "15371457"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a01"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Nicotine-induced calcium influx was mediated by protein kinase C (PKC) and p38 MAPK in HBEC and activated ERK1/2 in airway fibroblasts",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82",
                "id": "17615396"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a00"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "bronchial epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Induction of DNA DSBs stimulates the activation of the MAPK p38 in a RhoA-dependent manner; and this is required to delay cell death in response to toxin treatment or ?-irradiation (Guerra et al., 2008a).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2011 Aug 15 124(Pt 16) 2735-42",
                "id": "21807938"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "These results indicate that extracellular stressors can induce caveolin-1 tyrosine phosphorylation through the activation of well established upstream elements, such as p38 MAP kinase and c-Src kinase.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Mar 16 276(11) 8094-103",
                "id": "11094059"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709ed"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Interestingly, although the ERK1/2, p38 and JNK MAPKs were still induced in the Mekk3 knockdown cells, their levels were consistently lower than those in the control cells with similar kinetics at early time-points",
              "citation": {
                "type": "PubMed",
                "name": "Immunology 2007 Feb 120(2) 242-50",
                "id": "17116170"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709dc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The exact role of P38MAPK in TLR-4-induced IL-8 production/release remains unclear, although P38MAPK has been shown to play a key role in increasing the mRNA stability of IL-8, GM-CSF, and TNF-a in LPS-treated lung macrophages [54].",
              "citation": {
                "type": "PubMed",
                "name": "Exp Lung Res 2009 Aug 35(6) 439-85",
                "id": "19842832"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The p38 mitogen-activated protein kinase (MAPK) signaling pathway is also activated in response to IL-12, followed by phosphorylation of STAT4 on serine 721, which is required for STAT4 full transcriptional activity. ",
              "citation": {
                "type": "PubMed",
                "name": "Genes Cells 2005 Dec 10(12) 1153-62",
                "id": "16324152"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "p38 MAPK has also been reported to stimulate glucose transport by means of increased MEF2 transcriptional activity through an increase of PGC-1 phosphorylation and activation",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2003 Jun 12 423(6941) 762-9",
                "id": "12802337"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscles"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We showed that the fast-releasing NO donor DPTA-NO significantly enhanced the phosphorylation levels of the MAP kinases JNK and p38, which increased to a peak within 3 h (about six- and ninefold, respectively), but did not affect the high basal level of ERK1/2 kinase phosphorylation in U937 cells (Figs. 6A, B, and D)",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2010 Jan 15 48(2) 298-305",
                "id": "19892011"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709b6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Studies of IL-24 mRNA stability in anisomycin-treated keratinocytes reveal that the p38 MAPK inhibitor SB 202190 accelerates IL-24 mRNA decay suggesting p38 MAPK to regulate IL-24 expression by mRNA-stabilizing mechanisms.",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2010 5(1) e8671",
                "id": "20072629"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The downregulated connexin32 expression was inhibited by treatment with a MAP-kinase inhibitor (PD98059), whereas the upregulated claudin-2 expression was blocked by p38 MAP and PI3-kinase inhibitors (SB203580 and LY294002)",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2004 Oct 1 299(2) 427-41",
                "id": "15350541"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709a6"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Most surprisingly, b-Raf also enhanced Rin-mediated activation of p38 (Fig. 6, F  and G), suggesting that b-Raf participates in a Rin-dependent p38 activation pathway. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Nov 11 280(45) 37599-609",
                "id": "16157584"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709a2"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The blockade of p38 with the pharmacologic inhibitor SB203580 abrogated IL-8 production by cell stretching",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2002 Jul 27(1) 107-14",
                "id": "12091253"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "VES treatment induced nuclear translocation and activation of p38 kinase. Pretreatment with p38 kinase inhibitor blocked the VES-induced increase in NAG-1 protein and mRNA levels, whereas an inhibition of protein kinase C, Akt, c-Jun NH(2)-terminal kinase, or MEK activity had no effect on VES-induced NAG-1 levels.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2008 Apr 7(4) 961-71",
                "id": "18413810"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407099d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "IL-33 rapidly activated ERK1/2, JNK, p38, and NF-kB signaling cascades, as evidenced by phosphorylation of MAP kinases and phosphorylation and degradation of the NF-kB inhibitor IkB-a.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2009 Feb 12 113(7) 1526-34",
                "id": "18955562"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407099c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "basophil",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Activation of c-Jun N-terminal kinase (JNK) by TNF-? was also diminished by depletion of SphK1 (Fig. 1a) or its inhibition (Supplementary Fig. 3b). Likewise, SK1-I reduced activation of p38 (Supplementary Fig. 3a).",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2010 Jun 24 465(7301) 1084-8",
                "id": "20577214"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070997"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Inhibition of p38 MAPK selectively blocks the accumulation of neutrophils into the airspaces",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2000 Feb 15 164(4) 2151-9",
                "id": "10657669"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070993"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Phosphorylated ERK1/2, JNK, p38 and ERK5 were significantly increased by exposure to TS, indicating the activation of these MAPK pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2005 Dec 26(12) 2187-95",
                "id": "16051644"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070988"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "stimulation of p38 MAPK isoforms phosphorylated purified Nrf2 protein and caused an increase in the interaction between Nrf2 and Keap1 in vitro and the suppression of Nrf2 translocation into the nucleus.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Sep 1 66(17) 8804-13",
                "id": "16951197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407097e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In C3H/HeOuJ mice treated with ETX, activation of p38 MAP kinase was also evident in macrophages and endothelial cells, and JNK kinase in macrophages. In contrast, reduced protein kinase B (AKT) was noted in macrophages.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Mol Pathol 2007 Dec 83(3) 311-26",
                "id": "17996232"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070979"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Using pharmacological inhibitors, we further show that p38 MAPK and Akt signaling pathways are crucial for the ErbB2-induced MMP-9 up-regulation, invasion and migration of MCF10A cells",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Lett 2009 Mar 18 275(2) 227-33",
                "id": "19022565"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070978"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Taken together, RhoA, ROCK, p38MAPK, ERK1/2, and p47(PHOX) may be subsequently activated, leading to activation of NADPH oxidase to produce superoxide. ",
              "citation": {
                "type": "PubMed",
                "name": "Exp Mol Med 2005 Dec 31 37(6) 575-87",
                "id": "16391519"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070970"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The increase in the level of the p38 MAPK substrate HSP27 was less pronounced and there was no change in the level of ERK1/2 substrate p90RSK upon IL-33 stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2010 Sep 10 316(15) 2527-37",
                "id": "20406635"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070960"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "p38 is one of the substrates of MEKs. MEK3 and MEK6 both strongly activate p38 kinase, however MEK3 is more active on p38?, while MEK6 activates all p38 isoforms",
              "citation": {
                "type": "PubMed",
                "name": "J Mammary Gland Biol Neoplasia 2003 Jan 8(1) 45-73",
                "id": "14587863"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070950"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The epithelial senescence was accompanied by p38 MAPK-dependent airway inflammation. Senescent NCI-H441 cells impaired epithelial wound repair and secreted increased amounts of pro-inflammatory cytokines in a p38 MAPK-dependent manner. Clara cell senescence in COPD patients was accelerated and accompanied by p38 MAPK activation",
              "citation": {
                "type": "PubMed",
                "name": "Respir Res 2011 12 78",
                "id": "21663649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070940"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Clara cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "TNF-alpha , added alone, significantly increased the phosphorylation of p38 MAPK (Fig. 4, A and C). ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2002 Aug 283(2) L418-27",
                "id": "12114204"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407093e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In addition, TNF-alpha was shown to induce the expression of VCAM-1 in a p38 kinase-dependent manner; also, TNF-alpha-induced p38 kinase activation was blocked by inhibition of PKCdelta, suggesting that p38 kinase is apparently situated downstream of PKCdelta in the TNF-alpha-signaling pathway to VCAM-1 expression.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2005 Feb 288(2) L307-16",
                "id": "15489375"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407093a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "we found that IL-33R signaling induced a time-dependent activation of Erk1/2, protein kinase B (PKB), JNK1/2, NF-kB, and p38, and degradation of IkB (supplemental Figure 1B).",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2010 May 13 115(19) 3899-906",
                "id": "20200353"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070932"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In parallel, after stimulation with 10 ?M HNE, p38 MAPK was rapidly and strongly phosphorylated within 5 min, and this phosphorylation was maintained up to 45 min (Fig. 6B), suggesting a possible role of p38 MAPK in HNE-induced 5-LO activation.",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2009 Mar 1 46(5) 692-8",
                "id": "19135147"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407092f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": " In addition, inhibition of JNK and p38 suppressed TGFbeta induction of TGFbeta3 transactivation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Oct 6 281(40) 29479-90",
                "id": "16891311"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407092e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Science 1996 May 31 272(5266) 1347-9",
                "id": "8650547"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407091a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Reduced SCF-induced activation of Rac1 and Rac2 GTPases, p38 mitogen-activated protein kinase, and filamentous actin polymerization was observed in fyn(-/-) mast cells compared to wild-type mast cells.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2007 May 1 109(9) 3679-86",
                "id": "17213284"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070912"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Inhibition of protein kinase C delta, geranyl transferase 1, or stress-activated protein kinase p38 eliminates the expression of collagen I and III in scleroderma cells.62,63",
              "citation": {
                "type": "PubMed",
                "name": "N Engl J Med 2009 May 7 360(19) 1989-2003",
                "id": "19420368"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407090e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "AG 1478 (EGF receptor tyrosine kinase inhibitor), PD 98059 (ERK1/2 inhibitor), and SB 203580 (p38 inhibitor) significantly inhibited EGF-induced p11 expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 11 277(41) 38431-40",
                "id": "12163506"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708f0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Phosphorylation of MEF2A by p38 MAPK strongly increases the transcriptional activity of MEF2A",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 25 278(17) 15297-303",
                "id": "12586839"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Inhibition of p38, which is known to stimulate TonEBP/OREBP transcriptional activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Feb 1 283(5) 2554-63",
                "id": "18056707"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708e1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "ERK and p38 play a role in alpha-adrenergic-stimulated NCX1 upregulation, and (3) p38 activation alone is sufficient for NCX1 upregulation.",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2002 Nov 976 237-47",
                "id": "12502566"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "These effects of IL-1alpha were prevented by pretreatment of the cells with the specific inhibitors of the p38 MAP kinase, SB203580 and PD169316, suggesting that this kinase is an important part of IL-1alpha signaling in the immature Leydig cell.",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Endocrinol 2003 Feb 30(1) 59-67",
                "id": "12580761"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708df"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Leydig Cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In T cells CD137-induced signals lead to the recruitment of TRAF family members and activation of several kinases, including ASK-1, MKK, MAPK3/ MAPK4, p38, and JNK/SAPK  CD137 = TNFRSF9 ASK1 = MAP3K5",
              "citation": {
                "type": "PubMed",
                "name": "Immunol Res 2004 29(1-3) 197-208",
                "id": "15181282"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708dd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "This analysis demonstrated that MKK6 caused p38 MAP kinase activation (Fig. 6C).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Mar 16(3) 1247-55",
                "id": "8622669"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708d5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Additionally, Mig and SDF-1alpha activated MAPKs p44/42 and p38 on melanoma cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 30 276(48) 45098-105",
                "id": "11571298"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708c6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "TNF activates NFKB transcriptional activity in macrophages and epithelial cells . TNF similarly activates p38 MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "Pharmacol Rev 2004 Dec 56(4) 515-48",
                "id": "15602009"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708c5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Epithelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Thus, stimuli that activate these kinases, including exposure to pro-inflammatory cytokines, UV irradiation, DNA damage or change in ROS, are among the classic inducers of ATF2 transcriptional activity (van Dam et al., 1995).ATF2 mediates both transcription and DNA damage control, through its phosphorylation by JNK/p38 or ATM/ATR respectively. ",
              "citation": {
                "type": "PubMed",
                "name": "Pigment Cell Res 2007 Dec 20(6) 498-506",
                "id": "17935492"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "PMA stimulation resulted in translocation of NF?B and this translocation was inhibited by both SB-202190 and bis I (Fig. 6). (SB-202190 is a p38 inhibitor)",
              "citation": {
                "type": "PubMed",
                "name": "J Surg Res 2008 Mar 18",
                "id": "18675993"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708ae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The results indicate that ERK3 expression is a consequence of p38 pathway activation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 6 276(14) 10759-66",
                "id": "11148204"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070890"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Hypoxia and PDGF-BB induced synthesis of soluble collagen type I via Erk1/2 and p38 MAP kinase",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jan 12 282(2) 908-15",
                "id": "17099219"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407088b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "TRAF6 activates the extracellular signalregulated kinases (ERK) 1 and 2 as well as p38 mitogen-activated protein kinase (MAPK),11,118125",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2001 Dec 7 89(12) 1092-103",
                "id": "11739273"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407086e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Inhibitors of ERK (U0126, PD98059, and ERK1/2 antisense phosphorothioate oligonucleotide), JNK (SB203580, SP600125, and curcumin), and p38 (SB203580 and SB202190) pathways down-regulated the TNF-stimulated expression of MMP-13.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2003 Aug 1 288(1) 208-17",
                "id": "12878172"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407086d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "chondrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "To further assess the role of p38 MAPK and JNK1 in VILI, we ventilated mice genetically deficient either in mkk3 (mkk3-/-), the major upstream activating kinase of p38 MAPK",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2008 3(2) e1601",
                "id": "18270588"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070866"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The treatment of NCI-N87 cells with EGF resulted in increases in phosphorylation of Erk1/2, Akt, and P38. Blockade of the Erk, phosphatidylinositol-3 kinase/Akt, or P38 pathways in this cell line",
              "citation": {
                "type": "PubMed",
                "name": "Br J Cancer 2003 Mar 10 88(5) 796-802",
                "id": "12618892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070860"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "p38 kinase, a stress-activated kinase, becomes activated in response to hypoxia",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 14359-65",
                "id": "11278616"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070842"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Other inducers of the UPR, such as the protein glycosylation inhibitor, tunicamycin, and the sarcoendoplasmic reticulum calcium ATPase inhibitor, thapsigargin, are known to activate p38 (Hung et al., 2004; Li and Holbrook, 2004).",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2005 Oct 10 171(1) 61-73",
                "id": "16203857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407083d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Kinases that were inhibited by low levels of GSTp expression included JNK, MKK3, p38, and MKK7.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Aug 1 60(15) 4053-7",
                "id": "10945608"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407082a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Fig. 3. CREB phosphorylation is induced by OxPAPC via PKA, PKC, p38MAPK, and ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 19 278(51) 51006-14",
                "id": "14523007"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407081c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The superoxide donor menadione activated p38 MAPK and phosphorylation of STAT1 at serine 727, but not at tyrosine 701 (Fig. 8B),",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Aug 25(15) 6821-33",
                "id": "16024814"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070812"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "the MAPKp38 inhibitors \\\"SB-202190\\\"/SB203580 enhanced the magnitude of insulin inhibition and significantly increased the level of activated ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2003 May 52(5) 1073-80",
                "id": "12716735"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407080d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "2 hours after the LPS stimulation, the phosphorylation levels of ERK1/2, p38 MAPK and JNK all increased.  ",
              "citation": {
                "type": "PubMed",
                "name": "Chin Med J (Engl) 2007 Jun 20 120(12) 1075-81",
                "id": "17637225"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The human beta-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2005 Aug 1 175(3) 1776-84",
                "id": "16034119"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "It is known that LPS stimulation leads to increased activation of three subgroups of MAPKs, i.e., ERK, JNK, and p38, in murine macrophages and human monocytes (38, 39).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2002 Aug 1 169(3) 1401-9",
                "id": "12133965"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707ee"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "By combining pharmacological and genetic approaches, we show here that the Ras/ERK pathway and phosphatidylinositol 3-kinase (PI3K) are both required for cortical neuron migration. By dissecting the downstream signals necessary for this event, we found that Rac1/p38 and Akt are required, whereas the c-Jun N-terminal kinase (JNK) and mTOR/p70(s6k) pathways are dispensable.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Feb 24 281(8) 4771-8",
                "id": "16361255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707df"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2006 Oct 20(12) 2112-4",
                "id": "16935932"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707dc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In cultured myoblasts evidence has been presented that MEF2 binding is necessary for p38 MAPK regulation of muscle creatine kinase promoter-driven reporter gene expression (Zetser et al. 1999).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Nutr Soc 2004 May 63(2) 227-32",
                "id": "15294035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707d9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "myoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Fig. 2B demonstrates that stimulation of cells with IL-1b leads to the activation of p38 as previously reported (44). Interestingly, this activation requires functional Akt because concomitant expression of a dominant negative mutant of Akt (DN-Akt) effectively abolished the ability of IL-1b to activate p38.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 1 276(22) 18934-40",
                "id": "11259436"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "p38 MAPK is activated in a ERK-dependent fashion, thus indicating that Ras promotes premature senescence by sequentially activating the ERK and p38 MAPK pathway [68].",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 2004 Feb 36(2) 175-83",
                "id": "14871544"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Recent studies have shown that MEF2C is activated by MAP kinase P38 during  inflammation, resulting in an increase in c- jun gene transcription ( 19 ).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Oct 2 273(40) 26123-9",
                "id": "9748293"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Figure 1B shows that MKK3(Glu) caused marked activation of p38 MAP kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Mar 16(3) 1247-55",
                "id": "8622669"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707aa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "CaMKIV, and p38 MAPK were also the kinases involved in CREB Ser(133) phosphorylation induced by CD3/CD28.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2001 Jan 1 166(1) 284-92",
                "id": "11123304"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707a8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Degterev, Yuan, and others identified chemical compounds named necrostatins that allosterically inhibit the kinase activity of RIP1 and that can block necrosis without affecting RIP1-mediated activation of nuclear factor {kappa}B (NF-{kappa}B), p38 mitogen?activated protein kinase (MAPK), or c-Jun N-terminal kinase (JNK) (2, 15).",
              "citation": {
                "type": "PubMed",
                "name": "Sci Signal 2010 3(115) re4",
                "id": "20354226"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707a6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "TNFR1-stimulated p42/44 MAPK and p38 MAPK activities were insensitive to pharmacological caspase inhibition or CrmA.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2002 Aug 15 366(Pt 1) 145-55",
                "id": "11996667"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407079d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The present study demonstrates that p38 MAPK negatively regulates AngII-induced ERK1/2 activity, Rb phosphorylation, cyclin D1 expression, and DNA-synthesis in human CASMC.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2003 Jun 6 305(3) 552-6",
                "id": "12763029"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407079a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In addition, a recent report demonstrated that exposure of SK-N-MC cells to FGF induces the p38 MAPK pathway, which then leads to CREB Ser-133 phosphorylation (66).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1998 Apr 18(4) 1946-55",
                "id": "9528766"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070782"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "neuroblastoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Mice with haploinsufficiency of the Grb2 gene (Grb2(+/-) mice) appear normal at birth but have defective T cell signaling. In response to pressure overload, cardiac p38 MAPK and JNK activation was inhibited and cardiac hypertrophy and fibrosis was blocked in Grb2(+/-) mice.",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2003 Mar 111(6) 833-41",
                "id": "12639989"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070781"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "VEGF-C/Flt-4 signaling-induced activation of p38 MAPK and upregulation of CNTN-1 were both abolished by transfection with p38AF-dominant negative form of p38 MAPK (Figure 4B)",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2006 Mar 9(3) 209-23",
                "id": "16530705"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407077a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Moreover, release of arachidonic acid induced by VWF was strongly impaired by inhibition of p38MAPK. We also found that VWF induced phosphorylation of cytosolic phospholipase A(2), and that this process was prevented by the p38MAPK inhibitor SB203580.",
              "citation": {
                "type": "PubMed",
                "name": "Thromb Haemost 2004 Jan 91(1) 102-10",
                "id": "14691575"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070776"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Blood Platelets",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "IL-8 treatment lasting 15 min failed to recruit flavocytochrome b(558), p47(phox), or Rac2, but did enhance the Btk- and p38 MAPK-dependent phosphorylation and the translocation of p67(phox) into detergent-resistant microdomains. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Nov 4 280(44) 37021-32",
                "id": "16115878"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407076d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "S1P stimulated expression of the transcription factor KLF5 in manners dependent on G(i), Ras, and ERK/p38 MAPK",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Mar 26 279(13) 12300-11",
                "id": "14711826"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070767"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "the IL-16-mediated activation of SAPKs and p38 MAPK in macrophages alone induces no detectable apoptotic cell death.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1998 Jun 15 160(12) 5874-9",
                "id": "9637499"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070765"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "At the transcription level, inhibition of p38 MAPK inhibits CCR7 mRNA expression. Finally, we demonstrated that transcription factors CREB-1 and C/EBPalpha and C/EBPbeta are translocated to the nucleus following PGE(2) stimulation and bind the potent CCR7 promoter region. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Immunol 2009 Aug 46(13) 2682-93",
                "id": "19545899"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070761"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "RAGE-mediated NF-kappaB activation was suppressed by the selective p38 MAPK inhibitor SB203580 and by coexpression of a kinase-dead p38 dominant-negative mutant.",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2001 Jun 50(6) 1495-504",
                "id": "11375353"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407074c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "NGF was also found to stimulate p38 MAPK activity, as measured in an immune complex kinase assay (Fig. 5B).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1998 Apr 18(4) 1946-55",
                "id": "9528766"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070743"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Addition of CHA, CGS 21680, and Compound 24 induced a concentration-dependent increase of pERK1/2, pp38, and pAkt, whereas Cl-IB-MECA was involved only in ERK1/2 phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2010 Jan 30(1) 90-7",
                "id": "19834107"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070741"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Foam Cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Furthermore, GA treatment induces MAPKs activation (SAPK/JNK and p38) and Hsp70 expression in ROS dependent manner, suggesting that GA turns on the signaling pathway by generation of ROS through Rac1.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biochem 2004 Apr 259(1-2) 23-33",
                "id": "15124904"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407073a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Inhibitors of p38 (SB203580) and PKC (calphostin C) reduced significantly the mRNA expression stimulated by IL-17 of IL-8, GRO-alpha and GRO-beta in SFC, indicating IL-8, GRO-alpha, GRO-beta mRNA expression is mediated through p38 and PKC when stimulated with IL-17.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Exp Immunol 2002 Mar 127(3) 539-46",
                "id": "11966773"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070737"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "MEKK1 also activated SKK2/MKK3 and SKK3/MKK6, the direct upstream activators of SAPK2a/p38 (MEKK1 = MAP3K1, MKK3 = MAP2K3, MKK6 = MAP2K6)",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 1998 Jul 1 333 ( Pt 1) 11-5",
                "id": "9639556"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070732"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Two distinct inhibitors of p38MAPK, SB 203580 (10 microm) and SB 202190 (10 microm), prevented bFGF (0.3-3 nm)-stimulated cell proliferation",
              "citation": {
                "type": "PubMed",
                "name": "Br J Pharmacol 2004 Aug 142(7) 1182-90",
                "id": "15249425"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070725"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Reduction in p38 phosphorylation following 24-hours of atheroprone flow in the presence of blocking antibody R28C8, but not the control 12F1  ",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2008 Aug 28(8) 1534-41",
                "id": "18556570"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070722"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The amounts of IL-1Ra stimulated by WPE or beta-LG + alpha-LA significantly reduced the IL-1 activity in EL4 cells. Inhibitors of p38 and extracellular signal-regulated kinases (ERK)1/2 mitogen-activated protein kinase, and nuclear factor-kappaB cascades reduced neutrophil production of IL-1Ra.",
              "citation": {
                "type": "PubMed",
                "name": "J Nutr 2010 Feb 140(2) 382-91",
                "id": "20032479"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407071b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Recombinant TTP was phosphorylated by three members of the mitogen-activated protein (MAP) kinase family, p42, p38, and JNK, with half-maximal phosphorylation occurring at approximately 0.5, 0.25, and 0.25 microM protein, respectively....we expressed human and mouse TTP as glutathione S-transferase and maltose-binding protein (MBP) fusion proteins in Escherichia coli, and purified them by affinity resins and Mono Q chromatography. ",
              "citation": {
                "type": "PubMed",
                "name": "Arch Biochem Biophys 2003 Apr 1 412(1) 106-20",
                "id": "12646273"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407070b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Phospho-p38+ alveolar macrophages and phospho-p38+ cells in alveolar walls were increased in patients with severe and mild/moderate COPD, compared with smoking and nonsmoking controls. ",
              "citation": {
                "type": "PubMed",
                "name": "Eur Respir J 2008 Jan 31(1) 62-9",
                "id": "17959643"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706fc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Phosphorylation of p38 in response to HNE was also significantly increased (Fig. 6);",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2005 Aug 1 39(3) 355-64",
                "id": "15993334"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706f4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "exercise leads to the activation of at least three MAPK signalling pathways, i.e. ERK1/2, p38 MAPK and JNK, in skeletal muscle (Zierath, 2002).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Nutr Soc 2004 May 63(2) 227-32",
                "id": "15294035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "These results suggest that inhibin/activin beta(A) gene activation is achieved by the JNK and p38 kinase activation through the calmodulin pathway in mast cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2003 Jun 15(6) 605-13",
                "id": "12681448"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706f2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "RANKL stimulated the phosphorylation of Ser727 of STAT1, which required p38 activity.",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2005 Apr 1 105(7) 2963-9",
                "id": "15585657"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706f1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Two-dimensional phosphopeptide mapping using mutation of phosphorylation sites for MAPK revealed that the nine serine residues in Foxo1 are specifically phosphorylated by Erk and that five of the nine residues are phosphorylated by p38 in vivo. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2007 Mar 19(3) 519-27",
                "id": "17113751"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706e8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Smoke exposure of GM-Ms also resulted in the rapid activation of the MAP kinases ERK and p38 (Figure 4).",
              "citation": {
                "type": "PubMed",
                "name": "Exp Lung Res 2008 Nov 34(9) 599-629",
                "id": "19005923"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Cyclosporin A inhibited Fc epsilon RI-mediated JNK and p38 activation, but did not affect the activation of these kinases when stimulated through the SCFR.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Feb 15 162(4) 2087-94",
                "id": "9973482"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706d4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Exposure of endothelial cells to matrix-bound VEGF elicits prolonged activation of VEGFR2 with differential phosphorylation of Y1214, and extended activation kinetics of p38.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2010 Feb 22 188(4) 595-609",
                "id": "20176926"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706d2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The results revealed that p38 MAPK was activated by IL-13 from 15 min to later stages of treatments (up to 4 h) (Fig. 4A).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Jun 23(11) 3918-28",
                "id": "12748293"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Leptin-induced MUC5B expression was blocked by the ERK1/2 and p38 pathway inhibitors, but not by the JAK2/STAT3 pathway inhibitor.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Lung Res 2010 Jun 36(5) 262-9",
                "id": "20497020"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706cd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Lung airway"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "TNFa (10 ng/ml) also increased p38-MAPK phosphorylation [Fig. 2(b) and (c)].",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 1999 Dec 31(12) 2087-99",
                "id": "10640438"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706b7"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "myocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "CO activated p38 MAPK, pERK1/2 and Akt at 30 min as determined by phosphorylation in a dose (Figure 4A) and time (Figure 4B) dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2009 4(12) e8139",
                "id": "19956541"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706b0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In addition, SB202190 and U0126 both inhibited the induction of MUC5AC mRNA expression by IL-13 (Fig. 4c).",
              "citation": {
                "type": "PubMed",
                "name": "Respirology 2008 Mar 13(2) 191-202",
                "id": "18339016"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706ad"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Treatment with LPS resulted in significant increases in ERK, JNK, and p38 phosphorylation compared with control, and these events were not inhibited by cotreatment with lutein (Fig. 4D).",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2008 Sep 15 45(6) 885-96",
                "id": "18620044"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070696"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "leukemia",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "ET-1-induced transcription of the immediate early gene c-fos requires the concomitant activation of both the PKC/ERK- and p38MAPK-dependent pathways, because inhibitors of either pathway block the ET-1-induced increase of c-fos mRNA.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2001 Nov 15 21(22) 8842-53",
                "id": "11698596"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070692"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The ability of SB203580 to inhibit p38 MAPK activity in intact cells was determined by an assay for MAPKAPK-2 activity, a kinase activated by p38 MAPK [36]. Figure 8 shows that SB203580 inhibits TNF-alpha stimulation of p38 MAPK. Similar results were seen with GM-CSF-stimulated MAPKAPK-2 activity",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 1998 Oct 64(4) 537-45",
                "id": "9766635"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407067b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "IGFBP-5-induced phosphorylation of p38 MAP kinase, which was abolished by SB203580, or expression of a dominant negative Ras mutant, Ras(S17N), and phosphorylation of Erk1/2, which was abolished by a Raf1 kinase inhibitor, U1026, or expression of Ras(S17N).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 7 277(23) 20563-71",
                "id": "11923300"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070678"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Chemical inhibition of p38 MAPK and SAPK/JNK activation blocks TNF  -alpha-induced ephrin A1 expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 27 276(17) 13771-7",
                "id": "11278471"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070650"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Results showed a time-dependent response of increased Txnip expression and p38 MAPK and JNK phosphorylation by ceramide in both Jurkat T cells (Figure 6A) and 10I cells (Figure S4A). ",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2008 Apr 15 111(8) 4365-74",
                "id": "18270325"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070642"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "sLRP1, which was purified from human plasma, and full-length LRP1, purified from mouse liver, activated cell signaling when added to cultures of RAW 264.7 cells and BMMs. Robust activation of p38 MAPK and JNK was observed. The IKK-NF-??B pathway was transiently activated.",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 2010 Oct 88(4) 769-78",
                "id": "20610799"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070631"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Treatment with p38 inhibitors, such as SB202190, SB203580, and PD169316, substantially reduced LPS-induced p62 mRNA expression, as well as IL-6 mRNA (Fig. 4D and Fig. S4C).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2011 Jan 25 108(4) 1427-32",
                "id": "21220332"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070630"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In addition, nickel-induced activation of p38 MAPK was attenuated by a small interference of RNA specific to ASK1 (siRNA ASK1), implying that p38 MAPK was downstream of ASK1, ",
              "citation": {
                "type": "PubMed",
                "name": "Chem Res Toxicol 2010 Mar 15 23(3) 568-77",
                "id": "20112989"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407062f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "This betaPix-induced p38 activation was blocked by coexpression of dominant-negative Cdc42/Rac or kinase-inactive PAK, indicating that the effect of betaPix on p38 is exerted through the Cdc42/Rac-PAK pathway and requires PAK kinase activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jul 6 276(27) 25066-72",
                "id": "11309380"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407062c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The phosphorylation of MAPKs including ERK1/2, p38, and JNK was measured by immunoblot analysis using specific Abs. LPS-induced phosphorylation of ERK1/2, p38, and JNK was inhibited by EGCG (Fig. 4A?C). However, in 67LR-ablated cells, the inhibitory effect of EGCG on LPSinduced upregulation of phosphorylation was attenuated (Fig. 4A?C).",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Jul 1 185(1) 33-45",
                "id": "20511545"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407062a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "leukemia",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Instead, GCs inhibit GATA-3 activity by inhibition of p38 mitogen-activated protein kinase induced GATA-3 phosphorylation. GCs also inhibit GATA-3 mRNA and protein expression.",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2009 May 23(5) 1558-71",
                "id": "19124555"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070629"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Rapid activation of mitogen-activated protein kinases (Erk1/2, p38, and JNK MAPK) were observed in CSE-treated NL cells.  ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Am Thorac Soc 2006 Aug 3(6) 466",
                "id": "16921106"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070609"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In addition to inducing G protein- and non-G protein-related signaling pathways, ANG II, via AT(1) receptors, carries out its functions via MAP kinases (ERK 1/2, JNK, p38MAPK), receptor tyrosine kinases [PDGF, EGFR, insulin receptor], and nonreceptor tyrosine kinases [Src, JAK/STAT, focal adhesion kinase (FAK)].",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2007 Jan 292(1) C82-97",
                "id": "16870827"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705fd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We propose that Foxo1 turns on a feed-forward loop, relayed by p38 and acting to amplify both PKB activation and Foxo1 inhibition",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2007 Feb 15",
                "id": "17303659"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705ef"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "stimulation with the PAR-2 peptide produced a rapid increase in ERK1/2 activation that did not significantly decline even after 4 h of exposure. SLIGKV also activated p38MAPK with similar levels of activation evident at both early and late time points (Fig. 4B).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Apr 28 281(17) 11792-804",
                "id": "16467309"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705e2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": " Inhibition of the p38 mitogen-activated protein kinase pathway blocked the induction of p16(INK4a) and cellular senescence",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2009 May 23(5) 1358-65",
                "id": "19124561"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "erythroid progenitor",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "TNF activates NFKB transcriptional activity in macrophages and epithelial cells . TNF similarly activates p38 MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "Pharmacol Rev 2004 Dec 56(4) 515-48",
                "id": "15602009"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705d9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Interestingly, araA, an AMPK inhibitor, prevented the activation of p38 MAPK, whereas SB203580, a p38 MAPK inhibitor, did not affect AMPK activation, suggesting that p38 MAPK is a downstream signaling factor of AMPK. ",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2006 Sep 55(9) 2562-70",
                "id": "16936205"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705ca"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "positive regulatory events, such as activation of Syk, Btk, JNK, p38, Akt, and NF-kappaB, are substantially reduced in hck(-/-) mast cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2007 May 18",
                "id": "17513616"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705b2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "AGTR2 inhibition with PD diminished p38 and p42/44 phosphorylation in fibroblast isolated from bleomycin-, but not saline-treated mouse lungs (Figures 6A?6D).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2007 Dec 37(6) 640-50",
                "id": "17630322"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705a6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "In prostate DU145 cells, both FGF1 and FGF2 activated ERK1/2 potently and p38 moderately.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Aug 30 20(38) 5359-65",
                "id": "11536048"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407059c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "TAK1 is thought to activate two divergent pathways that lead to the transcription factors NF-kB and AP-1 through kinase cascades involving the canonical I?B kinase complex (IKK-a, IKK-b, and IKK-g) and MAP kinases (ERK, JNK, p38), respectively, to induce the expression of target genes.  ",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Res Ther 2005 7(1) 12-9",
                "id": "15642149"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070597"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "dendritic cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "VEGF-C/Flt-4 signaling-induced activation of p38 MAPK and upregulation of CNTN-1 were both abolished by transfection with p38AF-dominant negative form of p38 MAPK (Figure 4B)",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2006 Mar 9(3) 209-23",
                "id": "16530705"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070595"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "SB203580, a p38MAPK inhibitor, blocked the stimulatory effect of BMP7",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jan 12",
                "id": "14718543"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070587"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Stimulatory doses (0.25 nM) of BMP7 increased p38MAPK activity and stimulated phosphorylation of endogenous activating transcription factor (ATF2) in a p38MAPK-dependent manner",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jan 12",
                "id": "14718543"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070577"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "kidney epithelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "AG1478 inhibited ERK, JNK, and p38 kinase signaling pathways stimulated by cigarette smoke. ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Jun 34(6) 666-9",
                "id": "16484683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407056a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The activation of p38 MAPK activates C/EBP?, a transcription factor that has a critical role in adipogenesis . ",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2010 5(5) e10493",
                "id": "20463961"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070562"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Growth plate injury-induced p38 activation is mediated by TNF-alpha",
              "citation": {
                "type": "PubMed",
                "name": "J Bone Miner Res 2006 Jul 21(7) 1075-88",
                "id": "16813528"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070561"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "Bone and Bones"
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Figure 4.  T1/ST2 activates MAP kinases p42/44 and p38",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 20 277(51) 49205-11",
                "id": "12368275"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407055c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "The decrease in eNOS expression was signaled in large part through a p38 MAPK-dependent mechanism.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 6 277(36) 32498-504",
                "id": "12082097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070559"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "expression of MKK6b(E), a constitutive activator of p38(MAPK), significantly reduced LDL receptor promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jul 9 274(28) 19593-600",
                "id": "10391894"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070550"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "UA strikingly induced both Raf-1 and MEK1/2 activation within 2 min and that of ERK1/2 within 5 min, as compared with the nontreated cells (Fig. 2). Similarly, both MKK3/6 and p38 MAPK were activated within 2 min, whereas phosphorylation of JNK1/2 was not observed.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2007 Apr 15 178(8) 4854-64",
                "id": "17404266"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407054b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "Cadmium rapidly activates p38 and ERK1/2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 5 278(49) 49246-53",
                "id": "14504288"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407053e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Nov 8(5) 971-82",
                "id": "11741533"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407051f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(SFAM:\"MAPK p38 Family\") actsIn kin(p(SFAM:\"MAPK p38 Family\"))",
              "summary_text": "We found that 20% CSE caused significant increases in the phosphorylation of all three MAPK members (ERK1/2, p38, and JNK) within from 10 min to 1hr of exposure (Fig. 2).",
              "citation": {
                "type": "PubMed",
                "name": "J Toxicol Sci 2010 35(1) 33-9",
                "id": "20118622"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407050b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RASSF1)",
        "relation": "decreases",
        "target": "kin(p(SFAM:\"MAPK JNK Family\"))",
        "directed": false,
        "label": "p(HGNC:RASSF1) decreases kin(p(SFAM:\"MAPK JNK Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526ca",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RASSF1) decreases kin(p(SFAM:\"MAPK JNK Family\"))",
              "summary_text": "The exogenous expression of RASSF1A suppressed JNK phosphorylation, and cells stably transfected with RASSF1A showed reduced JNK and c-Jun phosphorylation and Cyclin D1 down-regulation. An in vitro kinase assay showed that the exogenous expression of RASSF1A inhibited JNK activity and that JNK activity suppression due to ectopically expressed RASSF1A was revived by RASSF1A siRNA treatment.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 May 1 65(9) 3682-90",
                "id": "15867363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:NF1)",
        "relation": "decreases",
        "target": "gtp(p(SFAM:\"RAS Family\"))",
        "directed": false,
        "label": "p(HGNC:NF1) decreases gtp(p(SFAM:\"RAS Family\"))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526cf",
          "evidences": [
            {
              "bel_statement": "p(HGNC:NF1) decreases gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "In this translational investigation, we found that Nf1 activity regulates excessive drinking and basal and ethanol-stimulated GABA release in the mouse central amygdala",
              "citation": {
                "type": "Other",
                "name": "NCBINCBI Logo\n    Skip to main content\n    Skip to navigation\n    Resources\n    How To\n    About NCBI Accesskeys\n\nSign in to NCBI\nPubMed\nUS National Library of Medicine National Institutes of Health\nSearch database\nSearch term\nClear input\n\n    Advanced\n    Help\n\nResult Filters\n\n    Abstract\n\nSend to:\nBiol Psychiatry. 2014 Aug 19. pii: S0006-3223(14)00606-4. doi: 10.1016/j.biopsych.2014.07.031. [Epub ahead of print]\nNf1 Regulates Alcohol Dependence-Associated Excessive Drinking and Gamma-Aminobutyric Acid Release in the Central Amygdala in Mice and Is Associated with Alcohol Dependence in Humans.\nRepunte-Canonigo V1, Herman MA2, Kawamura T1, Kranzler HR3, Sherva R4, Gelernter J5, Farrer LA6, Roberto M2, Paolo Sanna P7.",
                "id": ""
              },
              "metadata": {
                "created_by": "jmoranmontes",
                "id": "54e597ab89e3620158e4a412"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NF1) decreases gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "Neurofibromin expression was significantly decreased within 2 days after infection (Figure 3A). Concomitant with this decrease was an increase in ERK and AKT activity as assessed by their phosphorylation status....Ras-GTP levels were elevated 2 days after infection",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2006 Dec 10(6) 459-72",
                "id": "17157787"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c42"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NF1) decreases gtp(p(SFAM:\"RAS Family\"))",
              "summary_text": "NF1, a tumor suppressor and negative regulator of Ras",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2010 Jun 29",
                "id": "20587590"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(EGID:51776)",
        "relation": "actsIn",
        "target": "kin(p(EGID:51776))",
        "directed": false,
        "label": "p(EGID:51776) actsIn kin(p(EGID:51776))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526f9",
          "evidences": [
            {
              "bel_statement": "p(EGID:51776) actsIn kin(p(EGID:51776))",
              "summary_text": "By a previous study, we investigated the involvement of a MAP3K, ZAK, which in cultured H9c2 cardiac cells is a positive mediator of cell hypertrophy",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Nov 5 324(1) 424-31",
                "id": "15465036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708a0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(EGID:51776) actsIn kin(p(EGID:51776))",
              "summary_text": "Moreover, the level of cyclin E in ZAK-expressed cells decreased further at a faster rate than the control cells. Conversely, T-ZAK-expressed cells exhibited a higher level of sustained cyclin E.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2002 Sep 13 297(1) 105-10",
                "id": "12220515"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070510"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RAF1)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:RAF1))",
        "directed": false,
        "label": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3518d3fbfd4c340526eb",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 20 277(38) 34679-91",
                "id": "12105209"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407051c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "PMID 10620507 We found previously that protein kinase C-z (PKC-z) can phosphorylate and activate Raf-1 in a signalling complex. We report now that PKCz-Raf-1 interaction is mediated by 14-3-3 proteins in ?itro and in ?i?o. the results suggest that 14-3-3 binds both PKC-z (at phospho-Ser-186) and Raf-1 ina ternary complex. Complex formation was much stronger with a kinase-inactive PKC-z mutant than with wild-type PKC-z, supporting the idea that kinase activity leads to complex dissociation 14-3-3B and Q with its putative PKCz phosphorylation sites mutated enhanced co-precipitation between PKC-z and Raf-1, suggesting that phosphorylation of 14-3-3 by PKC-z weakens the complex in in vivo",
              "citation": {
                "type": "PubMed",
                "name": "DNA Cell Biol 1999 Jul 18(7) 555-64",
                "id": "10433554"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d16"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "The three classes of PDE4 isoforms differ in these regulatory modules, allowing phosphorylation by ERK to lead to either inhibition or activation. ERK inhibition of long isoforms is regulated by a unique feedback control whereby elevated cAMP levels cause PKA (protein kinase A) to phosphorylate UCR1 and ablate the inhibitory action of ERK. PDE4 isoforms can also be found in complex with beta-arrestins where they provide a novel part of the cellular desensitization mechanism to receptor-mediated cAMP signalling. Stimulation of the beta(2)-adrenoceptor recruits beta-arrestins with bound PDE4, delivering an enzyme capable of degrading cAMP at its site of synthesis at the plasma membrane a major role of recruited PDE4 is to regulate plasma membrane PKA activity involved in phosphorylating the beta(2)-adrenoceptor. Recruited PDE4 thus desensitizes the ability of the beta(2)-adrenoceptor to activate ERK via G(i) inhibition of Raf1 functioning can be achieved through its phosphorylation by PKA",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Soc Trans 2003 Dec 31(Pt 6) 1186-90",
                "id": "14641023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c35"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Western blot analysis was performed on protein extracts isolated from HPECs overexpressing Cdc37 or the vector only (Fig. 1C) ?  .Raf-1 steady-state levels were unchanged. However, Raf-1 activity, measured by the abundance of phosphorylated S217/221 MEK1/2, a direct target of Raf-1 (30)  , was consistently elevated in Cdc37-overexpressing cells, whereas total MEK1/2 levels were unchanged. Increases in Cdk4 levels and markedly reduced p16 expression were also consistently observed in Cdc37-overexpressing HPECs. ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Aug 1 63(15) 4614-9",
                "id": "12907640"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c1c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bc0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Summary: Raf-1 is a MAP kinase kinase kinase (MAP3K) which functions downstream of the Ras family of membrane associated GTPases to which it binds directly. Once activated Raf-1 can phosphorylate to activate the dual specificity protein kinases MEK1 and MEK2 which in turn phosphorylate to activate the serine/threonine specific protein kinases ERK1 and ERK2. Activated ERKs are pleiotropic effectors of cell physiology and play an important role in the control of gene expression involved in the cell division cycle, apoptosis, cell differentiation and cell migration.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 22 277(47) 44996-5003",
                "id": "12244094"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070aaa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "acti-Fig. 3. PKCb in insulin signal-ing. Insulin-stimulated insulin receptor (IR) phosphorylates IRS1. IRS1 recruit various signaling molecules through SH2-phos-photyrosine interactions. IRS1-binding proteins containing an SH2 domain include Grb2, PI3K, SHP-2, and Nck. Insulin-induced ERK activation in L6 myocytes occurs largely through Raf-1 rather than Ras activation. In contrast, EGF-induced ERK acti-vation is dependent on Grb2/Sos-mediated Ras activation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biochem (Tokyo). 2002 Nov;132(5):677-82",
                "id": "12417015"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a05"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "The life history of cancer cells encompasses a series of genetic missteps in which normal cells are progressively transformed into tumor cells that invade surrounding tissues and become malignant. Most prominent among the regulators disrupted in cancer cells are two tumor suppressors, the retinoblastoma protein (RB) and the p53 transcription factor. Here, we discuss interconnecting signaling pathways controlled by RB and p53, attempting to explain their potentially universal involvement in the etiology of cancer. Pinpointing the various ways by which the functions of RB and p53 are subverted in individual tumors should provide a rational basis for developing more refined tumor-specific therapies.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2002 Aug 2(2) 103-12",
                "id": "12204530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709b5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "When serum-deprived MRC-5 lung fibroblasts were incubated in the presence of HABP the phosphorylation of intracellular proteins, many of which act as kinases in signalling pathways was observed (Fig. 1). This included the time-dependent phosphorylation of the MAP kinase ERK1/2 (extracellular signal-related kinase), the MAPK kinase MEK1/2 and c-Raf, a kinase that phosphorylates and thus activates MEK1/2. A transient activation of the p90RSK was detectable as well (Fig. 1A).",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2005 Dec 17(12) 1486-94",
                "id": "16153533"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070915"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "In Swiss 3T3 and REF52 fibroblasts, activated MEKK induces cell death involving cytoplasmic shrinkage, nuclear condensation, and DNA fragmentation characteristic of apoptosis. Expression of activated MEKK enhanced the apoptotic response to ultraviolet irradiation, indicating that MEKK-regulated pathways sensitize cells to apoptotic stimuli. Inducible expression of activated MEKK stimulated the transactivation of c-Myc and Elk-1. Activated Raf, the serine-threonine protein kinase that activates the ERK members of the MAPK family, stimulated Elk-1 transactivation but not c-Myc",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Feb 9 271(6) 3229-37",
                "id": "8621725"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070883"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Figure 8. Model for the role of HBP1/p16INK4A  in Ras-induced premature senescence. The results of this article are summarized in this schematic diagram. Activated Ras in primary cells initiates a premature senescence program that is orchestrated by MEK/MKK3/6-p38 MAPK/HBP1/p16INK4A pathway activation. Our study data indicate that p16INK4A is a novel target of the transcription factor HBP1. HBP1 is involved in Ras-induced premature senescence by mediating p16INK4A expression. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2010 Sep 9 29(36) 5083-94",
                "id": "20581871"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407078c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Activated Ras has the ability to interact with the serine/threonine kinase Raf-1, leading to its activation. The targets for Raf- 1 kinase activity are the dual-specificity kinases Mek1 and Mek2 [63], which are activated by phosphorylation. The serine/threonine kinases Erk1 and Erk2 are activated through phosphorylation by Mek1/2 [64]. Activated Erks dimerize and are translocated to the nucleus [65], where transcription factors are phosphorylated whereby their activities are regulated, influencing gene transcription",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2004 Oct 61(19-20) 2535-48",
                "id": "15526160"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407076c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Despite remarkable progress in dissecting the signaling pathways that are crucial for the metabolic effects of insulin, the molecular basis for the specificity of its cellular actions is not fully understood. One clue might lie in the spatial and temporal aspects of signaling. Recent evidence suggests that signaling molecules and pathways are localized to discrete compartments in cells by specific protein interactions. Also, the rapid termination of tyrosine or lipid phosphorylation by phosphatases or serine kinases might tightly control the strength of a signaling pathway, thus determining its effect on growth, differentiation and metabolism. Insulin is the most potent anabolic hormone known, promoting the synthesis and storage of carbohydrates, lipids and proteins and inhibiting their degradation and release back into the circulation. Decreased secretion of insulin, coupled with resistance to its actions, results in type 2 diabetes, a devastating disease that is reaching epidemic proportions [1]. Even in the absence of diabetes, insulin resistance is often associated with central obesity, hypertension, polycystic ovarian syndrome, dyslipidemia and atherosclerosis. At the cellular level, insulin action is characterized by diverse effects, including changes in vesicle trafficking, stimulation of protein kinases and phosphatases, promotion of cellular growth and differentiation and activation or repression of transcription. This complexity suggests that insulin action must involve multiple signaling pathways that diverge at or near the activation of its tyrosine kinase receptor. In fact, it is likely that even individual effects of the hormone require multiple signaling inputs. Evidence is emerging that the coordination of these pathways might be governed by their intracellular compartmentalization or duration of action. Here, we consider how temporal and spatial aspects of signal transduction play a crucial role in determining the specificity of insulin action, focusing on signal initiation from the receptor that is spatially segregated into discrete domains of the plasma membrane, as well as the mechanisms that determine the duration of individual signaling pathways. Together, these factors help to differentiate insulin from other hormones that share some of the same overall signaling properties. Divergent signaling pathways are initiated by insulin receptor substrates. The insulin receptor is a tyrosine kinase that catalyzes the phosphorylation of several intracellular substrates, including the insulin receptor substrate (IRS) proteins [2], GAB-1 [3], Shc [4], APS [5], p60DOK [6], SIRPS [7] and c-Cbl [8] (Fig. 1). Each of these substrates recruits a distinct subset of signaling proteins containing Src homology 2 (SH2) domains, which interact specifically with sequences surrounding the phosphotyrosine residue. Moreover, each of these substrates can be confined to distinct locations in the cell by specific sequences that direct interactions with other proteins or lipids. Most attention in the field of insulin receptor substrates has focused on the IRS family of proteins. Mice lacking the IRS-1 protein are insulin resistant but do not develop overt diabetes [9,10]. By contrast, animals lacking IRS-2 exhibit both impaired glucose tolerance and diabetes [11], which appears to result from a defect in insulin secretion as well as insulin resistance, presumably owing to decreased b-cell proliferation in the pancreas in the face of increased demand for insulin. Despite the similarity in structure and function, the apparent differences in phenotype between IRS1 and IRS2 knockout mice underscore a specific signaling specificity that probably results from their tissue distribution, subcellular location, activation&ndash;inactivation kinetics and combinatorial interactions with downstream effectors [12]. The tyrosine phosphorylation of IRS family members generates docking sites for sev...",
              "citation": {
                "type": "PubMed",
                "name": "Trends Cell Biol 2002 Feb 12(2) 65-71",
                "id": "11849969"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070746"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Mitogen-activated protein (MAP) kinases comprise a family of ubiquitous proline-directed, protein-serine/threonine kinases, which participate in signal transduction pathways that control intracellular events including acute responses to hormones and major developmental changes in organisms. MAP kinases lie in protein kinase cascades. This review discusses the regulation and functions of mammalian MAP kinases. Nonenzymatic mechanisms that impact MAP kinase functions and findings from gene disruption studies are highlighted. Particular emphasis is on ERK1/2.",
              "citation": {
                "type": "PubMed",
                "name": "Endocr Rev 2001 Apr 22(2) 153-83",
                "id": "11294822"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706a8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Protein kinase C (PKC) regulates activation of the Raf-1 signaling cascade by growth factors, but the mechanism by which this occurs has not been elucidated. Here we report that one mechanism involves dissociation of Raf kinase inhibitory protein (RKIP) from Raf-1. Classic and atypical but not novel PKC isoforms phosphorylate RKIP at serine 153 (Ser-153). RKIP Ser-153 phosphorylation by PKC either in vitro or in response to 12-O-tetradecanoylphorbol-13-acetate or epidermal growth factor causes release of RKIP from Raf-1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 11 278(15) 13061-8",
                "id": "12551925"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070644"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "The ERF protein is also hyperphosphorylated in cells transformed by the activated Ha-ras and v-src genes and the transcription repressor activity of ERF is decreased after co-transfection with activated Ha-ras or the kinase domain of the c-Raf-1 gene, indicating that ERF activity is probably regulated by the ras/MAPK pathway.......These data suggest that the repression ability of ERF may be regulated, at least partially, by phosphorylation of Thr526 (Substitution of Thr526 for glutamic acid also decreases the repression ability of ERF).",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1995 Oct 2 14(19) 4781-93",
                "id": "7588608"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "We chose to analyze pancreatic cancer cells since this tumor type displays the highest frequency of somatic mutations of RAS genes of all human malignancies (5, 22). Hs766T cells express activated KRAS and display elevated levels of pERK1/2 and pAKT (Fig. 4C). Treatment of Hs766T cells with the PI3'-kinase inhibitor LY294002 led to a selective decrease in pAKT with little or no effect on pERK1/2. By contrast, treatment of the cells with the MEK inhibitor U0126 or CI-1040 led to a selective decrease in pERK1/2 with little or no effect on pAKT. Strikingly, both the PI3'-kinase and the MEK inhibitors led to accumulation of p27Kip1 expression. These data are consistent with the observation that both MEK and PI3'-kinase inhibitors elicited a G0/G1 cell cycle arrest in Hs766T cells (data not shown). Further consistent with these observations, treatment of a panel of pancreatic cancer cells (eight cell lines) (57) with a MEK inhibitor (U0126 or CI-1040) led to a consistent G0/G1 cell cycle arrest accompanied by induced expression of p27Kip1 in all eight cell lines tested (S. Gysin and M. McMahon, sub- mitted for publication). For the most part, treatment of cells with MEK inhibitors led to a cytostatic rather than a cytotoxic effect, although cell death was often observed after prolonged treatment (+6 days). Treatment of pancreatic cancer cells with LY294002 led in some cases to a cytostatic effect and in others to a more rapid cytotoxic effect. Consistent with the observations in Fig. 4C, inhibition of PI3'-kinase by LY294002 led to elevated p27Kip1 expression in five of eight pancreas cancer cell lines tested. These data are fully consistent with the hypothesis that the RAS-activated RAF-MEK-ERK and PI3'-kinase- PDK-AKT pathways play a role in the regulation of p27Kip1 expression in bona fide human cancer cell lines.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Dec 24(24) 10868-81",
                "id": "15572689"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "However, it is p27 that seems to be the primary target of SKP2, given that Skp2 ko mice show a marked accumulation of p27 (REF. 24), and that prominent cellular phenotypes apparent in Skp2 00 mice (see Supplementary information S1 (table)) including nuclear enlargement, polyploidy and an increased number of centrosomes that are probably caused by overreplication of chromosomes and centrosomes disappear in Skp2 ko p27 ko double mutant mice. The oncogenic potential of SKP2 has also been shown in transgenic mouse models 35,36. Furthermore, Ras signalling induces SKP2 expression through the binding of GA-binding protein, an Ets-family transcription factor, to the SKP2 promoter37. Such evidence supports the notion that SKP2 is a growth promoter and an oncoprotein.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2006 May 6(5) 369-81",
                "id": "16633365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070582"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407057c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Another major signaling pathway is the Ras/MAP kinase cascade [33] (fig. 1). The activated Kit recruits SH-2-containing proteins such as Grb2, Shc and SHP2. Grb2 may bind Kit either directly or indirectly through interaction with Shc or SHP2. Since Grb2 is constitutively associated with Sos, a guanine nucleotide exchange factor, the recruitment of Grb2 to the activated Kit resultes in the colocalization of Sos and Ras and the subsequent activation of Ras. This promotes the interaction of Ras with Raf serinethreonine kinase and then the activation of MEK (a MAP kinase kinase). MEK phosphorylates ERK (a MAP kinase), and ERK phosphorylates a number of substrates, including pp90rsk [33]. Imatinib mesylate also inhibits the phosphorylation of ERK [34]. This process is considered to be due to blocking of the Kit signaling by this drug. Thus, both major signaling pathways of Kit, the PI3K/Akt system and the Ras/MAP kinase cascade, are inhibited by imatinib mesylate.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2004 Dec 61(23) 2924-31",
                "id": "15583854"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070544"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "<E22> Raf1 can bind pRb and p130, which are not thereby dissociated from E2F complexes, although promoter inhibition is reversed (Wang et al., 1998). There was no detectable binding to p107. Binding to pRb is mediated by the Nterminal 28 amino acids of Raf1. The kinase activity of Raf1 was required to reverse the pRb-mediated promoter repression (Wang et al., 1998), but the phosphorylation sites on pRb remain to be described and therefore are not indicated in the diagram.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d98"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "NIH3T3 cells expressing either Raf :ER-DD or Raf : ER-YY synthesized RALT upon stimulation with Tamoxifen for 4  8 h in serum-deprived medium (Figure 4b). The effect of tamoxifen was as strong as serum stimulation and was reverted by the administra- tion of U0126 (Figure 4b)",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Sep 19 21(42) 6530-9",
                "id": "12226756"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c8b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "1) STAT proteins play an essential role in angiotensin II-induced vascular smooth muscle cell proliferation, 2) JAK2 plays an essential role in the tyrosine phosphorylation of Raf-1, and 3) convergent mitogenic signaling cascades involving the cytosolic kinases JAK2, MEK1, and ERK1 mediate vascular smooth muscle cell proliferation ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Sep 26 272(39) 24684-90",
                "id": "9305939"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b5e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "When extracts of non-transgenic control and tumor lung tissue were compared, several proteins were found to be differentially expressed. There was a preponderance of proteins being repressed in tumor proteomes, whereas only a few proteins appeared to be enriched and overexpressed. Figure 6 depicts examples of differentially expressed proteins from control and tumor-bearing mice and prominent examples are discussed below:",
              "citation": {
                "type": "PubMed",
                "name": "Proteomics 2006 May 6(10) 3127-37",
                "id": "16688788"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ab9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "One gene whose expression was lower in the metastatic cell line than in the non-metastatic cell line was Raf kinase inhibitor protein (RKIP), which encodes a protein that inhibits Raf-1 (a serine/threonine kinase)-mediated phosphorylation and thereby activation of MEK-1 (a mitogen-activated protein [MAP] kinase kinase, which specifically phosphorylates the regulatory threonine and tyrosine residues present in MAP kinases) by Raf",
              "citation": {
                "type": "PubMed",
                "name": "J Natl Cancer Inst 2003 Jun 18 95(12) 878-89",
                "id": "12813171"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407086f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) differentially activate Raf, resulting in protection from distinct pathways of apoptosis in human endothelial cells",
              "citation": {
                "type": "PubMed",
                "name": "Science 2003 Jul 4 301(5629) 94-6",
                "id": "12843393"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407084a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": "Endothelium"
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "hSpry2 did not cause any detectable inhibition of ERK2 phosphorylation when the constitutively active mutants of Raf (RafY340D) or Mek (MekS222D/S226D), respectively, were employed to activate the pathway (Fig. 4, C and D). The above data indicate that hSpry2 is exerting its inhibitory effect at the level of activation of Raf.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Feb 1 277(5) 3195-201",
                "id": "11698404"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070648"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "bFGF activated Raf-1 via p21-activated protein kinase-1 (PAK-1) phosphorylation of serines 338 and 339, resulting in Raf-1 mitochondrial translocation and endothelial cell protection from the intrinsic pathway of apoptosis, independent of the mitogen-activated protein kinase kinase-1 (MEK1)",
              "citation": {
                "type": "PubMed",
                "name": "Science 2003 Jul 4 301(5629) 94-6",
                "id": "12843393"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070580"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "activation of ERK depended on EGFR, Src tyrosine kinase and calcium calmodulin in PC12 cells (31), while requiring ras/Raf-1/MEK activation in human neutrophils (58).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407056e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Focus formation was consistently observed with both mutants. However, C-RAF mutant proteins caused the formation of much smaller cell aggregates (Fig. 5A) as compared with v-Raf.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Apr 1 66(7) 3401-8",
                "id": "16585161"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070da9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "We show that wild-type B-RAF forms a complex with C-RAF in a RAS-dependent manner, whereas the mutants bind independently of RAS. Importantly, we show that wild-type B-RAF can also activate C-RAF.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2005 Dec 22 20(6) 963-9",
                "id": "16364920"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070da4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "GnRH-induced phosphorylation of MAPK/ERK kinase 1 and c-Raf kinase was blocked by Cam inhibition",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2005 Sep 19(9) 2412-23",
                "id": "15890671"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d78"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "PAK1 and PAK5 significantly stimulated Raf-1 kinase activity",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2008 Sep 1 105(1) 167-75",
                "id": "18465753"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d71"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 30 276(48) 45372-9",
                "id": "11571288"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d6b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Evidence supporting a role for Raf-1 and p90 RSK in responses to GIP in the ?-cell (INS-1 clone 832/13) is shown in Fig. 4  B, under 0 mm glucose conditions.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 4 277(40) 37088-97",
                "id": "12138104"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d62"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Raf activation in SCLC caused reduction of hASH1.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Apr 1 61(7) 3200-5",
                "id": "11306509"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d3c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Sep 1 275(35) 27481-7",
                "id": "10867013"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d34"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Oct 19(10) 7203-15",
                "id": "10490655"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d2f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "The sentence from ResnetDB These data suggest that Src, Raf, and H-Ras oncoproteins stimulate elevated ARF6 expression is translated to the assertions Activation of ARF6 (Homo sapiens) Gene Expression by Oncogene Activation of ARF6 (Homo sapiens) Gene Expression by RAF1 (Homo sapiens) Protein",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Jan 23(2) 645-54",
                "id": "12509462"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d18"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes 2003 May 52(5) 1073-80",
                "id": "12716735"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d14"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1994 Apr 29 269(17) 12741-8",
                "id": "8175686"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d10"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1993 Jun 15 90(12) 5544-8",
                "id": "7685905"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d05"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Dec 1 163(11) 5796-805",
                "id": "10570262"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070d03"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Nov 26 286(5445) 1741-4",
                "id": "10576742"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1994 Nov 15 153(10) 4436-47",
                "id": "7963520"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ce6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "the BAG-1 COOH terminus is also required for interaction and activation of Raf-1 (26), a serine-threonine kinase involved in cell survival and proliferation that provides an alternate potential mechanism by which BAG-1 might promote cell survival",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Jul 15 63(14) 4150-7",
                "id": "12874020"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cd1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 31 278(5) 3251-6",
                "id": "12435725"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cc3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "he independent signaling competence of Tnfr1 and Tnfr2 was further confirmed in the studies of various kinases of the Erk/Mapk signal transduction cascade; Erk1, Erk2, Raf-1, Raf-B, Mek-1, Mekk, and p90rsk all were found to be activated independently by Tnfr1 as well as Tnfr2. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Nov 8 271(45) 28097-104",
                "id": "8910423"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cae"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "cyclic stretch causes AEC DNA damage and that FGF-10 attenuates these effects by mechanisms involving MAPK activation via the Grb2-SOS/Ras/RAF-1/ERK1/2 pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2003 Feb 284(2) L350-9",
                "id": "12533312"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070cab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Furthermore, constitutively active Rac2, Cdc42hs, and RhoA synergize with an activated form of Raf to increase ERK2 activity",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Jul 16(7) 3707-13",
                "id": "8668187"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c8c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 23 277(34) 31099-106",
                "id": "12048182"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c89"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 5 274(45) 32333-41",
                "id": "10542274"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c7e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Oct 13 270(41) 24435-41",
                "id": "7592658"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c7c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "title := \\\"Raf-1 activation disrupts its binding to keratins during cell stress.\\\" Raf activation during oxidative and toxin exposure in cultured cells and animals disrupt keratin-Raf association in a phosphorylation-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2004 Aug 16 166(4) 479-85",
                "id": "15314064"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c79"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Raf-1 phosphorylates and activates MEK-1, a kinase that activates the extracellular signal regulated kinases (ERK)",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1999 Sep 9 401(6749) 173-7",
                "id": "10490027"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c73"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "which are involved in cytokine signaling.86 Other Rasindependent activators of Raf include interferon beta, protein kinase C (PKC) alpha, antiapoptotic proteins (eg, Bcl-2), scaffolding proteins (eg, ceramide-activated protein kinase), ultraviolet light, ionizing radiation, retinoids, erythropoietin, and dimerization between Raf isoforms86-94 (Fig 3).",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Oncol 2005 Sep 20 23(27) 6771-90",
                "id": "16170185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c71"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jan 24(1) 25-35",
                "id": "14673140"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c6d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 9 278(19) 16667-74",
                "id": "12609989"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c66"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "LPS has also been shown to induce TNF-a biosynthesis through an additional Ras/Raf1/MEK1/ERK-2 pathway [137]. LPS-induced derepression of TNF-a translation is found to be mediated through the activation of the MEK-4 (mitogen-activated protein kinase kinase 4)/MAPK10 pathway in RAW-264.7 macrophages [138]. LPS-induced signaling pathways leading to TNF-a biosynthesis are depicted in Figure 7.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Lung Res 2009 Aug 35(6) 439-85",
                "id": "19842832"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c65"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Jul 20(13) 4494-504",
                "id": "10848576"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c62"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Figure 1 | The ErbB signalling network.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2001 Feb 2(2) 127-37",
                "id": "11252954"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c57"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "disruption of the KSR1/CK2 interaction or inhibition of CK2 activity significantly reduces the growth-factor-induced phosphorylation of C-Raf and B-Raf on the activating serine site in the negative-charge regulatory region (N-region).",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 2007 Jan 23 17(2) 179-84",
                "id": "17174095"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c40"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "A molecular analysis of the induced tumors shows that the K12V mutant protein interacts with Raf-1 and transduces signals mainly through the Erk pathway. ",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2006 Nov 27(11) 2190-200",
                "id": "16679305"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c3d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Both PKC and Pak3 have been implicated to phosphorylate and activate Raf",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Apr 15 14(8) 895-900",
                "id": "10783161"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c10"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "the phosphorylation of Raf-1 on Ser-259 induced by paclitaxel he region surrounding Ser-259 in Raf-1 conforms to a consensus sequence for phosphorylation by Akt",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 6 277(36) 33490-500",
                "id": "12087097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c0a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Dominant-negative STAT3 could block the induction, indicating that Raf can induce IFI16 only via the cell-extrinsic pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Feb 11 280(6) 4913-20",
                "id": "15572361"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070c01"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "A concentration of 10(-9) M EGF induced stimulation of c-Raf-1 kinase activity, whereas 10(-12) M EGF not only failed to activate c-Raf-1, but led to a moderate decrease in its kinase activity.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 1998 May 139(5) 2382-91",
                "id": "9564849"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bfc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1994 Dec 2 269(48) 30580-6",
                "id": "7982977"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bf5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Apr 2 279(14) 14287-93",
                "id": "14742435"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bf0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Here we report that in fibroblasts, activated H-Ras and Raf-1 oncogenes decrease biosynthesis, association with beta1 integrins, and surface expression of tTG because of down-regulation of tTG mRNA.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 12 278(37) 35609-19",
                "id": "12832399"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bdf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 1 276(22) 19102-10",
                "id": "11262401"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bd4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Co-transfection of the MAO B promoter with dominant negative forms of Ras, Raf-1, MEKK1, MEK1, MEK3, MEK7, ERK2, JNK1, and p38/RK inhibit the PMA-dependent activation of the MAO B promoter",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jun 21 277(25) 22222-30",
                "id": "11956220"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bd0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Mar 5 274(10) 6553-8",
                "id": "10037749"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bcf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Aug 23(16) 5516-25",
                "id": "12897127"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Expression of activated MEK completely blocked apoptosis induced by serum withdrawal (Fig. 5). In addition, the expression of active Ras and Raf-1, which also activate MEK, similarly inhibited cell death induced by growth factor deprivation",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Aug 19(8) 5308-15",
                "id": "10409722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bb6"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "H2O2-dependent stimulation of HDC promoter activity was completely inhibited by kinase-deficient ERKs, dominant-negative (N17 and N15) Ras, and dominant-negative Raf, and partially blocked by a dominant-negative EGFR mutant.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Sep 4 273(36) 23046-54",
                "id": "9722530"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bb4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "To address a possible role of mutant C-RAF proteins in the constitutive phosphorylation of ERK1/2, kinase assays were done with Myc-tagged C-RAF proteins immunoprecipitated from transiently transfected Cos-7 cells. Strong constitutive kinase activity was shown for S427GC-RAF whereas I448VC-RAF did not significantly differ from wt C-RAF (Fig. 3A).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Apr 1 66(7) 3401-8",
                "id": "16585161"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070bac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 May 7 274(19) 13718-27",
                "id": "10224146"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b9a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Exposure of SCLC or PNECs to NNK or nicotine increased expression of the a7nAChR and caused influx of Ca2+, activation of PKC, Raf-1, ERK1/2, and c-myc, resulting in the stimulation of cell proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 659(3) 221-31",
                "id": "18495523"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b8d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 1999 Mar 140(3) 1385-91",
                "id": "10067866"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b7b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "This zinc-induced protein kinase A activation inhibited Raf-1 activity by phosphorylation at serine 259, preventing activation of Raf-1 by phosphorylation of serine 338. ",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2007 Sep 15 179(6) 4180-6",
                "id": "17785857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b6c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "On the other hand, prostate cancer cells LNCaP or normal prostatic epithelial cells that were resistant to apoptosis by Par-4 did not show Fas or FasL trafficking. Par-4 is down-regulated by oncogenic-Ras, -Raf, or -Src.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Oct 1 61(19) 7255-63",
                "id": "11585763"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b63"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Jan 23 273(4) 1917-22",
                "id": "9442025"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b56"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "human endostatin binding to alpha 5 beta 1 integrin leads to the inhibition of focal adhesion kinase/c-Raf/MEK1/2/p38/ERK1 mitogen-activated protein kinase pathway",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Apr 15 100(8) 4766-71",
                "id": "12682293"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b49"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Transcription from several promoters, including the oncogene-responsive element in the polyomavirus enhancer, the c-fos promoter, as well as other AP-1- and Ets-dependent promoters, can be induced by Raf-1 kinase.",
              "citation": {
                "type": "PubMed",
                "name": "J Virol 1996 Apr 70(4) 2260-8",
                "id": "8642652"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b35"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Raf-1 activity, measured by the abundance of phosphorylated S217/221 MEK1 2, a direct target of Raf-1 (30) , was consistently elevated in Cdc37 overexpressing cells, whereas total MEK1 2 levels were unchanged.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Aug 1 63(15) 4614-9",
                "id": "12907640"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b2d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "We have previously shown that de novo-synthesized ceramide signals apoptosis in primary astrocytes via activation of the Raf-1/ERK cascade [8]. The eect of AICAR on the activity of these two kinases was therefore determined. The palmitate- induced activation of ERK (Fig. 3A) and Raf-1 (Fig. 3B) was prevented by AICAR.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2001 Feb 2 489(2-3) 149-53",
                "id": "11165240"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b25"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "astrocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2000 Feb 21 148(4) 791-800",
                "id": "10684259"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b17"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "expression of constitutively active Akt inhibited Raf-1 activity, suggesting that Akt negatively regulates Raf-1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 6 277(36) 33490-500",
                "id": "12087097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b16"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2003 Jan 10 103(2) 161-8",
                "id": "12455029"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070b09"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 18 276(20) 17420-8",
                "id": "11279018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070af3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "calcimycin, a calcium mobilizer, activates the RAF/MEK/ERK pathway through RAS,",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2005 Sep 16(9) 4437-53",
                "id": "16000378"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070aee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Thus, Raf-1 may promote cell survival through its protein-protein interactions in addition to its established MEK kinase function",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Jul 3 98(14) 7783-8",
                "id": "11427728"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ae1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "RIP2 in turn is activated through its interaction with Ras-activated Raf1.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 19 274(47) 33684-90",
                "id": "10559258"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ad1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Further, the expression of the catalytically inactive mutants of Ha-Ras, RhoA, c-Raf, and Erk2 or addition of the Mek1-specific inhibitor PD 098059 abrogated the stimulation of the urokinase promoter by HGF/SF.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jun 4 274(23) 16377-86",
                "id": "10347197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ac5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) differentially activate Raf, resulting in protection from distinct pathways of apoptosis in human endothelial cells",
              "citation": {
                "type": "PubMed",
                "name": "Science 2003 Jul 4 301(5629) 94-6",
                "id": "12843393"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ab7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Oct 15 274(42) 30154-62",
                "id": "10514505"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070ab0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Our results clearly demonstrate the importance of Raf kinase in the production of IFN-gamma from Th1 cells, but also show the lack of effect of this intracellular mediator on cytokine (IL-5, IL-4) release from Th2 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Int Arch Allergy Immunol 113(1-3) 275-8",
                "id": "9130547"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a92"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Th1 cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Nov 18 18(48) 6635-40",
                "id": "10597268"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a8f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "IGF1 binding activates the IGF1 receptor (IGFR), a receptor tyrosine kinase. The IGFR subsequently recruits the insulin receptor substrate (IRS1), which results in the activation of two signaling pathways: the RasRaf MEK ERK pathway  and the PI3K Akt pathway",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2003 Aug 9(8) 344-50",
                "id": "12928036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a83"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Jun 1 60(11) 3031-8",
                "id": "10850453"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a73"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Inhibiting Raf-1 in beta-cells led to a striking loss of Bad phosphorylation at serine 112 and an increase in the protein levels of both Bad and Bax.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Jan 25 283(4) 2407-17",
                "id": "18006502"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a6f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "pancreatic beta cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Aug 25 275(34) 26615-24",
                "id": "10851231"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a6c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1998 Sep 18(9) 5148-56",
                "id": "9710599"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a5e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 1995 Jun 95(6) 2822-30",
                "id": "7769122"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a59"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Dominant negative forms of Ras and Raf abolished the activation of VEGF promoter by acidic pH.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem. 2002 Mar 29;277(13):11368-74",
                "id": "11741977"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a55"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "B-Raf kinase interacts with and is inhibited by Rheb activation of Rheb is associated with decreased B-Raf and C-Raf phosphorylation at residues Ser-446 and Ser-338, respectively, concomitant with a decrease in the activities of both kinases and decreased heterodimerization of B-Raf and C-Raf.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Sep 1 281(35) 25447-56",
                "id": "16803888"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a54"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Epo has also been shown to stimulate activation of Ras and Raf-1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1994 Nov 25 269(47) 29962-9",
                "id": "7961995"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a39"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Hsp90alpha  and Hsp90beta  are found in the cytosol, where they are required for the stability and functional maturation of certain signaling proteins such as steroid receptors, the Raf serine kinases, cyclin-dependent kinase 4 (cdk4),",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 18 277(42) 39858-66",
                "id": "12176997"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a37"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Upon phosphorylation by Pak1, Raf-1 translocates to mitochondria and phosphorylates BAD at Ser-112",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jul 1 280(26) 24698-705",
                "id": "15849194"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a22"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Leukemia 2000 Nov 14(11) 1921-38",
                "id": "11069028"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a19"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "These results indicate that the strength of interaction with Ras and Rap1A at its CRD may be a critical determinant of regulation of the Raf kinase activity by the Ras family small GTPases. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Sep 19(9) 6057-64",
                "id": "10454553"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070a06"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 9 277(32) 28742-8",
                "id": "12042315"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709de"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Apr 1 16(7) 1695-709",
                "id": "9130714"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Shc and FRS2 mediates recruitment of Grb2-SOS complexes leading to Ras/ERK stimulation, and of Grb2-GAB1/2 complexes leading to stimulation of the phosphatidylinositol-3-kinase (PI3K)/AKT pathway. ShcC and IRS are required to trigger PI3K/AKT activation.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2004 Dec 61(23) 2954-64",
                "id": "15583857"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709c9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Paclitaxel treatment of parental MCF-7 cells caused a marked inhibition of Raf-1 kinase activity, concomitant with its mobility shift after 18 h exposure.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Lett 2003 Apr 10 193(1) 57-64",
                "id": "12691824"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "We show that this loss is regulated at the level of gene expression and that both Raf-dependent and Raf-independent pathways are required to cause Ras down-regulation of transgelin in RIE-1 cells, whereas Raf alone is sufficient to cause its loss in NIH 3T3 fibroblasts.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Mar 22 277(12) 9790-9",
                "id": "11773051"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709af"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Plasma membrane-targeted Raf-1 did not protect from apoptosis and resulted in phosphorylation of ERK-1 and ERK-2",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1996 Nov 15 87(4) 629-38",
                "id": "8929532"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Jun 5 22(23) 3562-77",
                "id": "12789265"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340709a4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Vasc Res 41(1) 64-74",
                "id": "14730203"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407098d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Feb 21(3) 854-64",
                "id": "11154272"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407098b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "we found that exogenous Id-1 expression led to phosphorylation of Raf-1 and MEK1/2 kinases",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2004 Jun 25(6) 881-7",
                "id": "14742319"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070982"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": " We further observed that VEGF induced electric mobility shifting of the MEK kinase Raf-1, consistent with Raf-1 activation, which was abrogated by anti-VEGF antibody (data not shown). ",
              "citation": {
                "type": "PubMed",
                "name": "Blood 2001 Jul 15 98(2) 428-35",
                "id": "11435313"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070972"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Sep 20(17) 6323-33",
                "id": "10938109"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407096d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "However, apoptosis suppression by C-Raf also occurs in cells lacking expression of Bad or Bcl-2. RESULTS: Here we show that even in the absence of Bcl-2/Bcl-XL, mitochondria-targeted C-Raf inhibits cytochrome c release and caspase activation induced by growth factor withdrawal.",
              "citation": {
                "type": "PubMed",
                "name": "BMC Cell Biol 2002 Jun 12 3 14",
                "id": "12079506"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070954"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Because Raf binds tightly to the GTP-bound form of Ras but not to the GDP-bound form, such differential affinity can be used to determine the GTP-bound status of Ras. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 5 274(45) 31981-6",
                "id": "10542228"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070952"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Dec 15 61(24) 8909-16",
                "id": "11751416"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407094c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Neuroscience 1999 Jan 88(2) 405-24",
                "id": "10197763"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407094b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Raf-1 can inactivate Rb function and can reverse Rb-mediated repression of E2F1 transcription and cell proliferation efficiently",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1998 Dec 18(12) 7487-98",
                "id": "9819434"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070931"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "We show that phospholipase C gamma, phosphatidylinositol 3-kinase/p70 S6 kinase, Shc, Grb2, Raf-1, and mitogen-activated protein kinase are downstream components of the Nyk/Mer signal transduction pathways. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1995 Dec 15(12) 6582-92",
                "id": "8524223"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070930"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "In this paper, we present a comprehensive pathway map of EGFR signaling and other related pathways. The map reveals that the overall architecture of the pathway is a bow-tie (or hourglass) structure with several feedback loops.  See figure 2: The bow-tie architecture of the EGFR signaling pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Syst Biol 2005 1 2005.0010",
                "id": "16729045"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407092c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Virol 1997 Jan 71(1) 398-404",
                "id": "8985363"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070918"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "The 14-3-3 protein family has received considerable attention recently in the literature, because of the finding that beta and zeta isoforms interact with and activate Raf",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Mar 17 270(11) 5706-9",
                "id": "7890696"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070914"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Clin Exp Immunol 2002 Mar 127(3) 539-46",
                "id": "11966773"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070910"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "we reported in H9C2 cardiomyocytes that peroxynitritemediated activation of ERK, although dependent on Raf-1 and MEK, was not due to upstream activation of p21ras (63).",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2009 14 4809-14",
                "id": "19273391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407090b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "c-Raf activates MEK1 by phosphorylating at serine residues 218 and 222 (3032).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Feb 9 271(6) 3265-71",
                "id": "8621729"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070906"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "The expression of Raf-1-catalytic domain-GFP also upregulated the expression of alphav integrin and promoted cell-cell adhesion in HSG cells. These results suggest that the active form of Raf-1 may interrupt cell-cell contact inhibition by promoting alphav integrin expression, which has been implicated in cell aggregation",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2002 Jul 23(7) 1251-8",
                "id": "12117785"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Increase in the abundance of pRaf-1 was first detected at 2min and peaked at 5min after the start of glyLDL treatment (Fig. 5A).",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2010 Sep 151(9) 4455-66",
                "id": "20630999"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Jul 26 271(30) 18122-7",
                "id": "8663436"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708e3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Here we show that Raf-1 and BAG-1 specifically interact in vitro and in yeast two-hybrid assays. Raf-1 and BAG-1 can also be coimmunoprecipitated from mammalian cells and from insect cells infected with recombinant baculoviruses encoding these proteins. Furthermore, bacterially-produced BAG-1 protein can increase the kinase activity of Raf-1 in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1996 Jul 9 93(14) 7063-8",
                "id": "8692945"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708c8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Once activated, Raf-1 phosphorylates serines in the catalytic sites of MKK/MEK [345,367]. MKK1/MEK1 and MKK2/MEK2 activate members of the MAP kinase family (ERK-1/ERK-2),",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 2000 Feb 1 28(3) 463-99",
                "id": "10699758"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708bb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 1997 Jan 6 185(1) 43-53",
                "id": "8996240"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340708b2"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "BDNF induction of keratinocyte proliferation is dependent on RAF1 and MEK activation ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2004 May 286(5) C1118-29",
                "id": "15075211"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407089a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 1998 Feb 23 82(3) 337-45",
                "id": "9486662"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070894"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Evidence is provided that attenuation of Erk-1/-2 activity by estrogen occurs via GPR30-dependent stimulation of adenylyl cyclase and cAMP-dependent signaling that results in Raf-1 inactivation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2002 Jan 16(1) 70-84",
                "id": "11773440"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070877"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "We show that Cdc2 inhibits EGF-mediated ERK activation through direct interaction and phosphorylation of several ERK pathway proteins, including the guanine nucleotide exchange factor, Sos-1, and Raf-1 kinase.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jul 1 280(26) 24524-31",
                "id": "15888452"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070873"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Apr 21(8) 2659-70",
                "id": "11283246"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407085b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Fig.1",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Nov 26 306(5701) 1506-7",
                "id": "15567848"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070856"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1994 Feb 1 91(3) 873-7",
                "id": "7508123"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407084c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "HER2/Neu overexpression stimulates the ability of p300 to acetylate ER81, likely by inducing phosphorylation of p300 through the Ras--Raf--mitogen-activated protein kinase pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Sep 23(17) 6243-54",
                "id": "12917345"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070848"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Dec 20(24) 9364-75",
                "id": "11094087"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070847"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "We show that JNK- but not p38-activating pathways regulate the DSE activity. Furthermore, the JNK/SAPK signaling pathway cooperates with the Raf-MEK-ERK cascade in TPA/ionomycin-induced DSE activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Apr 24 273(17) 10112-9",
                "id": "9553058"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070846"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Activation of raf-1 in the TT-raf cells resulted in high levels of phosphorylated MEK and ERK1/2, a morphologic transdifferentiation, and a decrease in chromogranin A and calcitonin levels that are associated with a reduction in hASH1 production.",
              "citation": {
                "type": "PubMed",
                "name": "Surgery 2003 Dec 134(6) 866-71; discussion 871-3",
                "id": "14668716"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407083c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Kit and other RTKs will activate the MAP kinase signaling pathway and has been reported both to increase the transcriptional activity of Mitf as well as down-regulate Mitf protein levels.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Jul 15 14(14) 1712-28",
                "id": "10898786"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070833"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2003 May 15 170(10) 5281-94",
                "id": "12734378"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070831"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Concomitant with the onset of cell cycle arrest, we observed the induction of the cyclin-dependent kinase (CDK) inhibitors p21(Cip1) and p16(Ink4a).",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1998 Oct 1 12(19) 2997-3007",
                "id": "9765202"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407082c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "PKC alpha directly phosphorylates and activates Raf-1 both in vitro and in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1993 Jul 15 364(6434) 249-52",
                "id": "8321321"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070823"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "The Raf-1 inhibitor, GW5074, dose-dependently blocked strain-induced Erk activation and Raf-1 phosphorylation. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2005 Mar 17(3) 311-20",
                "id": "15567062"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407081d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "mesangial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "This finding provides a mechanistic explanation for the ability of YopJ to inhibit activation of MEK as Ser-222 and Ser-226 lie in the activation loop of MEK2 and normally undergo phosphorylation by an upstream kinase to be activated.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2010 Jun 25 285(26) 19927-34",
                "id": "20430892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070814"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "exercise leads to the activation of at least three MAPK signalling pathways, i.e. ERK1/2, p38 MAPK and JNK, in skeletal muscle (Zierath, 2002).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Nutr Soc 2004 May 63(2) 227-32",
                "id": "15294035"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070810"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Sep 26 272(39) 24113-6",
                "id": "9305854"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070801"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Sp1, SRE-1 binding protein, and CBP are part of the transcriptional complex resulting in induction of LDL receptor expression in response to activation of the Raf/MEK/p42/44MAPK cascade. MEK=MAP2K1,2 p42=MAPK1 44MAP=MAPK3",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2003 Mar 44(3) 584-93",
                "id": "12562867"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707e9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 30 277(35) 32258-67",
                "id": "12077147"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707e5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Apr 15 62(8) 2423-9",
                "id": "11956106"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707dd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1998 Oct 18(10) 5780-7",
                "id": "9742095"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707d2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "This Raf-1-mediated fine tuning of Rok-a signaling allows the activation of junctional myosin and the timely maturation of AJ essential for maintaining cell cohesion during sprouting angiogenesis",
              "citation": {
                "type": "PubMed",
                "name": "Dev Cell 2012 Jan 17 22(1) 158-71",
                "id": "22209329"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707cb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Nov 1 21(21) 5635-44",
                "id": "12411481"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "RKIP has been shown to disrupt the Raf-1-MEK1/2 [mitogen-activated protein kinase-ERK (extracellular signal-regulated kinase) kinase-1/2]-ERK1/2 and NF-kappaB signaling pathways, via physical interaction with Raf-1-MEK1/2 and NF-kappaB-inducing kinase or transforming growth factor beta-activated kinase-1, respectively, thereby abrogating the survival and antiapoptotic properties of these signaling pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Adv Cancer Res 2004 91 169-200",
                "id": "15327891"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1995 Nov 17 270(46) 27489-94",
                "id": "7499206"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707bb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Bag1, a co-chaperone for heat-shock protein 70 (Hsp70), coordinates signals for cell growth in response to cell stress, by downregulating the activity of Raf-1 kinase. Raf-1 and Hsp70 compete for binding to Bag1, such that Bag1 binds to and activates Raf-1, subsequently activating the downstream extracellular signal-related kinases",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2001 Mar 3(3) 276-82",
                "id": "11231577"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707b9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "c-Raf-1 kinase was identified as an intracellular target of a signal transduction cascade initiated by binding of TNF-alpha to TNFR-I.",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 1999 Jun 7 189(11) 1707-14",
                "id": "10359574"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707b3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 May 28 279(22) 23151-7",
                "id": "15047712"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340707a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "As with GAL4-Sap, phosphorylation of Myc?Sap-1a was induced by both BXB and ERK-1 and p38 MAPK in vivo. Specifically, increased labeling of phosphopeptides 2'?4', which indicates phosphorylation at Ser381 and Ser387, as well as phosphopeptide d', which indicates phosphorylation at residues 420 and 425, was observed",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1997 Apr 1 16(7) 1620-7",
                "id": "9130707"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407078e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Immunoblotting with antibodies that recognize the phosphorylated (activated) forms of MEK1/2 reveals that mSef inhibited FGF-induced MEK activation (Fig. 2  A). immunoblotting with antibodies that recognize the Ser338 phosphorylation site of activated Raf-1 reveals a reduction in FGF-induced activation of Raf-1 by mSef (Fig. 2  A). ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 18 278(16) 14087-91",
                "id": "12604616"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070788"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Studies with specific inhibitors and evaluation of protein phosphorylation indicated the involvement in PAF synthesis of two intracellular signaling pathways leading to cytosolic phospholipase A(2) activation: a phospholipase Cgamma-protein kinase C-Raf-p42/p44-mitogen-activated protein kinase (MAPK) and a MAPK kinase-3/6-dependent activation of p38 MAPK.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2003 Nov 15 171(10) 5489-97",
                "id": "14607955"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407077f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Apr 21(7) 2373-83",
                "id": "11259586"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070764"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Phosphorylation at Raf-1 S43 and S259 by PKA only weakly inhibited EGF activation of Raf-1 and ERK when cells maintained high Raf-1 S338 phosphorylation.  Raf-1 inhibition in suspension was not due to excessive negative regulation on inhibitory sites S43 and S259, as these serines were largely dephosphorylated in suspended cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Jun 25(11) 4466-75",
                "id": "15899852"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070760"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Pak3 phosphorylates Raf-1 on serine 338 in vitro and in vivo. The p21-activated protein kinases are regulated by the Rho-family GTPases Rac and Cdc42.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1998 Nov 12 396(6707) 180-3",
                "id": "9823899"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407075e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "PLD Prevents Cell Cycle Arrest and Apoptosis In addition to enhancing cell proliferation, elevated PLD expression was also shown to be able to prevent cell cycle arrest and apoptosis. High-intensity Raf signaling induces cell senescence (120, 121) or apoptosis in the absence of serum",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2003 Sep 1(11) 789-800",
                "id": "14517341"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407075d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "The cyclic AMP (cAMP)-dependent protein kinase (PKA) can inhibit Raf-1 by direct phosphorylation.  We have mapped all cAMP-induced phosphorylation sites in Raf-1, showing that serines 43, 259, and 621 are phosphorylated by PKA in vitro and induced by cAMP in vivo. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 May 22(10) 3237-46",
                "id": "11971957"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070757"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "and (iii) promotion by AKT of the removal of RAF-induced p21Cip1 from cdk2 complexes, leading to sustained cyclin E/cdk2 activity.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Dec 24(24) 10868-81",
                "id": "15572689"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070756"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Although ligation of both receptors induces Ras and Raf-1 activation,",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1999 Feb 15 162(4) 2087-94",
                "id": "9973482"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407074a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "mast cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "These data indicate that GM-CSF, but not TNF-alpha, strongly stimulates Raf-1 kinase activation, and that this activation is inhibited by wortmannin.",
              "citation": {
                "type": "PubMed",
                "name": "J Leukoc Biol 1998 Oct 64(4) 537-45",
                "id": "9766635"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407073f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Neutrophils",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "GILZ inhibited Raf-1 phosphorylation, which resulted in the suppression of both MEK/ERK-1/2 phosphorylation and AP-1-dependent transcription. We demonstrate that GILZ interacts in vitro and in vivo with endogenous Raf-1 and that Raf-1 coimmunoprecipitated with GILZ in murine thymocytes treated with DEX",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Nov 22(22) 7929-41",
                "id": "12391160"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407072f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "hKSR-2 selectively inhibited the Cot-mediated activation of MEK by  60%. In contrast, hKSR-2 up-regulated the Rafmediated MEK activation by up to 70%.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 21 278(47) 47089-97",
                "id": "12975377"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407071a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "however, phosphorylation of Raf-1 was significantly lower in Hpca(-/-) slices. These results suggest that Hpca plays an important role in the activation of Raf conducted by Ras.",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci Res 2007 Mar 85(4) 837-44",
                "id": "17279541"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070710"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "these data suggest that Raf-1 kinase acts to suppress paclitaxel-induced apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 1998 May 4(5) 1111-6",
                "id": "9607567"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070708"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Overexpression of active Ras or Raf represses PEPCK gene transcription (28)",
              "citation": {
                "type": "PubMed",
                "name": "Diabetes. 2001 May;50(5):937-46",
                "id": "11334436"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070701"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Dec 29 275(52) 41011-7",
                "id": "11018025"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706f6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Jul 19 20(32) 4354-64",
                "id": "11466616"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706d9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Activation of Raf-1 suppresses integrin activation, potentially through the activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Dec 26 278(52) 52587-97",
                "id": "14506247"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jun 15 276(24) 21039-45",
                "id": "11274196"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706d0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "We had found previously that growth factor stimulation of quiescent cells lead to the direct binding of Raf-1 kinase to Rb, leading to its inactivation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Nov 24(21) 9527-41",
                "id": "15485920"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706cf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 12 278(37) 35609-19",
                "id": "12832399"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706c9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "inhibition of CaMKII activity by specific inhibitors inhibited Erk-1/2 phosphorylation. Whereas CaMK inhibition affected neither integrin-stimulated Akt phosphorylation nor p21Ras or Mek-1 activity, it was necessary for Raf-1 activity...Active CaMKII phosphorylated Raf-1 in vitro. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 14 278(46) 45101-8",
                "id": "12954639"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706c5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 10 279(50) 52543-51",
                "id": "15465815"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706c4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Dlx3 interacts with and induces Raf1 phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Apr 15 8(8) 1185-95",
                "id": "19282665"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706b6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 1999 Jan 5(1) 119-27",
                "id": "9918209"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706b5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "This inhibitory phosphorylation on Raf reduces the activity of MAPK pathway (Zimmermann and Moelling, 1999).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Sep 18 27(41) 5527-41",
                "id": "18794886"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706a4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 14 278(7) 4778-85",
                "id": "12473665"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340706a0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Using purified wild-type and mutant c-Raf-1 proteins, we demonstrate that Thr(269) is the major c-Raf-1 site phosphorylated by KSR in vitro and that phosphorylation of this site is essential for c-Raf-1 activation by KSR.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Mar 30 276(13) 9733-41",
                "id": "11134016"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407069f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Dec 6 271(49) 31742-8",
                "id": "8940199"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070695"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "MEK1/2 is activated through phosphorylation at Ser 217/Ser 221 catalyzed by Raf.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Pathol 2003 Sep 163(3) 845-58",
                "id": "12937126"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407067d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "Alzheimers disease",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Expression of an activated form of Raf (Raf-BXB) also inhibits TTF-1 function to a similar extent, ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Apr 20(8) 2783-93",
                "id": "10733581"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407067c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "JAK1 activity may be involved in activation of Raf-1 and ERK1",
              "citation": {
                "type": "PubMed",
                "name": "Immunopharmacology 1999 May 42(1-3) 187-93",
                "id": "10408379"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407065f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "mutations affecting NF1, Raf, and Ras induce a global negative feedback response that potently suppresses Ras and/or its effectors. Moreover, these signals promote senescence by inhibiting the Ras/PI3K pathway",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2006 Dec 10(6) 459-72",
                "id": "17157787"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407063c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Hum Mol Genet 2001 Mar 15 10(6) 605-16",
                "id": "11230180"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070638"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 1997 Oct 138(10) 4301-7",
                "id": "9322943"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070605"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Overexpression of CrkL also enhanced SDF-1-induced activation of the Raf-1/MEK/Erk signaling pathway as well as that of the small GTPases Ras, Rap1, and Rac, while a dominant negative mutant of Ras or Rac suppressed CrkL-enhanced Erk activation. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2006 Dec 18(12) 2162-71",
                "id": "16781119"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2002 May 8 518(1-3) 154-8",
                "id": "11997037"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705cd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Our results demonstrated that both transient and stable ectopic Id-1 expression in prostate cancer LNCaP cells led to activation of the Raf/MEK1/2 signaling pathway",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Dec 5 21(55) 8498-505",
                "id": "12466969"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705c6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Raf itself is negatively regulated by phosphorylation at Ser259 through Akt, an important effector of phosphoinositide 3-kinase (PI3K) signaling (30, 44).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2009 Mar 1 69(5) 1748-57",
                "id": "19223555"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "94178255;15175348;7624324;8039496;15466476;8131746",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705c0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Activation of the Raf serine/threonine protein kinases is tightly regulated by multiple phosphorylation events. Phosphorylation of either tyrosine 340 or 341 in the catalytic domain of Raf-1 has been previously shown to induce the ability of the protein kinase to phosphorylate MEK.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1997 Aug 17(8) 4509-16",
                "id": "9234708"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705ac"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Recent studies have shown that PAK3 can function as a Raf kinase,  thus contributing to the activation of Raf by growth factors and other stimuli",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Sep 15 275(37) 28688-94",
                "id": "10862777"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c340705a9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Oct 15 274(42) 30273-9",
                "id": "10514521"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070591"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "We also found that apoptosis signal-regulating kinase 1 (ASK1) strongly phosphorylated ALG-2. Importantly, Raf-1 blocks the ASK1-dependent ALG-2 phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Jul 22 333(1) 51-7",
                "id": "15925322"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070579"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Pretreatment with inhibitors for MEK1/2, Raf1 and MSK1, and overexpression of a Raf1 dominant-negative mutant significantly diminished IL-17F-induced CCL20 production.",
              "citation": {
                "type": "PubMed",
                "name": "J Allergy (Cairo) 2011 2011 587204",
                "id": "22013453"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070564"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "We report that in the CML cell line K562 Ras induces p21Cip1 expression through the Raf-MEK-ERK pathway.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 14 280(2) 1112-22",
                "id": "15528212"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070563"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 27 277(39) 36624-30",
                "id": "12151397"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070560"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "The recent suggestion that Pak3 could stimulate Raf-1 activity by directly phosphorylating S338 through a Ras/phosphatidylinositol 3-kinase (Pl3-K)/-Cdc42-dependent pathway has attracted much attention. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Apr 21(7) 2423-34",
                "id": "11259591"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407055f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Whilst Raf-1 and B-Raf are somewhat redundant for the induction of  c-Fos and Egr-1, BCR-mediated NFAT activation relies mainly on B-Raf. The Raf-1/B-Raf double deficient DT40 cells show an almost complete block both in ERK activation and in the induction of the immediate early gene products c-Fos and Egr-1.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2002 Nov 1 21(21) 5611-22",
                "id": "12411479"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407054c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "14-3-3 beta isoform has been shown to bind to the product of the protooncogene cRaf-1 and to facilitate its activation by Ras.",
              "citation": {
                "type": "PubMed",
                "name": "DNA Cell Biol 1999 Aug 18(8) 653-61",
                "id": "10463061"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407053b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Bcl-2 activates NF-kappa B by a signaling mechanism that involves Raf-1/MEKK-1 mediated activation of IKK beta.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 11 277(41) 38676-82",
                "id": "12167626"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070536"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Jun 19(6) 4209-18",
                "id": "10330161"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070532"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol. 1997 May;17(5):2576-86",
                "id": "9111327"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407052f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1996 Feb 1 156(3) 1020-9",
                "id": "8557975"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c3407052b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RAF1) actsIn kin(p(HGNC:RAF1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Sep 23 18(39) 5393-402",
                "id": "10498893"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b3526d3fbfd4c34070511"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:\"Smoke, cigarette\")",
        "relation": "increases",
        "target": "kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
        "directed": false,
        "label": "a(SCHEM:\"Smoke, cigarette\") increases kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
        "metadata": {
          "casual": false,
          "createdBy": "shaman.qn",
          "edgeId": "552c197689e36208d47855ca",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:\"Smoke, cigarette\") increases kin(p(SFAM:\"MAPK Erk1/2 Family\"))",
              "summary_text": "Both in vivo\nand in vitro experiments, the expression of ERK\nwas significantly increased in smokers",
              "citation": {
                "type": "Other",
                "name": "",
                "id": "25807439"
              },
              "metadata": {
                "created_by": "shaman.qn",
                "id": "552c197689e36208d478553f"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      }
    ]
  }
}
